Session » 2015 ACR/ARHP Annual Meeting
- 9:00AM-11:00AM
-
Abstract Number: 179
3D Ultrasound Doppler Findings in Finger Tendon Sheaths of Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 178
3D Ultrasound Doppler Findings in Wrist Tendon Sheaths of Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 275
A Comparison of the Clinical Features and Natural History of Autoimmune Interstitial Lung Disease Vs. Idiopathic Pulmonary Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 396
A Comparison of the Illness Experience Reported Via the Patient Reported Outcomes Measurement Information System Between Patients with Childhood-Onset Systemic Lupus Erythematosus, Juvenile Idiopathic Arthritis, and Widespread Chronic Musculoskeletal Pain
- 9:00AM-11:00AM
-
Abstract Number: 849
A Computational Tool for Individualized Prognosis of Percent of Predicted Forced Vital Capacity Trajectories in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 294
A Decline in Pulmonary Function over One Year Predicts Outcome in Myositis-Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 314
A Double-Blind, Randomized, Controlled, Four Parallel Arm, Dose-Finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Single Intra-Articular (IA) Injections of Fasitibant in Patients with Symptomatic OA of the Knee
- 9:00AM-11:00AM
-
Abstract Number: 104
A Genome-Wide Association Study Identifies SLC8A3 As a Susceptibility Locus for ACPA-Positive Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 220
A Genome-Wide Association Study Reveals Association of the Transferrin Receptor Locus with Gout
- 9:00AM-11:00AM
-
Abstract Number: 800
A High-Throughput System for Quantification of in Vitro Neutrophil Extracellular Trap Formation with Fluorescence Immunocytochemistry
- 9:00AM-11:00AM
-
Abstract Number: 353
A Longitudinal Cohort Study of Weekly Teriparatide, Denosmab, and Bisphosphonates for Prevention of Vertebral Fractures in Glucocorticoid-Induced Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 89
A Longitudinal Genome-Wide Association Study of Anti-Tumor Necrosis Factor Response Among Japanese Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 448
A Majority of Early Rheumatoid Arthritis (ERA) Patients Reach Remission By 6 Months in Usual Rheumatology Care
- 9:00AM-11:00AM
-
Abstract Number: 835
A Meta-Analysis to Determine If the Prevalence of Scleroderma Renal Crisis Decreasing with Time
- 9:00AM-11:00AM
-
Abstract Number: 213
A Method for Counting Monosodium Urate Crystals in the Synovial Fluid of Gout Patients
- 9:00AM-11:00AM
-
Abstract Number: 251
A New Genetic Mutation in TNF Receptor Associated Periodic Syndrome (TRAPS)
- 9:00AM-11:00AM
-
Abstract Number: 108
A New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12
- 9:00AM-11:00AM
-
Abstract Number: 737
A Paper Patient-Based Flare Study in SLE
- 9:00AM-11:00AM
-
Abstract Number: 491
A Paradigm Shift in the Disease Assessment of Rheumatoid Arthritis : From Blood to Urine Testing
- 9:00AM-11:00AM
-
Abstract Number: 150
A Preliminary Consensus on Core Outcome Domains for Total Joint Replacement Clinical Trials: An Omeract-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 782
A Proposal for Assessing Systemic Lupus Erythematosus Activity By a Multimodal Instrument That Includes Clinical Variables, Physician Assessment and Modification of Treatment
- 9:00AM-11:00AM
-
Abstract Number: 609
A Reduction in Serum Uric Acid Levels May be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from a Canadian Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 885
a Retrospective Analysis of Low Dose Cyclophosphamide Therapy in Systemic Vasculitides
- 9:00AM-11:00AM
-
Abstract Number: 583
A Serological Biomarker of Active MMP3, but Total MMP3, Can Early Assess Treatment Efficacy and Differentiate Doses of Tocilizumab and an Early Change in Active MMP3, but Not Total MMP3, Is Associated with Radiographic Change at 1 Year
- 9:00AM-11:00AM
-
Abstract Number: 752
A Strong Association Between Gout and Diuretic Use Among Lupus Patients
- 9:00AM-11:00AM
-
Abstract Number: 181
A Vascular Obstacle in Ultrasound Guided Hip Joint Injection
- 9:00AM-11:00AM
-
Abstract Number: 547
Abatacept Does Not Improve Subclinical Atherosclerosis Despite Good Response in Rheumatoid Arthritis: A Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 563
Abatacept Plus Methotrexate Can Effectively and Safely Regain the Target of Remission Following Re-Treatment for Flares after Drug-Free Withdrawal in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 865
Abdominal Visceral Adipose Tissue Measured By Dual Energy X-Ray Absorptiometry (DXA) As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides
- 9:00AM-11:00AM
-
Abstract Number: 304
Abnormal Pulmonary Function Tests, Interstitial Lung Disease, and Lung Function Decline in Patients with Classic and Clinically Amyopathic Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 155
Absence of Clinical and Ultrasound Activity of Hand and Foot: Is That Possible?: Experience in an Argentinian Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 206
Activation of Non-Canonical NF-Kappa B Signalling in Dendritic Cells Induces Extrathymic Autoimmune Regulator (AIRE) Expression
- 9:00AM-11:00AM
-
Abstract Number: 195
Activation of the Pyrin Inflammasome through the RhoA Signaling Pathway in Familial Mediterranean Fever (FMF) and Hyperimmunoglobulinemia D Syndrome (HIDS)
- 9:00AM-11:00AM
-
Abstract Number: 324
Activity Limitations in Persons with Low, Medium, and High Levels of Pain Prior to Total Knee Replacement: Implications for Appropriateness and Efficacy
- 9:00AM-11:00AM
-
Abstract Number: 589
Adalimumab Concentration at 16 Weeks of Treatment Is Associated with Treatment Discontinuation within One Year
- 9:00AM-11:00AM
-
Abstract Number: 432
Additional Intensive Treatment for Rheumatoid Arthritis Patients with Positive Power Doppler Signals Reduce the Radiological Joint Damage Even after Achieving Clinical Remission -SCRUM Study-
- 9:00AM-11:00AM
-
Abstract Number: 332
Adipokine SERUM Levels in Patients with EARLY Knee Osteoarthritis with and without Metabolic Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 546
Adipokines and Insulin-like Growth Factor 1 As Predictors of Clinical and Radiographic Outcomes in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 430
Adoption of Treat to Target Management in the Context of Achievable Goals and Satisfaction in RA
- 9:00AM-11:00AM
-
Abstract Number: 246
Adult Autoinflammatory Disease Frequency and Our Diagnostic Experience in an Adult Autoinflammatory Clinic
- 9:00AM-11:00AM
-
Abstract Number: 133
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH) in a Tertiary Referral Center: A Collaborative and Systems-Based Approach to Improve Access to Care
- 9:00AM-11:00AM
-
Abstract Number: 57
Age, Gender, Racial and Comorbidity Differences Among Systemic Lupus Erythematosus Patients Hospitalized with Ischemic Stroke Compared to the General Population: A Nationwide Analysis
- 9:00AM-11:00AM
-
Abstract Number: 157
Agreement Between DAS28, ACR/EULAR, SDAI, CDAI and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care
- 9:00AM-11:00AM
-
Abstract Number: 182
Agreement Between Ultrasound and Radiography for the Detection of Rhizarthrosis
- 9:00AM-11:00AM
-
Abstract Number: 283
Altered Serum Fatty Acid Profiles in Patients with Polymyositis or Dermatomyositis Compared to Healthy Individuals and in Relation to Immunosuppressive Treatment
- 9:00AM-11:00AM
-
Abstract Number: 13
Altered Soluble Mediators, Autoantibodies, and Lupus-Specific Connective Tissue Disease Questionnaire Scores Distinguish Blood Relatives with Incomplete Lupus from Unaffected Relatives and Relatives with Classified SLE
- 9:00AM-11:00AM
-
Abstract Number: 123
An Economic Evaluation of Tofacitinib (Xeljanz) Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the US
- 9:00AM-11:00AM
-
Abstract Number: 148
An Evaluation of the Virtual Monitoring Clinic, a Novel Nurse-Led Telemonitoring Service for Monitoring Patients with Stable Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 599
An Examination of Dose Escalation Among Remicade (infliximab) Users in a US RA Registry
- 9:00AM-11:00AM
-
Abstract Number: 93
An HLA-C Amino Acid Variant in Addition to HLA-B*27 Confers Risk for Ankylosing Spondylitis in the Korean Population
- 9:00AM-11:00AM
-
Abstract Number: 790
An Intervention to Improve Quality of Life for African-American Lupus Patients
- 9:00AM-11:00AM
-
Abstract Number: 261
Anakinra Treatment in Patients with Familial Mediterranean Fever: A Single-Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 33
Analysis of Incidence Rates of Pulmonary Embolism in the Rheumatoid Arthritis Population Compared with the Non-Rheumatoid Arthritis Population
- 9:00AM-11:00AM
-
Abstract Number: 105
Analysis of the Association of PTGER4 Gene Variants with Radiological Joint Damage in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 881
ANCA Associated Vasculitis with Hypocomplementemia Has More Diffuse Alveolar Hemorrhage and a Poor Prognosis
- 9:00AM-11:00AM
-
Abstract Number: 861
ANCA-Associated Pauci-Immune Glomerulonephritis: ¿Always Pauci-Immune?
- 9:00AM-11:00AM
-
Abstract Number: 282
Angiogenesis in Fasciitis Associated with Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 73
Anti -N-Methyl-D-Aspartate Receptor Antibody Is Associated with Fibromyalgia in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 405
Anti-C1q Antibodies As Potential Diagnostic and Prognostic Biomarkers in Juvenile Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 786
Anti-Carbamylated Protein Antibodies Identify Systemic Lupus Erythematosus Patients with Erosive Arthritis: Analysis of a Regional Swedish Register
- 9:00AM-11:00AM
-
Abstract Number: 152
Anti-CCP Positive Patients without Clinical Synovitis Progress If Ultrasound Positive
- 9:00AM-11:00AM
-
Abstract Number: 633
Anti-Centromere Antibodies Are Associated with More Severe Exocrine Glandular Dysfunction in Primary Sjögren’s Syndrome: An Analysis of the Sjögren’s International Collaborative Clinical Alliance Cohort
- 9:00AM-11:00AM
-
Abstract Number: 823
Anti-IFI16 Antibodies in Scleroderma Are Associated with Digital Gangrene
- 9:00AM-11:00AM
-
Abstract Number: 890
Anti-IgE Monoclonal Antibody in Refractory and/or Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Data from 17 Patients
- 9:00AM-11:00AM
-
Abstract Number: 774
Anti-Nuclear Antibodies Have High Sensitivity for Systemic Lupus Erythematosus: Results of a Systematic Literature Review and Meta-Regression of Diagnostic Data
- 9:00AM-11:00AM
-
Abstract Number: 781
Anti-Nucleosome Antibodies Versus Anti-DNA Antibodies in the Diagnosis and Monitoring of Activity of Systemic Lupus Erytematosus
- 9:00AM-11:00AM
-
Abstract Number: 534
Antibodies to Malondialdehyde-Acetaldehyde Adducts Are Highly Expressed in Rheumatoid Arthritis Synovial Fluid
- 9:00AM-11:00AM
-
Abstract Number: 811
Antibody Response to Periodontogenic Bacterium Aggregatibacter Actinomycetemcomitans and Lupus
- 9:00AM-11:00AM
-
Abstract Number: 518
Antibody Responses to Citrullinated Porphyromonas Gingivalis Peptidylarginine Deiminase: Associations with Disease Risk Factors and Severity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 483
Antibody to Malondialdehyde-Acetaldehyde (MAA) Adducts Serve As Biomarkers of Treatment Response in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 520
Antibody to Porphyromonas Gingivalis in Pre-Clinical Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 864
Anticytokine Autoantibody Profiling in Five Types of Systemic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 515
Are Changes in Autoantibody Levels Reflecting Change in Prognosis of Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 689
Are Individual or Country Level Socio-Economic Determinants Related to Disease Activity and Self-Reported Physical Function in Patients with Spondyloarthritis – Results from Multi-National Cross-Sectional Study Comospa
- 9:00AM-11:00AM
-
Abstract Number: 331
Are Metabolic Factors Associated with Shoulder Osteoarthritis? a Multicentric Study.
- 9:00AM-11:00AM
-
Abstract Number: 272
Are the Autoimmune/Inflammatory Syndrome Induced By Adjuvants (ASIA) and the Undifferentiated Connective Tissue Disease (UCTD) Related to Each Other? a Case-Control Study of Environmental Exposures
- 9:00AM-11:00AM
-
Abstract Number: 801
Artesunate Modulates Atherosclerosis Related Factors through the Inhibition of STAT1
- 9:00AM-11:00AM
-
Abstract Number: 661
ASDAS Can be Reliably Calculated When Only the Patient’s Overall Basdai Score Is Available, but Not the Score(S) of Its Individual Component(S)
- 9:00AM-11:00AM
-
Abstract Number: 650
ASDAS-Based Remission Was Less Frequent Than Basdai-Based Remission, and Both Were Related to CRP and Smoking in Early Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 638
Assessment of Myocardial Abnormalities in Primary Sjögren Syndrome Using a Comprehensive Cardiac Magnetic Resonance Approach
- 9:00AM-11:00AM
-
Abstract Number: 669
Assessment of Spinal Mobility in Axial Spondyloarthritis: First Validation Steps of a New Electronic Quantification Tool
- 9:00AM-11:00AM
-
Abstract Number: 356
Assessment of the Effect of 12 Months Administration of Denosumab in Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 642
Assignable Causes for Fatigue in Primary Sjögren’s Syndrome: Data from the UK Primary Sjögren’s Syndrome Registry
- 9:00AM-11:00AM
-
Abstract Number: 726
Associates of Pleurisy of Pericarditis in Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 354
Association Between Bone and Clinical Parameters in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 525
Association Between Fine Specificity of Anti-Citrullinated Peptide Antibodies and High Resolution Computed Tomography Parenchymal Lung Changes in Patients with Early RA
- 9:00AM-11:00AM
-
Abstract Number: 692
Association Between Improvement in Enthesopathy and Quality of Life: Results from a Phase 3 T in Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 639
Association Between Insomnia and EULAR Sjögren’s Syndrome Patient-Reported Index in Korean Patients with Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 573
Association Between Three Measures of Oral Glucocorticoid Exposure and Potential Adverse Events Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 267
Association of CXCL10 and CXCL13 Levels with Disease Activity and Cutaneous Manifestation in Active Adult-Onset Still’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 109
Association of HLA-G and Leukocyte Immunoglobulin-like Receptor A3 Polymorphisms with the Susceptibility to Pulmonary Hyterpention in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 63
Association of Smoking and Cognitive Function in Patients with Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 452
Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use
- 9:00AM-11:00AM
-
Abstract Number: 778
Associations Between Autoantibodies and Clinical Manifestations in Systemic Lupus Erythematosus: Data from a Multiethnic Latin American Cohort
- 9:00AM-11:00AM
-
Abstract Number: 328
Associations Between Body Composition Measures of Obesity and Radiographic Osteoarthritis in Older Adults: Data from the Dong-Gu Study
- 9:00AM-11:00AM
-
Abstract Number: 53
Associations Between Race and Income Disparity on Morbidity in Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 654
Associations Between Skin Outcomes By Body Area Affected and Health-Related Quality of Life in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 381
Associations Between Vitamin D Insufficiency, Osteoporotic Fractures and Comorbidites
- 9:00AM-11:00AM
-
Abstract Number: 58
Attribution of Cause of End-Stage Renal Disease Among Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 25
Attrition and Participant Characteristics in a Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 350
Atypical Femur Fracture in Rheumatoid Arthritis Patients Treated with Bisphosphonates: A Nested Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 346
Autoantibodies to Osteoprotegerin Are Independently Associated with Low Hip Bone Mineral Density and Increased Fractures in Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 892
Autoimmune Associated Orbital Inflammatory Masses and Response to Immunosuppressive Therapy
- 9:00AM-11:00AM
-
Abstract Number: 728
Autoimmune Hemolytic Anemia and Thrombocytopenia in a Single Centre Cohort of Patients with Systemic Lupus Erythematosus from Turkey : Clinical Associations and Effect on Disease Damage and Survival
- 9:00AM-11:00AM
-
Abstract Number: 86
Auxilin Is a Novel Susceptibility Gene for Congenital Heart Block Modulating Cardiac Function
- 9:00AM-11:00AM
-
Abstract Number: 103
Axial Disease in Psoriatic Arthritis: Genetic Biomarkers of Psoriatic Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 134
Axial Spondyloarthritis: Validation of an Inter-Professional Model of Care
- 9:00AM-11:00AM
-
Abstract Number: 756
Axl, Ferritin, IGFBP2 and TNFR2 As Biomarkers in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 186
B Flow, a Novel Ultrasound Modality in the Assessment of Synovitis in RA
- 9:00AM-11:00AM
-
Abstract Number: 183
B-Mode and Power Doppler Assessment As Predictors for Short and Long-Term Clinical Outcome in Cts Patients with or without Surgical Treatment
- 9:00AM-11:00AM
-
Abstract Number: 551
Baseline Autoantibodies Preferentially Impact Abatacept Efficacy in Patients with RA Who Are Biologic Naïve: 6-Month Results from a Real-World, International, Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 710
Baseline Characteristics of Early, Delayed, and Non-Responders in a Non-Radiographic Axial Spondyloarthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 714
Baseline MRI and CRP As Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
- 9:00AM-11:00AM
-
Abstract Number: 39
Baseline Obesity and Subsequent Weight Loss Are Independently Associated with Cardiovascular Mortality in Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 545
Baseline Serum Soluble Interleukin–2 Receptor Alpha (sIL–2Rα) Levels Increased as Intervals Decreased from Cohort Entry to Onset of Incident Rheumatoid Arthritis (pre–RA), not Observed in Matched Control (CN) Subjects
- 9:00AM-11:00AM
-
Abstract Number: 214
Basic Calcium Phosphate Crystal Interactions with Tenocytes: An in Vitro Model of Calcific Tendinitis
- 9:00AM-11:00AM
-
Abstract Number: 8
Bay 11-7085 Induces Glucocorticoid Receptor Activation and Autophagy to Initiate Human Synovial Fibroblast Cell Death
- 9:00AM-11:00AM
-
Abstract Number: 743
Behavior of Complement Levels and Risk of Organ Involvement in SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 750
Belimumab for Systemic Lupus Erythematosus: A Cochrane Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 735
Belimumab Reduces the Frequency of Flares and Prevents Damage Progression in SLE Patients: Experience in a Clinical Practice Setting
- 9:00AM-11:00AM
-
Abstract Number: 822
Beneficial Effect of Botulinum Toxin-a on Raynaud’s Phenomenon in Japanese Patients with Systemic Sclerosis: A Prospective, Open-Label Trial
- 9:00AM-11:00AM
-
Abstract Number: 475
Benefits of Achieving Comprehensive Disease Control (CDC) in Patients with Rheumatoid Arthritis: Evidence from the Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 325
Best Performing Definition of Accelerated Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 634
Big Data International Primary Sjögren Syndrome Registry: Baseline Characterization and Diagnostic Approach in 6047 Patients Fulfilling the 2002 AE Criteria
- 9:00AM-11:00AM
-
Abstract Number: 270
Biologic Agents in Refractory Adult Still’s Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab
- 9:00AM-11:00AM
-
Abstract Number: 464
Biologic Therapy Treatment Complications in the Alberta Aboriginal Population with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 617
Biological Down-Titration in RA: Patient Profile and Response to Retreatment in Flaring Patients
- 9:00AM-11:00AM
-
Abstract Number: 582
Biological Drugs Dose Tapering in Inflammatory Rheumatic Diseases: 2 Year Results at Basurto University Hospital
- 9:00AM-11:00AM
-
Abstract Number: 720
Biomarkers in Lupus Nephritis: The Possible Role of Serum Cystatin C, Serum β2-Microglobulin, Urinary α1-Microglobulin and Albuminâ�„Creatinine Ratio
- 9:00AM-11:00AM
-
Abstract Number: 722
Biomarkers/Pathways Discovery of Lupus Nephritis By Urine Proteomics
- 9:00AM-11:00AM
-
Abstract Number: 553
Body Mass Index Does Not Influence the Efficacy of Abatacept in Patients with RA Who Are Biologic Naïve: 6-Month Results from a Real-World, International, Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 202
Bone Accrual in the Dnase II-Deficient Model of Autoimmunity Requires Sting, As Well As Hematopoietic and Stromal Elements
- 9:00AM-11:00AM
-
Abstract Number: 358
Bone Microstructure Assessed By Hrpqct in Subjects with Hyperuricemia without Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 830
Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 215
Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors
- 9:00AM-11:00AM
-
Abstract Number: 330
Calf Muscle Adiposity Is Associated with Impaired Physical Performance in Knee OA
- 9:00AM-11:00AM
-
Abstract Number: 549
Calprotectin (MRP8/MRP14), a Major Leukocyte Protein, Is Highly Associated to Ultrasound Detected Synovitis and Is Responsive to Biologic Treatment
- 9:00AM-11:00AM
-
Abstract Number: 604
Calprotectin and TNF Antagonist Serum Trough Levels Identify Active Ultrasound Synovitis in Rheumatoid Arhritis and Psoriatic Arthritis Patients in Remission or Low Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 550
Can Anti-TNF-Induced Autoantibody Conversion be Reversed By Switching to Abatacept Therapy in Patients with RA on Background MTX?
- 9:00AM-11:00AM
-
Abstract Number: 630
Can Extraglandular Manifestations Differentiate Primary Sjögren’s Syndrome from Sjögren’s-Systemic Lupus Erythematosus Overlap Syndrome?
- 9:00AM-11:00AM
-
Abstract Number: 662
Can the New Contest Questionnaire Identify Psoriatic Arthritis in a Primary Care Population?
- 9:00AM-11:00AM
-
Abstract Number: 365
Can We Use Bone Turnover Markers As Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? an Analysis from Two Phase 3 Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 262
Canakinumab Therapy in Patients with Familial Mediterranean Fever
- 9:00AM-11:00AM
-
Abstract Number: 290
Cancer and Necrotizing Immune Mopathy: High Incidence in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive and Seronegative Patients but Not in Anti-Single Recognition Particle Positive Patients
- 9:00AM-11:00AM
-
Abstract Number: 37
Cardiovascular Disease in Immune-Mediated Inflammatory Diseases: Cross Sectional Analysis of the Influence of Demographic and Traditional Cardiovascular Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 300
Causes of Creatine Kinase Levels Greater Than 1,000 IU/L in Patients Referred to Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 10
CD13/Aminopeptidase N Contributes to Angiogenesis and Monocyte Chemotaxis in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 794
CD163+ Macrophages Display Mixed Polarizations in Discoid Lupus Skin
- 9:00AM-11:00AM
-
Abstract Number: 719
Cell of Origin of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 818
Cell-Bound Complement Activation Products (CB-CAP) Profiles in Patients with Pre-Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 889
Central Nervous System Involvement of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Retrospective Analysis of 26 Cases and Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 449
Change from SC to IV Abatacept and Back in Patients with Rheumatoid Arthritis As Simulation of a Vacation: A Prospective Phase IV, Open Label Trial (A-BREAK)
- 9:00AM-11:00AM
-
Abstract Number: 501
Change in RF Titers Reflects RA Disease Activity and Predicts Therapeutic Response during TNF Inhibitor Therapy; Patients with a Continuous Reduction of Serum RF Levels Show Good Response
- 9:00AM-11:00AM
-
Abstract Number: 707
Change of Enthesial Involvement Under Treatment Was Independent from the Therapeutic Strategy in Patients with Axial Spondyloarthritis within the Scqm Cohort
- 9:00AM-11:00AM
-
Abstract Number: 460
Changes in Body Composition and Metabolic Profile during Treatment with Tocilizumab in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 745
Changes in Serum Albumin Levels Correlate Highly with Severity and Activity of SLE
- 9:00AM-11:00AM
-
Abstract Number: 527
Characterisation of the Antibody Response to a Citrullinated Peptide – Derived from the Porphyromonas Gingivalis Peptidyl Arginine Deiminase Enzyme – in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 50
Characteristics and Outcomes Associated with Early Corticosteroid Use in a Large Multicenter Canadian RA Cohort
- 9:00AM-11:00AM
-
Abstract Number: 149
Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus (SLE) Initiating Treatment with Belimumab in a US Commercially Insured Database: 2010-2014
- 9:00AM-11:00AM
-
Abstract Number: 410
Characteristics of the Juvenile Systemic Sclerosis Cohort within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 408
Characterization of Pediatric Systemic Lupus Erythematosus with Acquired Angioedema
- 9:00AM-11:00AM
-
Abstract Number: 673
Characterization of Psoriatic Arthritis [Psa] in a Large, Integrated Health Plan: Demographics, Referral Patterns and Care Management
- 9:00AM-11:00AM
-
Abstract Number: 386
Chronic Arthritis in Systemic Lupus Erythematosus: Distinct Features in 336 Pediatric and 1,830 Adult Patients
- 9:00AM-11:00AM
-
Abstract Number: 817
Circulating Endothelial Cell (CEC) and CEC-Bound C4d Levels As Biomarkers of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 770
Circulating Levels of iC3b and C3 Correlate with Sledai-2K Responder Index-50 (S2K RI-50) Disease Activity Scores: The Castle (Complement Activation Signatures in Systemic Lupus Erythematosus) Study
- 9:00AM-11:00AM
-
Abstract Number: 217
Circulating Levels of Neo-Epitopes Reflecting Connective Tissue Turnover As Biomarkers of Gout and Frequent Gout Attacks in Men
- 9:00AM-11:00AM
-
Abstract Number: 526
Citrullinated Fibrinogen Promotes Bone Marrow Mesenchymal Stem Cells to Assume a Proinflammatory Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 198
CL-L1 and CL-K1 Complement Associated Pattern Recognition Molecules in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 421
Clinical Analysis and Outcome of Interstitial Lung Disease with Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 221
Clinical and Genetic Characteristics of Diuretic-Associated Gout: A Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 713
Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Treatment Results
- 9:00AM-11:00AM
-
Abstract Number: 693
Clinical and Imaging Features of Reactive Arthritis in Guatemala City
- 9:00AM-11:00AM
-
Abstract Number: 766
Clinical and Immunological Characteristics of 150 Systemic Lupus Erythematosus Patients in Urban Jamaica
- 9:00AM-11:00AM
-
Abstract Number: 389
Clinical and Serological Differences Between Juvenile-Onset and Adult-Onset Systemic LUPUS Erythematosus Patients from a National Registry of Patients
- 9:00AM-11:00AM
-
Abstract Number: 398
Clinical and Serological Profile of Children with Positive SSA-Ro/SSB-La Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 468
Clinical and Ultrasonographic Inflammation in DMARD-Naïve Early Rheumatoid Arthritis (RA) – Impact of the 2010 ACR/EULAR Classification Criteria Versus the 1987 ACR Classification Criteria
- 9:00AM-11:00AM
-
Abstract Number: 678
Clinical Characteristics and Disease Activity in Psoriatic Arthritis Patients with Dactylitis or Enthesitis: Results from Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 74
Clinical Characteristics of Fibromyalgia in a Chronic Pain Population
- 9:00AM-11:00AM
-
Abstract Number: 674
Clinical Characteristics of Japanese Patients with Reactive Arthritis Induced By Intravesical BCG Therapy for Bladder Cancer: A 19 Years Two-Center Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 440
Clinical Characteristics of Rheumatoid Arthritis Patients Achieving HAQ Remission with 6 Months of Biologic Treatment
- 9:00AM-11:00AM
-
Abstract Number: 476
Clinical Disease Activity Measures Change Substantially and Irregularly over Time in Individual Rheumatoid Arthritis Patients Considered to be in Steady State
- 9:00AM-11:00AM
-
Abstract Number: 773
Clinical Evaluation of Patients with Positive Antibodies to Extractable Nuclear Antigens but Negative ANA
- 9:00AM-11:00AM
-
Abstract Number: 466
Clinical Factors, Anti-Citrullinated Peptide Antibodies and MRI-Detected Subclinical Inflammation in Relation to Progression from Clinically Suspect Arthralgia to Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 394
Clinical Features of Children with Silent Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 154
Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound
- 9:00AM-11:00AM
-
Abstract Number: 688
Clinical Improvements in Psoriasis and Psoriatic Arthritis with Surgical Weight Loss
- 9:00AM-11:00AM
-
Abstract Number: 765
Clinical Improvements in Systemic Lupus Erthematosus Are Correlated to Cellular and Soluble Biomarkers in Classical Complement Pathway
- 9:00AM-11:00AM
-
Abstract Number: 467
Clinical Outcomes of Patients with Active Rheumatoid Arthritis with Normal Acute-Phase Reactant Values
- 9:00AM-11:00AM
-
Abstract Number: 264
Clinical Phenotype and Response to Treatment in Adult-Onset Still’s Disease with MEFV Variants
- 9:00AM-11:00AM
-
Abstract Number: 540
Clinical Relevance of Etanercept Levels and Anti-Etanercept Antibodies in Long-Term Treatment of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 653
Clinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 627
Clinical Subsets and Presenting Features in Primary Sjögren’s Syndrome: Results from a Single Center Inception Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 842
Clinical Utility of Serial KL-6 Measurement in Interstitial Lung Disease Associated with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 871
Clinicians’ Perspective on Aspects of ANCA-Associated Vasculitis That Influence Patients’ Function and General Health: A Delphi Exercise Based on the International Classification of Function, Disability and Health
- 9:00AM-11:00AM
-
Abstract Number: 91
Coevolution of a Uric Acid Transporter and Uricase: Implications for Gout
- 9:00AM-11:00AM
-
Abstract Number: 480
Comparative 10-Year Retention Rates of Adalimumab Used in Mono and Combination Therapy in Rheumatoid Arthritis (RA) Patients from the Rhumadata Clinical Database and Registry
- 9:00AM-11:00AM
-
Abstract Number: 505
Comparative Effectiveness and Time to Response Among Abatacept, Adalimumab, Certolizumab, Etanercept, Infliximab, Rituximab and Tocilizumab in a Real World Routine Care Registry
- 9:00AM-11:00AM
-
Abstract Number: 373
Compared to Non-Users, Current Glucocorticoids Users Have Less Prevalent Fractures at the Same Bone Mass: Results of a Large Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 311
Comparison Between Intra Articular Ozone and Placebo in the Treatment of Knee Osteoarthritis: A Multicentric, Comparative, Randomized and Double-Blinded Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 349
Comparison Between the American Recommendations and the Japanese Guidelines for Glucocorticoid-Induced Osteoporosis in Japanese Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 192
Comparison of Bone Scan with Xiralite (FOI) in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 548
Comparison of Dose Escalation and Co-Therapy Intensification Between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab
- 9:00AM-11:00AM
-
Abstract Number: 667
Comparison of Patient and Provider Assessments of Response to Therapy for Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 748
Comparison of Systemic Lupus Erythematosus in 3 Different Asian Ethnic Groups: Results from the 1000 Faces of Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 660
Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis in Patients with Psoriasis [Compaq Study]
- 9:00AM-11:00AM
-
Abstract Number: 438
Comparison of the Stanford and Indian Health Assessment Questionnaires for Disability Outcomes in a Phase 3, Randomized, Double-Blind, Active Comparator Study of Infliximab and Biosimilar Infliximab BOW15 in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 736
Complement Activation As a Marker for Increased Thrombosis Risk in SLE Patients with Antiphospholipid Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 30
Complications of Inflammatory Arthritis in First Nations and Non-First Nations Populations of Alberta, Canada
- 9:00AM-11:00AM
-
Abstract Number: 447
Components of Treatment Delay in Rheumatoid Arthritis Differ According to Autoantibody Status
- 9:00AM-11:00AM
-
Abstract Number: 176
Considerable Discrepancy Between Patient’s Assessment and Ultrasonography Assessment on the Most Affected Joint in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 665
Construct Validity of Disease Activity for Psoriatic Arthritis Composite Index and Tentative Cut-Off Values in a Cohort of Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 341
Construct Validity of Four Hand Mobility Measures in Hand Osteoarthritis (HOA)
- 9:00AM-11:00AM
-
Abstract Number: 337
Construct Validity of the Doyle Index in the Outcome Domain of Joint Activity in Hand Osteoarthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 863
Contribution of MPO-/PR3-ANCA Tests to the Diagnosis of ANCA-Associated Vasculitis in a Community Hospital: Evaluation of 2,782 Samples
- 9:00AM-11:00AM
-
Abstract Number: 45
Contributions of Social Determinants of Health on Probability of Remission in Early and Established Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 656
Convergent Construct Validity of PsAID12 in a Psoriatic Arthritis Cohort at Baseline
- 9:00AM-11:00AM
-
Abstract Number: 771
Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Sledai-2K
- 9:00AM-11:00AM
-
Abstract Number: 175
Correlating Semiquantitative Ultrasound Scores with Measured Synovial Thickness
- 9:00AM-11:00AM
-
Abstract Number: 613
Correlation Between Efficacy of Tocilizumab and Levels of Oxidative Stress Markers in Patients with Rheumatoid Arthritis: the 52-Week Analysis
- 9:00AM-11:00AM
-
Abstract Number: 492
Correlations Between Clinical, Laboratory and Ultrasound Joint Examination in RA Patients Treated with Rituximab
- 9:00AM-11:00AM
-
Abstract Number: 291
Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 366
Cost-Effective Osteoporosis Treatment Intervention Thresholds Based on FRAX in Portugal
- 9:00AM-11:00AM
-
Abstract Number: 82
Cross-Sectional Analysis of Heart Rate Variability in Patients with Fibromyalgia (FM): Correlations with Baseline Clinical Measures
- 9:00AM-11:00AM
-
Abstract Number: 513
Cumulative Association of Genetic Variants with Rheumatoid Joint Damage Progression in Mexican Americans and European Americans
- 9:00AM-11:00AM
-
Abstract Number: 696
Current and Past Smoking Are Associated with Functional Impairement and Increased Disease Activity in Axial Spondyloarthritis: Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 391
Current Provider Practices and Perceived Barriers for Mental Health Care of Adolescents with SLE
- 9:00AM-11:00AM
-
Abstract Number: 3
Cytokine Production Patterns in Osteoporosis Suggest a Pro-Inflammatory Bias
- 9:00AM-11:00AM
-
Abstract Number: 731
Damage and Mortality in SLE: Cluster Analysis of Patients from SLE Registry from the Spanish Society for Rheumatology (RELESSER)
- 9:00AM-11:00AM
-
Abstract Number: 876
Damage Develops Early and Is Common in Children with Chronic Systemic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 70
Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014
- 9:00AM-11:00AM
-
Abstract Number: 732
Decreased Disease Activity and Corticosteroid Usage and Improved Quality of Life during Belimumab Treatment in Patients with Systemic Lupus Erythematosus – a Prospective Real-Life Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 502
Decreased Vaccine Responses in Rheumatoid Arthritis Patients Receiving Anti-TNF Treatment and Relationship to B Cell Subsets
- 9:00AM-11:00AM
-
Abstract Number: 587
Defining the Conditions Under Which Long-Term Glucocorticoid Treatment Has a Good Benefit-Risk Ratio
- 9:00AM-11:00AM
-
Abstract Number: 132
Delivering a One-Stop, Integrated, Patient-Centred Service for Patients with Rheumatic Diseases. the Finnish Approach
- 9:00AM-11:00AM
-
Abstract Number: 12
Delta-like 1 Enhances the Production of Pro-Inflammatory Mediators By Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 384
Dental Treatments, Tooth Extraction, and Osteonecrosis at Jaw in Japanese Patients with Rheumatoid Arthritis; Results from the IORRA Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 747
Depletion of Serum Soluble CD40L Characterizes the Association Between Systemic Lupus Erythematosus and Thrombotic Thrombocytopenic Purpura: Longitudinal, Single-Center Study
- 9:00AM-11:00AM
-
Abstract Number: 395
Depression Risk Among Adults with Childhood- and Adult-Onset Systemic Lupus Erythematosus: 11 Years of Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 420
Description of the Juvenile Localized Scleroderma Subgroup of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 187
Detection of Power Doppler Ultrasound Signals in Rheumatic Diseases Using Superb Microvascular Imaging (SMI): Comparison with Conventional Power Doppler Ultrasound
- 9:00AM-11:00AM
-
Abstract Number: 363
Determination of the Osteoporotic Vertebral Fractures By a New Quantitative Approach: Intervertebral Volume Index
- 9:00AM-11:00AM
-
Abstract Number: 419
Development and Preliminary Validation of a New Composite Disease Activity Measure for Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 828
Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods
- 9:00AM-11:00AM
-
Abstract Number: 415
Development of a Juvenile Systemic Sclerosis Response Index (JSSRI)
- 9:00AM-11:00AM
-
Abstract Number: 708
Development of an Activity Disease Score in Patients with Uveitis
- 9:00AM-11:00AM
-
Abstract Number: 870
Development of an Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patient-Reported Outcome Measure: Identification of Salient Themes and Candidate Questionnaire Item Development
- 9:00AM-11:00AM
-
Abstract Number: 29
Development of Multimorbidity in Patients with Newly Diagnosed Rheumatoid Arthritis – a Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 493
Diagnostic Delay in Early Arthritis: Ten Years-Experience of a Single Center
- 9:00AM-11:00AM
-
Abstract Number: 218
Diet-Wide Association Study of Serum Urate Levels in 13,782 Individuals of European Ancestry
- 9:00AM-11:00AM
-
Abstract Number: 875
Differences in Early Damage Patterns in Various Forms of Primary Systemic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 209
Different Autoimmune Rheumatic Diease IgG Have Differential Effects upon Neutrophil Binding, Activation and Neutrophil Extracellular Trap Formation
- 9:00AM-11:00AM
-
Abstract Number: 296
Different Patterns of Involvement of Thigh Muscles in Dermatomyositis and Polymyositis Using Fat-Suppressed Magnetic Resonance Sequences
- 9:00AM-11:00AM
-
Abstract Number: 879
Diffuse Alveolar Hemorrhage Secondary to ANCA-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 359
Diminished Health-Related Quality of Life As Measured By the Short Form-10 in Children with Hypophosphatasia
- 9:00AM-11:00AM
-
Abstract Number: 789
Direct Coombs Positivity in SLE
- 9:00AM-11:00AM
-
Abstract Number: 65
Disability in the Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 595
Discovery of Serum Protein Biomarkers of Response to Adalimumab in Rheumatoid Arthritis and Their Relationship to Biomarkers of Response to Infliximab
- 9:00AM-11:00AM
-
Abstract Number: 671
Discrepancy Between Patients and Physicians Acceptable Symptomatic States in Axial Spondyloarthritis: Findings from the RAPID-AxSpA Study
- 9:00AM-11:00AM
-
Abstract Number: 862
Discriminative Performance of Nasal Endoscopic Findings and History Items in Patients with Granulomatosis with Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 400
Disease Activity and Health Care Utilization Among Young Adults with Childhood-Onset Lupus Transitioning to Adult Care: Data from the Pediatric Lupus Outcomes Study
- 9:00AM-11:00AM
-
Abstract Number: 666
Disease Activity Indices and Body Mass Index: Cross-Sectional Analysis of a Large Psoriatic Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 130
Disease Activity Patterns in Incident Onset Rheumatoid Arthritis Patients in the First 3-Years of Follow up
- 9:00AM-11:00AM
-
Abstract Number: 409
Disease Activity, Disease Damage and Predictive Factors in Juvenile Onset Mixed Connective Tissue Disease – a Norwegian Nationwide Study
- 9:00AM-11:00AM
-
Abstract Number: 456
Disease and Treatment Characteristics That Might Influence Long-Term Retention with Biologics in the Real-World Clinical Setting: Experience from the Rhumadata Clinical Database and Registry
- 9:00AM-11:00AM
-
Abstract Number: 470
Disease Outcome in Patients Fulfilling the 2010 Classification Criteria for Rheumatoid Arthritis: The Impact of the Different Criteria Components
- 9:00AM-11:00AM
-
Abstract Number: 734
Disease Patterns, Flare Incidence and Organ Damage Among Filipino Patients with Systemic Lupus Erythematosus: a One-Year Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 17
Disentangling the Role of Hypoxia-Inducible Factor 1 and 2 in the Adaption Process of Human Microvascular Endothelial Cells to Pathophysiological Hypoxia
- 9:00AM-11:00AM
-
Abstract Number: 797
Divergent Phenotypic Patterns Between Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive Individuals Reveal Distinct Differences in B Cell and Myeloid Populations Among Ethnicities
- 9:00AM-11:00AM
-
Abstract Number: 686
Does an Educational Leaflet Improve Attendance for Screening for Psoriatic Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 851
Does the Clinical Context Improve the Reliability of Rheumatologists Grading Digital Ulcers in Systemic Sclerosis?
- 9:00AM-11:00AM
-
Abstract Number: 659
Does the Inclusion of Extra-Articular Manifestations Improve Validity of the Self-Administered Comorbidity Questionnaire Modified for Spondyloarthritis (SpA-SCQ)? Results from ASAS-Comospa
- 9:00AM-11:00AM
-
Abstract Number: 42
Does the Risk of Mortality in Patients with RA Change over Time or Disease Duration?
- 9:00AM-11:00AM
-
Abstract Number: 106
Does the Timing of Phenotype Assessment Influence Association Results in Pharmacogenetics Studies of Anti-TNF Response in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 758
Dominican Patients with Systemic Lupus Erythematosus Residing in New York City Have a Higher SLICC/ACR Damage Index Than Those in the Dominican Republic
- 9:00AM-11:00AM
-
Abstract Number: 49
Dose Relationship Between Oral Glucocorticoids and TNF Inhibitors and the Risk of Hospitalized Infectious Events Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 570
Dose Selection of Namilumab, an Anti-GM-CSF Monoclonal Antibody: An Integrated Pharmacokinetic and Pharmacodynamic Approach for Phase II Studies in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 443
Drug Survival and Reasons for Discontinuation of Biological Disease Modifying Antirheumatic Drug in Thai Patients with Rheumatoid Arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization (RDPA) Register
- 9:00AM-11:00AM
-
Abstract Number: 489
Drug Survival and Toxicity of Methotrexate Monotherapy in Daily Clinical Practice. Results from an Early Arthritis Clinic
- 9:00AM-11:00AM
-
Abstract Number: 318
Dual Variable Domain-Immunoglobulin (Dvd-Ig™) Abt-981 Simultaneously and Dose-Dependently Inhibits Interleukin-1 Αlpha and -1 Βeta in Subjects with Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 434
Duration of Remission By Currently Available Criteria Can Predict Physical Functioning, but Not Radiological Progression in Early Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 557
Early Intensification of Treatment Induces Superior Outcomes in Two Randomized Trials According to Predicted Vs. Observed Radiographic Progression in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 487
Early Rheumatoid Arthritis Patients in the Worse Disease Trajectory Group Fail to Achieve Improvement in Physical Function
- 9:00AM-11:00AM
-
Abstract Number: 730
Early Symptoms of Systemic Lupus Erythematosus As Reported By Members of the German Lupus Erythematosus Patient Association
- 9:00AM-11:00AM
-
Abstract Number: 128
Economic Burden and Treatment Patterns of Cycling Between Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) Among Patients with Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 301
Economic Burden of Sporadic Inclusion Body Myositis in the United States of America: A Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 145
Economic Burden of Switching to an Anti-Tumor Necrosis Factor (anti-TNF) Versus a Non-Tumor Necrosis Factor (non-TNF) Biologic Therapy Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 598
Economic Impact of Decreasing Adalimumab and Etanercept Doses and Drug Monitoring in Patients with Rheumatoid Arthritis in Clinical Remission: Preliminary Study from a Local Biologics Unit
- 9:00AM-11:00AM
-
Abstract Number: 266
Effect of Tocilizumab on Adults Onset Still’s Disease in Korean Population: Multicenter Retrospecitve Study of 24 Cases
- 9:00AM-11:00AM
-
Abstract Number: 316
Effect of Vitamin D on Effusion-Synovitis in Knee Osteoarthritis: a Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 320
Effectiveness of Bracing in Elderly with Knee Osteoartritis: A Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 321
Effects of Bariatric Surgery on Long-Term Quality of Life Outcomes for Obese Patients with Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 216
Effects of Monosodium Urate Crystals on Mlo-Y4 Cell Viability; Is There a Role for Osteocytes in Erosive Gout?
- 9:00AM-11:00AM
-
Abstract Number: 248
Efficacy and Safety of Canakinumab in Patients with CAPS Aged <24 Months: Results from an Open-Label, Multicenter, Phase III Trial
- 9:00AM-11:00AM
-
Abstract Number: 626
Efficacy of Belimumab and Targeting of Rheumatoid Factor Positive B-Cells in Sjögren’s Syndrome: Follow-up of the Open-Label Phase II Study
- 9:00AM-11:00AM
-
Abstract Number: 343
Efficacy of Odanacatib in Postmenopausal Women with Osteoporosis: Subgroup Analyses of Data from the Phase 3 Long-Term Odanacatib Fracture Trial
- 9:00AM-11:00AM
-
Abstract Number: 499
Efficacy of Tocilizumab Monotherapy in Patients with RA Is Not Influenced By ACPA Positivity
- 9:00AM-11:00AM
-
Abstract Number: 451
Efficacy of Tofacitinib in a Real World Setting Using the Database Jointman
- 9:00AM-11:00AM
-
Abstract Number: 602
Efficacy of Very Low Dose (100mg) Rituximab in Active Rheumatoid Arthritis Despite Combination DMARD-Single Center, Prospective, Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 279
Ehlers-Danlos Syndrome Hypermobility Type (Type III) Is Associated with Rheumatological Conditions
- 9:00AM-11:00AM
-
Abstract Number: 856
Elderly Versus Younger Patients with ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 784
Electronic Health Record (EHR) As a Powerful Tool to Establish Clinical Research Lupus Cohorts
- 9:00AM-11:00AM
-
Abstract Number: 523
Elevated Antibody Response to Porphyromonas Gingivalis Detected in Sera Years before the Clinical Onset of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 821
Elevated Serum Levels of Soluble CD146 in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 893
Epidemiological Features of Childhood IgA Vasculitis (Henoch-Schönlein) in a French County: A Population-Based Survey
- 9:00AM-11:00AM
-
Abstract Number: 18
Epigallocatechin-3-Gallate (EGCG) Facilitates TAK1 Nuclear Translocation and Its Interaction with p300 to Inhibit Histone Acetylation in Human RA Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 482
Erosions in the Foot at Baseline Are Predictive of Orthopedic Shoe Use after 10 Years of Treat to Target Therapy
- 9:00AM-11:00AM
-
Abstract Number: 767
Estimating the Pre-Test Probability of Systemic Lupus Erythematosus By Utilizing Anti-Double Stranded DNA and Cell Bound Complement Activation Products Testing from Rheumatology Based Practices in the United States
- 9:00AM-11:00AM
-
Abstract Number: 461
Etanercept Has a Better Retention Rate at 10 Years Than Adalimumab in Patients with Rheumatoid Arthritis. Results from Rhumadata®: A Real-Life Clinical Database and Registry
- 9:00AM-11:00AM
-
Abstract Number: 643
Ethnicity of Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 485
Evaluate the Dose Efficacy Response Relationship of Baricitinib in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 76
Evaluating Weather’s Effect on Fibromyalgia Patients Using the Revised Fibromyalgia Impact Questionnaire and the Brief Pain Inventory
- 9:00AM-11:00AM
-
Abstract Number: 853
Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Granulomatosis with Polyangiitis in Large Healthcare Administrative Databases
- 9:00AM-11:00AM
-
Abstract Number: 684
Evaluation of Patient Acceptable Symptom State in Patients with Axial Spondylarthritis; Similar Thresholds for Radiographic and Non-Radiographic Subgroups
- 9:00AM-11:00AM
-
Abstract Number: 620
Evaluation of Patients from the Non-Biologic Arms of Inflammatory Arthritis Clinical Trials Identifies Several Predictors of Remission, As Well As, Distinct Responder Subgroups
- 9:00AM-11:00AM
-
Abstract Number: 506
Evaluation of Persistence and Outcomes in Patients Treated with TNF and Non-TNF Biologics Following Treatment Clinical Pathway in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 769
Evaluation of Soluble Alpha-Klotho in Neuropsychiatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 562
Evaluation of T Helper Cell 1(Th1) – and T Helper Cell 17(Th17) – Associated Chemokines As Prognostic Biomarkers for Tumor Necrosis Factor (TNF) Inhibitor Therapy in Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 670
Evaluation of the Predictive Value of Non-Specific Musculoskeletal Symptoms in Preclinical Phases of Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 883
Evaluation of Thiopurine Metabolites Monitoring in Patients Treated with Azathioprine for Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 289
Evaluation of Usefulness of Krebs Von Den Lungen-6 As a Biomarker of Interstitial Lung Disease with Polymyositis and Dermatomyositis Including in the Short Time Course after Treatment
- 9:00AM-11:00AM
-
Abstract Number: 194
Events Upstream of Caspase-1 Activation in NLRP3-Mediated Cell Death in NOMID
- 9:00AM-11:00AM
-
Abstract Number: 124
Experiences with a Structured Questionnaire for Administrative Personnel to Discriminate Urgent and Non-Urgent Rheumatic Patients Referred from Primary to Secondary Care
- 9:00AM-11:00AM
-
Abstract Number: 142
Exploration of General Practioners’ Difficulties with Methotrexate and Anti-TNF Therapies in Routine Practice
- 9:00AM-11:00AM
-
Abstract Number: 78
Exploratory Analysis of Somatic Symptoms in Fibromyalgia By Multidimensional Scaling and Latent Class Analysis
- 9:00AM-11:00AM
-
Abstract Number: 837
Exposure to ACE Inhibitors Prior to Onset of Scleroderma Renal Crisis Is Not Associated with Increased Risk of Mortality in a Large Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 590
Expression Levels of Selected Genes May Predict Response to TNF Alpha Blockers or Rituximab in the Individual Rheumatoid Arthritis Patient
- 9:00AM-11:00AM
-
Abstract Number: 22
Expression of High Mobility Group Box 1 Protein and the Receptor for Advanced Glycation End Products in Primary Gouty Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 813
Expression of Inducible Costimulator Ligand (ICOSL) on CD4+ T Cells in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 880
Extra-Corporeal Membrane Oxygenation and Diffuse Alveolar Haemorrhage: A Single Centre Case Series and Analysis of the ELSO Database
- 9:00AM-11:00AM
-
Abstract Number: 712
Factors Associated with Anti-TNF Treatment in a Longitudinally Followed Ankylosing Spondylitis (AS) Cohort
- 9:00AM-11:00AM
-
Abstract Number: 565
Factors Associated with Sustained Response in Patients with Rheumatoid Arthritis Who Received Rituximab within the US Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 824
Familial Risk of Systemic Sclerosis and Co-Aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study
- 9:00AM-11:00AM
-
Abstract Number: 147
Fatigue, Coping, Sleeping Disorders and Productivity Were Still Not Frequently Reported in Rheumatoid Arthritis Trials Published in 2014-2015: A Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 107
FCGR3A-158V/F Polymorphism Is Associated with a Lower Response Rate to Tumor Necrosis Factor α Blockers in Early Axial Spondyloarthritis: Data from the DESIR Cohort
- 9:00AM-11:00AM
-
Abstract Number: 46
Feasibility Study of Smartphone Data Collection for Cloudy with a Chance of Pain: Sustained Engagement for Daily Self-Reporting of Disease Severity in Rheumatoid Arthritis over Two Months
- 9:00AM-11:00AM
-
Abstract Number: 387
Features of 847 Childhood-Onset Systemic Lupus Erythematousus Patients in Three Age-Related Groups at Diagnosis: A Brazilian Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 829
Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 143
Fiber Optic Intubation in Patients with Rheumatoid Arthritis Who Had a Surgical Procedure
- 9:00AM-11:00AM
-
Abstract Number: 69
Fibrofog in Mild and Severe Variants of Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 75
Fibromyalgia and Positional Cervical Cord Compression Differ Only By Autonomic Nervous System Consequences: A Double-Blinded, Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 71
Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia Polysymptomatic Distress Scale
- 9:00AM-11:00AM
-
Abstract Number: 66
Fibromyalgia Patients Identify More Causes of Disease Flare Ups Than RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 458
First Year Canadian Experience with Subcutaneous Abatacept in Routine Practice for the Treatment of Patients with Rheumatoid Arthritis: Data from the Orencia Response Program (ORP) Network
- 9:00AM-11:00AM
-
Abstract Number: 236
Foot and Ankle Muscle Strength in People with Gout: A Two-Arm Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 131
Frequency of Lipid Testing and Management Among Rheumatoid Arthritis Patients Compared to the General Population and Patients with Diabetes
- 9:00AM-11:00AM
-
Abstract Number: 393
From Childhood to Adulthood: Identifying Latent Classes of Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 392
From Childhood to Adulthood: Longitudinal Trajectory of Damage in Patients with Childhood-Onset Systemic Lupus Erythematosus (cSLE)
- 9:00AM-11:00AM
-
Abstract Number: 785
Further Validation of Simple Index As a Simple Disease Activity Assessment Tool for SLE
- 9:00AM-11:00AM
-
Abstract Number: 764
Gastrointestinal Adverse Events of Azathioprine in Daily Clinical Practice: Independent of Thiopurine Methyltransferase Activity
- 9:00AM-11:00AM
-
Abstract Number: 417
Gender Differences in Pediatric Localized Scleroderma: Clinical and Patient-Reported Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 711
Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab
- 9:00AM-11:00AM
-
Abstract Number: 122
General Practitioners’ Perceptions of Methotrexate and Anti-TNF Therapies: A Qualitative Study
- 9:00AM-11:00AM
-
Abstract Number: 110
Genome-Wide DNA Epigenetic Profiling of Monozygotic Twins[L1] Discordant for ACPA or ACPA-Positive Rheumatoid Arthritis Reveals Novel Associated Genes
- 9:00AM-11:00AM
-
Abstract Number: 566
Genome-Wide Trans-Ancestry Meta-Analysis of Herpes Zoster in RA and Pso Patients Treated with Tofacitinib
- 9:00AM-11:00AM
-
Abstract Number: 97
Genomic Sequencing of Uric Acid Metabolizing and Clearing Genes in Relationship to Xanthine Oxidase Inhibitor Dose
- 9:00AM-11:00AM
-
Abstract Number: 721
Geographic Differences in Demographics, Clinical Characteristics, and Standard of Care in Multinational Studies of Patients with Moderate to Severe Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 754
Glutathione S Transferases (GST) Polymorphisms Are Independents Predictors of Efficacy and Toxicity in Lupus Nephritis Treated with Cyclophosphamide
- 9:00AM-11:00AM
-
Abstract Number: 193
Going Back to Basics – Redefining the Normal Pattern in Nailfold Capillaroscopy in a Large Healthy Population: Results of the German “Rheuma-Truck” Cohort
- 9:00AM-11:00AM
-
Abstract Number: 228
Gout and Risk of Non-Vertebral Osteoporotic Fracture
- 9:00AM-11:00AM
-
Abstract Number: 233
Gout Does Not Decrease the Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 225
Gout Patients Present Carotid Plaques at Presentation in Spite of Low-Risk Cardiovascular Score
- 9:00AM-11:00AM
-
Abstract Number: 377
Hand Bone Impairment By High-Resolution Peripheral Quantitative Computed Tomography in Patients with Diffuse Systemic Sclerosis: Correlation with Clinical Parameters, Quality of Life and Capillaroscopic Findings
- 9:00AM-11:00AM
-
Abstract Number: 658
Health Related Quality of Life in Psoriatic Arthritis from the Perspective of People Living with the Condition
- 9:00AM-11:00AM
-
Abstract Number: 281
Health Related Quality of Life Is Reduced in Adult Patients with Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 852
Health-Related Quality of Life in Early Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 808
Heritable Endotheliopathy and ApolipoproteinL1 Risk Traits in SLE
- 9:00AM-11:00AM
-
Abstract Number: 559
Herpes Zoster and Tofacitinib: The Risk of Concomitant Nonbiologic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 494
High C-Reactive Protein at Baseline Is Associated with Long-Term Treatment Persistence in Patients with Rheumatoid Arthritis Treated with Rituximab
- 9:00AM-11:00AM
-
Abstract Number: 807
High Levels of Serum IFN-Alpha Mark a Subgroup of SLE Patients with Distinct Immunophenotypic Features and Hyperresponsiveness to Toll-like Receptor Stimulation
- 9:00AM-11:00AM
-
Abstract Number: 795
High Mobility Group Box-1 (HMGB1) Affects Macrophage Polarization and Phagocytosis in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 374
High Prevalence of Osteoporosis and Fractures Is Associated with Abdominal Adiposity and Decreased Muscular Strength in Primary Necrotizing Vasculitides
- 9:00AM-11:00AM
-
Abstract Number: 866
High Rate and Bimodal Pattern of Severe Infection in a Selected ANCA Associated Vasculitis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 174
High Resolution Ultrasound of the Midfoot: Sonography Is Superior to Conventional Radiography in Detection of Osteophytes and Erosions in Inflammatory and Non-Inflammatory Joint Disease
- 9:00AM-11:00AM
-
Abstract Number: 191
High Specificity of Spectral Nail Assessment in Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 67
Higher Levels of Pro-Inflammatory and Lower Levels of Anti-Inflammatory Cytokines Are Present in Fibromyalgia Patients
- 9:00AM-11:00AM
-
Abstract Number: 26
Higher Scores of Women Compared to Men for Most Clinical Measures of Rheumatoid Arthritis (RA) Status: Greater Differences for Patient Self-Report Scores Than for Rheumatologist Estimates: A Cross-Sectional 3 Center Study from Routine Care
- 9:00AM-11:00AM
-
Abstract Number: 242
Higher Serum Uric Acid Levels Are Associated with an Increased Risk of Flares: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 453
Highly Elevated Rheumatoid Factor Is a Risk Factor for Abatacept Treatment Failure in Japanese Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 510
Histologic Scoring of Arthroplasty Synovial Samples May Predict RA Flare
- 9:00AM-11:00AM
-
Abstract Number: 204
Histone Methylation Profiling in Peripheral White Blood Cells As a Candidate Biomarker for Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 244
Hospitalization and Flare Risk in Patients with Established Gout: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 259
How Safe IT Is to TREAT Pregnant FMF Patients with Anakinra ?
- 9:00AM-11:00AM
-
Abstract Number: 479
How to Recruit Anti-CCP Positive Patients from Primary Care
- 9:00AM-11:00AM
-
Abstract Number: 297
How Useful Is Magnetic Resonance Imaging (MRI) in Monitoring Patients with Myositis?
- 9:00AM-11:00AM
-
Abstract Number: 357
Human Parathyroid Hormone for Preventing and Treating Glucocorticoid-Induced Osteoporosis: Cochrane Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 810
Human Parvovirus B19 Nonstructural Protein 1 (NS1) Helicase Breaks Tolerance to Self dsDNA: A Model for Viral Induction of Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 199
Human Type 1 and Ncr-Negative Type 3 Innate Lymphoid Cells Accumulate in the Inflamed Synovium in Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 310
Hyaluronic Acid Injections in Knee Osteoarthritis Patients Are Associated with Delay to Knee Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 232
Hyperuricemia, Urate Lowering Therapy and Kidney Function: A Systemic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 79
Hypervigilence: Patients with Fibromyalgia Often Appear Very Sensitive to Environmental Stresses
- 9:00AM-11:00AM
-
Abstract Number: 138
Identification and Documentation of Secondary Osteoarthritis in Patients with Primary Inflammatory Arthritides Using a Patient MDHAQ/RAPID3 and a Physician Estimate of Joint Damage to Recognize Patient Complexity and Inform Management Decisions
- 9:00AM-11:00AM
-
Abstract Number: 697
Identification Methods for Axial Spondyloarthritis in American Veterans
- 9:00AM-11:00AM
-
Abstract Number: 775
Identification of Candidate Items for Revised Classification Criteria for Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 802
Identification of Cyclin-Dependent Kinase 1 As a Novel Regulator for Controlling Type I Interferon Signaling in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 788
Identification of Molecular Biomarkers to Distinguish Systemic Lupus Erythematosus with Skin Involvement from Discoid Lupus Erythematosus and Subacute Cutaneous Erythematosus: Provisional Results from Cross-Sectional Studies
- 9:00AM-11:00AM
-
Abstract Number: 844
Identification of Subclinical Skin Involvement By High Frequency Ultrasound in Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 140
Identifying Psoriatic Arthritis and Ankylosing Spondylitis Patients Responsible for the Highest Costs of Care: Data from a Large US Cohort
- 9:00AM-11:00AM
-
Abstract Number: 118
Identifying the Investment Needed to Generate a Durable Prednisone Dose Decrement
- 9:00AM-11:00AM
-
Abstract Number: 742
IgM Antibodies Against Malondialdehyde and Phosphorylcholine Are T Cell Dependent and Strong Protection Markers for Atherosclerosis in SLE
- 9:00AM-11:00AM
-
Abstract Number: 544
IL-6 May Have an Important Role in the Resistance to Anti-TNF Therapies of Human T-Lymphotropic Virus Type 1 (HTLV-1) Positive Rheumatoid Arthritis (RA) Patients; HTLV-1 Infected Cells Activate the Inflammatory Responses of RA Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 83
Immediate Benefits of a Multidisciplinary Educational Program for Fibromyalgia on Patients’ Pain Related Self-Efficacy and Health Locus of Control
- 9:00AM-11:00AM
-
Abstract Number: 531
Immune Responses to Mycobacterium Heat Shock Protein 70 Accompany Self-Reactivity to Human Bip in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 529
Immunoglobulin-a and Immunoglobulin-G Isotypes of Anti-CCP Antibodies Are Present in the Sputum of Subjects at Risk for Future Development of RA
- 9:00AM-11:00AM
-
Abstract Number: 516
Immunological and Ultrasound Characteristics of Patients with Rheumatoid Arthritis in Clinical Remission – Can We Use These to Predict Outcomes?
- 9:00AM-11:00AM
-
Abstract Number: 530
Immunomodulation of Naïve RA Patients PBMCs with a Multi-Epitope Peptide Derived from Citrullinated Autoantigens
- 9:00AM-11:00AM
-
Abstract Number: 54
Impact of Age at Disease Diagnosis on Clinical Manifestations, Disease Activity, and Outcomes in Patients with Systemic Lupus Erythematosus: Single-Center Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 560
Impact of Anti-Citrullinated Protein Antibody Status and Response to Abatacept
- 9:00AM-11:00AM
-
Abstract Number: 471
Impact of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titer on Efficacy Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 760
Impact of Baseline Concomitant Medication Use on Belimumab Efficacy and Safety in Patients with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 478
Impact of Comorbidities on the Multi-Biomarker Disease Activity Test in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 370
Impact of Didactic Lecture on Osteoporosis Screening and Fracture Risk Assessment Among House Staff
- 9:00AM-11:00AM
-
Abstract Number: 681
Impact of Disease Duration on Patient Reported and Clinical Outcomes in Patients with Ankylosing Spondylitis Treated with Anti-TNF: An Analysis from a Prospective, Observational Registry
- 9:00AM-11:00AM
-
Abstract Number: 227
Impact of Gout on the Risk of Atrial Fibrillation
- 9:00AM-11:00AM
-
Abstract Number: 425
Impact of in Utero Hydroxychloroquine Exposure on Age of Onset of Cutaneous Neonatal Lupus
- 9:00AM-11:00AM
-
Abstract Number: 38
Impact of Obesity on the Disease Course of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 791
Impact of Online Education and Social Media Intervetion for Self-Management in Adolescents with SLE
- 9:00AM-11:00AM
-
Abstract Number: 508
Impact of Race on Patient Global Scores and the Misclassification of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 435
Impact of Sarilumab on Fatigue, Pain, Morning Stiffness, Productivity, and Health Related Quality of Life (HRQoL) in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti-TNF-α Therapy: Results from a Phase 3 Study (RCT)
- 9:00AM-11:00AM
-
Abstract Number: 606
Impaired Kidney Function Improves Treatment Response after 6 Months of Methotrexat Treatment in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 838
Impaired Quality of Life in Systemic Sclerosis and Patient Perception of the Disease: A Large International Survey
- 9:00AM-11:00AM
-
Abstract Number: 125
Implementation of a Bone Health Team Markedly Improves Osteoporosis Screening, Diagnosis and Treatment Initiation Rates Compared to Standard Primary Care Practice
- 9:00AM-11:00AM
-
Abstract Number: 141
Improved Follow-up of Hypertension in Rheumatology Patients: Results of a Pilot
- 9:00AM-11:00AM
-
Abstract Number: 877
Improved Survival in Granulomatosis with Polyangiitis: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 561
Improvement in Disease Activity and the Long-Term Risk of Serious Infectious Events in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 699
Improving Ankylosing Spondylitis Specific Outcomes at 6 Months Utilising a Novel Self-Management Education Program
- 9:00AM-11:00AM
-
Abstract Number: 509
In Early Undifferentiated Polyarthritis, 14-3-3η Seroreversion or Sustained Negativity Is Associated with Better Radiographic Outcomes, Even in DAS-28 Remitters
- 9:00AM-11:00AM
-
Abstract Number: 519
In Indigenous North Americans at High Risk for RA Complement C5 Level Is Associated with ACPA Positivity and C5a with Transition to Synovitis Even after Correcting for in Vitro Complement Activation Found with Prolonged Sample Storage
- 9:00AM-11:00AM
-
Abstract Number: 792
Incidence and Persistence of Cervical Human Papillomavirus Infection in Mexican Systemic Lupus Erythematosus Women
- 9:00AM-11:00AM
-
Abstract Number: 850
Incidence and Predictors of Severe Heart Disease in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 369
Incidence of Fragility Hip Fractures over 10 Years (2004-13) in Three UK Centres with Reference to Local Fracture Prevention (‘fracture liaison’) Service Activity
- 9:00AM-11:00AM
-
Abstract Number: 348
Incidence Rate of Potential Osteonecrosis of the Jaw Among Women with Postmenopausal Osteoporosis Treated with Prolia or Bisphosphonates
- 9:00AM-11:00AM
-
Abstract Number: 816
Incomplete Tolerance in Anergic B Cells in SLE: T Helper Signals Restore B Cell Receptor Signaling in Autoreactive Anergic B Cells By Upregulating CD45 Phosphatase Activity
- 9:00AM-11:00AM
-
Abstract Number: 243
Increase in Risk of Future Attacks in Patients with Incident Gout: A Population-Based Study over 20 Years
- 9:00AM-11:00AM
-
Abstract Number: 536
Increased Circulating CD14brightCD16+ Intermediate Monocytes Are Regulated By TNF-Alpha and IL-6 Axis in Accompany with Disease Activity in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 55
Increased Incidence of Tuberculosis Among Systemic Lupus Erythematous Patients – Should Tuberculosis Screening at Diagnosis be the Next Step?
- 9:00AM-11:00AM
-
Abstract Number: 40
Increased Mortality in Indigenous North Americans Persons with Rheumatoid Arthritis Is Partially Explained By Psychiatric and Physical Comorbidity: a Population Based Study
- 9:00AM-11:00AM
-
Abstract Number: 223
Increased Platelet Reactivity in Gout: A Potential Mechanism for Adverse Cardiovascular Events
- 9:00AM-11:00AM
-
Abstract Number: 496
Increased Serum Lipids Under Tocilizumab Is Not Influenced By Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 189
Indocyanine Green (ICG) -Enhanced Fluorescence Optical Imaging (FOI) in Patients with Active Rheumatoid Arthritis; A Comparative Study with Ultrasound and Association with Biomarkers
- 9:00AM-11:00AM
-
Abstract Number: 556
Induction-Maintenance in Early RA: A Meta-Analysis of Trials Using MTX Plus Adalimumab As Induction Therapy
- 9:00AM-11:00AM
-
Abstract Number: 241
Inflammatory Syndrome in Polyarticular Gout – Description of a Previously Neglected Entity
- 9:00AM-11:00AM
-
Abstract Number: 836
Influence of B Cell Depletion By Monoclonal Anti CD20 Antibodies in Systemic Sclerosis: Results of a Randomized Placebo Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 504
Influence of CDAI Measurement on the Decision of Community Rheumatologists to Initiate or Change Biologic Treatment
- 9:00AM-11:00AM
-
Abstract Number: 90
Influence of Susceptible HLA-DRB1 Alleles on Clinical Subphenotypes of Systemic Lupus Erythematosus in Koreans
- 9:00AM-11:00AM
-
Abstract Number: 7
Influence of TNF on Anti-Inflammatory Tyrosine-Hydroxylase-Positive Synovial Cells in Rheumatoid Arthritis and Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 201
Innate Lymphoid Cells Are Present at Normal Human Enthesis Providing a Potential Mechanism for Spondyloarthropathy Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 423
Institutional and Regional Variation in Childhood SLE 30-Day Hospital Readmission Rates: A Comparative Effectiveness Research Using the Pediatric Health Information System Database
- 9:00AM-11:00AM
-
Abstract Number: 88
Integrating Evidence for Genetic Association and Natural Selection Helps Detect New Systemic Lupus Erythematosus Risk Loci in African-Americans
- 9:00AM-11:00AM
-
Abstract Number: 407
Inter-Observer Variability of the Histological Classification of Lupus Glomerulonephritis in Children
- 9:00AM-11:00AM
-
Abstract Number: 805
Interferon Activity in Early and Established SLE: Interferon Score Is Lower in Early Disease and Not Seen without Antibodies to Extractable Nuclear Antigens
- 9:00AM-11:00AM
-
Abstract Number: 803
Interferon-Alpha Mediated Lowering of Pentraxin-3 Levels in Systemic Lupus Erythematosus?
- 9:00AM-11:00AM
-
Abstract Number: 287
Interleukin-35 in Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 887
Intravenous Immunoglobulin As Immunomodulating Agent in ANCA-Associated Vasculitides: A French Nationwide Study of 92 Patients
- 9:00AM-11:00AM
-
Abstract Number: 271
Investigating an Auto-Inflammatory Component of COPD That Contributes to Progressive Decline in Lung Function Despite Smoking Cessation
- 9:00AM-11:00AM
-
Abstract Number: 517
Investigating Psychological Predictors of Biologic Treatment Response in Patients with Severe Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 298
Investigating the Pathogenic Role of ER Stress Pathway Activation in the Idiopathic Inflammatory Myopathies (IIM): Skeletal Muscle Cells As a Source of Cytokines (Myokines)
- 9:00AM-11:00AM
-
Abstract Number: 306
Investigating the Pathogenic Role of ER Stress Pathways in the Idiopathic Inflammatory Myopathies (IIM): Interrogating the Role of Micro-RNA 133a As an Important Regulator of ER Stress Activation
- 9:00AM-11:00AM
-
Abstract Number: 715
Investigating the Role of Vitamin D in Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 24
Investigating the Role of Vitamin D in the Transition to Systemic Lupus Erythematosus in Individuals at Risk for the Disease
- 9:00AM-11:00AM
-
Abstract Number: 257
Investigation of the Arterial Stiffness and Associated Factors in Patients with Familial Mediterranean Fever
- 9:00AM-11:00AM
-
Abstract Number: 647
Involvement of Peripheral Nervous System in Primary Sjögren Syndrome, a Gessar Analysis
- 9:00AM-11:00AM
-
Abstract Number: 695
Is a Geriatric Rheumatology Sub-Group Worth Distinguishing? Disease Characteristics of a Geriatric Psoriatic Arthritis (Gero PsA) Subgroup Compared with Those of below 45 Years of Age
- 9:00AM-11:00AM
-
Abstract Number: 704
Is Axial Involvement Underestimated in Patients with Psoriatic Arthritis? Data from the Bepas Cohort
- 9:00AM-11:00AM
-
Abstract Number: 698
Is It Possible to Identify Psoriasis Patients Who Will Develop Axial Disease? Real Life Data from Psart (Psoriatic Arthritis Registry of Turkey)
- 9:00AM-11:00AM
-
Abstract Number: 437
Is Mode of Action Important When Switching Biologic Monotherapy in Rheumatoid Arthritis? Drug Adherence Results from the Swedish Ssatg Registry
- 9:00AM-11:00AM
-
Abstract Number: 702
Is Skin Disease More Important to Patients or Physicians in the Assessment of Disease Activity in Psoriatic Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 701
Is Skin Disease More Important to Women or Men in the Assessment of Disease Activity in Psoriatic Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 413
Is There a Difference in the Presentation of Diffuse and Limited Subtype of Juvenile Systemic Sclerosis in Childhood? Results from the Juvenile Scleroderma Inception Cohort Www.Juvenile-Scleroderma.Com
- 9:00AM-11:00AM
-
Abstract Number: 632
Isolated Atrioventricular Block of Unknown Origin in the Adult and Autoimmunity: Diagnostic and Therapeutic Considerations Exemplified By Three Anti-Ro/SSA-Associated Cases
- 9:00AM-11:00AM
-
Abstract Number: 703
Isotretinoin-Induced Spondilartropathy-Related Symptoms: A Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 269
Items of Yamaguchi Criteria Might be Associated with Disease Severity and Prognosis in Adult-Onset Still’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 597
JAK Inhibition Significantly Reduced Fibrogenesis in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 798
Keratinocyte-Associated IL-6 Is Elevated in Cutaneous Lupus Rashes and Production of IL-6 By Keratinocytes Is Enhanced in Non-Involved Lupus Skin
- 9:00AM-11:00AM
-
Abstract Number: 648
Klinefelter’s Syndrome (47,XXY) Among Men with Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 336
Lack of Uniform Diagnostic Criteria for Erosive OA: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 733
Late Onset Systemic Lupus Erythematosus: A Different Disease Subset?
- 9:00AM-11:00AM
-
Abstract Number: 894
Late-Onset IgA Vasculitis in Adult Patients Exhibits Distinct Clinical Characteristics and Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 334
Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project
- 9:00AM-11:00AM
-
Abstract Number: 135
Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site
- 9:00AM-11:00AM
-
Abstract Number: 406
Long Term Follow up of Inner City Pediatric Patients with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 619
Long-Term Adverse Events after Daily Concomitant Treatment with 10mg Prednisone in the 2-Year Computer Assisted Management in Early Rheumatoid Arthritis Trial-II
- 9:00AM-11:00AM
-
Abstract Number: 596
Long-Term High Remission Rates and Distinct Trajectories of Disease Activity Following the Implementation of Treat-to-Target in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 276
Long-Term Outcome in Mixed Connective Tissue Disease
- 9:00AM-11:00AM
-
Abstract Number: 404
Long-Term Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 780
Long-Term Prognosis and Factors Associated with Damage Accrual in Japanese Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 891
Long-Term Use of Rituximab for Eosinophilic Granulomatosis with Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 744
Longitudinal Assessment of Th1 and Th2 Cytokines: A Comparison Between Adult-Onset and Childhood-Onset Systemic Lupus Erythematous
- 9:00AM-11:00AM
-
Abstract Number: 397
Longitudinal Observation of Psychological Factors and Health-Related Quality of Life in Childhood-Onset Lupus
- 9:00AM-11:00AM
-
Abstract Number: 113
Longitudinal, Incremental Direct Medical Costs of Giant Cell Arteritis for the First Five Years Following Diagnosis: A General Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 352
Low Bone Density Is Associated with Atherosclerotic Disease in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 446
Low Disease Activity at 12 Weeks and 24 Weeks Is Predictive of Normalized Health-Related Quality of Life in Methotrexate-Experienced Patients with Active Rheumatoid Arthritis Treated with Intravenous Golimumab Plus Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 85
Low Socioeconomic Status, High Disability Rates, and Increased Use of Health Care Resources in Fibromyalgia Patients Taking Narcotics
- 9:00AM-11:00AM
-
Abstract Number: 882
Lung Damage in ANCA Associated Vasculitis Assessed By Vasculitis Damage Index: Recurrent Pulmonary Infections Have a Significant Contribution
- 9:00AM-11:00AM
-
Abstract Number: 814
Lupus Drives Atherosclerosis through CD4+CXCR3+ T Cells and Plasmacytoid Dendritic Cells
- 9:00AM-11:00AM
-
Abstract Number: 763
Lupus-Related SNPs and Risk of Diffuse Large B-Cell Non-Hodgkin Lymphoma
- 9:00AM-11:00AM
-
Abstract Number: 869
Lymphoma in Patients with Granulomatosis with Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 815
Lys63-Polyubiquitination By the E3 Ligase Casitas B-Lineage Lymphoma-b Modulates Peripheral Regulatory T Cell Tolerance in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 424
Magnetic Resonance and Echocardiographic Strain Rate Imaging for the Early Detection of Cardiac Involvement in Juvenile Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 313
Magnetic Resonance Imaging Outcomes Using an Intra-Articular Injection (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study
- 9:00AM-11:00AM
-
Abstract Number: 571
Malignancy Data in Tofacitinib-Treated Japanese Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 399
Management of Lupus Anticoagulant Hypoprothrombinemia Syndrome in Juvenile Systemic Lupus Erythematosus – Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 779
Mapping Perceptions of Medication Decision Making Facilitators: The Importance of Patient Context
- 9:00AM-11:00AM
-
Abstract Number: 663
Mases Correlates Linearly with Disease Activity and Patient Related Outcomes in Patients with Axial Spondyloarthritis within the Scqm Cohort
- 9:00AM-11:00AM
-
Abstract Number: 360
Massive Elimination of Multinucleated Osteoclasts By Eupatilin Is Due to Dual Inhibition of Transcription and Cytoskeletal Rearrangement
- 9:00AM-11:00AM
-
Abstract Number: 200
Mast Cell Regulation of Aortic IL-6 Expression Involves Histamine-1 Receptor, Suppressor of Cyotkine Signaling-1 and IL-10
- 9:00AM-11:00AM
-
Abstract Number: 293
Measurement of Advanced Glycation Endproducts in the Skin of Patients with Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 649
Measures of Health-Related Quality of Life in Psoriatic Arthritis: Are They Sensitive to Both Joint and Skin Aspects?
- 9:00AM-11:00AM
-
Abstract Number: 793
Mesenchymal Stem Cells Promote the Generation of CD206+ Macrophage and Increase Its Phagocytic Activity in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 507
Meta-Analysis of the Time Course of the Response to Adalimumab Plus Methotrexate or Methotrexate Monotherapy in Clinical Trials of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 574
Metabolomic Profiling Predicts Outcome of Rituximab Therapy in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 579
Methotrexate Does Not Influence 1-Year Bone Mineral Density in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 473
Methotrexate, Blood Pressure and Arterial Wave Reflection in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 541
Microrna-125b Expression in PBMCs Is Associated with Disease Activity in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 23
Microvesicle-Associated Hsa-Mir-223-3p Is Elevated in Rheumatoid Synovial Fluid Compared with Osteoarthritis Synovial Fluid
- 9:00AM-11:00AM
-
Abstract Number: 749
Microvesicles Containing Nucleic Acids and Expressing Immunoglobulins and HMGB1 Are Abundant in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 303
Mining RNA-Seq of Peripheral Blood Mononuclear Cells from JDM Alone Compared with JDM Plus Psoriasis for Biomarkers of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 682
Misalignment Between Physician and Patient Satisfaction with Current Psoriatic Arthritis Treatment
- 9:00AM-11:00AM
-
Abstract Number: 278
Mitral Valve Prolapse in Patients with Joint Hypermobility Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 205
Mode of Action of Therapeutic Anti-Citrullinated Protein Antibodies Revealed: Inflammation Reduction Due to Inhibition of Netosis
- 9:00AM-11:00AM
-
Abstract Number: 845
Modelling of Longitudinal Changes in Lung Function in Patients with Systemic Sclerosis and Their Association with Development of Pulmonary Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 605
Monitoring of Epstein Barr Virus, Cytomegalovirus and Varicella Zooster Virus Load in Patients Receiving Tocilizumab for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 422
Mood Disorder Is Highly Prevalent in a Multi-Ethnic Urban Pediatric Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 339
More Inflammatory Signs on Ultrasound, Severe Pain and Stiffness Are Associated with Erosive Than Non-Erosive Hand Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 60
Mortality of Systemic Lupus Erythematosus in Puerto Rico Assessed By Multiple-Cause-of-Death Analysis
- 9:00AM-11:00AM
-
Abstract Number: 465
MRI Bone Erosion at Baseline Predicts the Subsequent Radiographic Progression in Early-Stage RA Patients Who Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 514
MRI Bone Oedema at Enrollment Predicts the Development of Rapid Radiographic Progression at 1 Year Toward Patients with Early-Stage Rheumatoid Arthritis: Results from Nagasaki University Early Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 687
Mucosal Dysregulation in First-Degree Relatives of Ankylosing Spondylitis Patients
- 9:00AM-11:00AM
-
Abstract Number: 746
Multi-Center Delphi Exercise Reveals Important Key Items in Classifying SLE
- 9:00AM-11:00AM
-
Abstract Number: 538
Multidrug Resistant Lymphocytes of Patients with Rheumatoid Arthritis Are Predictive for DMARD and Glucocorticoid Treatment Response
- 9:00AM-11:00AM
-
Abstract Number: 253
Multiple Serum Cytokine Profiling to Identify Specific Molecular Networks in Attacks of Familial Mediterranean Fever
- 9:00AM-11:00AM
-
Abstract Number: 831
Mycophenolate Decreases the Frequency of Endoscopic Therapy for Gastric Antral Vascular Ectasia in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 724
Mycophenolate Mofetil in Non-Renal Manifestations of Systemic Lupus Erythematosus. an Observational Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 288
Myositis Associated Interstitial Lung Disease: Clinical Predictors of Failure to Conventional Treatment and Their Response to Tacrolimus
- 9:00AM-11:00AM
-
Abstract Number: 308
Nailfold Capillaroscopy in Patients with Early Onset-Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 854
Nationwide Incidence of Anti Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis in Iceland
- 9:00AM-11:00AM
-
Abstract Number: 846
Nationwide Trends in in-Hospital Mortality and Hospitalization Associated with Systemic Sclerosis (SSc)
- 9:00AM-11:00AM
-
Abstract Number: 843
Natriuretic Peptide Predicts Mortality in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 167
Negative Gaenslen’s (Squeeze) Test Has a High Negative Predictive Value for Significant Ultrasonographic Metatarsophalangeal Involvement in Early Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 292
Neoepitope Biomarkers As Biomarkers of Polymyositis and Dermatomyositis and Functional Status
- 9:00AM-11:00AM
-
Abstract Number: 761
Neurometabolic Alterations in Korean Lupus Patients with Chronic Daily Headache
- 9:00AM-11:00AM
-
Abstract Number: 569
Neurophil to Lymphocyte Ratio Is a Reliable Marker of Treatment Response in Rheumatoid Arthritis Patients during Tocilizumab Therapy
- 9:00AM-11:00AM
-
Abstract Number: 208
Neutrophil-Mediated Mechanisms of Drug-Induced Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 860
Neutrophil/Lymphocyte Ratio: Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis?
- 9:00AM-11:00AM
-
Abstract Number: 101
New Technologies for Typing Self-Identifying Antigens Encoded By HLA Genes Provide Cost-Effective Alternatives to Identifying B27 Allele Status in Rheumatoid Arthritis Subjects
- 9:00AM-11:00AM
-
Abstract Number: 371
New Vertebral Fractures after Vertebroplasty: Two Year Results from a Randomised Placebo-Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 94
NGS Panel for the Detection of Monogenic SLE in Children: Initial Results
- 9:00AM-11:00AM
-
Abstract Number: 848
Nitroglycerin Patch Application in Systemic Sclerosis: Evaluation By Laser Doppler Imaging
- 9:00AM-11:00AM
-
Abstract Number: 454
No Sex Bias in the Escalation of Therapy in the Treatment of Early Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 64
Nociceptive Flexion Reflex Threshold: Possible Surrogate Marker of Symptom Severity in Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 498
Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
- 9:00AM-11:00AM
-
Abstract Number: 839
Occupational Exposures in Patients with Systemic Sclerosis Associated with Increased Frequency of Interstitial Lung Disease and Primary Pulmonary Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 500
Ofatumumab for Rheumatoid Arthritis: A Cochrane Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 326
Older Adults without Extreme Obesity Are at Highest Risk for Accelerated Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 554
On Drug and Drug-Free Remission By Baseline Disease Duration: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 477
On-Demand Use of Etanercept Only for Disease Flares Reduced the Disease Activity Score and Structural Damage Equivalent to Fully-Use of Etanercept in RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 139
One-Year Cost of Etanercept, Adalimumab, and Infliximab per Treated Patient with Chronic Inflammatory Arthritides in US Veterans
- 9:00AM-11:00AM
-
Abstract Number: 144
One-Year Costs Following Switching Versus Dose-Escalation Among Prevalent Tumor Necrosis Factor Inhibitors Used for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 581
Optimization of Treatment Intervals of Tocilizumab and Golimumab By Measuring Serum Trough Levels in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 51
Oral Glucocorticoid Use Is Associated with Osteonecrosis in Adults with Chronic Inflammatory Diseases but Not in Children: A Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 723
Oral Ulcers in Systemic Lupus Erythematosus: Characterization and Clarification of an Important Clinical Manifestation
- 9:00AM-11:00AM
-
Abstract Number: 783
Osteonecrosis in Systemic Lupus Erythematosus: Predictive Factors
- 9:00AM-11:00AM
-
Abstract Number: 380
Osteoporosis Screening and Treatment of Rheumatoid Arthritis Patients at a Teaching Institution
- 9:00AM-11:00AM
-
Abstract Number: 378
Osteoporotic Fragility Tibia/Fibula Fractures Are Not Asociated with a Low Body Mass Index: An Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 585
Outcomes after Discontinuing Tumor Necrosis Factor Inhibitor in Rheumatoid Arthritis: 2 Years of ‘post-Golimumab’ after Completion of the 5-Year Extension Study in Korea
- 9:00AM-11:00AM
-
Abstract Number: 555
Outcomes Associated with Non-Medical Switching/Discontinuation of Anti-TNF Inhibitors Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 388
Pain, Fatigue and the Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus
- 9:00AM-11:00AM
-
Abstract Number: 641
Pain, Xerostomia and Younger Age Are Major Determinants of Fatigue in Korean Primary Sjögren’s Syndrome Patients: A Comprehensive Analysis of a Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 80
Paresthesias in Fibromyalgia Patients
- 9:00AM-11:00AM
-
Abstract Number: 668
Pasdas, Cpdai and MDA Evolution in the First 6 Months after Diagnosis of Early Psoriatic Arthritis Patients: Results of the Depar Study
- 9:00AM-11:00AM
-
Abstract Number: 62
Patient Perception of Disease Burden in Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 884
Patient Perceptions of Treatment with Glucocorticoids in ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 664
Patient Reported Outcomes and Assessment of the Quality of Life in a Cohort of Patients Affected By Enteropathic Spondyloarthritis: Definitive Results of a Monocentric Prospective Observational Study at One Year
- 9:00AM-11:00AM
-
Abstract Number: 411
Patient Reported Outcomes in Juvenile Dermatomyositis: Assessing the Importance of Different Measures to Patients and Families
- 9:00AM-11:00AM
-
Abstract Number: 126
Patients with Osteoarthritis and Rheumatoid Arthritis Seen at 4 Different Routine Rheumatology Care Sites at This Time Have Similar and Patient and Physician Global Estimates of Severity, and Scores for Functional Disability, Pain, and RAPID3
- 9:00AM-11:00AM
-
Abstract Number: 679
Patients with Psoriatic Arthritis and Oligoarthritic Subtype Report Higher Disease Burden Than Patients with a Polyarthritic Pattern – Data from the German Collaborative Arthritis Centres
- 9:00AM-11:00AM
-
Abstract Number: 809
Patients with SLE Who Are Anti-Factor Xa IgG Positive Are Less Likely to Have Atherosclerotic Plaque
- 9:00AM-11:00AM
-
Abstract Number: 19
Pentagalloyl Glucose (PGG) Exhibits Anti-Rheumatic Activity in Human RA Synovial Fibroblasts and Rat Adjuvant-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 414
Performance of the Adult Systemic Sclerosis Classification in Juvenile Systemic Sclerosis Patients. Results from the Juvenile Systemic Sclerosis Inception Cohorte Www.Juvenile-Scleroderma.Com
- 9:00AM-11:00AM
-
Abstract Number: 72
Performance of the New Survey Criteria for Fibromyalgia Under Conditions of Low and High Symptom Activity
- 9:00AM-11:00AM
-
Abstract Number: 323
Perioperative Interventions for Smoking Cessation in Hip and Knee Arthroplasty for Osteoarthritis and Other Non-Traumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 820
Peripheral Blood and Disease Features Associated with Complement Components C3 and C4 in SLE
- 9:00AM-11:00AM
-
Abstract Number: 486
Persistence Among Rheumatoid Arthritis Patients Initiating Intravenous or Subcutaneous Anti-Tumor Necrosis Factor Therapy in a Large US Registry Cohort
- 9:00AM-11:00AM
-
Abstract Number: 445
Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 99
Personalised Genetic Medicine: HLA-DRB1 Amino Acid Positions 11, 71 and 74 Predict Inflammation Level, Disease Activity and Disability in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 490
Personalizing the Treat to Target Approach in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 319
Phase 1 Studies of Anti-Interleukin-1 Dual-Variable Domain Immunoglobulin in Healthy Subjects and Patients with Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 210
Phenotypically Divergences of Monocyte Subsets and Microparticles in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 512
Physical Function and Inflammatory Activity in Rheumatoid Arthritis Patients. Is Disease Duration Important?
- 9:00AM-11:00AM
-
Abstract Number: 136
Physician Patterns of Patient Care in Systemic Lupus Erythematosus: Are We Ordering Unnecessary Tests?
- 9:00AM-11:00AM
-
Abstract Number: 524
Plasma Concentrations of Antibodies to Porphyromonas Gingivalis Are Increased before Onset of Symptom of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 888
Plasma Exchanges to Treat Primary Systemic Necrotizing Vasculitides: Data from a French Nationwide Study
- 9:00AM-11:00AM
-
Abstract Number: 532
Plasma Levels of Bone Morphogenetic Protein (BMP) Subgroups and Their Inhibitors (noggin, sclerostin) in Rheumatoid Arthritis Patients and Correlation with Disease Activity, Clinical and Radiographic Progression: Preliminary Results
- 9:00AM-11:00AM
-
Abstract Number: 309
Plasma Levels of Heat Shock Protein 90 Are Increased in Idiopathic Inflammatory Myopathies and Correlate with Disease Activity, Skeletal Muscle, Heart and Lung Involvement
- 9:00AM-11:00AM
-
Abstract Number: 48
Polypharmacy Is a Predictor of Hospitalisation in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 628
Poor Prognosis of Patients with Primary Sjögren Syndrome Who Fulfilled at Diagnosis the Classification Criteria for Concomitant Cryoglobulinemic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 584
Positivity for Rheumatoid Factor Is Associated with a Better Short-Term Response and Long-Term Drug Retention of Abatacept: Results from Consecutive 508 Patients with Rheumatoid Arthritis in a Japanese Multicenter Registry
- 9:00AM-11:00AM
-
Abstract Number: 576
Possibility of Extension of the Administration Interval of Tocilizumab in the Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 772
Post-Phlebotomy Stability of Soluble and Cellular Forms of Complement Activation: Implications in SLE Diagnostic Assays
- 9:00AM-11:00AM
-
Abstract Number: 250
Postvaccination Antibody Titer Data in CAPS Patients Aged 28 Days to 4 Years Treated with Canakinumab: Results of an Open-Label Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 127
Potential Use of Healthcare Databases for Post-Marketing Surveillance Registry: an Example Using Ustekinumab
- 9:00AM-11:00AM
-
Abstract Number: 159
Power Doppler Continuous Quantitative Assessment Techniques Is Faster Than Semiquantitative Assesment in Identification of Therapeutic Response
- 9:00AM-11:00AM
-
Abstract Number: 402
Predicting Area Under the Curve of Mycophenolate Mofetil in Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 593
Predicting the Need for Additional Treatment in Early Rheumatoid Arthritis Patients Treated to Target on Methotrexate Monotherapy
- 9:00AM-11:00AM
-
Abstract Number: 644
Predicting the Risk for Lymphoma Development in Sjögren’s Syndrome: An Easy to Use Clinical Tool
- 9:00AM-11:00AM
-
Abstract Number: 575
Predictive Factors for Achieving Low Disease Activity at 52 Weeks after Switching from Tumor Necrosis Factor Inhibitors to Abatacept: Results from a Multicenter Observational Cohort Study of Japanese Patients
- 9:00AM-11:00AM
-
Abstract Number: 503
Predictors for Attaining Remission at Two Consecutive Visits in Newly Diagnosed Early RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 572
Predictors of Long-Term Retention of Infliximab and Golimumab in Rheumatoid Arthritis: An Analysis from a Prospective, Observational Registry
- 9:00AM-11:00AM
-
Abstract Number: 61
Predictors of Mortality Among Patients with Sarcoidosis: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 455
Predictors of Real-World Treatment Sustainability in RA Patients Treated with Abatacept in Canada: Implications for Routine Care
- 9:00AM-11:00AM
-
Abstract Number: 859
Predictors of Renal Histopathology in Antineutrophil Cytoplasmic Antibody Associated Glomerulonephritis
- 9:00AM-11:00AM
-
Abstract Number: 739
Prednisone Increases Both Arterial and Venous Thrombosis in SLE
- 9:00AM-11:00AM
-
Abstract Number: 511
Pretreatment Prediction of Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptors in Individual Rheumatoid Arthritis Patient
- 9:00AM-11:00AM
-
Abstract Number: 43
Prevalence and Relevance of Depressive Symptoms in Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 372
Prevalence of Atypical Fractures in a Tertiary Hospital
- 9:00AM-11:00AM
-
Abstract Number: 226
Prevalence of Cardiovascular Disease in Patients with Gout, Osteoarthritis or Both
- 9:00AM-11:00AM
-
Abstract Number: 335
Prevalence of Hand Osteoarthritis and Factors Associated with Pain in Korean Farmers
- 9:00AM-11:00AM
-
Abstract Number: 841
Prevalence of Systemic Sclerosis in Primary Biliary Cirrhosis Using the New ACR/EULAR Classification Criteria
- 9:00AM-11:00AM
-
Abstract Number: 367
Prevention and Treatment of Bone Loss Following Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 621
Previous Diagnosis of Sjögren’s Syndrome As Rheumatoid Arthritis or Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 700
Problems of Untranslatability: Example of Turkish Version of Basdai
- 9:00AM-11:00AM
-
Abstract Number: 857
Prognosis Value of Geriatric Assessment Scales in Older Adults with New Onset ANCA-Associated Vasculitis: A Pilot Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 495
Prognostic Significance of Residual Inflammation and Autoantibodies for Disease Relapse upon DMARD Suspension in Patients with Rheumatoid Arthritis in Sustained Remission after DAS-Driven Therapy
- 9:00AM-11:00AM
-
Abstract Number: 709
Progression of Patients with Non-Radiographic Axial Spondyloarthritis to Ankylosing Spondylitis: A Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 439
Progression of Radiographic Joint Destruction in Patients with Rheumatoid Arthritis Treated with a Biologic Agent in Combination with Methotrexate Versus a Biologic Alone: A Systematic Review and Meta-Analysis of Randomized Trials
- 9:00AM-11:00AM
-
Abstract Number: 273
Progression Predictive Factors in Patients with Undifferentiated Connective Tissue Disease: A Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 804
Prolactin Induces Interferon Regulatory Factor 1 Activation and Histone H4 Hyperacetylation in Primary Monocytes Comparable to Changes Seen in Monocytes from Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 759
Prolactin Level Is Independently Associated with Circulating CD4+CD28null in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 172
Prospective Assessment of Carotid Intima Media Thickness in Relation to Activity of the Disease in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 588
Prospective Study about Extension of Dosing Interval with Tocilizumab Therapy in Rheumatoid Arthritis Patients in Remission Maintenance
- 9:00AM-11:00AM
-
Abstract Number: 5
Prospective Study of the Effect of Treatment with Adalumumab in Angiogenesis in Moderate or Severe Psoriasis for a Period of 6 Months
- 9:00AM-11:00AM
-
Abstract Number: 416
Prospective, Standardized, Longitudinal Assessment Reveals Higher Prevalence of Extracutaneous Manifestations in a Pediatric Localized Scleroderma Cohort
- 9:00AM-11:00AM
-
Abstract Number: 403
Proteinuria in Childhood Onset Lupus Nephritis: When Does It Go Away ?
- 9:00AM-11:00AM
-
Abstract Number: 21
Pseudostarvation Using the AMPK Activator Metformin Downregulates Inflammation in Rheumatoid Arthritis Synovial Tissue
- 9:00AM-11:00AM
-
Abstract Number: 252
Pyrin (MEFV) Mutations in New York: Revisiting the Mount Sinai Experience with Periodic Fever and Serositis
- 9:00AM-11:00AM
-
Abstract Number: 472
Quality Assessment in Clinical Management of Patients with Rheumatoid Arthritis. Are We Using the “Treat to Target” Strategy?
- 9:00AM-11:00AM
-
Abstract Number: 258
Quality of Life Changes with Canakinumab Therapy in Adults with Colchicine Resistant FMF
- 9:00AM-11:00AM
-
Abstract Number: 694
Quality of Life in Patients with Active Peripheral Spa Is Similarly Impaired As in Other Rheumatic Diseases and Influenced By Disease Activity but Not Disease Duration
- 9:00AM-11:00AM
-
Abstract Number: 539
Quantification of T-Cell Receptor Excision Circles (TREC) from Peripheral Blood in Patients with Inflammatory Polyarthritis of Recent Onset (EPA): Association with Radiographic Joint Damage
- 9:00AM-11:00AM
-
Abstract Number: 375
RA May Not Confer Addition Risk of Osteoporosis in Male Patients – Results of Cohort Analysis and Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 457
RA Patients with Medicare Only Insurance Have Similar Clinical Outcomes As Patients with Private Insurance Despite Having Less Access to Biologics
- 9:00AM-11:00AM
-
Abstract Number: 528
RA33 Challenges the Paradigm of Autoantigen Selection in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 484
Race Plays a Role in Influencing the Modest Lipid Lowering Effects of Hydroxychloroquine in Patients with Rheumatoid Arthritis, Independent of Statin Use
- 9:00AM-11:00AM
-
Abstract Number: 401
Racial and Ethnic Disparities in Depression Diagnosis and Treatment for Adolescents with SLE: Analysis of a National Medicaid Sample
- 9:00AM-11:00AM
-
Abstract Number: 340
Radiographic Assessment of Hand Osteoarthritis – the Role of Oblique View Images
- 9:00AM-11:00AM
-
Abstract Number: 462
Radiographic Progression in Patients with Early Rheumatoid Arthritis Has Not Become Milder over the Past Decades
- 9:00AM-11:00AM
-
Abstract Number: 16
Rantes/CCL5 Selectively Induces MMP-1 and MMP-13 Production in Rheumatoid Arthritis Synovial Fibroblasts Via PKC-δ and JNK Pathways
- 9:00AM-11:00AM
-
Abstract Number: 655
Rasch Analysis of the Hospital Anxiety and Depression Scale in Psoriatic Arthritis: Results from the Presta Study.
- 9:00AM-11:00AM
-
Abstract Number: 146
Rates of Lipid Testing and Statin Prescription Filling Among U.S. Medicaid Recipients with SLE, 2007-2010
- 9:00AM-11:00AM
-
Abstract Number: 542
Reduced Expression of Mir-204 in Early RA Promotes Inflammatory Pathways in Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 322
Reduction of Treatment Needed for Knee Osteoarthritis after Bariatric Surgery
- 9:00AM-11:00AM
-
Abstract Number: 362
Reference Curves of Bone Parameters Obtained By High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Healthy Women from 20 to 85 Years Old
- 9:00AM-11:00AM
-
Abstract Number: 683
Referral Strategies for the Early Diagnosis of Axial Spondyloarthritis- a Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 15
Regulation of Neutrophil Extravasation By Interleukin-8-Induced Intravascular Reactive Oxygen Species Production during the Inflammatory Response
- 9:00AM-11:00AM
-
Abstract Number: 895
Relapses and Predictive Factors in Henoch-SchÖnlein Purpura. study of 417 Patients
- 9:00AM-11:00AM
-
Abstract Number: 317
Relation of Incident Bisphosphonate Use to Trajectory of Joint-Space Width
- 9:00AM-11:00AM
-
Abstract Number: 170
Relationship Between Finger Joint Cartilage Evaluated By Ultrasound and Clinical Characteristics in Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 235
Relationship Between Tissue Stress during Gait and Patterns of Urate Deposition and Bone Erosion in Gout: A Biomechanical Computational Modelling Study
- 9:00AM-11:00AM
-
Abstract Number: 345
Relationship Between Total Hip BMD T-Score and Incidence of Nonvertebral Fracture with up to 8 Years of Denosumab Treatment
- 9:00AM-11:00AM
-
Abstract Number: 238
Relationship Between Ultrasonographic Synovial Inflammation and Ultrasonographic Urate Deposition Findings in Patients with Gout
- 9:00AM-11:00AM
-
Abstract Number: 418
Relationship of Race, Ethnicity, and Outcomes in Pediatric Localized Scleroderma: Possible Differences in Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 295
Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index Among Dermatologists, Rheumatologists, and Neurologists
- 9:00AM-11:00AM
-
Abstract Number: 827
Reliability of the Quantitative Assessment of Peripheral Blood Perfusion By Laser Speckle Contrast Analysis in a Systemic Sclerosis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 637
Repeated B Lymphocyte Depletion Therapy with Rituximab in Sjögren’s Syndrome: A Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 727
Repository Corticotropin Injection (H.P. Acthar® Gel) Attenuates Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus (SLE) Requiring Corticosteroids
- 9:00AM-11:00AM
-
Abstract Number: 203
Rescue of Copa Syndrome Cellular Phenotype By Autophagy Modifying Drugs
- 9:00AM-11:00AM
-
Abstract Number: 151
Residual Synovitis in Ultrasound (US) Is Associated with an Evolution Towards Rheumatoid Arthritis (RA) in Patients with Inflammatory Polyarthralgia without ANTI-Citrulinated Antibodies (ACPA)
- 9:00AM-11:00AM
-
Abstract Number: 302
Resource Utilization in a US Sample of Patients with Sporadic Inclusion Body Myositis
- 9:00AM-11:00AM
-
Abstract Number: 344
Results of a Phase 2 Clinical Trial to Evaluate the Effects of Romosozumab in Japanese Women with Postmenopausal Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 433
Rheumatoid Arthritis (RA) Biologic Switching and Cycling in a Large US Managed Care Population
- 9:00AM-11:00AM
-
Abstract Number: 87
Rheumatoid Arthritis (RA) Risk Gene CCR6 Polymorphism: Drug-Induced “Reversal” of ER Binding and the Expression of Inflammatory Mediators -Potential Molecular Mechanism Links Between Estrogen and RA
- 9:00AM-11:00AM
-
Abstract Number: 35
Rheumatoid Arthritis As a Risk Factor for Cardiovascular Events Following Hospitalized Pneumonia; A Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 184
Rheumatologists and Musculoskeletal Ultrasound: Discrepancy Between Attitudes, Desire and Reality in Routine Practice in South East England
- 9:00AM-11:00AM
-
Abstract Number: 129
Rheumatologists’ Approaches to Diagnosis and Treatment of Depression
- 9:00AM-11:00AM
-
Abstract Number: 212
Rising Incidence and Prevalence of Gout in the Canadian General Population
- 9:00AM-11:00AM
-
Abstract Number: 868
Risk Factors for Cytomegalovirus Reactivation in Patients with Antineutrophil Cytoplasmic Antibody -Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 616
Risk Factors for the Exacerbation of Interstitial Lung Disease (ILD) after Administration of Biologic Dmards in RA Patients with Pre-Existing ILD
- 9:00AM-11:00AM
-
Abstract Number: 32
Risk for Lung Cancer in RA and Different RA Phenotypes: Results from a Population-Based Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 31
Risk of Chronic Obstructive Pulmonary Disease in Rheumatoid Arthritis: A Population Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 610
Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Treated with Biologic Disease-Modifying Therapy Compared with Conventional Therapy
- 9:00AM-11:00AM
-
Abstract Number: 886
Rituximab As a Cyclophosphimide Sparing Agent for Patients with Multi-Relapsing Antineutrophil Cytoplasmic Antibody Associated Small Vessel Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 567
Rituximab Associated Late Onset Neutropenia – a Rheumatology Case Series and Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 277
Rituximab in Refractory Mixed Connective Tissue Disease: An Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 751
Rituximab Induced Serum Sickness: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 615
Rituximab Non Responders Fail to Down Regulated CD19 on Naive B Cells
- 9:00AM-11:00AM
-
Abstract Number: 20
Role of the Epigenetic Regulator EZH2 in Proinflammatory Macrophage Polarization and Signaling in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 591
Rosuvastatin Improves Endothelial Function in Patients with Inflammatory Joint Diseases, Longitudinal Associations with Atherosclerosis and Arteriosclerosis
- 9:00AM-11:00AM
-
Abstract Number: 657
Routine Assessment of Patient Index Data 3 Score (RAPID3) and Psoriasis Quality of Life (PQoL-12) Assess Different Domains in Psoriasis (PsO) and Psoriatic Arthritis (PsA) Patients
- 9:00AM-11:00AM
-
Abstract Number: 685
Sacroiliitis Misdiagnosed As Spondyloarthritis: Clinical Analysis of 581 Cases
- 9:00AM-11:00AM
-
Abstract Number: 833
Safety and Immunogenicity of Pneumococcal Vaccine in Patients with Systemic Sclerosis and Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 347
Safety Observations with 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab during the Pivotal 3-Year Trial and Subjects Who Crossed over to Denosumab during the Extension
- 9:00AM-11:00AM
-
Abstract Number: 608
Safety of Surgery in Patients with Rheumatoid Arthritis Treated By Abatacept: Data from the French Orencia in Rheumatoid Arthritis (ORA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 312
Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
- 9:00AM-11:00AM
-
Abstract Number: 738
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BCL-2 Inhibitor Venetoclax (ABT-199) in a Phase 1 Single and Multiple Ascending Dose Study in Female Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 629
Salivary Gland Ultrasonography As an Useful Tool to Distinguish Patients with Sjögren’s Syndrome at Risk for Non-Hodgkin’s Lymphoma Development
- 9:00AM-11:00AM
-
Abstract Number: 117
Same Day Rheumatology Access Clinic in an Academic Health Care Center
- 9:00AM-11:00AM
-
Abstract Number: 741
Satisfaction and Impact Associated with the Addition of Belimumab to Systemic Lupus Erythematosus (SLE) Treatment: A Cross-Sectional Survey of US Rheumatologists and Their Patients
- 9:00AM-11:00AM
-
Abstract Number: 677
Satisfaction in Psoriatic Arthritis Patients Despite Active Joint Disease
- 9:00AM-11:00AM
-
Abstract Number: 307
Screening for Pulmonary Hypertension in the Anti-Synthetase Syndrome; Utility of Four Different Screening Approaches
- 9:00AM-11:00AM
-
Abstract Number: 245
Seasonal Variation in Acute Gouty Arthritis: Data from Nationwide Inpatient Sample
- 9:00AM-11:00AM
-
Abstract Number: 855
Seasonality in ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 27
Self-Reported Sedentary Behavior in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 776
Sensitivity of Antinuclear Antibody By Immunofluorescence Testing for Detection of Anti-Ro/SSA Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 635
Seronegative Sjögren’s Syndrome Is Associated with a Higher Frequency of Patient-Reported Neuropathic Pain: An Analysis of the Sjögren’s International Collaborative Clinical Alliance Cohort
- 9:00AM-11:00AM
-
Abstract Number: 623
Seronegative Sjögren’s Syndrome Is Characterized By a Lower Prevalence of B-Cell Related Clinical Manifestations and a Lower Biologic Systemic Activity
- 9:00AM-11:00AM
-
Abstract Number: 171
Serum Calprotectin Levels Correlate with Ultrasonographic Synovitis in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 222
Serum Delta Neutrophil Index Measurement for Differentiating Acute Gouty Arthritis and Cellulitis in Normouricemic Patients
- 9:00AM-11:00AM
-
Abstract Number: 329
Serum Leptin and Risk of Knee Pain and Osteoarthritis: Multicenter Osteoarthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 753
Serum Levels of Tenascin-C Discriminate Patients with Active SLE from Inactive Patients and Healthy Controls, and Predict the Need to Escalate Immunosuppressive Therapy
- 9:00AM-11:00AM
-
Abstract Number: 607
Serum Progranulin (PRGN) Level Is Not a Biomarker for Responsiveness to Tumor Necrosis Factor (TNF)-Antagonist Therapy in Rheumatoid Arthritis (RA) Patients
- 9:00AM-11:00AM
-
Abstract Number: 230
Serum Uric Acid As Short Term Mortality Predictor in the Acute Care Setting
- 9:00AM-11:00AM
-
Abstract Number: 121
Serum Uric Acid Levels and Gout Flares in a US Managed Care Setting
- 9:00AM-11:00AM
-
Abstract Number: 9
Serum Visfatin Levels in Patients with Axial Spondyloarthitis and Early Rheumatoid Arthritis: Relation to Inflammation and Bone Changes
- 9:00AM-11:00AM
-
Abstract Number: 247
Severe Inflammation Following Vaccination Against Streptococcus Pneumoniae in Patients with Cryopyrin-Associated Periodic Syndromes
- 9:00AM-11:00AM
-
Abstract Number: 705
Sex Differences in Psoriatic Arthritis: Evaluation of a Real-Life Cohort of 2,118 Italian Patients Treated with Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 84
Sexual Dimorphism in the Association Between Multi-Site Pain and Other Fibromyalgia Features: an Analysis of Data from Three UK Population-Based Studies
- 9:00AM-11:00AM
-
Abstract Number: 274
Shrinking Lung Syndrome in Connective Tissue Disease
- 9:00AM-11:00AM
-
Abstract Number: 646
Sicca Syndrome in Rheumatoid Arthritis: Is It a Real Sjögren’s?
- 9:00AM-11:00AM
-
Abstract Number: 878
Significance of Interstitial Pneumonitis in Microscopic Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 224
Silent Monosodium Urate Crystals Deposits in Asymptomatic Hyperuricemia Lead to a Higher Need for Coronary Revascularization
- 9:00AM-11:00AM
-
Abstract Number: 867
Simultaneous Measurement of 25-Hydroxyvitamin D and Procalcitonin in Granulomatosis with Polyangiitis (GPA): Differentiation of Activity from Infection?
- 9:00AM-11:00AM
-
Abstract Number: 796
Single Cell Gene Expression Studies in Lupus Patient Monocytes Reveal a Unique Anti-Inflammatory Population of Non-Classical Monocytes Associated with Clinical Quiescence
- 9:00AM-11:00AM
-
Abstract Number: 488
Six-Year Retention Rates with Abatacept Vs TNF Inhibitors in the Treatment of Rheumatoid Arthritis: Experience from the Real-World Rhumadata Clinical Database and Registry
- 9:00AM-11:00AM
-
Abstract Number: 624
Sjögren’s Syndrome Foundation Clinical Practice Guidelines for Oral Disease Management: Caries Prevention
- 9:00AM-11:00AM
-
Abstract Number: 622
Sjögren’s Syndrome Foundation Clinical Practice Guidelines for Management of Dry Eyes
- 9:00AM-11:00AM
-
Abstract Number: 625
Sjögren’s Syndrome Foundation Clinical Practice Guidelines for Management of Systemic Disease
- 9:00AM-11:00AM
-
Abstract Number: 640
Sjögren’s Syndrome in Male Patients Presents with Higher Autoantibody Levels and More Extraglandular Manifestations
- 9:00AM-11:00AM
-
Abstract Number: 840
Skin Telangiectasia Identify a Subset of Systemic Sclerosis Patients with Severe Vascular Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 812
SLAMF3 Mediated Co-Stimulation Promotes Activation of the IL-2/IL-2R/STAT5 Pathway and Regulatory T Cells Differentiation in Human Naïve CD4+ T Cells – Implications for SLE
- 9:00AM-11:00AM
-
Abstract Number: 777
SLE-KeyTM Rule-out Test to Assess Lupus in Anti-Nuclear Antibody Positive Subjects Using the Immunarray iCHIP®
- 9:00AM-11:00AM
-
Abstract Number: 338
Smoking and Alcohol Use Are Associated with Structural and Inflammatory Hand Osteoarthritis Features in a Population Based Study
- 9:00AM-11:00AM
-
Abstract Number: 333
Smoking and Knee and Hip Osteoarthritis Evolution. Results from the Knee and Hip Osteoarthritis Long-Terme Assessment Cohort
- 9:00AM-11:00AM
-
Abstract Number: 361
Sodium Intake and Osteoporosis. Findings from the Women’s Health Initiative
- 9:00AM-11:00AM
-
Abstract Number: 691
Standards for the Classification of Non-Radiographic Axial Spondyloarthritis: A European Real World Study
- 9:00AM-11:00AM
-
Abstract Number: 806
STAT1 Activation Promotes TLR8 Overexpression and Facilitates Mirokine Signaling Via Exosomes Containing a Mir-21 Endogenous Ligand: A Novel Innate Inflammatory Pathway in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 601
Step-Down Strategy of Spacing TNF-Blockers Injections for Established Rheumatoid Arthritis in Remission: A within Randomized Control Trial Based Cost-Utility Analysis
- 9:00AM-11:00AM
-
Abstract Number: 383
Stiffness Index Study in Ehler Danlos Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 858
Stimulated Renal Glomerular Endothelial Cells Were Damaged By Fiber-like NETs Released By Neutrophils in ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 315
Structural Effects of Sprifermin in Knee Osteoarthritis: A Post-Hoc Analysis on Cartilage and Non-Cartilaginous Tissue Alterations
- 9:00AM-11:00AM
-
Abstract Number: 578
Study of the Production of Antinuclear Antibodies and Anti-Ds DNA Antibodies in Rheumatoid Arthritis Patients Treated with TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 164
Subclinical Ankle Involvement in Rheumatoid Arthritis. a Multicentre Ultrasound Study
- 9:00AM-11:00AM
-
Abstract Number: 825
Subclinical Atherosclerosis and Estimation of Cardiovascular Risk in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 645
Subclinical Cardiovascular Involvement in Patients with Primary Sjögren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 299
Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody
- 9:00AM-11:00AM
-
Abstract Number: 185
Success Rate and Utility of Ultrasound Guided Synovial Biopsies in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 568
Superiority of Initial Combination- over Step up Therapy in Treatment to the Target of Remission in Daily Clinical Practice in Early Rheumatoid Arthritis Patients: Results from the DREAM Registry
- 9:00AM-11:00AM
-
Abstract Number: 114
Surfing the Net: Patient Empowerment or Patient Deceit? Fifteen-Year Trends on the World Wide Web Information for Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 197
Synergy Between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of Dnase II Deficient Mice
- 9:00AM-11:00AM
-
Abstract Number: 717
Systemic Lupus Erythematosus and the Evaluation of Poor Sleep: The Sleeps Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 826
Systemic Sclerosis Inpatient Mortality Has Not Improved from 1995-2011. Results from a National Irish Audit of Scleroderma Co-Morbidities.
- 9:00AM-11:00AM
-
Abstract Number: 219
Targeted Deep Resequencing Identifies MRP4/ABCC4 as a Gout Risk Locus in the New Zealand Mä�ori and Pacific Island Populations
- 9:00AM-11:00AM
-
Abstract Number: 521
Targeted Quantitative Analysis to Identify Citrullinated Peptides in the Synovial Fluid of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 535
Taurine As a Biomarker for Prediction of Response to Biologic Therapy in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 305
The “Sleeve Sign”� in Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 96
The ABCG2 polymorphism Is Associated with Hyperuricemia in a Community-Based Korean Cohort
- 9:00AM-11:00AM
-
Abstract Number: 873
The ANCA-Vasculitis Index of Damage (AVID): Performance of a New Damage Instrument
- 9:00AM-11:00AM
-
Abstract Number: 173
The Automated Software-Guided Ultrasound Assessment of Bilateral Common Carotids Intima-Media Thickness for Investigation of Cardiovascular Risk in Psoriasis:Comparison Between Patients with or without Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 355
The Clinical and Genetic Spectrum of Low Alkaline Phosphatase in Adults
- 9:00AM-11:00AM
-
Abstract Number: 537
The Course of Bone Marrow Edema in Early Undifferentiated and Rheumatoid Arthritis; A Longitudinal MRI Study on Bone Level
- 9:00AM-11:00AM
-
Abstract Number: 28
The Decrease over Time of Orthopaedic Surgery in Patients with Rheumatoid Arthritis Is Mainly Due to Reduced Rates Among Those with Rheumatoid Factor Positive Disease – Results from a Well Defined Area
- 9:00AM-11:00AM
-
Abstract Number: 729
The Effect of Belimumab on Peripheral Blood Cells in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 342
The Effect of Erosive Status on Systemic Inflammatory Biomarkers in Hand Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 459
The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry
- 9:00AM-11:00AM
-
Abstract Number: 116
The Effect of the Formal Approval of Colchicine on Utilization of Emergency Department and Rheumatology Outpatient Services By Patients with Gout
- 9:00AM-11:00AM
-
Abstract Number: 368
The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital
- 9:00AM-11:00AM
-
Abstract Number: 834
The Efficacy of Rituximab in Systemic Sclerosis Joint Disease: A Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 211
The Epidemiology of Gout: Marked Increase in Incidence and Comorbidities over 20 Years
- 9:00AM-11:00AM
-
Abstract Number: 522
The Expression of mRNA for Peptidylarginine Deiminase Type 2 and Type 4 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 280
The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 543
The IL-20 Receptor Axis in Early Rheumatoid Arthritis: Novel Inflammation-Independent Links Between Autoantibody Positivity and Radiographic Progression
- 9:00AM-11:00AM
-
Abstract Number: 690
The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household
- 9:00AM-11:00AM
-
Abstract Number: 427
The Impact of Biologic Agent Initiation after 1 Versus 2 Prior Csdmards in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 34
The Impact of Cardiovascular and Lung Disorder Morbidities on Physical Activity in People with Inflammatory Arthritis Compared to the General Population in the UK
- 9:00AM-11:00AM
-
Abstract Number: 592
The Impact of Tobacco Smoking on the Effectiveness of Abatacept in Rheumatoid Arthritis: Data from a Paneuropean Analysis of RA Registries
- 9:00AM-11:00AM
-
Abstract Number: 36
The Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis: a 15 Years Observational Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 4
The Influence of Adipokines on the Interaction of Rheumatoid Arthritis Synovial Fibroblasts with Endothelial Cells
- 9:00AM-11:00AM
-
Abstract Number: 1
The Integrin Very Late Antigen-4 Plays a Key Role in the Recruitment of B Cells at the Inflammatory Foci
- 9:00AM-11:00AM
-
Abstract Number: 533
The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 762
The Interferon Signature Correlates with Longitudinal Disease Severity in Systemic Lupus Erythematosus, but Adds Little to Conventional Prognostic Indicators
- 9:00AM-11:00AM
-
Abstract Number: 254
The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in a Cohort of 13 Patients
- 9:00AM-11:00AM
-
Abstract Number: 768
The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Instrument Correlates Between Trained Clinical Investigators and Clinicians
- 9:00AM-11:00AM
-
Abstract Number: 98
The Mitochondrial DNA (mtDNA) Haplogroups Influence the Risk of Incidence Knee OA. Replication Study Including Data from Check and OAI Cohorts
- 9:00AM-11:00AM
-
Abstract Number: 111
The Mitochondrial DNA (mtDNA) Haplogroups Influence the Risk of Radiographic OA Progression. a Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 112
The Molecular Genetic Analysis of the Autoinflammatory Syndromes in Russian Patients with Manifestation of Systemic Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 618
The Multi-Biomarker Disease Activity Score in Methotrexate Incomplete Responders Predicts Clinical Responses to Non-Biological Versus Biological Therapy in Early RA
- 9:00AM-11:00AM
-
Abstract Number: 2
The Neutrophil Protein S100A12 Has Stronger Associations with a Comprehensive Ultrasound Score of Synovitis Than Vascular Endothelial Growth Factor in a Longitudinal Study of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 6
The Novel Role of Corticotropin-Releasing Hormone and Urocortin1 on Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 652
The Performance of Different Classification Criteria Sets for Spondyloarthritis in the Worldwide ASAS-Comospa Study
- 9:00AM-11:00AM
-
Abstract Number: 651
The Prediction of Long-Term Minimal Disease Activity and Its Benefits in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 256
The Predominant Attack Type and Associated Clinical-Laboratory Conditions in Patients with Familial Mediterranean Fever
- 9:00AM-11:00AM
-
Abstract Number: 740
The Prevalence of Anti-DFS70 Antibodies in an International Inception Cohort of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 237
The Prevalence of Chondrocalcinosis of the Symphysis Pubis on CT Scan and Correlation with Calcium Pyrophosphate Dihydrate Crystal Deposition Disease
- 9:00AM-11:00AM
-
Abstract Number: 44
The Prevalence of Depression and Anxiety in a Cross-Section of Rheumatological Conditions
- 9:00AM-11:00AM
-
Abstract Number: 196
The Pyrin Domain-Only Protein POP1 Inhibits NLRP3-Dependent Inflammatory Disease
- 9:00AM-11:00AM
-
Abstract Number: 611
The Rapid Kinetics of Optimal Treatment with Subcutaneous Methotrexate in Early Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 757
The Ratio Between TNF-a and P-Albumin – a Suggested Measure of Disease Activity in SLE
- 9:00AM-11:00AM
-
Abstract Number: 327
The Relation of Plasma Vitamin K Status to Meniscal Pathology in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 552
The Relationship Between Efficacy and Toxicity in Patients with Rheumatoid Arthritis Receiving Methotrexate in Combination with Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 376
The Relationships Between Bone Mineral Density and Radiographic Features of Hand or Knee Osteoarthritis in Older Adults: Data from the Dong-Gu Study
- 9:00AM-11:00AM
-
Abstract Number: 426
The Risk of Hospitalized Infection Following Initiation of Biologic Agents Versus Methotrexate in the Treatment of Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 239
The Role of Dual Energy Computed Tomography in Diagnosing Acute Gouty Arthritis: Comparison with Ultrasound and Aspiration
- 9:00AM-11:00AM
-
Abstract Number: 874
The Short Term Damage Burden in Vasculitis and Vasculitis Mimics As Measured By the Vasculitis Damage Index
- 9:00AM-11:00AM
-
Abstract Number: 14
The SLE Susceptibility Gene Macrophage Migration Inhibitory Factor Serves As an Upstream Regulator of NLRP3 (NOD-like receptor family pyrin domain containing 3) Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP Immune Complex
- 9:00AM-11:00AM
-
Abstract Number: 68
The Stroop Word-Naming Test in Fibromyalgia Patients
- 9:00AM-11:00AM
-
Abstract Number: 832
The Validity and Reliability of Online Obituaries As a Source of Mortality Data
- 9:00AM-11:00AM
-
Abstract Number: 81
The Value of Routine Use of Creatine Kinase and Thyroid Stimulating Hormone Tests in Patients with Suspected Fibromyalgia: Results of a Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 612
Thromboembolic Events Are Not Associated with Anti-Adalimumab Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 481
Time to Disease-Modifying Anti-Rheumatic Drug Treatment for New Patients with Rheumatoid Arthritis – Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 614
Time to First Signs of Loss of Response in Rheumatoid Arthritis Patients Treated with Anti TNF Agents: Correlations with Serum Drug Level, Immunogenicity and Csdmard Association
- 9:00AM-11:00AM
-
Abstract Number: 586
Titer of Anti-Citrullinated Peptide Antibody Affects the Efficacy of First Biological Treatment in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 268
TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still’s Disease and Their Association with Disease Activity and Clinical Manifestations
- 9:00AM-11:00AM
-
Abstract Number: 444
TNF Inhibitor Use Across Countries in Two Time Periods Using the Meteor Database
- 9:00AM-11:00AM
-
Abstract Number: 285
Tobacco Smoking in Different Racial Groups Is Differentially Associated with the Development of Myositis Autoantibodies and Interstitial Lung Disease in the Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 265
Tocilizumab Compared with Anakinra in Refractory Adult-Onset Still’s Disease. Multicenter Study of 75 Patients
- 9:00AM-11:00AM
-
Abstract Number: 260
Tocilizumab Is Effective in the Treatment of AA Amyloidosis Secondary to Familial Mediterranean Fever
- 9:00AM-11:00AM
-
Abstract Number: 600
Tocilizumab Serum Trough Levels and Disease Activity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 351
Trabecular Bone Score Is Severely Affected in Male Patients with Chronic Obstructive Pulmonary Disease
- 9:00AM-11:00AM
-
Abstract Number: 799
Transcriptional Profiling of Cutaneous Lupus Reveals Pronounced Changes in Keratinocyte and Myeloid Lineage Expressed Genes and Demonstrates Uniquely Regulated Interferon Pathways Between Rash Subtypes
- 9:00AM-11:00AM
-
Abstract Number: 390
Treatment and Outcomes in Pediatric SLE Patients in South Africa
- 9:00AM-11:00AM
-
Abstract Number: 497
Treatment Outcomes in Elderly Patients with Rheumatoid Arthritis: Results from a Nationwide Korean Biologics Registry
- 9:00AM-11:00AM
-
Abstract Number: 429
Treatment Preferences of Patients with Early Rheumatoid Arthritis: A Discrete-Choice Experiment
- 9:00AM-11:00AM
-
Abstract Number: 431
Treatment Target in a Disease Activity Score Steered Treatment Protocol in Early Arthritis Patients: Low Disease Activity or Remission
- 9:00AM-11:00AM
-
Abstract Number: 463
Treatment with Biologic Agents for RA in Patients with MTX-Associated Lymphoproliferative Disorders
- 9:00AM-11:00AM
-
Abstract Number: 580
Treatment with Biologic Agents in Rheumatoid Arthritis and Mortality Risk in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 41
Trends in Non-Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis: Is There Room for Improvement?
- 9:00AM-11:00AM
-
Abstract Number: 474
Trends in the Use of Opiates in Rheumatoid Arthritis (RA) Compared to Non-RA: A Population Based Study in 2003-2012
- 9:00AM-11:00AM
-
Abstract Number: 119
Triage in Chronic Rheumatic Diseases: Quantitative Physician Estimates for Inflammation (Reversible), Damage (Irreversible), and Distress in Patients with Rheumatoid Arthritis, Osteoarthritis, and Fibromyalgia Seen in Usual Care
- 9:00AM-11:00AM
-
Abstract Number: 847
Troponin T and NT-Probnp Are Prognostic Cardiac Disease Biomarkers in Patients with Systemic Sclerosis without Pulmonary Arterial Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 558
Tuberculosis Risk Among Patients with Rheumatoid Arthritis in a United States Claims Database Initiating Abatacept and Other Biologic Disease-Modifying Antirheumatic Drugs: Analyses Using International Classification of Diseases Codes and a Published Claims Algorithm
- 9:00AM-11:00AM
-
Abstract Number: 382
Twelve Months after Osteoporosis Associated Fracture – Has Adequate Therapy Been Initiated?
- 9:00AM-11:00AM
-
Abstract Number: 163
Ultrasonographic Assessment Covers Clinical Examination in the Localization of Ankle Pathology in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 436
Ultrasonographic Disease Activity in Rheumatoid Arthritis Patients Who Are in Clinical Remission According to Different Remission Criteria: Should We Insist on Achieving Boolean Remission?
- 9:00AM-11:00AM
-
Abstract Number: 161
Ultrasonographic Evaluation of Rheumatoid Hand: Hand Disability and Disease Activity Correlation
- 9:00AM-11:00AM
-
Abstract Number: 177
Ultrasonographic Joint Evaluation in Daily Practice: What Is Its Contribution to Clinical Assessment?
- 9:00AM-11:00AM
-
Abstract Number: 169
Ultrasonographic Signs of Inflammation of Metatarsophalangeal Joints in Rheumatoid Arthritis Patients Who Are Treated to Target
- 9:00AM-11:00AM
-
Abstract Number: 162
Ultrasonography Versus Clinical Examination in Early DMARD-Naïve Rheumatoid Arthritis – a Comparative Study of Synovitis on the Individual Joint Level
- 9:00AM-11:00AM
-
Abstract Number: 441
Ultrasound Assessment of Early Response to Certolizumab Pegol Can Predict Future Response in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 168
Ultrasound Evaluation of the Efficacy of Biologic and Targeted Synthetic Dmards Toward Rheumatoid Arthritis Patients: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort in Japan
- 9:00AM-11:00AM
-
Abstract Number: 190
Ultrasound Imaging with Elastography for the Medical Treatment of Dupuytren’s Contracture
- 9:00AM-11:00AM
-
Abstract Number: 180
Ultrasound Quantification of Fluid Shifts in the Knees of Arthritis Patients before and after Inflation of a Pneumatic Compressive Device
- 9:00AM-11:00AM
-
Abstract Number: 158
Ultrasound Score of Dominant Hand in Patients with Rheumatoid Arthritis Correlates with DAS28CRP, CDAI and SDAI but Not RAPID-3
- 9:00AM-11:00AM
-
Abstract Number: 706
Undifferentiated Spondylarthritis May More Frequent in Japanese
- 9:00AM-11:00AM
-
Abstract Number: 412
Update on the Juvenile Systemic Sclerosis Inception Cohort Project. Characteristics of the First 50 Patients at First Assessment. Www.Juvenile-Scleroderma.Com
- 9:00AM-11:00AM
-
Abstract Number: 819
Upregulation of Complement C3 and Alpha-2-Macroglobulin in Cerebrospinal Fluid of Neuropsychiatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 229
Uric Acid and Incident Dementia over 10 Years
- 9:00AM-11:00AM
-
Abstract Number: 231
Uric Acid Levels Predict Mortality in Women
- 9:00AM-11:00AM
-
Abstract Number: 385
Urinary Cell-Free Microrna’s As Biomarkers of Lupus Nephritis in Children
- 9:00AM-11:00AM
-
Abstract Number: 718
Urinary MBL : A Promising Biomarker for Predicting Flare in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 716
Urinary Proteomics Identifies Three Novel Biomarkers for Lupus Nephritis Activity: Retinol Binding Protein, Alpha-1-Antichymotrysin and Haptoglobin
- 9:00AM-11:00AM
-
Abstract Number: 442
Use of Adjunctive Neuroregulatory Medication to Improve Etanercept Treatment Response for Patients with Inflammatory Arthritis: A Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 428
Use of Rituximab Compared to Anti-TNF Agents As Second and Third Line Therapy in Patients with Rheumatoid Arthritis: 6-Year Follow-up Report from the Rhumadata® Clinical Database and Registry
- 9:00AM-11:00AM
-
Abstract Number: 263
Use of Serum Ferritin and Heme Oxygenase 1 for the Diagnosis of Adult-Onset Still’s Disease: A Preliminary Report of Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 47
Use of Social Media Data for Comparative Effectiveness and Safety Research: An Example from Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 577
Use of Subcutaneous MTX Does Not Prolong the Use of Traditional DMARD in Multi-DMARD Regimens and Has Insignificant Differences in Liver Enzymes Abnormalities When Compared with Oral MTX in Patients with Rheumatoid Arthritis: A Veteran Affairs Administrative Database Study
- 9:00AM-11:00AM
-
Abstract Number: 450
Use of Tofacitinib in a Real World Setting: Clinical Features in a Cohort of Patients Using the Database Jointman Compared to a Published Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 631
Usefulness of the Minimally-Invasive Minor Salivary Gland Biopsy in Patients Presenting with Sicca Syndrome: Prospective Evaluation of 200 Patients
- 9:00AM-11:00AM
-
Abstract Number: 156
Usefulness of the Stricter Remission Criteria for Assessing the Absence of Subclinical Activity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 636
Utility of IgA Anti-Alpha-Fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies As Substitute Immunological Criterion for Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 153
Utility of Ultrasound Synovitis Assessment As a Predictor of Flares in Clinically Inactive Joints
- 9:00AM-11:00AM
-
Abstract Number: 56
Utilizing City-Wide Electronic Health Record Data to Assess Care Fragmentation in Patients with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 755
Validating the RAIL Algorithm in Adult Lupus Nephritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 100
Validation of a Distinct Psoriatic Arthritis Risk Variant at IL23R
- 9:00AM-11:00AM
-
Abstract Number: 115
Validation of a Large Rheumatoid Arthritis Cohort and Preventive Health Screening
- 9:00AM-11:00AM
-
Abstract Number: 165
Validation of a New Ultrasound Criteria for Subclinical Synovitis in Chronic Inflammatory Polyarthritis
- 9:00AM-11:00AM
-
Abstract Number: 379
Validation of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 95
Validation of Differential Methylation in Paternally Versus Maternally Transmitted Psoriatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 787
Validation of Lupuspro V1.8, Disease Targeted Patient Reported Outcome for Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 284
Validation of the Sporadic Inclusion Body Myositis Physical Functioning Assessment
- 9:00AM-11:00AM
-
Abstract Number: 166
Validity and Sensitivity to Change of the Semi-Quantitative Omeract Ultrasound Scoring System for Tenosynovitis in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 672
Validity of Ankylosing Spondylitis Diagnoses in the Health Improvement Network
- 9:00AM-11:00AM
-
Abstract Number: 52
Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian As Patients
- 9:00AM-11:00AM
-
Abstract Number: 120
Validity of the Inpatient Diagnosis of Systemic Lupus Erythematosus: Clarifying Hospital Readmission Rates
- 9:00AM-11:00AM
-
Abstract Number: 564
Value of Antinuclear Antibodies As a Predictor of Therapeutic Efficacy of Biologics in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 680
Variability over Time in Patient-Reported Outcome Measures in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 92
Variation at Interleukin-6 Receptor Gene Is Associated to Joint Damage in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 59
Variation in Heart Failure Hospitalizations Among U.S. Medicaid Recipients with SLE 2000-2010, By Race and Ethnicity
- 9:00AM-11:00AM
-
Abstract Number: 364
Very High Frequency of Fragility Fractures Associated with High-Dose Glucocorticoids in Postmenopausal Women: A Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 675
Vitamin D Deficiency in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis. Results of the CARMA Study
- 9:00AM-11:00AM
-
Abstract Number: 240
Volumetric Assessment of Tophaceous Gout
- 9:00AM-11:00AM
-
Abstract Number: 234
Weight Variables and Their Association with Serum Urate Concentrations and Hyperuricemia in Young Adults
- 9:00AM-11:00AM
-
Abstract Number: 255
What Acute Phase Reactants Accurately Identify Patients Who Will Develop Amyloidosis in Familial Mediterranean Fever? a Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 676
What Proportion of Patients with Psa Fail to Achieve MDA Based on Patient Reported Outcomes? an Analysis from a Prospective, Observational Registry
- 9:00AM-11:00AM
-
Abstract Number: 160
When Compared with a Computerized System Both Experienced and in-Training Sonographers Have Difficulties to Select the Best Doppler Image from a Cine-Loop
- 9:00AM-11:00AM
-
Abstract Number: 603
Which Seronegative RA Patients Respond to Rituximab? – Preliminary Analysis of a Merged Clinical Trials Dataset
- 9:00AM-11:00AM
-
Abstract Number: 188
Whole-Body Synovial Uptake of a 99mtc-Labelled RGD Peptide Is Highly Correlated with Power Doppler Ultrasound
- 9:00AM-11:00AM
-
Abstract Number: 137
Willingness to Pay for Highly Effective Drug Treatments in Brazilian Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 469
Window of Opportunity to Achieve Major Outcomes in Early Rheumatoid Arthritis Patients: How Persistence with Therapy Matters
- 9:00AM-11:00AM
-
Abstract Number: 872
Work Limitations and Disability in Patients with Systemic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 102
Xanthine Oxidase Gene Variants and Their Association with Blood Pressure and Incident Hypertension: A Population Based Study
- 11:00AM-12:30PM
-
Abstract Number: 900
A Multidimensional Immunomics Approach Annotates an Immunome Shaped By the Interplay Between the Periphery and the Skin Microenvironment in Systemic Sclerosis
- 11:00AM-12:30PM
-
Abstract Number: 898
A Randomized Double-Blind Study of Denosumab Compared with Zoledronic Acid in Postmenopausal Women with Osteoporosis Previously Treated with Oral Bisphosphonate
- 11:00AM-12:30PM
-
Abstract Number: 899
HA20: A Novel Autoinflammatory Disease Caused By Haploinsufficiency of A20, Encoded By TNFAIP3
- 11:00AM-12:30PM
-
Abstract Number: 896
Herpes Zoster and the Short Term Risk for Ischemic Stroke in Patients with Autoimmune Diseases
- 11:00AM-12:30PM
-
Abstract Number: 897
Intra-Articular Corticosteroids Are Safe and Have No Major Effect on Structural Progression of Synovitic Knee OA: A 2-Year Randomized Controlled Trial of 3-Monthly Triamcinolone Hexacetonide
- 2:30PM-4:00PM
-
Abstract Number: 913
A Comparison of Physician Based and Patient Based Criteria for the Diagnosis of Fibromyalgia
- 2:30PM-4:00PM
-
Abstract Number: 972
A Phase 2b Study Evaluating the Efficacy and Safety of Subcutaneously Administered Tregalizumab in Subjects with Active Rheumatoid Arthritis (RA) Despite Treatment with Methotrexate (MTX)
- 2:30PM-4:00PM
-
Abstract Number: 998
A Psychometric Analysis of the Social Interaction Anxiety Scale (SIAS-6) in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort
- 2:30PM-4:00PM
-
Abstract Number: 977
A Randomized, Double-Blind, Active- and Placebo-Controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naïve to Biologic Disease Modifying Anti-Rheumatic Drugs with Active Psoriatic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 944
Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features
- 2:30PM-4:00PM
-
Abstract Number: 1002
Aiming for Remission in Early RA: Impact on Pain during the First Year of Treatment
- 2:30PM-4:00PM
-
Abstract Number: 961
Altered Th Cell Plasticity Favors Th17 Cells in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 945
Anti-Hmgcr Antibodies As Specific Marker for Immune Mediated Necrotizing Myopathies
- 2:30PM-4:00PM
-
Abstract Number: 981
Anti-IL-17A Treatment Blocks Inflammation, Destruction and New Bone Formation in Experimental Spondyloarthritis in HLA-B27 Transgenic Rats
- 2:30PM-4:00PM
-
Abstract Number: 986
Application of New EULAR Definitions of Remission in SLE: Durable 1-Year Remission Is Rare
- 2:30PM-4:00PM
-
Abstract Number: 916
Assessing Alternative Selection Criteria for Fibromyalgia Patients within a Multicenter Chronic Pain Claims Database
- 2:30PM-4:00PM
-
Abstract Number: 918
Assessment of the Temporal Variation of the Fibromyalgia Patient Profile Between 2005 and 2013: Do Guidelines Inform Clinical Care?
- 2:30PM-4:00PM
-
Abstract Number: 980
Association of Platelet Endothelial Cell Adhesion Molecule-1 and ß1 Integrin Gene Polymorphisms with Uveitis Development in Ankylosing Spondylitis
- 2:30PM-4:00PM
-
Abstract Number: 948
Autoimmune Myopathies: Effects of Intravenous Immunoglobulin Therapy on Muscle Strength and Predictors of Response
- 2:30PM-4:00PM
-
Abstract Number: 919
Automated Case Identification of Lupus from an Electronic Health Record Using Novel Informatics Approaches
- 2:30PM-4:00PM
-
Abstract Number: 991
CaMK4 Facilitates Recruitment of IL-17 Producing Cells to Target Organs through the CCR6/CCL20 Axis in Th17-Driven Inflammatory Diseases
- 2:30PM-4:00PM
-
Abstract Number: 955
Cancer Risk in 5,108 Patients with Juvenile Idiopathic Arthritis (JIA)
- 2:30PM-4:00PM
-
Abstract Number: 982
CD4+CD146+ T Cells: The Primed IL-17 Secreting Cells in the Pathogenesis of Psoriatic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 968
Certolizumab Pegol in Combination with Methotrexate in DMARD-Naïve Patients with Active, Severe, Progressive Rheumatoid Arthritis: Results from a Randomized, Double-Blind, Controlled Phase 3 Study
- 2:30PM-4:00PM
-
Abstract Number: 903
CGEN-15001, a Novel B7-like Protein, Controls Inflammation in a Translational Rheumatoid Arthritis (RA) Assay and Induces Treg Driven Long-Term Remission in an Autoimmune Disease Model
- 2:30PM-4:00PM
-
Abstract Number: 917
Chronic Widespread Pain in Adolescents Is Highly Associated to Stress and Anxiety
- 2:30PM-4:00PM
-
Abstract Number: 905
Citrullinated Epithelial-Derived Neutrophil-Activating Peptide 78 (ENA-78/CXCL5) Induces Monocyte Migration Via JNK and NFκB Signaling Pathways
- 2:30PM-4:00PM
-
Abstract Number: 947
Cohesin Complex Is a New Myositis Autoantigen
- 2:30PM-4:00PM
-
Abstract Number: 951
Comparative Effectiveness of Tai Chi Versus Physical Therapy in Treating Knee Osteoarthritis: A Randomized, Single-Blind Trial
- 2:30PM-4:00PM
-
Abstract Number: 978
Continuous Versus on Demand Treatment of Ankylosing Spondylitis with Diclofenac over 2 Years Does Not Prevent Radiographic Progression of the Spine: Results from a Randomized Prospective Multi-Center Trial
- 2:30PM-4:00PM
-
Abstract Number: 952
Cost-Effectiveness of Opioids for the Treatment of Knee Osteoarthritis: Impact of Chronic Opioid Use on Total Knee Arthroplasty Outcomes
- 2:30PM-4:00PM
-
Abstract Number: 965
Crystal Structure of Porphyromonas Gingivalis peptidylarginine Deiminase: Implications for Autoimmunity in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 915
Defining Pain for Fibromyalgia Criteria: Multi-Site or Widespread? an Analysis of Data from Four UK Population-Based Studies
- 2:30PM-4:00PM
-
Abstract Number: 933
DEK-Targeting DNA Aptamers As Novel Therapeutics for Inflammatory Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 943
Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use
- 2:30PM-4:00PM
-
Abstract Number: 926
Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis through a Data-Driven Approach
- 2:30PM-4:00PM
-
Abstract Number: 999
Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation
- 2:30PM-4:00PM
-
Abstract Number: 906
Distinct Expression of IL-36α, β, γ and Their Antagonists IL-36Ra and IL-38 in Psoriasis, Rheumatoid Arthritis and Crohn’s Disease
- 2:30PM-4:00PM
-
Abstract Number: 929
Diurnal Variation of Power Doppler in Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 957
Double Blind Placebo Controlled Randomized Trial of Probiotics in Enthesitis-Related-Arthritis Category of JIA: Effect on Clinical and Immunological Parameters
- 2:30PM-4:00PM
-
Abstract Number: 989
Economic Evaluation of Lupus Nephritis in an International Inception Cohort: Comparing the Hospitalization, Medication, Dialysis, and Procedure Costs of Those with and without Nephritis
- 2:30PM-4:00PM
-
Abstract Number: 963
Ectopic Lymphoid Tissue in the Lung Is Associated with Serum Rheumatoid Arthritis-Related Autoantibodies Even in Absence of Clinically Apparent Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 953
Effectiveness of a Progressive Resistence Strength Programme on Hand Osteoarthritis: A Randomized Crontrolled Trial
- 2:30PM-4:00PM
-
Abstract Number: 970
Efficacy and Safety of Sarilumab in Combination with Csdmards in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti–TNF-α Therapy: Results from a Phase 3 Study
- 2:30PM-4:00PM
-
Abstract Number: 960
Efficacy of Canakinumab in Systemic Juvenile Idiopathic Arthritis Patients Previously Exposed to Biologics
- 2:30PM-4:00PM
-
Abstract Number: 983
ERAP1 Deficiency Protects HLA-B27 Transgenic Rats from Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 930
Evaluation of Temporomandibular Joint Arthritis with Ultrasound in Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 922
Factors Associated with Performance on Quality Measures Pertaining to Assessment of Disease Activity in Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 988
Factors Associated with Renal Remission, Relapse and Long-Term Renal Function Decline in Lupus Nephritis Treated with Combined Prednisolone and Mycophenolate Mofetil (MMF) or Tacrolimus (Tac)
- 2:30PM-4:00PM
-
Abstract Number: 993
Failure in Nutrient Sensing Supports mTOR Hyperactivity and Proinflammatory Functions in T Cells from Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 997
Feasibility and Influential Factors in Performing Self-Evaluation of DAS28 with Smart System of Disease Management (SSDM) By RA Patient in China
- 2:30PM-4:00PM
-
Abstract Number: 979
HLA Class I Genes As Susceptibility Markers of Psoriatic Arthritis in Patients with Psoriasis – a Meta-Analysis
- 2:30PM-4:00PM
-
Abstract Number: 936
IL-1 Receptor Antagonist Maintains Intestinal Microbial Homeostasis to Prevent Overt Toll-like Receptor 4-Dependent Intestinal Th17 Differentiation and Autoimmune Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 985
Improved Survival in Systemic Lupus Erythematosus: A Population-Based Study
- 2:30PM-4:00PM
-
Abstract Number: 950
In a Two-Year Double-Blind Randomized Controlled Multicenter Study, Chondroitin Sulfate Was Significantly Superior to Celecoxib at Reducing Cartilage Loss with Similar Efficacy at Reducing Disease Symptoms in Knee Osteoarthritis Patients
- 2:30PM-4:00PM
-
Abstract Number: 995
In Rheumatoid Arthritis Only a Few Expanded T-Cell Clones Dominate in Joint Inflammation: A Study in Seven RA Patients Undergoing Paired Synovial Tissue Biopsies in Multiple Joints
- 2:30PM-4:00PM
-
Abstract Number: 966
In Rheumatoid Arthritis, Smoking Is Not Associated with Anti-Citrullinated Protein Antibodies per Se, but with the Concurrent Presence of Rheumatoid Factor, Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies
- 2:30PM-4:00PM
-
Abstract Number: 902
Inhibitor of DNA Binding 1 As a Fibroblast Derived Inflammatory Angiogenic Agonist in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 904
Intracerebroventricular Tweak (TNF-like weak inducer of apoptosis) Induces Depressive-like Behavior and Cognitive Dysfunction in Non-Autoimmune Mice
- 2:30PM-4:00PM
-
Abstract Number: 932
IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus
- 2:30PM-4:00PM
-
Abstract Number: 939
Long-Term Efficacy and Safety of Canakinumab in Active Hyperimmunoglobulinemia D with Periodic Fever Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 938
Long-Term Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF Receptor-Associated Periodic Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 996
Metabolic Control of Invariant Natural Killer T Cell Function
- 2:30PM-4:00PM
-
Abstract Number: 935
Microrna-146a Provides Feedback Regulation of Monosodium Urate-Induced Gouty Arthritis in Mice By Targeting Tumor Necrosis Factor Receptor Associated Factor 6 and Interleukin-1 Receptor-Associated Kinase 1
- 2:30PM-4:00PM
-
Abstract Number: 931
mTOR Complex 1 Signaling Is Required for the Steady-State in Vivo Development of Inflammatory Monocytes
- 2:30PM-4:00PM
-
Abstract Number: 925
Musculoskeletal Ultrasound (MSK-US): Innovation or Overutilization?
- 2:30PM-4:00PM
-
Abstract Number: 969
Namilumab, an Anti-Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Monoclonal Antibody: Results of the First Study in Patients with Mild-to-Moderate Rheumatoid Arthritis (RA)
- 2:30PM-4:00PM
-
Abstract Number: 964
Neutrophil Extracellular Traps Are Not Only Targets for ACPA-Positive IgG from Rheumatoid Arthritis Patients but Also Directly Trigger Pro- and Anti-Inflammatory Effects Partly Mediated By the C1q Complement Protein
- 2:30PM-4:00PM
-
Abstract Number: 940
NOD2-Associated Autoinflammatory Disease: Therapy and Outcomes
- 2:30PM-4:00PM
-
Abstract Number: 901
Novel B Cell-Derived Peptide Regulation of Homeostatic T-Cell Trafficking Is Subverted in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 946
Novel Tripartite Motif Proteins Linked to Membrane Integrity As Biomarkers of Dermatomyositis and Polymyositis
- 2:30PM-4:00PM
-
Abstract Number: 1000
Obesity and Foot Problems in the Framingham Foot Study: Does Foot Structure or Foot Function Protect Against Hallux Valgus?
- 2:30PM-4:00PM
-
Abstract Number: 924
Patient and Provider Factors in Optimal Gout Management
- 2:30PM-4:00PM
-
Abstract Number: 920
Patient Preferences for the Development of a Mobile Health (mHealth) Application (App) for Systemic Lupus Erythematosus (SLE) Patients: A Qualitative Study
- 2:30PM-4:00PM
-
Abstract Number: 911
Patients with Rheumatoid Arthritis Are at Increased Risk of Both Ischemic and Non-Ischemic Heart Failure
- 2:30PM-4:00PM
-
Abstract Number: 923
Perceptions of Infectious Risk of Immunosuppressive Medications Among Treating Physicians
- 2:30PM-4:00PM
-
Abstract Number: 990
Performance of the Systemic Lupus International Collaborating Clinic Classification Criteria Versus the 1982 and Revised 1997 American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus: A Population-Based Study
- 2:30PM-4:00PM
-
Abstract Number: 934
Platelet-Independent Role of Megakaryocytes in Antibody-Mediated Murine Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 921
Poverty Associated with Increase in Damage in SLE over Two-Year Period
- 2:30PM-4:00PM
-
Abstract Number: 987
Pre-Emptive Renal Transplantation Among End Stage Renal Disease Patients with and without SLE
- 2:30PM-4:00PM
-
Abstract Number: 962
Profiling at the Single-Cell Level Reveals Evidence for Antigen-Driven Oligoclonal Expansion of Citrullinated Vimentin-Specific CD4+ T Cells in Peripheral Blood of Rheumatoid Arthritis (RA) Patients
- 2:30PM-4:00PM
-
Abstract Number: 941
Relationship Between Colchine Plasma Level and Frequency of Familial Mediterranean Fever Attacks
- 2:30PM-4:00PM
-
Abstract Number: 959
Results from the Childhood Arthritis and Rheumatology Research Alliance Systemic JIA Consensus Treatment Plans Pilot Study
- 2:30PM-4:00PM
-
Abstract Number: 937
Safety and Efficacy of Canakinumab in Patients with CAPS: Interim Results from the Beta-Confident Registry
- 2:30PM-4:00PM
-
Abstract Number: 971
Safety and Tolerability of Subcutaneous Sarilumab Compared to Intravenous Tocilizumab in Patients with RA
- 2:30PM-4:00PM
-
Abstract Number: 967
Safety, Tolerability, and Pharmacodynamics of ABT-122, a Dual TNF- and IL-17-Targeted Dual Variable Domain (DVD)-IgTM in Subjects with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 912
Secondary Preventive Pharmacotherapy and Longterm Outcomes Following Acute Coronary Events in Patients with Prevalent Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 974
Secukinumab Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: 52-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with Subcutaneous Loading and Maintenance Dosing
- 2:30PM-4:00PM
-
Abstract Number: 909
Smoking Behavior Changes after Rheumatoid Arthritis Diagnosis and Risk of Mortality during 36 Years of Prospective Follow-up
- 2:30PM-4:00PM
-
Abstract Number: 994
Th17/Tfh Cell Predict Disease Severity in Rheumatoid Arthritis Patients Receiving TNF Inhibitor Therapy
- 2:30PM-4:00PM
-
Abstract Number: 956
The Addition of One or More Biologics to Methotrexate in Children with Juvenile Idiopathic Arthritis Increases the Incidence of Infections and Other Adverse Events
- 2:30PM-4:00PM
-
Abstract Number: 975
The Effect of TNF Inhibition on Radiographic Progression in Ankylosing Spondylitis: An Observational Cohort Study of 374 Patients
- 2:30PM-4:00PM
-
Abstract Number: 973
The Effect of TNF Inhibitor Treatment on Occurrence of Anterior Uveitis in Ankylosing Spondylitis: Results from the Swedish Biologics Register
- 2:30PM-4:00PM
-
Abstract Number: 949
The Metabolic Syndrome, Its Elements and Knee Osteoarthritis: The Framingham Osteoarthritis (OA) Study
- 2:30PM-4:00PM
-
Abstract Number: 907
The Natural History of an Inception Cohort of Patients with Inflammatory Polyarthritis Followed for 20 Years: Disease Activity, Disability and Surgery
- 2:30PM-4:00PM
-
Abstract Number: 976
The Reason of Discontinuation of a First TNF Inhibitor Affects Drug Retention of a Second Anti-TNF Agent in Axial Spondyloarthritis
- 2:30PM-4:00PM
-
Abstract Number: 954
The Relationship Between Osteoarthritis and Cardiovascular Disease: Results from a Population-Based Cohort
- 2:30PM-4:00PM
-
Abstract Number: 958
The Time Spent in Inactive Disease before MTX Withdrawal Is Relevant with Regard to the Recurrence of Active Disease in Juvenile Idiopathic Arthritis (JIA) Patients
- 2:30PM-4:00PM
-
Abstract Number: 928
The Value of Early Ultrasound-Detected Osteophytes in Hand Osteoarthritis: Predicting the Future
- 2:30PM-4:00PM
-
Abstract Number: 992
Therapeutic Targeting of CD4+ T Cell Metabolism in Murine Models of Lupus
- 2:30PM-4:00PM
-
Abstract Number: 984
Tofacitinib Inhibits Inflammation and New Bone Formation in Murine Spondyloarthritis but Does Not Adversely Inhibit Normal Human MSC Function
- 2:30PM-4:00PM
-
Abstract Number: 910
Tumor Necrosis Factor-Alpha Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 927
Ultrasound Assessment of Heel Entheses in Spondyloarthritis Patients: A Comparative Study with Radiography and Magnetic Resonance Imaging
- 2:30PM-4:00PM
-
Abstract Number: 942
Update in the Management of Biologic Response Modifiers and Disease-Modifying Antirheumatic Drugs Following Coccidioidomycosis
- 2:30PM-4:00PM
-
Abstract Number: 1001
What Is the Most Cost-Effective Physical Therapy Strategy to Treat Knee Osteoarthritis?
- 2:30PM-4:00PM
-
Abstract Number: 914
When Fibromyalgia Criteria Misclassify
- 4:30PM-6:00PM
-
Abstract Number: 1087
“It Was Just My Right Pace”: A Qualitative Study Exploring Yoga Practice in Adults with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1018
A 32-Mer Aggrecan Fragment Generated through Adamts-4/5 and MMP-Mediated Cleavage Can Directly Excite Nociceptive Neurons
- 4:30PM-6:00PM
-
Abstract Number: 1017
A Novel Mechanism of Arthritis-Induced Pain: Activation of Sensory Neurons By Autoantibodies
- 4:30PM-6:00PM
-
Abstract Number: 1054
A Potential Role of Type III Interferon in the Glandular Involvement of Sjögren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 1020
Abnormal Resting State Functional Connectivity in Chronic Fatigue Syndrome Patients: An Arterial Spin-Labeling fMRI Study
- 4:30PM-6:00PM
-
Abstract Number: 1032
Adherence Patterns to American Academy of Ophthalmology Guidelines for Hydroxychloroquine Baseline Screening: Quality Assurance Assessment Utilizing Highmark Claims Data
- 4:30PM-6:00PM
-
Abstract Number: 1081
Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis
- 4:30PM-6:00PM
-
Abstract Number: 1063
Admissions and Readmissions of Patients with Systemic Lupus Erythematosus Is a Major Cause of Direct and Indirect Health Care Costs
- 4:30PM-6:00PM
-
Abstract Number: 1082
ANCA-Negative and Myeloperoxidase-ANCA-Positive Patients with Granulomatosis with Polyangiitis: Clinical Manifestations and Risk of Relapse
- 4:30PM-6:00PM
-
Abstract Number: 1056
Aquaporin Gene Therapy Corrects Bone Morphogenetic Protein 6 Associated Exocrine Gland Dysfunction in Mouse Model of Sjögren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 1057
Are Ankylosing Spondylitis, Psoriatic Arthritis and Undifferentiated Spondylarthritis Associated with an Increased Risk of Cardiovascular Disease?
- 4:30PM-6:00PM
-
Abstract Number: 1068
Assessment of 10-Year Risk of Myocardial Infarction or Stroke in SLE
- 4:30PM-6:00PM
-
Abstract Number: 1005
Association of Baseline Knee Sagittal Dynamic Joint Stiffness during Gait and 2-Year Cartilage Damage Progression in Knee Osteoarthritis (OA)
- 4:30PM-6:00PM
-
Abstract Number: 1065
Atherosclerotic Vascular Events in a Multinational SLE Inception Cohort: Description and Predictive Risk Factors over a 15 Year Period
- 4:30PM-6:00PM
-
Abstract Number: 1073
B Cell Subsets Are Epigenetically and Transcriptionally Dysregulated in Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 1045
Baricitinib, Methotrexate, or Baricitinib Plus Methotrexate in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Phase 3 Trial Results
- 4:30PM-6:00PM
-
Abstract Number: 1072
Baseline Gene Expression Profiles in 1760 Patients from Two Phase III Trials of BAFF/BLyS Blockade in SLE
- 4:30PM-6:00PM
-
Abstract Number: 1019
Brain Functional Connectivity Differentially Predicts Response to Two Centrally Acting Analgesics in Fibromyalgia
- 4:30PM-6:00PM
-
Abstract Number: 1070
CD 14(C-159T) Polymorphism and Soluble CD14 Are Associated with Increased Disease Activity and Nephritis in SLE
- 4:30PM-6:00PM
-
Abstract Number: 1007
Change in Semi-Quantitative Imaging Biomarkers Predicts Knee Osteoarthritis Progression: Data from the Fnih OA Biomarkers Consortium
- 4:30PM-6:00PM
-
Abstract Number: 1090
Characteristics and Trajectories of Child Pain, Function, and Psychological Outcomes Associated with Conversion Disorder in Intensive Interdisciplinary Pediatric Pain Rehabilitation
- 4:30PM-6:00PM
-
Abstract Number: 1047
Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in Two Phase 3 Studies
- 4:30PM-6:00PM
-
Abstract Number: 1069
Child’s HLA-DRB1 Genotype Increases Maternal Risk of Systemic Lupus Erythematosus: Results from the Mother-Child Immunogenetic Study in Autoimmunity
- 4:30PM-6:00PM
-
Abstract Number: 1016
Collagen Antibodies Induce Pain-like Behavior in Mice Independent of Inflammation and Complement Activation but Requires Fcγrs
- 4:30PM-6:00PM
-
Abstract Number: 1015
Contribution of TNF and Type I Interferon to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice
- 4:30PM-6:00PM
-
Abstract Number: 1078
CXCL4 Does Not Predict Extent or Progression of Interstitial Lung Disease in Systemic Sclerosis
- 4:30PM-6:00PM
-
Abstract Number: 1010
Differing Perspectives Between Doctor, Nurse and Patient Views on Professionalism and Empathy: An Inter-Professional 360-Degree Rheumatology Objective Structured Clinical Examination
- 4:30PM-6:00PM
-
Abstract Number: 1024
Disruptions in Folate Homeostasis May Lead to Increased Risk for Methotrexate Intolerance in Juvenile Idiopathic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1074
DNA Methylation Patterns in Naïve CD4+ T Cells Identify Epigenetic Susceptibility Loci for Malar Rash and Discoid Rash in Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 1086
Does Adding Azathioprine to Glucocorticoid Induction Increase the Remission Rate and Prevent Relapses in Patients with Systemic Necrotizing Vasculitides without Poor-Prognosis Factors? a Multicenter, Double-Blind Randomized Controlled Trial
- 4:30PM-6:00PM
-
Abstract Number: 1088
Effect of Training on Knee Torsional Stiffness and Its Relationship to Tibial Compressive and Anterior Shear Forces in Recreational Female Runners
- 4:30PM-6:00PM
-
Abstract Number: 1091
Effectiveness of Multidisciplinary Pain Rehabilitation Programs for Patients with Fibromyalgia Syndrome: A Systematic Review
- 4:30PM-6:00PM
-
Abstract Number: 1043
Enhancing Comparative Effectiveness Research By Combining Observational and Randomized Trial Data to Personalize the Choice Between Methotrexate and Triple Therapy for Methotrexate-Naïve Patients with Early Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1055
Expansions of Salivary Gland CD4+ T Cells from Sjögren’s Syndrome Patients: Single-Cell Repertoire Analysis and Correlation with Clinical Measures of Disease
- 4:30PM-6:00PM
-
Abstract Number: 1040
Factors Associated with Long Term Rituximab Use in Rheumatoid Arthritis – Results from the British Society of Rheumatology Biologics Register
- 4:30PM-6:00PM
-
Abstract Number: 1064
Feasibility and Validity of Patient Reported Outcome Measurement Information System (PROMIS) in SLE
- 4:30PM-6:00PM
-
Abstract Number: 1049
Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor Is Effective As Monotherapy in Patients with Active Rheumatoid Arthritis: Results from a Phase 2B Dose Ranging Study
- 4:30PM-6:00PM
-
Abstract Number: 1048
Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from a Phase 2B Dose Ranging Study
- 4:30PM-6:00PM
-
Abstract Number: 1077
High Levels of CCL-18 Are Associated with Deterioration of Lung Function, Increased Annual Fibrosis Progression Rate and Decreased Survival in Systemic Sclerosis
- 4:30PM-6:00PM
-
Abstract Number: 1052
Identification of Novel Sjogren’s Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1
- 4:30PM-6:00PM
-
Abstract Number: 1022
Identification of Shared Genomic Regions in Distantly Related Pairs of Cases with Juvenile Idiopathic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1092
Illicit Drug Use in US Adults with Chronic Low Back Pain: Nhanes 2009-2010
- 4:30PM-6:00PM
-
Abstract Number: 1034
Immunomodulation By a Second-Generation Peptidyl Arginine Deiminase Inhibitor Abrogates Collagen-Induced Arthritis in a Therapeutic Protocol
- 4:30PM-6:00PM
-
Abstract Number: 1011
Impact of a Musculoskeletal “Mini-Residency” Continuing Professional Education Program on Knee MRI Orders By Primary Care Providers
- 4:30PM-6:00PM
-
Abstract Number: 1037
Impaired Regulatory T Cell Survival in the Pathogenesis of Autoreactive Arthritis Mediated By CD11c-Deletion of Flip
- 4:30PM-6:00PM
-
Abstract Number: 1036
Important Role of microRNA-146a in Inflammatory Arthritis By Controlling Local Bone Destruction
- 4:30PM-6:00PM
-
Abstract Number: 1084
Improved Survival in Granulomatosis with Polyangiitis: A General Population-Based Study
- 4:30PM-6:00PM
-
Abstract Number: 1014
Improvement in Mentoring Associated with Implementation of an Inter-Institutional Mentoring Program within Pediatric Rheumatology
- 4:30PM-6:00PM
-
Abstract Number: 1029
Improving Gout Outcomes Using a Disease Management Program within an Integrated Health System
- 4:30PM-6:00PM
-
Abstract Number: 1028
Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients at a Tertiary Care Children’s Hospital
- 4:30PM-6:00PM
-
Abstract Number: 1006
Incident Frequent Knee Pain Is Associated with Changes in Semi-Quantitative Imaging Biomarkers of Inflammation
- 4:30PM-6:00PM
-
Abstract Number: 1059
Increased Risk of Atrioventricular Block, Atrial Fibrillation and Pacemaker Implantation in Ankylosing Spondylitis, Undifferentiated Spondylarthritis and Psoriatic Arthritis Compared to the General Population
- 4:30PM-6:00PM
-
Abstract Number: 1025
Interstitial Lung Disease in Sting-Associated Vasculopathy with Onset in Infancy (SAVI): Genotype-Phenotype Correlation
- 4:30PM-6:00PM
-
Abstract Number: 1085
Levamisole Triggers Neutrophil Extracellular Trap Formation through Muscarinic Receptors in Patients with Drug-Induced Vasculitis
- 4:30PM-6:00PM
-
Abstract Number: 1044
Many Patients with Early Rheumatoid Arthritis Want Triple Therapy: An Analysis Combining Comparative Effectiveness Research and Patients Preferences to Inform Treatment Recommendations
- 4:30PM-6:00PM
-
Abstract Number: 1041
Methotrexate Monotherapy and Methotrexate Combination Therapy with Traditional and Biologic Dmards for Rheumatoid Arthritis: A Cochrane Systematic Review and Network Meta-Analysis
- 4:30PM-6:00PM
-
Abstract Number: 1026
Microrna-125a-5p Has Increased Expression in Active Systemic Juvenile Idiopathic Arthritis and Is an Essential Modulator of Regulatory Macrophage Phenotypes in Vitro
- 4:30PM-6:00PM
-
Abstract Number: 1080
Modified Rodnan Skin Score Thresholds for the Optimization of Cohort Enrichment in Clinical Trials in Skin Fibrosis in Patients with Diffuse Cutaneous Systemic Sclerosis
- 4:30PM-6:00PM
-
Abstract Number: 1008
Morphometric Study of Algerian Hips: An Etiological Study to Explain the Low Prevalence of Hip Osteoarthritis in Algeria
- 4:30PM-6:00PM
-
Abstract Number: 1083
Nationwide Trends in Hospitalization and in-Hospital Mortality Associated with Granulomatosis with Polyangiitis (GPA)
- 4:30PM-6:00PM
-
Abstract Number: 1033
Novel Ligand-Independent Peptide Inhibitors of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) and T Cell Receptor (TCR): Efficacy in a Collagen-Induced Arthritis Model Suggests New Targeted Treatment for Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1021
Nucleic Acids Sensing Receptors RIG-I and MDA5 As Potential Amplifiers of the Interferon Signature in Childhood Onset Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 1061
Patients with Fibromyalgia (FM) Do Not Fulfill Classification Criteria for Axial Spondyloarthritis (axSpA) but Patients with Axspa May Fulfill Classification Criteria for FM
- 4:30PM-6:00PM
-
Abstract Number: 1053
Phosphatidylinositol-3-Kinase Delta Pathway a Novel Therapeutic Target for Sjogren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 1042
Pragmatic Multicenter Open-Label Randomized Controlled Trial of Stopping TNF-Inhibitors in Rheumatoid Arthritis Patients in Remission or Stable Low Disease Activity in the Netherlands
- 4:30PM-6:00PM
-
Abstract Number: 1062
Predictive Validity of the ASAS-Classification Criteria for Axial and Peripheral Spondyloarthritis – a Final Analysis
- 4:30PM-6:00PM
-
Abstract Number: 1004
Prevalence and Cross-Sectional Risk Factors of Ankle Osteoarthritis in a Community-Based Cohort
- 4:30PM-6:00PM
-
Abstract Number: 1058
Prevalence of Comorbidities in Spondyloarthritis and Evaluation of Their Monitoring: Results of the International Cross-Sectional ASAS-Comospa Study
- 4:30PM-6:00PM
-
Abstract Number: 1046
Previous Biologic Disease-Modifying Antirheumatic Drug (bDMARD) Exposure and Efficacy and Safety Analysis from a Phase 3 Study of Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitors
- 4:30PM-6:00PM
-
Abstract Number: 1009
Promoting Professional Development of Medical Educators in Rheumatology: Perspectives of Clinician Scholar Educators
- 4:30PM-6:00PM
-
Abstract Number: 1031
Quantifying the Delays to Rheumatologist Consultation and Treatment Among Patients with Systemic Inflammatory Rheumatic Diseases
- 4:30PM-6:00PM
-
Abstract Number: 1050
Response to Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies
- 4:30PM-6:00PM
-
Abstract Number: 1089
Responsiveness of Physical Activity Measures Following Exercise Intervention in Individulas after Total Knee Arthroplasty
- 4:30PM-6:00PM
-
Abstract Number: 1027
Rheumatoid Arthritis Disease Activity Assessment Frequencies in Clinical Practices Do Not Support Treat-to-Target Care
- 4:30PM-6:00PM
-
Abstract Number: 1076
Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease
- 4:30PM-6:00PM
-
Abstract Number: 1051
Serum Calprotectin As Biomarker of Carotid Atherosclerosis in Patients with Primary Sjögren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 1067
Sex Differences in Rates of End-Stage Renal Disease and Death Among Medicaid Patients with Incident Lupus Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 1071
Single-Cell RNA Sequencing of Human Podocytes, Endothelial Cells, and Tubular Cells Identifies Markers and Gene Profiles Differentiating Class IV and Class V Renal Disease in Lupus Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 1035
Synovium-Derived microRNAs Inhibit Bone Formation in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1066
Temporal Trends and Outcomes of Acute Myocardial Infarction in Systemic Lupus Erythematosus Hospitalizations
- 4:30PM-6:00PM
-
Abstract Number: 1013
The Fellow As Clinical Teacher Curriculum: Improving Rheumatology Fellows’ Teaching Skills during Inpatient Consultation
- 4:30PM-6:00PM
-
Abstract Number: 1079
The Potential Effect on Recruitment of Restricting Skin Scores Eligibility Criteria in Early Diffuse Scleroderma Trials
- 4:30PM-6:00PM
-
Abstract Number: 1039
The Safety and Effect on Disease Activity of Tocilizumab in Combination with MTX Versus Tocilizumab Monotherapy in Patients with Mild to Moderate RA: An Attempt to Optimise the Treatment Response
- 4:30PM-6:00PM
-
Abstract Number: 1075
The Scleroderma Lung Study II (SLS II) Shows That Both Oral Cyclophosphamide (CYC) and Mycophenolate Mofitil (MMF) Are Efficacious in Treating Progressive Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc)
- 4:30PM-6:00PM
-
Abstract Number: 1060
The View of Healthy Persons on the Impact of Spondyloarthritis on Functioning and Health: Results of a Best-Worst Scaling Based on the ASAS Health Index
- 4:30PM-6:00PM
-
Abstract Number: 1038
Tumor Necrosis Factor Alpha and Peptidylarginine Deiminase 4 in Lung and Joint Inflammation
- 4:30PM-6:00PM
-
Abstract Number: 1023
Tumor Necrosis Factor-a (TNF-a) and Interferon Gamma Inducible Protein-10 (IP-10) As Predictors of Active Disease Status in Localized Scleroderma
- 4:30PM-6:00PM
-
Abstract Number: 1030
Unwanted Variations in Rheumatology Clinic Rooming: A Time Study Tool and Analysis
- 4:30PM-6:00PM
-
Abstract Number: 1003
Use of Nsaids Correlates with the Risk of Venous Thromboembolism in Knee OA Patients: A UK Population-Based Case-Control Study
- 4:30PM-6:00PM
-
Abstract Number: 1012
Use of Social Media By Rheumatology Fellows in North America
- 9:00AM-11:00AM
-
Abstract Number: 1319
18F-Fluorodeoxyglucose Positron Emission Computer Tomography and Ultrasonography for Assessing Remission in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1681
4-Week Treatment of Rheumatoid Arthritis Patients with the JAK1-Selective Inhibitor Filgotinib (GLPG0634) Changes Lipid Profile with a Preferential Increase in HDL
- 9:00AM-11:00AM
-
Abstract Number: 1420
6-Month Change in Pain and Function By Pre-Surgery Pain and Function Among Patients Selected for Total Knee Replacement in the United States
- 9:00AM-11:00AM
-
Abstract Number: 1474
8-Year Follow-up Study: Differences Between HLA-B27 Positive and Negative Children with Juvenile Idiopathic Arthritis in Finland
- 9:00AM-11:00AM
-
Abstract Number: 1940
A Circulating Reservoir of Pathogenic-like CD4+ T Cells Shares a Genetic and Phenotypic Signature with the Inflamed Synovial Micro-Environment
- 9:00AM-11:00AM
-
Abstract Number: 1733
A Close Correlation Between Radiologic Progression Severity and Trabecular Bone Loss in Male Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1469
A Comparison of Pain and Disability, and Their Association Between Juvenile Primary Fibromyalgia Syndrome and Pediatric Rheumatic Diseases: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry
- 9:00AM-11:00AM
-
Abstract Number: 1293
A Comparison of Prenatal Care in Mothers with and without JIA: Association with Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 1481
A Description of the Transition Aged Population in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 1782
a Double-Blind, Randomized, Parallel-Group Study of Hydroxychloroquine on Cutaneous Lupus Erythematosus in Japan
- 9:00AM-11:00AM
-
Abstract Number: 1411
A Double-Blind, Randomized, Placebo-Controlled Trial of Mesenchymal Stem Cells for the Treatment of Patients with Full-Thickness Rotator Cuff Tears
- 9:00AM-11:00AM
-
Abstract Number: 1810
A Five-Year Follow-up of Microvascular Dysfunction and Coronary Artery Disease in SLE: Results from a Community-Based Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1131
A Histone Deacetylase Inhibitor SAHA Induce MCPIP1 Expression and Suppress IL-6 Expression By Upregulating Cebpα Expression and Downregulating the Expression of Mir-9 in Human OA Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 1652
A HPLC-SRM-MS Based Method for the Detection of Adherence to Low-Dose Oral Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 1591
A Low Adiponectin Level in Rheumatoid Arthritis Is Associated with Coronary Artery Disease
- 9:00AM-11:00AM
-
Abstract Number: 1870
A Lupus-Associated Variant in Purine Nucleoside Phosphorylase (PNP) Causes Cell Cycle Abnormalities
- 9:00AM-11:00AM
-
Abstract Number: 1389
A Meta-Analysis of the Prevalence of the Ocular Manifestations in All Inflammatory Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1443
A Multiple Ascending-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirogabalin in Healthy Elderly Subjects
- 9:00AM-11:00AM
-
Abstract Number: 1770
A New Perspective in Extracorporeal Immunotherapy of Systemic Lupus Erythematosus: Dnase I-Based Blood Perfusion Experiment Using Rat Model
- 9:00AM-11:00AM
-
Abstract Number: 1800
A Novel Anti-CD28 Domain Antibody Antagonist Shows a Favorable Pharmacokinetic, Pharmacodynamic and Safety Profile
- 9:00AM-11:00AM
-
Abstract Number: 1628
A Novel Histone Deacetylase 6 Inhibitor, CKD-H059 Inhibits the Inflammatory Response in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1946
A Novel HLA-DRB1*10:01 Restricted T Cell Epitope from Citrullinated Type II Collagen Relevant for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1470
A Population-Based Study of Outcomes of Patients with Juvenile Idiopathic Arthritis (JIA) Compared to Non-JIA Subjects
- 9:00AM-11:00AM
-
Abstract Number: 1110
A Proliferative Inducing Ligand (APRIL) Promotes IL-10 Production of Human B Cells
- 9:00AM-11:00AM
-
Abstract Number: 1647
A Randomized, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of Etoricoxib in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1201
A Short Training on Solution Focused Approach May be Helpful in Providing Psychological Support Skills to Nurses Involved in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1960
a Structured and Extensive Training Program on Vascular Ultrasound, Results in an Excellent Agreement Between Ultrasound and Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1642
A Systematic Review and Network Meta-Analysis on the Efficacy of Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy Versus Triple Therapy in Methotrexate Inadequate Responders with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1654
A Systematic Review and Network Meta-Analysis on the Efficacy of Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy Versus Triple Therapy in Methotrexate-Naïve Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1503
A Systematic Screening of Comorbidities By the Rheumatologist in Inflammatory Rheumatisms Impacts Chronic Disease Care
- 9:00AM-11:00AM
-
Abstract Number: 1741
Abdominal Fat Mass Assessment in Recent Onset Spondyloarthritis: Data from the DESIR Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1724
Abdominal X-Rays Can Reliably Detect the Majority of CT Positive Sacroiliitis in an IBD Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1985
Abnormal B-Cell Distribution Is Improved By Tocilizumab Monotherapy in Patients with Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 1580
Abnormal High Density Lipoproteins in Synovial Fluid from Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1757
Absence of Estrogen Receptor Alpha Is Protective Against Nephrotoxic Serum-Induced Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1515
Accounting for Rheumatoid Arthritis in the Determination of 10 Year Cardiovascular Risk
- 9:00AM-11:00AM
-
Abstract Number: 1093
Activation of Syk-Btk Signal in Peripheral Blood B Cells in Patients with Rheumatoid Arthritis: A Potential Target for Abatacept Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1759
Activation of T-Follicular Helper Cells and B Cells in Ultraviolet Light-Induced Murine Model of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1158
Active Non-Canonical NF-Kappab Signaling in Microvessels of Atherosclerotic Lesions in Coronary Arteries Is Associated with Inflammatory Cell Infiltration and Myocardial Infarction
- 9:00AM-11:00AM
-
Abstract Number: 1966
Active PMR and GCA Is Associated with Changes in Monocyte Subset Composition
- 9:00AM-11:00AM
-
Abstract Number: 1705
Acute Anterior Uveitis in Ankylosing Spondylitis: Association with Inflammatory Bowel Disease and Psoriasis Independent of HLA-B27
- 9:00AM-11:00AM
-
Abstract Number: 1388
Adalimumab in Patients with Inactive, Non-Infectious Uveitis Requiring Systemic Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1184
Addressing Medical Non-Adherence from Lack of Finances in an Observed Structured Clinical Exam of Rheumatology Fellows
- 9:00AM-11:00AM
-
Abstract Number: 1493
Adherence in Patients Who Are on Stable Doses of Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 1480
Adiposity in Children with Juvenile Psoriatic Arthritis (JPsA)
- 9:00AM-11:00AM
-
Abstract Number: 1631
Adverse Events to Biologic Agents in Elderly Patients with Rheumatoid Arthritis: Cohort with 13 Years of Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 1298
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH): A Collaborative and Systems-Based Approach to Improve Access to Care
- 9:00AM-11:00AM
-
Abstract Number: 1431
Age and Sex Impacts the Development of Hypersensitivity in the Murine Partial Medial Menisectomy Model of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1325
Age Effects Joint Space Narrowing in Early Active Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1533
Age Related Disability in Daily Life Should be Considered in Older Than Sixty-Five-Year-Old Rheumatoid Arthritis Patient
- 9:00AM-11:00AM
-
Abstract Number: 1165
Age-Dependent Effects of HLA-B27/β2m Expression on Host Immunity and the Intestinal Microbiota
- 9:00AM-11:00AM
-
Abstract Number: 1215
Air Pollution and the Rheumatic Diseases: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1154
Ajulemic Acid Is a Novel Cannabinoid That Suppresses the Secretion of TNF-α and IFN-α from the Peripheral Blood Mononuclear Cells of DM Patients In Vitro
- 9:00AM-11:00AM
-
Abstract Number: 1694
All-Cause Mortality and Malignancies in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study
- 9:00AM-11:00AM
-
Abstract Number: 1758
Alterations in Nuclear Structure Promote Lupus Autoimmunity in a Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 1132
Altered Histone 3 Dynamics at the Matrix Metalloproteinase 1 (MMP1) Transcription Start Site Contributes to MMP1 Suppression in Betaine Supplemented Synovial Fibroblasts in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1181
Ambulatory Rheumatology Curriculum: Effect of Fellow Teaching Multimodal Simulation Curriculum Enhancement
- 9:00AM-11:00AM
-
Abstract Number: 1378
AMP-Activated Protein Kinase As an Anti-Inflammatory Target for Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 1179
An Evidence-Based Analysis and Revision of a Pediatric Rheumatology Academic Half-Day Program
- 9:00AM-11:00AM
-
Abstract Number: 1457
An Organ Based Diagnostic Approach to Macrophage Activating Syndrome in Children Demonstrates Impaired Reticuloendothelial System Clearance
- 9:00AM-11:00AM
-
Abstract Number: 1278
An Underlying Diagnosis of Osteoarthritis Is Associated with Better Outcomes after Total Hip Arthroplasty Than Avascular Necrosis of Bone
- 9:00AM-11:00AM
-
Abstract Number: 1427
Analgesic Effects of the Novel Alpha-2-Delta Ligand Mirogabalin (DS-5565) in Experimental Animal Models of Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 1120
Analysis of SLE Plasmablasts By High Throughput Pairing of the Immunoglobulin Heavy and Light Chain (VH-VL)
- 9:00AM-11:00AM
-
Abstract Number: 1355
Ankle Periarthritis, a New Sign for Chikungunya : Ultrasound Study of Joint Lesions at the Acute Phase of Chikungunya
- 9:00AM-11:00AM
-
Abstract Number: 1740
Anti-Cyclic Citrullinated Peptide Antibodies and Inflammatory Bowel Disease
- 9:00AM-11:00AM
-
Abstract Number: 1463
Anti-Cyclic Citrullinated Peptide Antibody Subclass Phenotypes in Polyarticular Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1861
Anti-Ds-DNA Antibodies Regulate Atherothrombosis in Systemic Lupus Erythematosus through the Induction of Netosis and the Prothrombotic and Proinflammatory Activities of Monocytes
- 9:00AM-11:00AM
-
Abstract Number: 1939
Anti-GM-CSF Treatment Promotes Synovial Monocyte-Derived Dendritic Cells and Increases Th17 Cells during Experimental Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1859
Anti-Interferon Autoantibodies in Systemic Lupus Erythematosus Are Biologically Active and Have Distinct Functions
- 9:00AM-11:00AM
-
Abstract Number: 1772
Anti-Pentraxin 3 Antibodies Ameliorate Disease Manifestations and Lupus-like Nephritis in New Zealand Black/New Zealand White F1 Mice
- 9:00AM-11:00AM
-
Abstract Number: 1851
Antibody Against Ribonuclease-H Is a Novel Autoantibody Specifically Recognized in Systemic Lupus Erhythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1899
Aortic Stenosis Is Increased in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Compared to Other Forms of Pulmonary Arterial Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 1263
Applications of Protein Microarray for Saliva Diagnostics in Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1898
Are There Risk Factors for Calcinosis in Scleroderma?
- 9:00AM-11:00AM
-
Abstract Number: 1542
Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1332
Assessing Radiographic Damage in Ankylosing Spondylitis: Variability in Reliability of the Modified Stoke Ankylosing Spondylitis Spine Score According to the Statistical Method
- 9:00AM-11:00AM
-
Abstract Number: 1226
Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration
- 9:00AM-11:00AM
-
Abstract Number: 1738
Assessing the Validity of the Multi-Biomarker Disease Activity Assay in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1320
Assessment of 18F-Fluoro-Deoxyglucose Uptake in the Ascending Aorta of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1185
Assessment of a Rheumatology Curriculum Utilizing Multiple Learning Modalities
- 9:00AM-11:00AM
-
Abstract Number: 1333
Assessment of Focal Fat Infiltration in Sacroiliac Joints in Patients with Spondyloarthritis By 1.5T Versus 3.0T Magnetic Resonance Imaging: Is the Field Strength Important to Contrast to Noise Ratios, Reproducibility and Total Scores?
- 9:00AM-11:00AM
-
Abstract Number: 1464
Assessment of Left Ventricle Functions in Children with Familial Mediterranean Fever with Tissue Doppler and Strain Echocardiography
- 9:00AM-11:00AM
-
Abstract Number: 1903
Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from a Multicentric Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1466
Assessment of Transition Readiness in Adolescents and Young Adults with Chronic Health Conditions
- 9:00AM-11:00AM
-
Abstract Number: 1865
Association Between Changes in Expression of Gene Signatures and Disease Activity Among Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1852
Association of Antibodies to the NR1 Subunit of N-Methyl-D-Aspartate Receptors with Neuropsychiatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1458
Association of Chronic, Extreme Elevation of Serum IL-18 with the Development of Macrophage Activation Syndrome in a Cohort of Autoinflammatory Disease Patients: A Potential Diagnostic Biomarker?
- 9:00AM-11:00AM
-
Abstract Number: 1869
Association of CLEC16A with SLE in a Large Multi-Ancestry Cohort and Implication in B-Cell Receptor Signaling
- 9:00AM-11:00AM
-
Abstract Number: 1883
Association of Myocardial Abnormalities with Disease Characteristic and Brain Natriuretic Peptide (BNP) in Systemic Sclerosis without Cardiac Symptoms As Assessed Using Cardiac Magnetic Resonance Imaging; A Prospective Multi Center Study
- 9:00AM-11:00AM
-
Abstract Number: 1579
Association of Myocardial Abnormalities with N-Terminal Pro-Brain Natriuretic Peptide and Disease Activity in Rheumatoid Arthritis without Cardiac Symptoms, Assessed By Cardiac Magnetic Resonance Imaging
- 9:00AM-11:00AM
-
Abstract Number: 1901
Association of Serum Adipokines Adipsin, Adiponectin, and Leptin/Adiponectin Ratio with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1612
Association of Single Nucleotide Polymorphisms of PADI4 and HLA-DRB1 Alleles with Susceptibility to Rheumatoid Arthritis-Related Lung Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1804
Association of the Metabolic Syndrome (MetS) with Vascular Complications, End Stage Renal Failure (ESRF) and Mortality in Patients with Systemic Lupus Erythematosus (SLE): A Cohort Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1460
Association of Vitamin D Receptor Polymorphism with Juvenile Idiopathic Arthritis (JIA)
- 9:00AM-11:00AM
-
Abstract Number: 1209
Associations Between Rheumatoid Arthritis (RA)-Related Autoimmunity, Joint Symptoms, and Physical Activity in First-Degree Relatives without RA in a Prospective Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1574
Associations of Serum Anti-Malondialdehyde-Acetaldehyde (MAA) Antibodies with Cardiovascular and Respiratory Mortality in Men with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1860
Autoantibodies Utilizing the Immunoglobulin Heavy Chain Variable Region Gene 4-34 (VH4-34) Exhibit Autoreactivity Towards, and Potential Competition with Galectins within Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 1356
Autoimmune Manifestations in Hepatitis C: A Single-Centered Experience
- 9:00AM-11:00AM
-
Abstract Number: 1934
Autophagy Pathway As a Target of Therapeutic P140 Peptide Used in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1392
Azathioprine May be an Effective Steroid Sparing Agent in Patients with Isolated Recurrent Pericarditis
- 9:00AM-11:00AM
-
Abstract Number: 1942
B Cell Depletion By Rituximab in Lymphocyte Subpopulations from Peripheral Blood in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1641
B Cell Depletion with Rituximab in Patients with Rheumatoid Arthritis: Multiplex Bead Array Reveals Kinetics of IgG and IgA Autoantibodies to Citrullinated Antigens
- 9:00AM-11:00AM
-
Abstract Number: 1122
B Cell Phenotypic Changes in Anti-Nuclear Antibody Positive Individuals Prior to the Onset of Systemic Autoimmune Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1113
B Cell Signature Profiling in Systemic Lupus Erythematosus Patients on Belimumab
- 9:00AM-11:00AM
-
Abstract Number: 1115
B Cell-Intrinsic Interferon Gamma Signals Promote the Development of Systemic Lupus Erythematosus By Enhancing the Formation of Spontaneous Autoimmune Germinal Centers
- 9:00AM-11:00AM
-
Abstract Number: 1096
B Cells Are Prime Producers of Tumor Necrosis Factor Alpha in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1754
BANK1 Controls the Development of SLE By Modulating TLR7 Signaling and Type I IFN-Induced Translation Initiation Pathway in B Cells
- 9:00AM-11:00AM
-
Abstract Number: 1424
Barriers to Primary Care Clinician Adherence to Clinical Guidelines for the Management of Low Back Pain: A Systematic Review and Meta-Synthesis of Qualitative Studies
- 9:00AM-11:00AM
-
Abstract Number: 1979
Baseline Data on Patients Enrolled in a Randomized, Double-Blind Trial of Tocilizumab in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1602
Beta Cells Function and Insulin Resistance during Tocilizumab Treatment in Non-Diabetic RA Patients: Results from a Single-Center Study
- 9:00AM-11:00AM
-
Abstract Number: 1853
Binding of a Novel IgG3 VH4-34 Monoclonal Antibody to ssRNA in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1964
Biomarkers in Temporal Artery Biopsies and Sera of Patients with Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1868
BLK Pathway-Associated rs13277113 GA Genotype Is More Frequent in Systemic Lupus Erythematosus Patients and Associated with Low Gene Expression and Increased Flares
- 9:00AM-11:00AM
-
Abstract Number: 1771
Blockade of Immune Complex-Mediated Glomerulonephritis By Highly Selective Inhibition of Bruton’s Tyrosine Kinase
- 9:00AM-11:00AM
-
Abstract Number: 1175
Blood Outgrowth Endothelial Cells Isolated from Systemic Sclerosis Patients Exhibit a Pro-Inflammatory Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 1843
Bloodstream Infections in Systemic Lupus Erythematosus Patients Are Associated with Severe Lupus Flares
- 9:00AM-11:00AM
-
Abstract Number: 1686
Body Mass Index Is Associated with Hip Arthritis in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1334
Bone Erosion in Gout: Relationship with Tophus Urate and Soft Tissue Volumes. a Conventional and Dual Energy CT Study
- 9:00AM-11:00AM
-
Abstract Number: 1774
Bone Marrow Derived Dendritic Cells Modified By Lentiviral-Mediated RelB shRNA Possess Tolerogenic Phenotype and Functions on Lupus Splenic Lymphocytes
- 9:00AM-11:00AM
-
Abstract Number: 1121
Breach of B Cell Anergy in New Zealand Black Congenic Mice
- 9:00AM-11:00AM
-
Abstract Number: 1124
Bruton’s Tyrosine Kinase Levels Are Increased in B Cells from Patients with Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1284
Burden of Illness Associated with Non-Radiographic Axial Spondyloarthritis: A European Real World Database Analysis from the Clinical and Healthcare System Perspective
- 9:00AM-11:00AM
-
Abstract Number: 1290
Burden of Rheumatoid Arthritis in the US Elderly Population: Comorbidities, Healthcare Resource Utilization, and Cost
- 9:00AM-11:00AM
-
Abstract Number: 1894
Calcium Channel Blockers Are More Effective in the Treatment of Primary Raynaud’s Phenomenon Compared to Secondary: A Meta-Analyis
- 9:00AM-11:00AM
-
Abstract Number: 1299
Can Bone Marrow Lesions be Scored More Reliably and Responsively in Knee Osteoarthritis Using a Web-Based Overlay System (KIMRISS) Than By Standard MRI Osteoarthritis Knee Scoring (MOAKS)? Data from the Osteoarthritis Initiative and a Prospective Trial of Adaluminab Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1490
Can Patients Forget Their Artificial Joint after Arthroplasty?
- 9:00AM-11:00AM
-
Abstract Number: 1719
Can Structural Progression on MRI of Sacroiliac Joints in Patients with Spondyloarthritis be Reliably Detected and What Type of Calibration Is Necessary to Achieve This?
- 9:00AM-11:00AM
-
Abstract Number: 1969
Can We Predict the Relapse of Giant Cell Arteritis?
- 9:00AM-11:00AM
-
Abstract Number: 1581
Cardiac Involvement in Patients with Amyloid a Amyloidosis Due to Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1568
Cardiac Morphology and Function in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1972
Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1604
Cardiovascular Disease in a Large Incident Cohort of Early Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1540
Cardiovascular Risk Management in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1505
Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression over 24 Weeks
- 9:00AM-11:00AM
-
Abstract Number: 1876
Caveolin 1 Gene Variants May Effect Disease Progression in Systemic Sclerosis Related Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1102
CD19+CD24-CD38hi B-Cell Subset: A Potential Biomarker for IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 1370
CD40/CD40L Pathway Is Associated with Increased Oxidative Burst and Neutrophil Extracellular Traps Release in Behcet´s Disease
- 9:00AM-11:00AM
-
Abstract Number: 1435
Central Pain Sensitization in Rheumatoid Arthritis – Role of ACPA?
- 9:00AM-11:00AM
-
Abstract Number: 1331
Change in MRI in Patients with Spondyloarthritis Treated with Anti-TNF Agents : Systematic Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 1363
Changes in Cyclooxygenase-2’s Expression, and PGE2’s and 6-Keto-PGF1α Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjogren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1221
Characteristics and Outcomes of RA Patients Who Start Biosimilar Infliximab in South Korea
- 9:00AM-11:00AM
-
Abstract Number: 1779
Characterization of Anti-Nuclear Antibody (ANA) Signatures in Murine Models of Lupus Using Genalyte Maverick Technology
- 9:00AM-11:00AM
-
Abstract Number: 1177
Characterization of Different Phosphorylation Sites of Mcl-1 in Human Rheumatoid Arthritis Synovial Fibroblasts and Their Correlation with RA Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 1752
Characterization of Epitopes Identified with Cerebral Vasculature Injury
- 9:00AM-11:00AM
-
Abstract Number: 1380
Characterization of Lymphocytes Subsets in Peripheral Blood of Untreated IgG4-Related Disease Patients
- 9:00AM-11:00AM
-
Abstract Number: 1436
Characterization of Patient Reported Pain Medication in Early Vs. Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1372
Characterization of Synovial Mast Cells in Knee Osteoarthritis: Association with Clinical Parameters
- 9:00AM-11:00AM
-
Abstract Number: 1880
Circulating Microparticle Populations May Differentiate Between Connective Tissue Diseases.
- 9:00AM-11:00AM
-
Abstract Number: 1100
Citrullinated Antigen-Specific B Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis: Identification and Phenotypic Characterization
- 9:00AM-11:00AM
-
Abstract Number: 1174
Class 3 Semaphorins Modulate the Invasive Capacity of Rheumatoid Arthritis Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 1538
Clinical Analysis of 30 Rheumatoid Arthritis Patients Complicated with Malignant Lymphoma, Especially Methotrexate-Related Lymphoproliferative Disorder
- 9:00AM-11:00AM
-
Abstract Number: 1382
Clinical and Serum IgG4 Characteristics of a Unique British Columbian IgG4-Related Disease Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1636
Clinical Benefit of 1-Year Certolizumab Pegol Treatment in MTX-Naïve, Early Rheumatoid Arthritis Patients Is Maintained after Discontinuation up to 1 Year
- 9:00AM-11:00AM
-
Abstract Number: 1559
Clinical Characteristics and Medication Use Among Arab Patients with Rheumatoid Arthritis in Some Arab States
- 9:00AM-11:00AM
-
Abstract Number: 1348
Clinical Characteristics and Outcomes of Patients with Septic Arthritis Treated without Surgery
- 9:00AM-11:00AM
-
Abstract Number: 1349
Clinical Characteristics and Outcomes of Septic Bursitis
- 9:00AM-11:00AM
-
Abstract Number: 1785
Clinical Characteristics and Relative Factors of Infections in Southern Chinese Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1749
Clinical Characteristics of Axial Spondyloarthritis Patients Progressing from Non-Diagnostic to Diagnostic Radiographic Sacroiliitis
- 9:00AM-11:00AM
-
Abstract Number: 1599
Clinical Characteristics of Interstitial Lung Disease (ILD) in Rheumatoid Arthritis (RA) Patients in High Resolutional CT (HRCT) and Titer of Anti Citrullinated Peptide Antibodies (anti-CCP2)
- 9:00AM-11:00AM
-
Abstract Number: 1394
Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1562
Clinical Correlates, Outcomes and Predictors of Episcleritis and Scleritis Associated with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1986
Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study.
- 9:00AM-11:00AM
-
Abstract Number: 1639
Clinical Outcomes for Rheumatoid Arthritis Patients Receiving Tofacitinib Monotherapy in the Open-Label Long-Term Extension over 6 Years
- 9:00AM-11:00AM
-
Abstract Number: 1667
Clinical Parameters and B Cell Subsets As Biomarkers of Response to Tocilizumab in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1317
Clinical Utility of Joint Space Width and X-Ray Radiogrammetry in RA: Markers for Early Radiographic Progression
- 9:00AM-11:00AM
-
Abstract Number: 1450
Clostridium Difficile Infection-Associated Reactive Arthritis in a Pediatric Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1109
Co-Crystal Structure of TACI and APRIL-BAFF-BAFF Heteromer Suggests That Charged Residues in APRIL and BAFF Dictate Their Receptor Binding Affinities
- 9:00AM-11:00AM
-
Abstract Number: 1408
Cogan Syndrome: Differential Response to Biologic Agents and Role of PET-CT in the Increased Diagnosis of Aortitis
- 9:00AM-11:00AM
-
Abstract Number: 1153
Colonic Intraepithelial Lymphocytes Produce IL-6 in Response to Resident Bacteria to Modulate Epithelial Barrier Function
- 9:00AM-11:00AM
-
Abstract Number: 1959
Color Doppler Ultrasonography Appears to Perform Better Than Magnetic Resonance Angiography in the Diagnostics of Patients with Systemic Large Vessel Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1957
Colour-Doppler Ultrasonography of Epiaortic Arteries in Patients with Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1707
Comorbidity Burden and Medication Use Among Patients with Psoriatic Arthritis in the US
- 9:00AM-11:00AM
-
Abstract Number: 1781
Comparative Efficacy and Safety of Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide As Induction Therapy for Lupus Nephritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 1486
Comparative Study of Instruments to Assess Disease Activity in Fibrolyalgia
- 9:00AM-11:00AM
-
Abstract Number: 1300
Comparison Between Semiquantitative and Quantitative Methods for the Assessment of Knee Synovitis Using Non-Enhanced and Gadolinium-Enhanced MRI
- 9:00AM-11:00AM
-
Abstract Number: 1548
Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1819
Comparison of Electrocardiographic ST-T Changes and QTc Duration in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1280
Comparison of Health Service Utilization Costs Between Aboriginal and Non-Aboriginal Patients with Rheumatoid Arthritis Requiring Biologic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1384
Comparison of IgG4-Related and Non-IgG4-Related Retroperitoneal Fibrosis; A 12 Year Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1478
Comparison of JIA and RA Patients in the National Data Bank for Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1651
Comparison of Oral Glucocorticoid (OGC)-Sparing Effects in Tocilizumab and Other Biologic Dmards Using Multilevel Models in an Administrative Health Care Claims Database
- 9:00AM-11:00AM
-
Abstract Number: 1545
Comparison of Statin Eligibility According to the Adult Treatment Panel III, ACC/AHA Blood Cholesterol Guideline and Presence of Carotid Plaque By Ultrasound in Hispanics with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1414
Comparison of Surgical and Conservative Therapy of Lumbar Disc Herniation with Radicular Signs and Symptoms in a Quality Management Program
- 9:00AM-11:00AM
-
Abstract Number: 1371
Complement-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 1188
Comprehensive Musculoskeletal Course Improves Post-Graduate Trainees’ Confidence in Performing Joint Injections
- 9:00AM-11:00AM
-
Abstract Number: 1187
Comprehensive Musculoskeletal Exam Curriculum for Rheumatology Fellows
- 9:00AM-11:00AM
-
Abstract Number: 1152
Comprehensive Novel Proteomic Analysis of RA Synovial Fluid Highlights the Distinct Protein Profiles of Bone and Cartilage Metabolism
- 9:00AM-11:00AM
-
Abstract Number: 1734
Computer Aided Syndesmophyte Measurement on Spinal Radiographs in Axial Spondyloarthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1539
Control of Modifiable Cardiovascular Risk Factors in Rheumatoid Arthritis Patients Compared to Traditional High-Risk Cardiovascular Disease Patients
- 9:00AM-11:00AM
-
Abstract Number: 1522
Correlation of Oxidized Low Density Lipoprotein Levels with Carotid Intima Media Thickness in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1895
Correlation of Scleroderma Interstitial Lung Disease with Gastroesophageal Reflux
- 9:00AM-11:00AM
-
Abstract Number: 1976
Corticosteroid Therapy in Giant Cell Arteritis, Predictors for Long-Term Remission
- 9:00AM-11:00AM
-
Abstract Number: 1990
Corticosteroid Use in Idiopathic Aortitis: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 1271
Cost Savings and Interest in Pediatric Rheumatology Telemedicine Visits
- 9:00AM-11:00AM
-
Abstract Number: 1689
Cross Sectional Study Investigating the Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1169
Crossregulatory Mechanisms Between Synovial Fibroblasts and Macrophages Relevant in RA Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 1425
Current Tobacco Use and the Rates of Complications after Total Hip Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 1818
Cyclophosphamide and Cumulative Steroid Dose Associated with Higher Risk of Infections in Patients with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1357
Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center
- 9:00AM-11:00AM
-
Abstract Number: 1937
Dalazatide (ShK-186), a First-in-Class Blocker of Kv1.3 Potassium Channel on Effector Memory T Cells: Safety, Tolerability and Proof of Concept of Immunomodulation in Patients with Active Plaque Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 1944
Dalazatide Modulates CD4+ Effector Memory T-Cell Activity of Patients with Granulomatosis with Polyangiitis in Vitro
- 9:00AM-11:00AM
-
Abstract Number: 1404
Death and Infection Rates Appear Reduced in a Modern Cohort of ICU Patients with Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1254
Deciphering the Immunome of Clinically Effective Immune Tolerization in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1116
Decreased Expression of Negative Regulators of Toll-like Receptor Signaling and Increased TLR7 Responsiveness in Expanded IgD- CD27- B Cells from Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1875
Deep Vein Thrombosis and Pulmonary Embolism in Systemic Sclerois
- 9:00AM-11:00AM
-
Abstract Number: 1887
Deficiency in Micronutrients Is a Frequent Burden in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1146
Deficiency of TLR2 and TLR4 Impairs Autophagic Flux in Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 1309
Defining an Acceptable Level of MRI Inflammation in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1748
Degenerative Changes at the Lumbar Spine in Patients with Axial Spondyloarthritis and Non-Specific Mechanical Low Back Pain: A Magnetic Resonance Imaging Study
- 9:00AM-11:00AM
-
Abstract Number: 1811
Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1967
Deregulation of Interleukin-22 Pathway in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1587
Deriving a Comorbidity Index Form the Meddra Classification: Performance of Rheumatic Disease Comorbidity Index, Charlson-Deyo Index and Functional Comorbidity Index Among Patients with RA in NOR-DMARD Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1442
Descriptive Characteristics of Patients Prescribed Opioids for the Treatment of Chronic Pain
- 9:00AM-11:00AM
-
Abstract Number: 1198
Design and Implementation of a Patient-Centered Navigator Program to Improve Adherence to Disease-Modifying Antirheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 1315
Detecting Subtle Changes in Bone Structure Following Three-Month Anti-TNF Theraphy Using High-Resolution Peripheral Quantitative Computed Tomography
- 9:00AM-11:00AM
-
Abstract Number: 1358
Detection of a Unique Viral Infection in Salivary Glands of Sjögren’s Syndrome Patients and Viral-Mediated Recapitulation of Disease in Vivo
- 9:00AM-11:00AM
-
Abstract Number: 1525
Detection of Previous Tuberculosis Infections in Japanese Rheumatoid Arthritis Patients: Comparison of Two Interferon-G Releasing Assays and the Impact of CD4-Positive Lymphocytes
- 9:00AM-11:00AM
-
Abstract Number: 1190
Developing an Introductory Musculoskeletal Ultrasound Curriculum for Rheumatology Fellows
- 9:00AM-11:00AM
-
Abstract Number: 1917
Developing and Validating a Serum Biomarker for the Extent of Skin Disease in Patients with Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1484
Development and Validation of Juvenile Autoinflammatory Disease Multidimensional Assessment Report (JAIMAR)
- 9:00AM-11:00AM
-
Abstract Number: 1712
Development of a Novel SI Joint CT Score for Diagnosis of Axial Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1635
Development of New Bioassay System Measuring Inhibitory Strength of IL-6/STAT3 Signal Under Tocilizumab Treatment in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1402
Development of Systemic Juvenile Idiopathic Arthritis Manifestations Following Remission of Hemophagocytic Lymphohistiocytosis
- 9:00AM-11:00AM
-
Abstract Number: 1904
Development of the Mawdsley Calcinosis Questionnaire (MCQ) Version 1 – a Patient-Reported Outcome Measure (PROM) for Systemic Sclerosis Related Calcinosis (SSc-Ca)
- 9:00AM-11:00AM
-
Abstract Number: 1596
Diagnosis of Carotid Plaque By 4 Cardiovascular Risk Scores in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1393
Diagnostic Categorization of Ocular Sarcoidosis Based on the International Criteria Proposed By the First International Workshop on Ocular Sarcoidosis. a Case Series of 11 Spanish Patients
- 9:00AM-11:00AM
-
Abstract Number: 1878
Diagnostic Performance of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis: Results from a Brazilian Validation Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1958
Diagnostic Value of Ultrasonography-Derived Signs in Giant Cell Arteritis: Literature Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1783
Dietary Fish Oil Supplementation Raises Serum Essential Fatty Acid Concentrations in Patients with Systemic Lupus Erythematosus and Correlates with Improvements in Inflammation and Pain
- 9:00AM-11:00AM
-
Abstract Number: 1260
Differential DNA Methylation and Reduced Expression of Transcription Factors in Human OA Cartilage
- 9:00AM-11:00AM
-
Abstract Number: 1245
Differential DNA Methylation Associated with Lupus Nephritis Shows Enrichment in Genes Involved in Regulation of TH2 Differentiation and Renal Development
- 9:00AM-11:00AM
-
Abstract Number: 1391
Differential Expression of Interferon Gamma in Exudate from Hidradenitis Suppurativa Lesions Compared to Chronic Wounds
- 9:00AM-11:00AM
-
Abstract Number: 1249
Differential Expression of SLE Susceptibility Genes By Interferon-Alpha and the HLA-DRB1*03:01 Haplotype in Ex Vivo B Cells
- 9:00AM-11:00AM
-
Abstract Number: 1139
Differential Inflammatory Profile in Experimental Models of Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1920
Differential Production of Th17-Related Cytokines By Toll like Receptor (TLR)-Ligands-Stimulated Monocyte-Derived Dendritic Cells (Mo-DCs) from Systemic Sclerosis (SSc) Patients; Relevance of IL-22 and IL-33 According to Disease Subtype and Stage
- 9:00AM-11:00AM
-
Abstract Number: 1728
Diffusion Weighted Imaging Is a Sensitive and Specific MRI Protocol for the Diagnosis and Assessment of Disease Severity in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1248
Discovery of Novel Serum Biomarkers for Osteoarthritis Using Affinity Proteomics
- 9:00AM-11:00AM
-
Abstract Number: 1671
Discovery of PRN1008, a Novel, Reversible Covalent BTK Inhibitor in Clinical Development for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1227
Discrepancies Between Registered and Published Primary Outcomes in Randomized Controlled Trials of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1778
Disease Progression Is Altered By Moderate Exercise and Social Stress in a Murine Model of Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1677
Disease-Regulated Expression of Anti-Inflammatory Interleukin-10 for the Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1968
Distinct Distribution Patterns of Large Vessel Vasculitis Assessed with 18f-FDG PET/CT: Evidence from Principal Component and Cluster Analyses
- 9:00AM-11:00AM
-
Abstract Number: 1160
DNA Hydroxylmethylation Regulates Pro-Inflammatory Cytokine Expression in Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 1250
DNA Methylation and Its Relation to Immunological Phenotypes in Peripheral Blood: A Study of Anti-CCP Antibody Positivity from a Population-Based Pool
- 9:00AM-11:00AM
-
Abstract Number: 1610
DNA Methylation Changes Observed in Rheumatoid Arthritis Joint Tissue Are Detectable in CD4+ Naive T Cells from Peripheral Blood
- 9:00AM-11:00AM
-
Abstract Number: 1620
DNA Methylation Profiling of Rheumatoid Arthritis Peripheral Blood Identifies Hypermethylation of TRIM69 Promoter Region in CD4+ T Cells Associated with Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 1974
Do Patients with Giant Cell Arteritis Meet the 2011 United Kingdom Department of Health Guidance on Physical Activity?
- 9:00AM-11:00AM
-
Abstract Number: 1632
Do RA Susceptibility Loci Predict Response to Methotrexate As First DMARD in Early RA?
- 9:00AM-11:00AM
-
Abstract Number: 1307
Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 1791
Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients from Atherosclerotic Cardiovascular Events? a Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1678
Does the Level of Disease Control Achieved with Biologics Influence Overall Costs for Health Care and Work Loss in RA?
- 9:00AM-11:00AM
-
Abstract Number: 1127
Downregulation of nuclear Factor-Erythroid 2-Related Factor (Nrf2)/Heme Oxygenase-1 Axis in Diabetic Cartilage: Towards a Better Phenotyping of diabetes-Related Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1987
Dramatic Efficacy of Tocilizumab As First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1267
Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
- 9:00AM-11:00AM
-
Abstract Number: 1288
Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry
- 9:00AM-11:00AM
-
Abstract Number: 1163
Dynamic Regulation of Enhancers and Super-Enhancers in Rheumatoid Arthritis Synovial Finroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1563
Dyslipidemia and Hyperglycemia, Two Cardiometabolic Parameters, Independently Predict Poor Outcome in Early Rheumatoid Arthritis: Results from Espoir Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1638
Early Response As a Predictor of Long-Term Remission in DMARD-Naïve Patients with Severe, Active and Progressive Rheumatoid Arthritis Treated with Certolizumab Pegol in Combination with Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 1948
Early Rheumatoid Arthritis Patients Have Higher Fractions of Circulating Th2 Cells, Th17 Cells and Regulatory T Cells, Similar Fractions of Follicular Helper T Cells, and Lower Fractions of Th17/Th1 Cells and Th1 Cells Compared to Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 1896
Early Signs, Symptoms and Auto-Antibodies to Predict Diffuse Cutaneous or Limited Cutaneous Systemic Sclerosis at First Presentation
- 9:00AM-11:00AM
-
Abstract Number: 1178
Educational Impact of a Clinical Anatomy Workshop on 1st-Year Orthopedic and Rheumatology Fellows and a Comparison of Scores Between Specialties in Mexico
- 9:00AM-11:00AM
-
Abstract Number: 1311
Effect of a Non Biologic Treat-to-Target Strategy on MRI-Determined Inflammatory and Destructive Changes in Early Rheumatoid Arthritis – Results from a 2-Year Investigator-Initiated Double-Blind Randomized Controlled Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 1576
Effect of Conventional Synthetic and Biological Disease Modifying Anti-Rheumatic Drugs on the Immunogenicity of Hepatitis B Vaccine in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1553
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of HDL-Enriched Serum in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1640
Effect of Methotrexate Dose on the Efficacy of Tofacitinib: Treatment Outcomes from a Phase 3 Clinical Trial of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1144
Effect of PEP-1-Glrx-1 on Catabolic Gene Expression in Human Articular Chondrocytes and in Mouse Carrageenan-Induced Paw Edema Model
- 9:00AM-11:00AM
-
Abstract Number: 1537
Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1180
Effective Knowledge Transfer: A Demonstration of Video Illustration in the Immunology Curriculum for Rheumatology Trainees
- 9:00AM-11:00AM
-
Abstract Number: 1655
Effectiveness of Monotherapy in Rheumatoid Arthritis (RA) Patients Initiating a Tumor Necrosis Factor Inhibitor (TNFi) Vs a Non-TNFi in a Large US Commercial and Medicare Advantage Plan
- 9:00AM-11:00AM
-
Abstract Number: 1491
Effects of Drug Induced Toxicity on Patient Reported Outcomes in Early Rheumatoid Arthritis Treated-to-Target Using Conventional Triple DMARD Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1988
Efficacy and Safety of Mizoribine for Polymyalgia Rheumatica: Analysis of 47 Cases
- 9:00AM-11:00AM
-
Abstract Number: 1675
Efficacy and Safety of Switched CT-P10 from Innovator Rituximab Compared to Those of Maintained CT-P10 in Patients with Rheumatoid Arthritis up to 56 Weeks
- 9:00AM-11:00AM
-
Abstract Number: 1385
Efficacy and Tolerance of Rituximab in IgG4-Related Disease: A Retrospective Multicentric Study in 24 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1310
Efficacy of Abatacept in Patients with Rheumatoid Arthritis Assessed By MRI Scans of Bilateral Hands
- 9:00AM-11:00AM
-
Abstract Number: 1106
Efficacy of Abbv-105, a Selective and Irreversible Inhibitor of Bruton’s Tyrosine Kinase (BTK), in Multiple Models of Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 1814
Efficacy of Isoniazid Chemoprophylaxis in Lupus Nephritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1485
Efficacy of Yttrium-90 Radiosynovectomy in Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1526
Employment and Quality of Life Among Patients with Rheumatoid Arhtritis in Four Latin-American Countries
- 9:00AM-11:00AM
-
Abstract Number: 1570
End Stage Renal Disease (ESRD) in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1498
Engaging Clinic Staff in Work System Redesign to Adapt a Hypertension Protocol for Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 1938
Engaging PD-1 Resuscitates Synovial Treg Cells and Dampens the Joint Infiltrating T Cells in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1369
Enhanced Myelopoiesis Downstream of Toll-like Receptor 9 Activation Drives a Feed-Forward Inflammatory Response
- 9:00AM-11:00AM
-
Abstract Number: 1605
Enhanced Oxidant Signaling in Inflammatory Macrophages in Rheumatoid Arthritis (RA) and in Coronary Artery Disease (CAD)
- 9:00AM-11:00AM
-
Abstract Number: 1718
Entheseal Abnormalities and Nail Involvement at the Distal Interphalangeal Joints on Ultrasound Examination in Patients with Psoriasis and Psoriatic Arthritis. Could the Nail-Enthesitis Theory be Supported?
- 9:00AM-11:00AM
-
Abstract Number: 1711
Enthesitis in Psoriatic Arthritis – Disease Association and Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 1710
Enthesitis in Psoriatic Arthritis: Incidence, Prevalence and Characteristics
- 9:00AM-11:00AM
-
Abstract Number: 1233
Epidemiology of GCA in Bergen (Western Norway) 1972-2012
- 9:00AM-11:00AM
-
Abstract Number: 1235
Epidemiology of Kikuchi-Fujimoto Disease in Martinique and Characteristics in an Afro-Caribbean Population: Close Relation with Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1234
Epidemiology of Sarcoidosis 1976-2013: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1863
Epigenetic Changes in SLE Implicate Enhancers As a Force in Pathologic Cell Behavior
- 9:00AM-11:00AM
-
Abstract Number: 1373
Epigenetic Mechanisms Contribute to the Lack of LPS-Induced Tolerance in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1624
Epigenetic Profiling of CD14+ and CD16+ Monocyte Subtypes in Rheumatoid Arthritis. Alterations Related to Cardiovascular Disease and Endothelial Dysfunction
- 9:00AM-11:00AM
-
Abstract Number: 1262
Epigenome-Wide DNA Methylation Patterns Associated with Fatigue in Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1683
Epithelial Changes in Response to Tocilizumab Combined with Methotrexate in Rheumatoid Arthritis: Evaluated on Circulating Fragments of Type IV Collagen
- 9:00AM-11:00AM
-
Abstract Number: 1108
Epratuzumab, a Monoclonal Antibody Targeting CD22 on B Cells, Stimulates the Phosphorylation of Upstream Inhibitory Signals of the B Cell Receptor
- 9:00AM-11:00AM
-
Abstract Number: 1807
Estimated Sodium and Potassium Intake Are Associated with Blood Pressure in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1228
Estimating Under-Diagnosis of Rheumatoid Arthritis in Primary Care Data from the UK Clinical Practice Research Datalink
- 9:00AM-11:00AM
-
Abstract Number: 1506
EULAR Recommendations for Cardiovascular Risk Management in Patients with Rheumatoid Arthritis and Other Inflammatory Joint Diseases – 2015 Update
- 9:00AM-11:00AM
-
Abstract Number: 1296
Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team
- 9:00AM-11:00AM
-
Abstract Number: 1657
Evaluation of Bone and Joint Proteins for Prognostic Association with Radiographic Progression and Disease Activity in Methotrexate Inadequate Responder Rheumatoid Arthritis Patients in a Sarilumab Phase 3 Study
- 9:00AM-11:00AM
-
Abstract Number: 1524
Evaluation of Changes in Cardiovascular Risk Factors Among Patients with RA Prescribed Biologic Dmards
- 9:00AM-11:00AM
-
Abstract Number: 1601
Evaluation of Glucose Metabolism in Rheumatic Patients: A Case Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1617
Evidence for Citrullinated Inhibitor of DNA Binding 1 (Id1) As a Novel Autoantigen Candidate in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1808
Exercise Is Associated with Improved Cardiometabolic Risk Factors in Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 1889
Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1856
Exosomes from Patients with Active Systemic Lupus Erythematosus Induce a Strong Inflammatory Response
- 9:00AM-11:00AM
-
Abstract Number: 1166
Expression and Function of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (PIM-1) Kinase in Rheumatoid Arthritis Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 1613
Expression of the Genes Facilitating Methotrexate Action within Rheumatoid Subcutaneous Nodules
- 9:00AM-11:00AM
-
Abstract Number: 1145
Expression of Xylosyltransferase-1 Is Modulated By Fibronectin Fragment in Human Articular Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 1244
Extracellular MicroRNAs in Synovial Fluid Reveal a Marked Proliferative Signature in Patients with Antibiotic-Refractory Lyme Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1335
Factors Associated with Progressive Radiographic Damage in Gout: A Prospective Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 1717
Factors Associated with the Decision of the Rheumatologist to Order Sacro-Iliac Joints Magnetic Resonance Imaging (SI-MRI) or Order HLA-B27 Testing in Patients with Spondyloarthritis in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 1721
Factors Predictive of Radiographic Progression in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1274
Factors That Impact Job Selection in Pediatric Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 1866
Fall in Dicer1 Gene Expression Flags Abnormal Lymphocyte Activation in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1871
Familial Aggregation of Rheumatoid Arthritis, Sjögren’s Syndrome, and Systemic Sclerosis Were Detected in Systemic Lupus Erythematous Families
- 9:00AM-11:00AM
-
Abstract Number: 1454
Familial Mediterranean Fever in Childhood: a Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 1462
Farber Disease: Important Differential Diagnostic Information for JIA and Other Inflammatory Arthritis Phenotypes Is Revealed By Data from the Largest Clinical Cohort to Date
- 9:00AM-11:00AM
-
Abstract Number: 1713
Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1695
Fatigue May be Independently Active at a Certain Part of Spondyloarthritis Patients: Hur-BIO Real Life Results
- 9:00AM-11:00AM
-
Abstract Number: 1475
Fatigue, Quality of SLEEP and PAIN in Children with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1367
Fibroblast-like Synoviocytes Shape and Perpetuate the Inflammatory Immune Responses Associated with Antibiotic-Refractory Lyme Arthritis.
- 9:00AM-11:00AM
-
Abstract Number: 1690
Fibromyalgia in Spondyloarthritis: Impact on Disease Activity Assessment
- 9:00AM-11:00AM
-
Abstract Number: 1742
Fingerprint Biomarkers of Type I and III Collagen in Axial Spondyloarthropathy (axSpA) and Psoriatic Arthritis (PsA). Association with Disease Activity and Diagnostic Capacity
- 9:00AM-11:00AM
-
Abstract Number: 1327
Five-Year Follow-up of Radiographic Sacroiliitis: Progression As Well As Improvement?
- 9:00AM-11:00AM
-
Abstract Number: 1550
Flares of Disease Activity As Risk Factor for the Occurrence of Myocardial Infarction in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1775
Fn14 Deficiency Protects Lupus-Prone Mice from Cutaneous Lesions Induced By Ultraviolet B (UVB) Irradiation
- 9:00AM-11:00AM
-
Abstract Number: 1488
Following the American College of Rheumatology Quality Guidelines Can Enhance the Safety of Rheumatoid Arthritis Patients Treated with Disease Modifying Drugs
- 9:00AM-11:00AM
-
Abstract Number: 1164
Four Types of Calcium Pyrophosphate Crystals Differentially Induce IL-1beta Production By Monocytes through ATP/Potassium Efflux/ROS Dependent Pathways
- 9:00AM-11:00AM
-
Abstract Number: 1897
Fragmented Qrs Patterns Do Not Correlate with the Degree of Lung and Skin Involvement in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1744
Free DKK-1 Serum Levels Are Unchanged in Spondyloarthritis Patients Treated By Etanercept
- 9:00AM-11:00AM
-
Abstract Number: 1155
Free Fatty Acids Promote Inflammation in Bone of Rheumatic Patients Via Osteoblast
- 9:00AM-11:00AM
-
Abstract Number: 1805
Functional and Mechanistic Characterization of Anifrolumab, a Fully Human, Anti-IFNAR1 Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1867
Functional Androgen Receptor Variants Associated with Greater Damage in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1360
Functional Consequences of NOD2 Gene Variants in Patients with NOD2-Associated Autoinflammatory Disease
- 9:00AM-11:00AM
-
Abstract Number: 1173
G Protein Coupled Receptor Kinase 3 Regulation of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1256
Gas Chromatography/Time-of-Flight-Mass Spectrometry-Based Metabolomic Profiling in Cultured Fibroblast-like Synoviocytes from Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1743
Gender Differences in Ankylosing Spondylitis: Men Derive Greater Benefit from Tumor Necrosis Factor Alpha Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1246
Gene Expression Analysis of Adult Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis Suggest a Single Disease Continuum
- 9:00AM-11:00AM
-
Abstract Number: 1611
Gene Expression Profiling Reflects Increased Expression of Coronary Artery Disease Associated Genes in a Case-Control Matched Study of Patient with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1949
Generation and Immunophenotyping of Citrullin-Specific T Cell Lines from Peripheral Blood and Synovial Fluid of ACPA+ RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 1265
Genetic and Epigenetic Mapping of Very Early RA Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1621
Genetic Contributions to Radiographic Damage in African Americans with Rheumatoid Arthritis on a Panel of Autoimmune Disease Markers
- 9:00AM-11:00AM
-
Abstract Number: 1919
Genetic Deletion of Toll-like Receptor 4 (Tlr4) Abrogates TGF-β1-Induced Endothelial-to-Mesenchymal Transition (EndoMT) in Murine Pulmonary Endothelial Cells
- 9:00AM-11:00AM
-
Abstract Number: 1619
Genetic Influences of Susceptibility to Rheumatoid Arthritis in African Americans
- 9:00AM-11:00AM
-
Abstract Number: 1210
Genetic, Environmental, and Serologic Risk Factors for Inflammatory Joint Signs Among First-Degree Relatives without Rheumatoid Arthritis in a Prospective Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1622
Genome-Wide Association Analysis and Whole Genome Sequencing Identify Variants Associated with Radiographic Severity of Rheumatoid Arthritis in African Americans
- 9:00AM-11:00AM
-
Abstract Number: 1623
Genome-Wide Association Study of DNA Methylation in Th1 and Th17 Cells in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1255
Genome-Wide DNA Methylation Patterns in CD4+ T Reveal Significant Contribution of DNA Methylation to Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1257
Genome-Wide DNA Methylation Signatures of Salivary Gland Inflammation in Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1555
Geography and the Influence of Comorbidity on the Prevalence of Depression in Patients with Rheumatoid Arthritis,a Study Across Seventeen Countries
- 9:00AM-11:00AM
-
Abstract Number: 1242
Germ Line DNA Methylation Profiling Provides Novel Insights into the Parent-of-Origin Effect in Psoriatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1973
Giant Cell Arteritis and Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1130
Global DNA Methylation Analysis of Osteoarthritic Subchondral Bone Reveals Significant Regional Variation and Similarity to Overlying Cartilage
- 9:00AM-11:00AM
-
Abstract Number: 1912
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Immune Abnormalities in Animal Models of Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1730
Good Control of Inflammation Counterbalances a Negative Impact of Radiographic Spinal Progression on Functional Status and Spinal Mobility in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1236
Google-Driven Search for Autoimmune Big Data Links Air Pollution and Younger Age at Diagnosis of Systemic Lupus Erythematosus: Geoepidemiological Analysis of 171,000 Adult Patients
- 9:00AM-11:00AM
-
Abstract Number: 1339
Granulomatosis with Polyangiitis or Post Pulmonary Tuberculosis: Can CT Chest Help in Differentiating in a Tuberculosis Endemic Area?
- 9:00AM-11:00AM
-
Abstract Number: 1864
H3K4me3 Peak Shape Dictates Transcription and Regulates Differential Expression in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1467
Health Related Quality of Life Is Reduced in Pediatric Patients with Juvenile Idiopathic Arthritis and Juvenile-Onset Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 1971
Healthcare Utilization and Direct Medical Costs of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1289
Healthcare Utilization Differences According to Sex Among Children and Adults in Medicaid with Incident Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1829
Heart Rate Variability Is Associated with SLE Flare and with TNF- and IFN-Mediated Signaling
- 9:00AM-11:00AM
-
Abstract Number: 1390
Hidradenitis Suppuritiva Is Associated with Inflammatory Eye Disease
- 9:00AM-11:00AM
-
Abstract Number: 1627
HIF-1alpha Knockdown Down-Regulates Glycolytic Metabolism and Induces Rheumatoid Synovial Fibroblast Cell Death
- 9:00AM-11:00AM
-
Abstract Number: 1565
High Disease Activity over Time and Persistent Inflammation Are Associated with Increased Risk of Cardiovascular Disease in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1693
High Prevalence of Cardiac Disease in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1698
High Prevalence of Traditional Cardiovascular Risk Factors in an Ankylosing Spondylitis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1119
High Resolution Motif Mapping of in Situ Anti-Native-Vimentin Antibodies in Lupus Tubulointerstitial Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1379
High Serum IgG4 Concentration Is a Risk Factor for Relapse in IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 1218
Higher Education Is Associated with a Better Rheumatoid Arthritis Outcome Concerning Pain and Function but Not Disease Activity: Results from Swedish Registers
- 9:00AM-11:00AM
-
Abstract Number: 1845
HMGB1 Early Marker in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1322
How Can We Reduce the Time for Scoring Radiographic Joint Damage in Rheumatoid Arthritis? Initial Results with a New Computer-Based Documentation Tool
- 9:00AM-11:00AM
-
Abstract Number: 1954
How Can We Use Ultrasound in the Diagnosis and Management of Patients with Giant Cell Arteritis?
- 9:00AM-11:00AM
-
Abstract Number: 1352
How Frequently Does Tuberculosis Screening Test Become Positive in Rheumatic Patients Treated with ANTI-Tumor Necrosis Factor-ALPHA Therapy? an Analysis of Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 1840
How Good a Job Are We Rheumatologists Doing in Screening for Hepatitis B and C before Immuno-Suppressive/s Initiation in SLE?
- 9:00AM-11:00AM
-
Abstract Number: 1571
How Substantive Is Heart Rate Variability As a Predictor of Anti-TNF Treatment Outcome for Inflammatory Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 1208
How Well Do Acpas Discriminate and Predict RA in the General Population – a Study Based on 12,590 Population-Representative Swedish Twins
- 9:00AM-11:00AM
-
Abstract Number: 1766
HPV Vaccination of Nzbxw/F1 Mice
- 9:00AM-11:00AM
-
Abstract Number: 1815
Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence
- 9:00AM-11:00AM
-
Abstract Number: 1802
Hydroxychloroquine Level Variants and Predictors in a Connective Tissue Disease Population
- 9:00AM-11:00AM
-
Abstract Number: 1801
Hydroxychloroquine Retinopathy: Application of the 2011 Screening Guidelines in an Academic Practice
- 9:00AM-11:00AM
-
Abstract Number: 1806
Hydroxychloroquine Serum Levels and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1400
Hyperferritinemia and Fever in Adults
- 9:00AM-11:00AM
-
Abstract Number: 1947
Hypermethylation of Treg-Specific Demethylated Regions in the Ikaros Transcription Factor Family Members, Helios and Eos, in Rheumatoid Arthritis Tregs
- 9:00AM-11:00AM
-
Abstract Number: 1854
Identification and Characterization of microRNAs Related to the Pathogenesis of Cardiovascular Disease in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus. Role of Specific Autoantibodies
- 9:00AM-11:00AM
-
Abstract Number: 1885
Identification and Clinical Correlations of Rare Autoantibodies in Systemic Sclerosis and Poly/Dermatomyositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1241
Identification and Validation of Diagnostic and Activity Urinary Metabolomic Biomarkers in Immune-Mediated Inflammatory Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1253
Identification and Validation of Novel Putative Salivary Proteomic Biomarkers in Sjögren’s Syndrome and Different Disease Subsets
- 9:00AM-11:00AM
-
Abstract Number: 1930
Identification of a Broadly Immunogenic Prevotella Copri T Cell Epitope in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1258
Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract
- 9:00AM-11:00AM
-
Abstract Number: 1750
Identification of Autoantibody-Inducing CD4 T Cell (aiCD4 T cell) That Causes Systemic Lupus Erythematosus (SLE) As DOCK8+ CD4 T Cell: Proof of Concept of Self-Organized Criticality Theory
- 9:00AM-11:00AM
-
Abstract Number: 1095
Identification of Carbamylated Alpha-1-Anti-Trypsin (A1AT) As an Antigenic Target of Anti-Carp Antibodies in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1616
Identification of Genes Regulating TRAIL-Induced Apoptosis in Rheumatoid Arthritis Fibroblasts-like Synoviocytes (RA FLS)
- 9:00AM-11:00AM
-
Abstract Number: 1953
Identification of Genetic Factors Associated with Clinical Manifestations of Giant Cell Arteritis through a Stratified Large-Scale Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1862
Identification of Homogeneous Systemic Lupus Erythematosus (SLE) Patient Groups Using Clustered Autoantibody Reactivities
- 9:00AM-11:00AM
-
Abstract Number: 1134
Identification of Novel Micro-RNAs in IL-1β-Stimulated OA Chondrocytes By Next-Generation Sequencing
- 9:00AM-11:00AM
-
Abstract Number: 1243
Identification of the Gene Expression Signatures Predicting the Responses to Three Biologics (infliximab, tocilizumab, and abatacept) in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1857
Identification of the Long Noncoding RNA NEAT1 As a Novel Inflammatory Regulator Acting through MAPK Pathway in Human Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1583
Identifying Risk Factors for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1846
IGFBP-2 As a Novel Biomarker for Disease Activity and Renal Pathology in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1799
IgG Levels Correlate Inversely with Proteinuria Among Participants in the Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis Trial, but Hypogammaglobulinemia Was Not Associated with an Increased Risk of Serious Infection
- 9:00AM-11:00AM
-
Abstract Number: 1136
IL-1β-Induced Stress Granules Sequester COX-2 mRNA and Regulates Its Expression in Human OA Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 1932
IL-17A-Low CCR6+ Th Cell Populations of Patients with Rheumatoid Arthritis Are Pathogenic, Multidrug Resistant and Associated with DMARD and Glucocorticoid Treatment Response
- 9:00AM-11:00AM
-
Abstract Number: 1377
IL-22 Drives the Proliferation and Differentiation of Human Bone Marrow Mesenchymal Stem Cells (MSCs); A Novel Pathway That May Contribute to Aberrant New Bone Formation in Human Spa and Beyond
- 9:00AM-11:00AM
-
Abstract Number: 1162
IL37 Reduces Pro-Inflammatory Cytokine and Catabolic Enzyme Production in Human Chondrocytes: A Protective Role in Osteoarthritis?
- 9:00AM-11:00AM
-
Abstract Number: 1552
Illness Perceptions in Rheumatoid Arthritis: A Comparison of Canadian and Nigerian Patients
- 9:00AM-11:00AM
-
Abstract Number: 1735
Imaging and Clinical Factors Associated with Subchondral Sacroiliac Fatty Marrow in Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1993
Imaging Findings of Cerebral Amyloid Angiopathy, Abeta-Related Angiitis (ABRA) and Cerebral Amyloid Angiopathy-Related Inflammation: A Single Institution 25 Year Experience
- 9:00AM-11:00AM
-
Abstract Number: 1341
Imaging Growing Joints By Diffraction Enhanced-Computed Tomography Using a Synchrotron Light Source
- 9:00AM-11:00AM
-
Abstract Number: 1403
Immune Related Adverse Events Associated with Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review of Case Reports
- 9:00AM-11:00AM
-
Abstract Number: 1879
Immunosuppressive “Routine”� Treatment of SSc Patients with Limited Cutaneous Involvement and Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1892
Impact of Cardiac Magnetic Resonance Imaging with T1 Mapping and Multi-b Value Diffusion-Weighted Sequences in Systemic Sclerosis for the Assessment of Myocardial Microscopic Fibrosis and Perfusion
- 9:00AM-11:00AM
-
Abstract Number: 1500
Impact of Menopause on Functional Impairment of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1589
Impact of Osteoarthritis of the Hand on Disease Activity Scores and Health Status in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1287
Impact of Participation in Adalimumab Patient Support Program (PSP) on Clinical Outcomes and Predictors of PSP Utilization Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1329
Impact of Repeating Imaging of the Sacroiliac Joints after One Year on the Classification of Patients According the ASAS Axial Spa Criteria
- 9:00AM-11:00AM
-
Abstract Number: 1874
Impact of Socioeconomic Status on Survival in Connective Tissue Disease Associated and Idiopathic Pulmonary Arterial Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 1595
Impaired Coronary Flow Reserve in Rheumatoid Arthritis: A Robust Indicator of Cardiac Structure Associated with Systemic Inflammation and Rheumatoid Arthritis Treatments
- 9:00AM-11:00AM
-
Abstract Number: 1492
Implementation in Clinical Practice of a Medication Assessment Tool Specific for Rheumatoid Arthritis, Rhmat
- 9:00AM-11:00AM
-
Abstract Number: 1547
Implementing an Electronic Medical Recorded-Based Clinical Decision Support Tool Did Not Improve Cardiovascular Risk Screening in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1768
Improved Tissue Clearing and 2-Photon Imaging of Mouse Kidneys Reveals Immune Cell Architecture in Nephrotoxic Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1276
Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey
- 9:00AM-11:00AM
-
Abstract Number: 1476
Improvement of the Long-Term Outcome in Greek Adult Patients with Juvenile Idiopathic Arthritis in the 21st Century
- 9:00AM-11:00AM
-
Abstract Number: 1786
Improvements in Health-Related Quality of Life and Fatigue Following Administration of an IL-6 Monoclonal Antibody (PF-04236921) in an Enriched Population of Subjects with Active SLE
- 9:00AM-11:00AM
-
Abstract Number: 1297
Improving the Medication Prior Authorization Process in a University Based Rheumatology Practice
- 9:00AM-11:00AM
-
Abstract Number: 1984
Incidence and Intensity of 18fdg Uptake on Whole Body PET/CT in Patients with Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 1472
Incidence and Mortality in a Population-Based Cohort of Patients with Juvenile Arthritis 1960-2013
- 9:00AM-11:00AM
-
Abstract Number: 1970
Incidence and Predictors of Thoracic Aortic Damage in Biopsy-Proven Giant Cell Arteritis: A Single-Institution Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1514
Incidence and Risk Factors of Malignancy in a Cohort of Rheumatoid Arthritis Patients from Singapore
- 9:00AM-11:00AM
-
Abstract Number: 1512
Incidence of Co-Morbid Autoimmune Diseases in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1238
Incident Systemic Lupus Erythematosus in Males in a Northern California County Hospital
- 9:00AM-11:00AM
-
Abstract Number: 1338
Increased Aortic Wall Thickness for the Diagnosis of Aortitis: a Computed Tomography-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1687
Increased Carotid Intima-Media Thickness in Psoriatic Arthritis Patients Compared with Systemic Lupus Erythematosus Patients and Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 1910
Increased Circulating CD204/CD206 Double Positive Monocyte/Macrophages in Systemic Sclerosis Patients with “Early” Capillaroscopic Pattern of Microvascular Damage
- 9:00AM-11:00AM
-
Abstract Number: 1848
Increased Expression of Bruton Tyrosine Kinase in Patients with Lupus Nephritis and Its Clinic Significance
- 9:00AM-11:00AM
-
Abstract Number: 1981
Increased Extracellular Water Measured By Bioimpedance Analysis in Polymyalgia Rheumatica Patients – Sign of Volume Overload
- 9:00AM-11:00AM
-
Abstract Number: 1588
Increased Fracture Risk in Patients with Early Rheumatoid Arthritis: A Prospective General Population-Matched Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1094
Increased IgA Plasmablasts Are Associated with Rheumatoid Arthritis-Related Autoantibodies in the Absence of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1850
Increased Levels of Immunoglobulin Binding Protein 1 Are Associated with Disease Activity Including Renal Damage in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1737
Increased Osteoclast Precursors with an Elevated DC-STAMP Expression May Identify Psoriasis Patients at Risk for Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1511
Increased Prevalence of Anti-Nuclear and Anti-SSA Autoantibodies in African American Rheumatoid Arthritis Patients Versus Matched Caucasian Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1504
Increased Risk of Thromboembolism Among Patients with VTE Association with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1924
Increased Stat1 and Stat 1 Phosphorylation in Patients with Systemic Sclerosis (SSc)
- 9:00AM-11:00AM
-
Abstract Number: 1419
Increasing Comorbidity Is Associated with Worsening Physical Function during Intermediate-Term Follow-up of Primary Total Knee Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 1294
Infection and Screening Costs Related to Tumor Necrosis Factor-Alpha Inhibitor Use
- 9:00AM-11:00AM
-
Abstract Number: 1224
Infection Rate in HIV Patients Who Received TNF-a Inhibitor Therapy for Concomitant Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1789
Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
- 9:00AM-11:00AM
-
Abstract Number: 1302
Inflammation Signs on Magnetic Resonance Imaging in Chronic or Recurrent Gonarthritis Treated with Intra-Articular Infliximab or Corticosteroids
- 9:00AM-11:00AM
-
Abstract Number: 1461
Inflammatory Bowel Disease in Children with Systemic Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1663
Influence of Age and Renal Impairment on Pharmacokinetics of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor
- 9:00AM-11:00AM
-
Abstract Number: 1107
Inhibition of B Cell Activation and Plasma Cell Differentiation By Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22
- 9:00AM-11:00AM
-
Abstract Number: 1907
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Dermal Fibrosis By Interfering with the Release of Pro-Fibrotic Cytokines from M2-Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 1831
Initial Risk Factor Profile and Long-Term Cardiovascular Outcome in Women with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1502
Initiating Statin Medication and Risk of Fatigue in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1564
Initiation of Disease Modifying Therapies and Subsequent Weight Change in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1787
Innate Immunity, Arterial Inflammation and Vascular Stiffness in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1365
Innate Lymphoid Cells. New Players in Systemic Sclerosis Correlate with Extent of Skin and Lung Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 1797
Insulin Resistance Is Not Associated with Increased Risk of Subclinical Atheromatosis in Patients with Systemic Lupus Erythematosus from Northern Spain
- 9:00AM-11:00AM
-
Abstract Number: 1128
Insulin-Induced Cartilage Degradation in Osteoarthritis Is Associated to Defective Autophagy
- 9:00AM-11:00AM
-
Abstract Number: 1873
Inter and Intrarater Reliability of the Modified Rodnan Skin Score in Early Diffuse Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1962
Inter-Rater Analysis of Ultrasound and Histological Findings in Patients with Suspected Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1321
Inter-Reader Agreement of a Novel Method of Radiographic Scoring of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1098
Interleukin-1 Reciprocally Regulates Interferon-Gamma Induced B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) and Interleukin-6 in Human Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1925
Interleukin-35 Is Upregulated in Systemic Sclerosis and Its Serum Levels Are Increased in Early Disease
- 9:00AM-11:00AM
-
Abstract Number: 1176
Interleukin-37 Prevents New-Onset Joint Inflammation but Does Not Inhibit Existing Experimental Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1189
Internal Medicine Subspecialty Fellows’ Attitudes Towards Teaching and Learning How to Teach: A Needs Assessment
- 9:00AM-11:00AM
-
Abstract Number: 1961
Interobserver Agreement on Ultrasonographic and Magnetic Resonance Angiography Findings in Patients with Large Vessel Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1983
Interspinous Bursitis Evaluation By Ultrasound Is Very Useful for Diagnosis of Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 1362
Investigating the Role of Dendritic Cell Maturation & T Cell Activation within the Inflamed Synovium in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1212
Investigation of Vitamin D Supplement Use, Rheumatoid Arthritis-Related Autoimmunity and Joint Signs Among Those at Increased Risk for the Development of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1303
Is MRI More Sensitive Than Conventional Radiographs to Detect Hand Osteoarthritis Progression over 5 Years Follow-up?
- 9:00AM-11:00AM
-
Abstract Number: 1316
Is MRI of Use in Identifying Which Undifferentiated Arthritis Patients Will Develop RA?
- 9:00AM-11:00AM
-
Abstract Number: 1881
Is the Presence of Esophageal Dilation a Poor Prognostic Factor in Dilated Interstitial Lung Disease Associated with Systemic Sclerosis?
- 9:00AM-11:00AM
-
Abstract Number: 1793
Is There a Relationship Between Antimalarial Treatment and Elevated Muscle Enzymes in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1401
Is There Any Difference Between Autoimmune or Hemato-Oncology Etiology of Macrophage Activation Syndrome?
- 9:00AM-11:00AM
-
Abstract Number: 1736
Is There Evidence to Support Replacing Conventional AP Pelvis Radiographs with Dedicated Sacroiliac Joint Views for the Diagnosis of Sacroiliitis?
- 9:00AM-11:00AM
-
Abstract Number: 1523
Ischemia Modified Albumin Levels in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1928
Isolation and Initial Characterization of Dermal Vascular Smooth Muscle Cells in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1582
Joint Damage Associated with Loss of Body Mass in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1142
Joint Specific Function of Synovial Fibroblasts – Integrating Positional Transcriptomes and Anatomic Patterns of Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1838
Joint Ultrasonography May be Useful to Assess Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: A Prospective Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 1473
Juvenile Psoriatic Arthritis Manifestations in a Cohort of 361 Patients from US and Canada
- 9:00AM-11:00AM
-
Abstract Number: 1455
Juvenile Spondyloarthropathies: a Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 1202
Knowledge and Perception of Cardiovascular Disease Risk in Patients with Psoriatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1135
Krüppel-like Factors (Klfs), Novel Transcriptional Regulators of Articular Chondrocytes That Are Abnormally Expressed in Osteoarthritic Cartilage
- 9:00AM-11:00AM
-
Abstract Number: 1609
Lack of Association Between ZHX2, Lepr, Gckr and ASCL1 and Carotid Intima-Media Thickness, Carotid Plaques and Cardiovascular Disease in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1952
Lack of Association of a 6.7 Kbp Deletion of LILRA3 with Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1659
Lack of Effect of Reduced Folic Acid Supplementation on Disease Activity in RA
- 9:00AM-11:00AM
-
Abstract Number: 1615
Lack of Replication of the Association Between Anti-Citrullinated Fibrinogen and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1991
Large Vessel Involvement By IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 1821
Leptin, Adiponectin, and Resistin As Serum Markers of Fatigue in Systemic Lupus Erythematosus: A Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 1508
Lipid Target Achievement Among Patients with Recent-Onset Rheumatoid Arthritis during the First Six Years of Follow-up: Results from a French Multicenter Cohort of Early Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1788
Lipoprotein Subfractions and Cardiovascular Disease in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1396
Long Term Outcome of Neurosarcoidosis
- 9:00AM-11:00AM
-
Abstract Number: 1701
Long Term Outcome of Total Hip Replacement in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1446
Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
- 9:00AM-11:00AM
-
Abstract Number: 1351
Long-Term Efficacy of Latent Tuberculosis Infection Screening in Juvenile Idiopathic Arthritis Patients Prior to Anti-TNF Treatment in an Endemic Area
- 9:00AM-11:00AM
-
Abstract Number: 1816
Long-Term Outcome of Tacrolimus Therapy As a Maintenance Strategy in Patients with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1633
Long-Term Radiographic and Patient-Reported Outcomes Based on Clinical Disease Activity Index Responses with Tofacitinib at 6 Months
- 9:00AM-11:00AM
-
Abstract Number: 1649
Long-Term Safety and Efficacy of Olokizumab in Patients with Moderate-to-Severe Rheumatoid Arthritis Who Have Previously Failed Anti-TNF Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1795
Long-Term Safety and Efficacy of Tacrolimus for Lupus Nephritis Patients in Real World Setting -Results from 5 Year Interim Analysis of Post Marketing Surveillance of 1376 Patients in Japan-
- 9:00AM-11:00AM
-
Abstract Number: 1977
Long-Term Survival of Methotrexate in Giant Cell Arteritis Patients in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 1225
Long-Term Use of Biological Therapy and Discontinuation Rates in Rheumatoid Arthritis – Real World Patient Data
- 9:00AM-11:00AM
-
Abstract Number: 1137
Low Molecular Weight Polyphenol Harpagoside Inhibits IL-1β-Induced Expression of IL-6 By Blocking the Expression and Activity of c-Fos in Primary Human Osteoarthritis Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 1270
Low Socioeconomic Status As a Predictor of Long-Term Direct Medical Costs Following Diagnosis of Granulomatosus with Polyangiitis: A General Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1777
Lymphocyte Depletion, Recovery and Efficacy in NZBWF1 Lupus Mice Following Continuous or Intermittent Dosing Regimen of Venetoclax (ABT-199), a Potent and Selective BCL-2 Inhibitor
- 9:00AM-11:00AM
-
Abstract Number: 1913
Lysyl Oxidase Induces Fibrosis Via Upregulation of IL-6 and Serves As a Biomarker to Monitor Response to Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1908
Macitentan Responsiveness Supports the Validity of a Murine Model of Pulmonary Hypertension in Scleroderma Associated with Altered Tgfbeta/BMPR2 Signalling
- 9:00AM-11:00AM
-
Abstract Number: 1456
Macrophage Activation Syndrome and Familial Hemophagocytic Lymphohistiocytosis: Is Their Clinical Phenotype Really Similar?
- 9:00AM-11:00AM
-
Abstract Number: 1684
Malignancies in Patients with Incident Psoriatic Arthritis 1970-2008 in Relation to a Comparator Cohort: A Population-Based Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1386
Malignancy Prevalence Is Increased Among Patients before the Onset of IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 1441
Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials
- 9:00AM-11:00AM
-
Abstract Number: 1285
Markers of Non-Compliance with ASAS/EULAR Management Recommendations Among Early Spa Patients: Evidence over 3 Years in the DESIR Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1101
Matrix Metalloproteinase-10 (Stromelysin 2) Is a Target of Robust Autoimmune T and B Cell Responses in Antibiotic-Refractory Lyme Arthritis, but Not in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1204
Measuring the Effectiveness of Patient Education of Patients Receiving Injectable Biologic Medications
- 9:00AM-11:00AM
-
Abstract Number: 1269
Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand up and be Counted Survey
- 9:00AM-11:00AM
-
Abstract Number: 1413
Medial Meniscus Extrusion and Spontaneous Osteonecrosis of the Knee
- 9:00AM-11:00AM
-
Abstract Number: 1841
Meningitis in Systemic Lupus Erythematosus Patients: Epidemiologic Profile of Listeria Monocytogenes Infection. a Single-Center Study
- 9:00AM-11:00AM
-
Abstract Number: 1685
Metabolic Syndrome in Patients with Psoriatic Arthritis Is Associated to Peripheral Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 1584
Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1247
Methylation Analysis of HLA-B Locus in Familial Behçet Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1950
Methylation-Dependent Interference of Two Promoters for the Treg-Specific Protein, Garp, Contributes to Altered Treg Function in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1133
Microrna-128 Interference Mitigates the Progression of Keen Osteoarthritis By Regulating Sirtuin-1
- 9:00AM-11:00AM
-
Abstract Number: 1945
microRNA-30a Promotes the Inflammatory Response of Rheumatoid Arthritis By Regulating Th1 Cell Differentiation
- 9:00AM-11:00AM
-
Abstract Number: 1168
MiR125a-5p Mediates Angiogenic Mechanisms in Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1765
MiR155 Deficient Mice Show Reduced Disease Severity in Pristane-Induced Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1666
Mitochondrial Haplogroups in Patients with Rheumatoid Arthritis with Respect to Biological Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1643
Modified-Release Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared with Immediate-Release Tofacitinib and Impact of Food
- 9:00AM-11:00AM
-
Abstract Number: 1751
Modulation of IRF4 Function Promotes Expansion of Effector Tregs in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1261
Molecular Analysis of Vascular Smooth Muscle Cells from Patients with Giant Cell Arteritis: Targeting Endothelin-1 Receptor to Control Proliferation
- 9:00AM-11:00AM
-
Abstract Number: 1911
Monocyte Chemoattractant Protein-1 (MCP-1, CCL2) Is a Potential Local Marker of Renal Involvement in Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 1343
Mortality Due to Sepsis in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1104
Mouse B Cells Require Glucose and Free Fatty Acids As Carbon Sources for Cytokine and Chemokine Secretion
- 9:00AM-11:00AM
-
Abstract Number: 1306
MRI Erosions in Undifferentiated Arthritis. Different Associations with the Collagen IIA N-Terminal Propeptide (PIIANP) and Galectin-3 in Pre-RA and Other Arthritides
- 9:00AM-11:00AM
-
Abstract Number: 1308
MRI Measures of Disease Activity and Joint Damage Are Associated with Patient-Reported Outcomes in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1727
MRI Vertebral Corner Inflammation Followed By Fat Deposition Is the Strongest Contributor to the Development of New Bone at the Same Vertebral Corner: A Multi-Level Longitudinal Analysis in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1374
Mucosal-Associated Invariant T- Cells Are Decreased and Functionally Immature in Peripheral Blood of Patients with Primary Sjögren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1350
Multi-Targeted Loop-Mediated Isothermal Amplification for Rapid Diagnosis of Osteoarticular Tuberculosis in 60 Minutes: Experience from North India
- 9:00AM-11:00AM
-
Abstract Number: 1398
Musculoskeletal and Serologic Findings in an Adult Cystic Fibrosis Clinic Population-a Systematic Review and Collation with Disease Status
- 9:00AM-11:00AM
-
Abstract Number: 1465
Musculoskeletal Anomalies in Children with Trisomy 21
- 9:00AM-11:00AM
-
Abstract Number: 1833
Musculoskeletal Complications of Systemic Lupus Erythematosus: Risk Factors for and Prevalence of Avascular Necrosis and Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 1186
Musculoskeletal Ultrasound Education Among Rheumatology Fellowship Programs in the United States
- 9:00AM-11:00AM
-
Abstract Number: 1790
Mycophenolate Mofetil Suppresses Humoral Response to Pneumococcal Vaccine in Patients with Systemic Lupus Erythematosus and Other Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1886
Myocardial Fibrosis Detected By Magnetic Resonance Imaging Is a Predictor of Heart Failure in Systemic Sclerosis (SSc) Patients
- 9:00AM-11:00AM
-
Abstract Number: 1817
Myocardial Tissue Characterization with Native Myocardial T1 Mapping in SLE Patients with Chest Pain
- 9:00AM-11:00AM
-
Abstract Number: 1909
Nailfold Capillaroscopic Assessment and Vascular Biomarkers in Systemic Sclerosis: Low CD40L Levels in Patients with Late Scleroderma Patterns
- 9:00AM-11:00AM
-
Abstract Number: 1366
Natural Antibodies, Not B Cells, Contribute to Acute Cell Death-Induced Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 1451
Neurologic Findings and Serial Neuroimaging in Patients with Linear Scleroderma En Coup De Sabre (ECDS) and Parry-Romberg Syndrome (PRS)
- 9:00AM-11:00AM
-
Abstract Number: 1434
Neuropathic Pain in Patients with Rheumatoid Arthritis: Relation with Clinical Variables
- 9:00AM-11:00AM
-
Abstract Number: 1530
Neutrophil Function and Survival Unaffected in Healthy Subjects Following Single Administration of Tocilizumab
- 9:00AM-11:00AM
-
Abstract Number: 1763
Neutrophil Netosis Formation during the UVB Induced-Skin Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 1407
New Clinical Features of Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1125
Next-Generation Sequencing Demonstrates Dynamic Recirculation of B Cell Clones in Ectopic Lymphoid Structures of Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1594
No Association of Anti-Citrullinated Peptide Antibodies with Coronary Artery Calcification in Two Rheumatoid Arthritis Cohorts without Clinical Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 1629
Non-Interventional Clinical Study Investigating the Use of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in Germany – 3rd Interim Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1767
Noninvasive Assessment of Macrophage Activation in Experimental Glomerulonephritis Using Optical Imaging with Near-Infrared Light Serves As a Surrogate of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 1150
Novel Chitosan Hydrogels for the Treatment of Osteoarthritis: Mechanical Support, Lubrication and Prevention of Cartilage Degradation in a Rabbit Model of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1813
Novel Mechanism of Action of Anti-Malarial Drugs in the Inhibition of Type I Interferon Production
- 9:00AM-11:00AM
-
Abstract Number: 1699
Obesity and Pediatric Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1598
Obesity and the Risk for Development of Rheumatoid Arthritis – Results from a Population-Based Nested Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1703
Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1112
Obinutuzumab Outperforms Rituximab at Inducing B-Cell Cytotoxicity in Vitro through Fc-Mediated Effector Mechanisms in Rheumatoid Arthritis and Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1697
Obstructive Sleep Apnea and Fatigue in Inflammatory Arthritis Patients Taking TNF-Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1567
Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting
- 9:00AM-11:00AM
-
Abstract Number: 1532
Occurrence of Valvular Heart Disease in Rheumatoid Arthritis: A Population Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1914
Oncostatin M As a Potential Molecular Target in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1672
One-Year Safety of Sirukumab Monotherapy: Results from a Randomized, Double-Blind, Parallel-Group, Multicenter Study in Japanese Subjects with Moderate to Severe Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1295
Online Consultation for Rheumatic Disease Patients Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics
- 9:00AM-11:00AM
-
Abstract Number: 1230
Only One-Third of Patients with Spondyloarthritis Are Managed By Rheumatologists
- 9:00AM-11:00AM
-
Abstract Number: 1792
Optimal Monitoring for Coronary Heart Disease Risk in Systemic Lupus Erythematosus Patients: a Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 1220
Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1438
Oral Potassium (K+) Reduces Pain in RA: A Randomized Active Control Study of Diet Based K+ Intervention
- 9:00AM-11:00AM
-
Abstract Number: 1702
Osteoporosis in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1825
Osteoprotegerin Is Associated with Lupus and with Coronary Artery Calcification
- 9:00AM-11:00AM
-
Abstract Number: 1440
Outcomes and Cost-Effectiveness of Shoulder Injections with Sonographic Needle Guidance
- 9:00AM-11:00AM
-
Abstract Number: 1780
Oxidative Stress Protects Against Nephritis Induced By Chronic Graft Versus Host Disease
- 9:00AM-11:00AM
-
Abstract Number: 1422
Pain after Total Knee Arthroplasty: Poverty Modifies the Effect of Race and Education
- 9:00AM-11:00AM
-
Abstract Number: 1301
Pain Central Sensitization Assessed By Functional Magnetic Resonance Imaging in Patients with Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1773
Pan JAK Inhibitor Tofacitinib Ameliorate Autoimmunity and Nephritis in Lupus Prone Mice Via Inhibition of Interferon Signaling Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1497
Panlar Consensus on Hand, Hip and Knee OA
- 9:00AM-11:00AM
-
Abstract Number: 1891
Parameters That Predict Worsening of Skin Thickness in Patients with Early Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1915
Pathogenetic Overlap Between Localised and Systemic Scleroderma: A Study of Nodular and Keloidal Morphea Occurring in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1196
Patient Education in Spondyloarthritis Should be Guiding, Reliable and Available and Presented in Varied Formats
- 9:00AM-11:00AM
-
Abstract Number: 1203
Patient Satisfaction and Outcomes of a NOVEL Ankylosing Spondylitis Education and Self-Management Project
- 9:00AM-11:00AM
-
Abstract Number: 1746
Patient’s Ability of Coping Is Influencing the Correlation Between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1499
Patients Who Take Many Medications for Their Fibromyalgia Symptoms at the Initial Office Visit Tend to Have a Worse Clinical Course
- 9:00AM-11:00AM
-
Abstract Number: 1399
Patterns of Arthropathy in Patients with Cystic Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 1477
Patterns of Enthesitis and Arthritis in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1668
Patterns of Relapse in the Rheumatoid Arthritis Cohort Treated with Rituximab at University College London
- 9:00AM-11:00AM
-
Abstract Number: 1452
Pauciimmune and Immune Mediated Pulmonary Capillaritis in Children
- 9:00AM-11:00AM
-
Abstract Number: 1760
PD-1 Signaling Interferes with OX40 to Alter the Suppressive Function and Proliferation of CD4+ Regulatory T Cells in Lupus Mice
- 9:00AM-11:00AM
-
Abstract Number: 1483
Pediatric Rheumatologists’ Perceptions of Career Satisfaction, Confidence in Fulfilling Their Roles, and Burn-out
- 9:00AM-11:00AM
-
Abstract Number: 1275
Pediatric Rheumatology Work Force and Patients Status in Latin America. a Snap Shot Web Based Survey
- 9:00AM-11:00AM
-
Abstract Number: 1328
Pelvic Plain Radiograph, Thoraco-Abdominal and Pelvic CT Scan and MRI Compared to the CT of the Sacroiliac Joints Taken As Gold Standard in the Diagnosis of Structural Sacroiliitis
- 9:00AM-11:00AM
-
Abstract Number: 1900
Performance of the Detect Protocol for Pulmonary Arterial Detection in Systemic Sclerosis Patients in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 1830
Periodontal Disease in Lupus Erythematosus and Cardiovascular Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 1577
Periodontal Evaluation Is Associated with Increased Likelihood of Achieving Low Disease Activity in Rheumatoid Arthritis with Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 1922
Peripheral B Lymphocytes Secrete Both Interleukin 6 and Transforming Growth Factor-Beta and Potentiate Fibroblast Activation in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1430
Peripheral HMGB1 Regulates Arthrtis-Associated Pain-like Behaviour
- 9:00AM-11:00AM
-
Abstract Number: 1282
Persistence with Osteoporosis Therapies in Postmenopausal Women in a Large US National Health Plan
- 9:00AM-11:00AM
-
Abstract Number: 1286
Persistent Individual and Neighborhood Poverty Are Independent Risk Factors for Accumulated Lupus Damage
- 9:00AM-11:00AM
-
Abstract Number: 1495
Person-Centred Care Can Help Patients to Become More Effective Consumers in the Use of Health Information Than Regular Care – an RCT in Patients with Arthritis Undergoing Biological Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1822
Pharmacokinetics of the Selective B-Cell Lymphoma-2 (Bcl-2) Inhibitor, ABT-199, in Female Subjects with Systemic Lupus Erythromatosus
- 9:00AM-11:00AM
-
Abstract Number: 1918
Pharmacologic Targeting of Mitochondrial Dysfunction in Systemic Sclerosis: Enhanced SIRT3 Signaling
- 9:00AM-11:00AM
-
Abstract Number: 1217
Phenome-Wide Association Study of Novel Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1471
Phenotypic Differences Between HLA-B27 Positive and Negative Children with Enthesitis-Related Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1103
Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion By Human Regulatory B Cells
- 9:00AM-11:00AM
-
Abstract Number: 1445
Physicians’ Perspectives on the Diagnosis and Treatment of Chronic Nonbacterial Osteomyelitis
- 9:00AM-11:00AM
-
Abstract Number: 1251
Physiological Evidence for Diversification of the IFNα- or IFNβ-Mediated Response Programs in Different Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1572
Plasma Apolipoprotein B48 Levels in Patients with Rheumatoid Arthritis: Evaluating Novel Cardiovascular Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 1992
Plasma Endothelin-1 Parallels the Vasoconstriction Phase in Reversible Cerebral Vasoconstriction Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1827
Plasma Myeloperoxidase Levels Are Inversely Associated with Carotid Plaque in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1573
Plasma Pentraxin 3 Concentration Is Associated with Progression of Radiographic Joint Damage but Not with Carotid Atherosclerosis in Female Patients with Rheumatoid Arthritis: Results from a 3-Year Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1171
Plasma Soluble ST2 Levels Are Independently Associated with Both Carotid Atherosclerosis and Compromised Cortical Volumetric Bone Mineral Density and Microstructure in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1931
PLCe1 Mediates Cellular Adhesion Downstream of SDF-1 in T Cells
- 9:00AM-11:00AM
-
Abstract Number: 1519
Pleuropulmonary Manifestations in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1368
PMN Reactivity Contribute to Acute Onset Joint Inflammation By Increasing CXCL8 Production in Joints of RA Patients with Anti-Collagen II Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1447
Positive Power Doppler Signal Increases the Risk of Clinical Flare of Patients with Juvenile Idiopathic Arthritis in Clinical Remission: A Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1416
Postoperative Complications Rate in Orthopaedic Surgery Performed in Rheumatic Patients in Use of Biologic Agents
- 9:00AM-11:00AM
-
Abstract Number: 1943
Potent and Selective Tyk2 Inhibitors Block Th1- and Th17- Mediated Immune Responses and Reduce Disease Progression in Rodent Models of Delayed-Type Hypersensitivity and Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 1097
Pre-Clinical Development of a Novel, Potent and Selective BTK Inhibitor for Autoimmune Disease and Inflammation Including Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1837
Predictability of Musculoskeletal Flares and Hand Deformities in Systemic Lupus Erythematosus By High Resolution Ultrasound : 5-Year Clinical and Imaging Prospective Follow-up Study
- 9:00AM-11:00AM
-
Abstract Number: 1433
Predicting Response to Osteoarthritis Treatment Based on Patient Reported Outcome Measures and Quantitative Sensory Testing
- 9:00AM-11:00AM
-
Abstract Number: 1318
Prediction of Large Joint Destruction in Patients with Rheumatoid Arthritis Using FDG-PET/CT: A Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1674
Predictive Factors of Persistence in Therapy with Abatacept in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1207
Predictive Utility of Anti- Citrullinated Peptide Antibodies and Rheumatoid Factor – a Retrospective Dataanalysis
- 9:00AM-11:00AM
-
Abstract Number: 1729
Predictors and Clinical Factors Associated with Change in Spinal Inflammation Assessed on MRI over 2 Years: Data from Tasmanian Ankylosing Spondylitis Study
- 9:00AM-11:00AM
-
Abstract Number: 1708
Predictors of Depression Severity in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1528
Predictors of Employment, Work Productivity Loss, Activity Impairment, and Regaining Employment in Latinos with Rheumatoid Arthritis in the United States
- 9:00AM-11:00AM
-
Abstract Number: 1747
Predictors of Survival on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage
- 9:00AM-11:00AM
-
Abstract Number: 1745
Predictors of Sustained Remission on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage
- 9:00AM-11:00AM
-
Abstract Number: 1206
Presence of ACPA in a Large (>40.000) Population Based Cohort from the Netherlands
- 9:00AM-11:00AM
-
Abstract Number: 1376
Presence of the Interferon Signature in Anti-Nuclear Antibody Positive Individuals Prior to the Onset of Systemic Autoimmune Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1219
Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Poland: First Nationwide Study
- 9:00AM-11:00AM
-
Abstract Number: 1706
Prevalence and Factors Associated with Non-Traumatic Vertebral Fractures in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1877
Prevalence and Risk Factors for Left Ventricular Diastolic Dysfunction in Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 1820
Prevalence and Risk-Factors for Asymptomatic Coronary-Artery Calcifications in Young Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1395
Prevalence and Significance of MEFV GENE Mutations in Patients with Sarcoidosis
- 9:00AM-11:00AM
-
Abstract Number: 1549
Prevalence of Co-Morbidities and Evaluation of Their Monitoring in Korean Patients with RA: Comparison with the Results of an International, Cross-Sectional Study (COMORA)
- 9:00AM-11:00AM
-
Abstract Number: 1232
Prevalence of Idiopathic Inflammatory Myopathies in Sweden in 2012 – a National Register Study
- 9:00AM-11:00AM
-
Abstract Number: 1716
Prevalence of Joint Symptoms and Frequency of Joint Exams for Patients with Plaque Psoriasis without Confirmed Psoriatic Arthritis: A US Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1305
Prevalence of MR-Detected Ramris-Defined Erosions in the General Population
- 9:00AM-11:00AM
-
Abstract Number: 1704
Prevalence of Obesity and Metabolic Syndrome in Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1437
Prevalence of Pain, Its Impact and Management in a Population-Based Cohort of Patients with Rheumatoid Arthritis: Data from the Australian Rheumatology Association Database
- 9:00AM-11:00AM
-
Abstract Number: 1723
Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized CT Scoring System
- 9:00AM-11:00AM
-
Abstract Number: 1501
Prevalence of Unassessed and Uncontrolled Cardiovascular Disease Risk Factors Among Rheumatoid Arthritis Patients in an Academic Rheumatology Practice
- 9:00AM-11:00AM
-
Abstract Number: 1114
Profiling Circulating Plasmablasts from Anti-Ro Positive Mothers of Children with Congenital Heart Block to Identify Antigenic Targets Conferring Pathogenicity
- 9:00AM-11:00AM
-
Abstract Number: 1796
Progression of Atherosclerosis Might be Prevented By Decrease of Serum Resistin Level after Glucocorticoid Therapy in Patients with Systemic Autoimmune Disease
- 9:00AM-11:00AM
-
Abstract Number: 1798
Progression of Noncalcified and Calcified Coronary Plaque (by CT Angiography) in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1630
Progressive Destruction of Large Joints in Patients with Rheumatoid Arthritis Treated with Biologic Agents
- 9:00AM-11:00AM
-
Abstract Number: 1448
Progressive Pseudorheumatoid Arthropathy of Childhood (PPAC) – a Single Center Case Series
- 9:00AM-11:00AM
-
Abstract Number: 1410
Prolotherapy Versus Corticosteroid Injections and Phonophoresis for the Treatment of Plantar Fasciitis: A Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 1489
Promoting Smoking Cessation Among Rheumatoid Arthritis Patients: What Motivations and Barriers Are Reported after Being Offered a Smoking Cessation Intervention?
- 9:00AM-11:00AM
-
Abstract Number: 1213
Prospective Study of Dietary Patterns and Risk of Rheumatoid Arthritis in Women
- 9:00AM-11:00AM
-
Abstract Number: 1608
Protective Role of the Vitamin D Receptor Apai (rs7975232) Polymorphism Against Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis from Northern Spain
- 9:00AM-11:00AM
-
Abstract Number: 1337
Pulmonary Computed Tomography Changes in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1600
Pulmonary Manifestations in Early Rheumatoid Arthritis: A 6 Month Follow up Study
- 9:00AM-11:00AM
-
Abstract Number: 1126
Pyrrolopyrimidine Derivatives That Inhibit BAFF Binding to Its Receptor, BR3, Decrease IgG Production By B Cells in Vitro and in Vivo Model of Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1479
Qualitative Assessment of Patient Important Long-Term Outcomes in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1516
Quality Improvement in Elderly Patients with Rheumatoid Arthritis: Pharmacotherapy and Identification of Cognitive Dysfunction
- 9:00AM-11:00AM
-
Abstract Number: 1720
Quantitative Assessment of Bone Marrow Fat Using Magnetic Resonance Imaging in Patients with Spondyloarthropathy
- 9:00AM-11:00AM
-
Abstract Number: 1314
Quantitative MRI Measurement of Tenosynovitis Demonstrates Differing Responses of Synovitis and Tenosynovitis after RA Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1459
Racial Comparisons of Children with Idiopathic Uveitis: Results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 1423
Racial Disparities in Pain and Function after Total Knee Arthroplasty in the United States: A Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 1279
Racial Variation in Total Knee Replacement in a Diverse Community-Based Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 1312
Radiocarpal Cartilage Matrix Changes 3-Months after Anti-TNF Treatment for Rheumatoid Arthritis – Feasibility Study Using MR T1ρ� Imaging
- 9:00AM-11:00AM
-
Abstract Number: 1731
Radiographic Damage of Facet Joints and Vertebral Bodies in the Cervical Spine in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1670
Rapidity of Therapeutic Response of Biologics Compared to Methotrexate Monotherapy in Early RA: A Network Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1323
Reaching Consensus – Volumetric Joint Space Width Calculations in Finger Joints of Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1513
Reactivation of Hepatitis B-Infection in German Patients with Inflammatory Rheumatic Diseases Treated with Biologics – a Monocentric Analysis Involving 1107 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1809
Real Life Implementation of Lupus Nephritis Randomized Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 1762
Reciprocal Roles of Intestinal Microbiota in the Pathogenesis of Organ-Specific Autoimmune Diseases in a Lymphopenia-Induced Autoimmunity Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 1832
Recurrence-Rate of Thrombotic Events in SLE Patients Negative for Antiphospholipid Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1143
Reduced Hydrogen Sulfide Synthesis in the Joint, a New Player in the Pathogenesis of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1439
Reducing Gastric Ulcers in Patients with a History of Gastrointestinal (GI) Ulcers Who Require Long-Term High-Dose Non-Steroidal Anti-Inflammatory Drug (NSAID) Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1281
Reduction in Rural-Urban Disparity in Discharge Disposition to Home after Total Knee Arthroplasty in the U.S
- 9:00AM-11:00AM
-
Abstract Number: 1229
Regional Variation in Measured Detection of Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1935
Regulation of T Follicular Helper Cells in Systemic Lupus Erythematosus By E3 Ubiquitin Ligase Cbl-b
- 9:00AM-11:00AM
-
Abstract Number: 1123
Regulatory B Cells Regulate Skin and Lung Fibrosis and Immunological Abnormalities in a Topoisomerase I and Complete Freund’s Adjuvant-Induced Scleroderma Model Via an Antigen-Specific Manner
- 9:00AM-11:00AM
-
Abstract Number: 1111
Relapse of Lupus after B-Cell Depletion Therapy Is Associated with Loss of Apoptotic Cell Clearance and Elevated Type I Interferon Responses in Lupus Prone BXD2
- 9:00AM-11:00AM
-
Abstract Number: 1518
Relationship Between Estimated Sodium and Potassium Intake with Blood Pressure and Inflammatory Markers in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1432
Relationship Between Patient Reported Outcome Measures and Evoked Pain Measures in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1893
Relationship Between Vitamin D Levels and Disease Activity in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1726
Reliability of Radiographic Assessment of Psoriatic Arthritis Mutilans
- 9:00AM-11:00AM
-
Abstract Number: 1725
Reliable Evaluation of Structural Lesions of the Sacroiliac Joints on MRI in Patients with Axial Spondyloarthritis That Is Comparable to Evaluation of Inflammation Despite Minimal Calibration
- 9:00AM-11:00AM
-
Abstract Number: 1656
Repeated CD4+ T-Cell Depletion in Patients with Rheumatoid Arthritis over Multiple Cycles of Rituximab Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1140
Resident Non-Classical Monocytes Are Critically Important for Tissue Destruction in Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1264
Residential Proximity to Highways, DNA Methylation and Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1544
Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1753
Response Gene to Complement-32 Promotes Plasma Cell Differentiation and Enhances Lupus-like Chronic Graft Versus Host Disease
- 9:00AM-11:00AM
-
Abstract Number: 1214
Rheumatoid Arthritis in Female Spouses in the Agricultural Health Study: Associations with Pesticides and Other Farm Exposures
- 9:00AM-11:00AM
-
Abstract Number: 1933
Rheumatoid Arthritis Patient T Cells Recognize Neutrophil Extracellular Traps
- 9:00AM-11:00AM
-
Abstract Number: 1590
Rheumatoid Arthritis-Related Interstitial Lung Disease (RA-ILD): Methotrexate and the Extension of Lung Disease Are Associated to Prognosis
- 9:00AM-11:00AM
-
Abstract Number: 1607
Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner
- 9:00AM-11:00AM
-
Abstract Number: 1658
Rheumatoid Factor Status Affects the Efficacy of First Biological Treatment in RA
- 9:00AM-11:00AM
-
Abstract Number: 1551
Rheumatoid Vasculitis: A Decline in the XXI Century
- 9:00AM-11:00AM
-
Abstract Number: 1266
Rheumatologic Diagnoses, Characteristics and Needs of Somali Patients Referred to a Rheumatology Clinic Serving the Somali Population
- 9:00AM-11:00AM
-
Abstract Number: 1195
Rheumatology Nurse Advice Line in Singapore Tertiary Hospital – Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 1182
Rheumatology Training Experience – European Survey Among Rheumatology Trainees & Newly Qualified Specialists
- 9:00AM-11:00AM
-
Abstract Number: 1844
Risk Factors for Complicated Pneumonia in Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 1359
Risk Factors for the Development of Gout in HIV Patients: A Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1956
Risk of Cerebrovascular Accident in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1975
Risk of Mortality of Patients with Giant Cell Arteritis: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1507
Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis Patients: The Frequency and Associated Disease Features
- 9:00AM-11:00AM
-
Abstract Number: 1569
Rituximab Efficacy in the Treatment of Diffuse Interstitial Lung Disease Associated with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1625
Role of Macrophages in the Cardiovascular Disease Associated to Rheumatoid Arthritis: Effects of ANTI-CCPS in the Phenotypic Switching and the Insulin Signalling
- 9:00AM-11:00AM
-
Abstract Number: 1118
Role of the Chemokine Receptor CXCR3 in the Function of Regulatory B Cells in Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 1921
Role of TLRs in the Abnormal Secretion of CXCL-4 By Plasmacytoid Dendritic Cells of Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1769
Role of Topical Administration of Peptidylarginine Deiminase Inhibitors in Murine Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1644
Routine Assessment of Patient Index Data 3 (RAPID3)-Defined Remission Is As Stringent As ACR/EULAR Boolean-Defined Remission in a Clinical Trial of Patients with Early Rheumatoid Arthritis Treated with Abatacept
- 9:00AM-11:00AM
-
Abstract Number: 1417
Rural Residence Does Not Impact Total Ankle Arthroplasty Utilization and Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 1375
S100A8/A9, a Serum and Imaging Biomarker for Assessing Joint Inflammation and Destruction in Experimental Seronegative Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1839
Safety and Immunogenicity of Quadrivalent Human Papilloma Virus (qHPV) Vaccine (Gardasil®) in Systemic Lupus Erythematous (SLE), Phase I Trial Completion
- 9:00AM-11:00AM
-
Abstract Number: 1603
Safety of Biologic and Non-Biologic Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Veterans with Rheumatoid Arthritis and Chronic Hepatitis C Infection
- 9:00AM-11:00AM
-
Abstract Number: 1520
Safety, Clinical and Immunologic Effectiveness of the Live Zoster Vaccine Administered to Patients Receiving Anti-TNF Biologics
- 9:00AM-11:00AM
-
Abstract Number: 1927
Salinomycin Induces Potent Suppression of TGF-β1-Mediated Expression of Profibrotic Genes in Cultured Dermal Fibroblasts from Normal Donors and from Donors with Systemic Sclerosis (SSc): A Novel Anti-Fibrotic Treatment for Tissue Fibrosis in SSc
- 9:00AM-11:00AM
-
Abstract Number: 1696
Score Classification Underestimates the Real Cardiovascular Risk in Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1521
Screening for Urinary Tract Infection in Rheumatoid Arthritis Patients Treated with TNF-Inhibitors in the Daily Clinic
- 9:00AM-11:00AM
-
Abstract Number: 1680
Selective JAK1 Inhibition with Filgotinib (GLPG0634) Decreases Plasma Markers of Inflammation and Joint Damage in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1941
Senescent T-Cells Expedite RANKL-Dependent Bone Loss in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1884
Sensitivity to Change of Nailfold Videocapillaroscopy and Relationship with Disease Progression
- 9:00AM-11:00AM
-
Abstract Number: 1715
Sensivity and Specificity of Clinical Criteria to Identify Patients in Ultrasound Remission in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1536
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients without Traditional Cardiovascular Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 1692
Serious Infections in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study
- 9:00AM-11:00AM
-
Abstract Number: 1803
Serum Adipocyte Fatty Acid-Binding Protein Level Is Elevated in Patients with Systemic Lupus Erythematosus (SLE) but Not Associated with Biophysical Markers of Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 1849
Serum Axl and Tumor Necrosis Factor Receptor II Portend Long-Term Renal Outcome in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1252
Serum Biomarkers Associated with Disease Activity and Response to Ustekinumab in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1558
Serum Cathepsin S and Cystatin C Relation with Carotid Subclinical Atheromatosis in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1847
Serum Ferritin and Insulin-like Growth Factor-Binding Protein 2 As Biomarkers of Clinical and Histopathological Treatment Response in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1527
Serum Inflammation Identifies Increased Risk of Frailty in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1509
Serum Nitrite Levels in Rheumatoid Arthritis and Relationship to Cardiovascular Risk Factors and Atherosclerosis Biomarkers
- 9:00AM-11:00AM
-
Abstract Number: 1578
Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Associated with Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1669
Serum Survivin Predicts Responses to Treatment in Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1858
Serum Tartrate Resistant Acid Phosphatase (TRAP) Levels Are Decreased and Associated with Anti-Maa Antibodies in Systemic Lupus Erythematosus (SLE) Patients
- 9:00AM-11:00AM
-
Abstract Number: 1575
Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1554
Severe Pneumonia after a 13-Prevalent Pneumonoccal Conjugate Vaccine (Prevena 13) Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1592
Sex Differences in Cardiovascular Risk Factors and Event Rates in Patients with Rheumatoid Arthritis – Data from 13 Rheumatology Centers
- 9:00AM-11:00AM
-
Abstract Number: 1211
Shift of Rheumatoid Arthritis Onset Toward Old Age in Japan Based on a Nationwide Cohort Database
- 9:00AM-11:00AM
-
Abstract Number: 1239
Significant Impact of Microrna-Target Gene Networks on the Genetics of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1776
Significantly Reduced Lymphadenopathy, Salivary Gland Infiltrates and Proteinuria in MRL-Lpr/Lpr Mice Treated with Ultrasoluble Curcumin/Turmeric: Increased Survival with Curcumin Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1324
Simplified Larsen Erosion Score Is Compatible with the Classic Larsen Score but Less Time Consuming in Practice
- 9:00AM-11:00AM
-
Abstract Number: 1099
Single Cell RNA-Seq Analysis of Citrullinated Alpha-Enolase Peptide-Specific B Cells in RA
- 9:00AM-11:00AM
-
Abstract Number: 1172
Single Cell Sequencing of Non-Lesional Non-Sun Exposed Skin from SLE Patients with Proteinuria Supports Widespread Endothelial Activation
- 9:00AM-11:00AM
-
Abstract Number: 1732
Slow Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1826
Small LDL-P Increases with Increased Disease Activity in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1929
Somatic Mutations in Clonally Expanded Cytotoxic Lymphocytes in Patients with Newly Diagnosed Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1982
Sonographic Scoring of the Synovial Components in the Shoulder Revealed That Shoulder Synovitis in PMR Patients Is Milder Than That in Elderly-Onset RA Patients with PMR-like Onset
- 9:00AM-11:00AM
-
Abstract Number: 1963
Specialty of Provider Referring for Temporal Artery Biopsy Affects the Likelihood of Giant Cell Arteritis (GCA) Diagnosis
- 9:00AM-11:00AM
-
Abstract Number: 1157
Specific Profile of Serum Free Fatty Acids Is Found in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1836
Standardized Incidence Ratio (SIR), Time Trend and Risk Factors of Avascular Bone Necrosis (AVN) in Patients with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 1936
STAT3-Regulated Gene Expression in Circulating CD4+ T Cells Discriminates RA Patients Independently of Clinical Parameters in Early Arthritis: A Validation Study
- 9:00AM-11:00AM
-
Abstract Number: 1906
Stimulators of Soluble Guanylate Cyclase (sGC) Improve Wound Healing in the Tsk-1 Mouse Skin Fibrosis Mode
- 9:00AM-11:00AM
-
Abstract Number: 1905
Stimulators of Soluble Guanylate Cyclase (sGC) Inhibit Experimental Skin Fibrosis of Different Aetiologies
- 9:00AM-11:00AM
-
Abstract Number: 1304
Studying MR-Detected Inflammation in Symptom-Free Persons from the General Population to Generate Ramris-Based Reference Values
- 9:00AM-11:00AM
-
Abstract Number: 1428
Subchondral Bone Structure and Pain Behaviors in Complete Freund’s Adjuvant (CFA) Monoarthritis in Mice Treated with Intra-Articular (IA) Neurotoxin
- 9:00AM-11:00AM
-
Abstract Number: 1700
Subclinical Atherosclerosis in Ankylosing Spondylitis. Does It Really Exist and Which Are the Effects of Treatments? a Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 1709
Subclinical Atherosclerosis in Patients with Psoriatic Arthritis and the Role of Vitamin D
- 9:00AM-11:00AM
-
Abstract Number: 1890
Subclinical Biventricular Systolic Function Is Impaired in Patients with Systemic Sclerosis with Real Time 3-D Echpcardiography: 1 Year Follow-up Study
- 9:00AM-11:00AM
-
Abstract Number: 1409
Subglottic Stenosis: A Unique Inflammatory Disorder
- 9:00AM-11:00AM
-
Abstract Number: 1541
Subgroups of Established Rheumatoid Arthritis Patients Can be Characterized By Patient and Physician Assessment Discrepancy, Anxiety and Depression and Presence of Depression Might be Associated with Slower Response to Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1397
Successful Treatment of Cardiac Sarcoidosis with Biologic and Immunosuppressive Combination Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1194
Support for Community-Based Programs for Managing Hip and Knee Osteoarthritis: Results of a Public Survey
- 9:00AM-11:00AM
-
Abstract Number: 1682
Suppression of Chronic Arthritis By a Novel Nuclear Factor of Activated T-Cell 5 (NFAT5) Inhibitor
- 9:00AM-11:00AM
-
Abstract Number: 1138
Suppressor of Cytokine Signaling 1 Inhibits Interleukin-1β Induced Matrix Metalloproteinases Expression in Human Chondrocytes By Modulating p38-CREB- C/Ebpβ Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1453
Surveillance of Periodic Fever Syndromes in Canada
- 9:00AM-11:00AM
-
Abstract Number: 1664
Switch from Tocilizumab + Methotrexate to Tocilizumab Monotherapy. Maintenance of Response in Patients with Rheumatoid Arthritis at Low Disease Activity.
- 9:00AM-11:00AM
-
Abstract Number: 1872
Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 1361
Synovial Macrophages Promote TGF-β Signaling but Protect Against Influx of S100A8/S100A9-Producing Cells after Intra-Articular Injections of Oxidized Low-Density Lipoproteins
- 9:00AM-11:00AM
-
Abstract Number: 1161
Synovial Th9 Cells Prolong Neutrophil Survival and Functionally Enhance the Infiltrating T Cells in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1141
Synovial Ultrasound Power Doppler Enhancement Reflects Multiple Cytokine Expression in Synovial Tissue, Distinguishing Distinct High Macrophage-Associated and Low Inflammation Profiles
- 9:00AM-11:00AM
-
Abstract Number: 1240
Systematic Protein-Protein Interaction and Pathway Analyses in the Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 1676
Systematic Review and Network Meta-Analysis of Combination Treatments in Disease Modifying Anti-Rheumatic Drug Experienced Patients with Severe Rheumatoid Arthritis: Analysis of American College of Rheumatology Criteria Scores 20, 50, and 70: An Update
- 9:00AM-11:00AM
-
Abstract Number: 1842
Systemic Lupus Erythematosus and Chikungunya Fever: Interactions during the 2014 Outbreak in Martinique
- 9:00AM-11:00AM
-
Abstract Number: 1835
Systemic Lupus Erythematosus Does Not Increase Risk of Adverse Events in the First 6 Months after Total Knee Replacement
- 9:00AM-11:00AM
-
Abstract Number: 1855
Systemic Lupus Erythematosus Exosomes Contain Distinct RNA Transcripts That Differentiate Disease Activity and Modulate Cellular Function
- 9:00AM-11:00AM
-
Abstract Number: 1902
Systemic Sclerosis and Lung Cancer Risk: Data from the Canadian Scleroderma Research Group
- 9:00AM-11:00AM
-
Abstract Number: 1965
T Cell Activation, Proliferation and Differentiation Markers Lack Diagnostic Accuracy for Detecting Active GCA and PMR
- 9:00AM-11:00AM
-
Abstract Number: 1383
T-Cell Subset Analysis in IgG4-Related Disease and Lymphocyte-Variant Hypereosinophilic Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1828
Target Modulation of a Type I Interferon Gene Signature and Pharmacokinetics of Anifrolumab in a Phase IIb Study of Patients with Moderate to Severe Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1606
Telomere Damage in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1593
Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1534
Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations
- 9:00AM-11:00AM
-
Abstract Number: 1482
Temporomandibular Pain in Patients with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1147
TGFß1 Blocks Chondrocyte Hypertrophy and Increases Cell Viability in Cultured Cartilage Explants but Does Not Protect Against Proteoglycan Loss
- 9:00AM-11:00AM
-
Abstract Number: 1156
Th17 Cytokines Regulate Osteoclastogenesis in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1149
The Active Metabolite of Fostamatinib, R406, Only Decreases the Inflammation-Driven Extracellular Matrix Turnover of the Joint at High Concentrations Ex Vivo
- 9:00AM-11:00AM
-
Abstract Number: 1170
The Alarmins S100A8/A9 Induce Canonical Wnt Signaling in Naïve Joints and Experimental OA
- 9:00AM-11:00AM
-
Abstract Number: 1510
The Association Between HDL Cholesterol Efflux Capacity, Citrullinated ApoA1 and Anti-Citrullinated ApoA1 Antibodies in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1626
The Association of HLA-DRB1 Alleles and Amino Acid Residues with Radiographic Severity in African Americans with Seropositive Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1117
The B Cell Survival Cytokine BAFF Promotes Systemic Lupus Erythematosus Via Activation of TACI, Not BAFF Receptor
- 9:00AM-11:00AM
-
Abstract Number: 1648
The Balance of Foxp3/Ror-Gammat Expression Is Altered By Tocilizumab and By Abatacept in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1283
The Burden of Non-Radiographic Axial Spondyloarthritis from the Employer Perspective: A Real World European Study
- 9:00AM-11:00AM
-
Abstract Number: 1531
The Changing Face of Septic Arthritis Complicating Rheumatoid Arthritis in the Era of Biotherapies. Retrospective Single-Center Study over 35 Years
- 9:00AM-11:00AM
-
Abstract Number: 1199
The Charla De Lupus (Lupus Chat)® Program: An Evaluation of a Lupus Support Program for Teens, Young Adults and Parents
- 9:00AM-11:00AM
-
Abstract Number: 1216
The Clinical and Ultrasonographic Presentation of Seronegative RA Is More Severe Compared to Seropositive RA in an Inception Cohort of DMARD-Naïve Patients Classified According to the 2010 ACR/EULAR Criteria
- 9:00AM-11:00AM
-
Abstract Number: 1535
The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study
- 9:00AM-11:00AM
-
Abstract Number: 1183
The Country Where You Perform Your Rheumatology Training Is Associated with the Acquired Confidence, the Education Received and the Assessment in Core Competences
- 9:00AM-11:00AM
-
Abstract Number: 1560
The Effect of Anti Estrogen Therapy (AET) on Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1426
The Effect of Anti-Interleukin-6 Receptor Antibody in Ovariectomized Mice
- 9:00AM-11:00AM
-
Abstract Number: 1429
The Effect of Gabapentin and Cyclooxygenase Inhibitors on Evoked and Ongoing Pain-like Behavior in Two Arthritis Models in Mice
- 9:00AM-11:00AM
-
Abstract Number: 1449
The Effect of IL-1 Receptor Antagonist Anakinra (Kineret®) on Measures of Central Nervous System Inflammation and Headaches in Pediatric Patients with Severe Cryopyrin-Associated Periodic Syndromes
- 9:00AM-11:00AM
-
Abstract Number: 1561
The Effect of TNF Blockers on Bone Mineral Density in Rheumatoid Arthritis Patients Receiving Bisphosphonate
- 9:00AM-11:00AM
-
Abstract Number: 1193
The Effectiveness of Low-Impact Exercise Program on Musculoskeletal Health of Asian Older Adults
- 9:00AM-11:00AM
-
Abstract Number: 1634
The Effects of Glucocorticoids on the Efficacy of Tofacitinib As Monotherapy and in Combination Therapy with Nonbiologic Dmards: An Analysis of Data from Six Phase 3 Studies
- 9:00AM-11:00AM
-
Abstract Number: 1192
The F-Word: Why Is Talking about Fatigue so Hard?
- 9:00AM-11:00AM
-
Abstract Number: 1812
The First Randomized Control Trial to Evaluate the Effectiveness of Bortezomib for Refractory Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1105
The IgG/IgG4 mRNA Ratio By Quantitative PCR Accurately Diagnoses IgG4-Related Disease and Predicts Treatment Response
- 9:00AM-11:00AM
-
Abstract Number: 1614
The Impact of High Risk Susceptible Gene LILRA3 on Joint Inflammation in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1557
The Impact of Hindfoot Deformity on Disability of Korean Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1345
The Impact of Prior Antibiotic Treatment on Culture Results of Patients with Septic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1566
The Impact of Severe Extra-Articular Manifestations and Patient Reported Outcome Measures on Cardiovascular Disease in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1418
The Importance of Comorbidity in Understanding the 6-Month Trajectories of Pain and Function after Total Hip Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 1237
The Incidence and Prevalence of Systemic Lupus Erythematous in a Defined Population in United Arab Emirates
- 9:00AM-11:00AM
-
Abstract Number: 1951
The Incidence Rate of Giant Cell Arteritis in Slovenia
- 9:00AM-11:00AM
-
Abstract Number: 1755
The Lymphotoxin/Megakaryoblastic Leukemia 1/Actin Axis As a Master Regulator of TLR Signaling in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1556
The Medication Information-Seeking Behaviors of Rheumatoid Arthritis Patients Who Are Prescribed a New DMARD
- 9:00AM-11:00AM
-
Abstract Number: 1756
The Oxidative Burst Mediates Anti-Inflammatory Clearance of Dead Cells in a Mouse Model of SLE and Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1291
The Pediatric Rheumatology Workforce in 2015: A Survey of Pediatric Rheumatologists
- 9:00AM-11:00AM
-
Abstract Number: 1955
The Performance of Colour-Doppler Sonography of Temporal Arteries in Patients Suspect of Having Giant Cell Arteritis in Daily Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 1344
The Positive Synovial Fluid Culture: Septic Arthritis or Contamination?
- 9:00AM-11:00AM
-
Abstract Number: 1882
The Predictive Value of Pulmonary Function Tests to Diagnose Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1691
The Presence of Fibromialgia May Influence the Clinimetric Evaluation of Patients with Ankylosing Spondylitis, but Has No Impact on Disease Activity Assessment
- 9:00AM-11:00AM
-
Abstract Number: 1346
The Presentation and Outcomes of Surgically Treated Septic Arthritis: the Impact of Culture Results
- 9:00AM-11:00AM
-
Abstract Number: 1347
The Presentations and Outcomes of Prosthetic Joint Septic Arthritis: a Comparison of Culture-Positive and Culture-Negative Disease
- 9:00AM-11:00AM
-
Abstract Number: 1231
The Prevalence of Non-Radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain in Rheumatology Practices
- 9:00AM-11:00AM
-
Abstract Number: 1468
The Proposed Outcome Parameters of the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC) with Uveitis Disability VAS Score Correspond Significantly with Uveitis “Classicaly Assessed” Uveitis Activity
- 9:00AM-11:00AM
-
Abstract Number: 1618
The Protective Effect of HLA-DRB1*13 Alleles during Specific Phases in the Development of ACPA-Positive RA
- 9:00AM-11:00AM
-
Abstract Number: 1151
The Proteomic Profile of Histological Samples Derived from a Surgical Mouse Model of Osteoarthritis Reveals an Unexpected Mode of Action for the Anti-Aggrecanase-2 Monoclonal Antibody CRB0017
- 9:00AM-11:00AM
-
Abstract Number: 1739
The Ratio of Glycated Hemoglobin A1c (HbA1c) to Glycated Albumin (GA) Is Correlated with Ankylosing Spondylitis Disease Activity Score (ASDAS) in Non-Diabetic Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1415
The Relationship Between Obesity and Low Back Pain and Disability Is Affected By Mood Disorders – a Population-Based, Cross-Sectional Study of Men
- 9:00AM-11:00AM
-
Abstract Number: 1381
The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 1421
The Risk Factor of Preoperative Deep Vein Thrombosis in Patients Undergoing Total Knee Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 1222
The Risk of Tuberculosis (TB) in Rheumatoid Arthritis Patients Treated with TNF Inhibitors and the Safety of Resuming Biologic Dmards for Patients Who Developed TB after Anti-TNF Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1494
The Role of a Nurse-Led Clinic in the Assessment and Prevention of Cardio-Vascular Risk
- 9:00AM-11:00AM
-
Abstract Number: 1923
The Role of Inflammatory Myeloid Cell Compartment in Myocardial Fibrogenesis and Remodelling in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1148
The Role of TRPC6 in CXCR2-Mediated Chondrocyte Phenotypic Stability
- 9:00AM-11:00AM
-
Abstract Number: 1205
The Spectrum of Early RA Practice Across the Globe: Results from a Multinational Cross Sectional Survey
- 9:00AM-11:00AM
-
Abstract Number: 1673
The Transcription Factor Nuclear Protein Transcriptional Regulator 1 May Contribute to Increased Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1406
The Treatment of Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 1888
There Is a Need for New Systemic Sclerosis Subset Criteria: A Content Analytic Approach
- 9:00AM-11:00AM
-
Abstract Number: 1387
Thoracic Paravertebral Masses and IgG4-Related Disease: Report of 8 Cases and Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 1412
Thread Carpal Tunnel Release (TCTR) Completely Divides the Transverse Carpal Ligament (TCL) As Well As Open and Endoscopic Surgery: A Cadaver Study
- 9:00AM-11:00AM
-
Abstract Number: 1637
TNFi Combination Therapy, Switching and Persistence Patterns By Longitudinal Disease Activity Strata in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1336
To PET or Not to PET in General Rheumatology Practice
- 9:00AM-11:00AM
-
Abstract Number: 1487
Tocilizumab in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Who Have Failed to Disease-Modifying Antirheumatic Drugs: Long Term Results of the Brazilian Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1980
Tocilizumab in Giant Cell Arteritis: A Multicentre Open-Label Study in France
- 9:00AM-11:00AM
-
Abstract Number: 1978
Tocilizumab in Refractory Large Vessel Vasculitis with Aorta Involvement. Study on 10 Patients Evaluated By Positron Emission Tomoghraphy
- 9:00AM-11:00AM
-
Abstract Number: 1650
Tocilizumab Monotherapy in Early Rheumatoid Arthritis: Data from Two Phase 3 Randomized Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 1405
Tocilizumab Serum Levels and Antidrug Antibodies and Its Relationship with Disease Activity in Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1645
Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years
- 9:00AM-11:00AM
-
Abstract Number: 1834
Total Hip Arthroplasty Outcomes: A 17 Year Experience in a Single-Center: Is Systemic Lupus Erythematosus a Real Risk Factor for Adverse Outcomes?
- 9:00AM-11:00AM
-
Abstract Number: 1529
Trabecular Bone Score in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1543
Traditional Risk Score Underestimates the Cardiovascular Risk in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1159
Transcription Factor SOX5 Promotes Rheumatoid Arthritis Synovial Fibroblast Migration and Invasion By Regulating MMP9 Expression
- 9:00AM-11:00AM
-
Abstract Number: 1661
Translational Data and Phase 1 Study Results of a New Monoclonal Antibody Targeting Toll like Receptor 4 (TLR4) Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine
- 9:00AM-11:00AM
-
Abstract Number: 1129
Transthyretin Deposition Accelerates the Development of Experimental Osteoarthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 1662
Treat to Target of Remission Is Effective but Not All Patients Are Always in Remission
- 9:00AM-11:00AM
-
Abstract Number: 1167
Treating Experimental Arthritis with Adenoviral Overexpression of IL-22 or with Blocking Antibodies Against Endogenous IL-22 Both Reduces Inflammation and Destruction
- 9:00AM-11:00AM
-
Abstract Number: 1364
Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 1989
Treatment of Refractory Non-Infectious Aortitis: Tocilizumab Compared to Antitnf Alfa Agents. Multicenter Study of 44 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1665
Treatment Patterns in Rheumatoid Arthritis after Methotrexate: Data from a Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1784
Treatment with Belimumab in SLE Does Not Impair Antibody Response to 13-Valent Pneumococcal Conjugate Vaccine
- 9:00AM-11:00AM
-
Abstract Number: 1688
Trends in Hospitalizations and Charges for Ankylosing Spondylitis, 1993-2012
- 9:00AM-11:00AM
-
Abstract Number: 1653
Trends over Time in Achievement of Low Disease Activity Among Biologic Initiators with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1824
Tripterygium Wilfordii for the Treatment of Systemic Lupus Systematosus: Meta-Analysis of Randomized Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 1313
Tumour Necrosis Factor Inhibitor Treatment Normalises Hand Bone Loss in a Minority of Rheumatoid Arthritis Patients Treated in Clinical Practice. Results from the Copenhagen Osteoarthritis Study and the Danbio Registry
- 9:00AM-11:00AM
-
Abstract Number: 1197
Two Strategies for Recruiting Rural Faith-Based Organizations for a Fall-Prevention Exercise Intervention in a Population with High Rates of Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1660
Two-Year Prospective Study of Patients with Rheumatic Disease on Dose Reduction of Biological Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1764
Type 1 Interferon in the Skin Stimulated By Ultraviolet B Light Generates Immune Suppression Mediated By Idoleamine 2,3-Dioxygenase 1
- 9:00AM-11:00AM
-
Abstract Number: 1496
Uncovering and Addressing Issues Related to Medication Adherence Among Patients with Rheumatic Diseases: A Patient Navigator Pilot Program
- 9:00AM-11:00AM
-
Abstract Number: 1794
Unexplained Decline in Rates of Cardiovascular Events in a Large Cohort of SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 1273
Uptake of the First Biosimilar Infliximab Since Its Approval in South Korea
- 9:00AM-11:00AM
-
Abstract Number: 1277
US Adult Rheumatologists Perspective on the Transition Process for Young Adults with Rheumatic Conditions
- 9:00AM-11:00AM
-
Abstract Number: 1200
Use of Focus Groups and Patient Partners to Revise an Internet Self-Management Program
- 9:00AM-11:00AM
-
Abstract Number: 1272
Utilization of Ambulatory Physician Encounters, Emergency Room Visits and Hospitalizations By SLE Patients: A 13 Year Population Health Study
- 9:00AM-11:00AM
-
Abstract Number: 1268
Utilization of Viscosupplementation: 2011 – 2013
- 9:00AM-11:00AM
-
Abstract Number: 1585
Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Disease-Modifying Anti-Rheumatic Drug Therapy: A Retrospective Cohort Study Using UK Primary Care Electronic Medical Records
- 9:00AM-11:00AM
-
Abstract Number: 1444
Validation of a Revised Version of the Michigan Body Map
- 9:00AM-11:00AM
-
Abstract Number: 1916
Validation of Novel Biomarker Candidates for Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1191
Validity Evidence for Two Objective Structured Clinical Examination Stations to Assess Core Examination Skills of the Shoulder and Knee
- 9:00AM-11:00AM
-
Abstract Number: 1340
Value of 18F-FDG PET for Therapeutic Assessment in Patients with Polymyalgia Rheumatica Treated in First Line By Tocilizumab
- 9:00AM-11:00AM
-
Abstract Number: 1597
Variability in Health Assessment Questionnaire Based on Type of Health Insurance Coverage and Rheumatology Practice
- 9:00AM-11:00AM
-
Abstract Number: 1259
Verification of Haptoglobin and Von Willebrand Factor As Potential Biomarkers of Knee Osteoarthritis Using a Targeted Proteomics Approach in Serum
- 9:00AM-11:00AM
-
Abstract Number: 1679
Vicm Is a Novel Biomarker of Macrophage Activity Evaluated in a Phase IIb Clinical Trial of Mavrilimumab
- 9:00AM-11:00AM
-
Abstract Number: 1823
Visceral Adiposity in Premenopausal Lupus Patients: Correlation with Systemic Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 1586
Weight Loss in Obese Rheumatoid Arthritis (RA) Patients Improves Disease Activity without Modifying RA Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1722
What Is the Clinical Utility of MR Imaging in the Management of Nr-Axspa Patients?
- 9:00AM-11:00AM
-
Abstract Number: 1292
What Is the Effect of TNF Inhibitors on Employment Status in Rheumatoid Arthritis Patients and What Are the Predictors of Progression to Unemployment?
- 9:00AM-11:00AM
-
Abstract Number: 1546
What Is the Impact of Smoking on the Risk of Rheumatoid Arthritis Progression: A Systematic Review of the Risk Factor Paradox
- 9:00AM-11:00AM
-
Abstract Number: 1330
What Is the Reliability of Recognizing Structural MRI Lesions of Sacroiliac Joints in Patients with Recent Inflammatory Back Pain in Clinical Practice?
- 9:00AM-11:00AM
-
Abstract Number: 1646
Which Factors Influence the Prescription of Tocilizumab Alone or in Combination with Dmards in Rheumatoid Arthritis Patients in a Real Life Setting? the ACT-Solo Study: An Analysis of Efficacy and Safety at 12 Months
- 9:00AM-11:00AM
-
Abstract Number: 1326
Which Score to Use for Radiographic Damage Assessment of the Spine in (early) Axial Spondyloarthritis? Two-Year Data from the DESIR Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1354
Whipple’s Disease: The Diagnostic Utility of Synovial Fluid Tropheryma Whipplei Polymerase Chain Reaction
- 9:00AM-11:00AM
-
Abstract Number: 1926
Wnt5a Activates Wnt/PCP-Signaling to Promote Fibroblast Activation and Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 1714
Young Patients with Back Pain and Maximally 1 Spa Feature: Is It Useful to Test HLA-B27 or Image the Sacroiliac Joints?
- 11:00AM-12:30PM
-
Abstract Number: 1998
A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR’s Rheumatology Informatics System for Effectiveness (RISE)
- 11:00AM-12:30PM
-
Abstract Number: 1996
Complement Activation Predicts Adverse Pregnancy Outcome in Patients with SLE and/or aPL Antibodies
- 11:00AM-12:30PM
-
Abstract Number: 1995
Does the Risk of Serious Infections Among Elderly RA Patients Differ By Age of Disease Onset?
- 11:00AM-12:30PM
-
Abstract Number: 1994
Electronic Patient Reported Outcome Measures in Systemic Lupus Erythematosus : A Potential Disease Modifying Impact on the Management of Disease Activity Flares and Damage Accrual
- 11:00AM-12:30PM
-
Abstract Number: 1999
Improvement in Mortality in RA Compared to the General Population – Closing the Mortality Gap
- 11:00AM-12:30PM
-
Abstract Number: 1997
Underuse of Methotrexate (MTX) in the Treatment of Rheumatoid Arthritis (RA) in the United States (US): Results of a Comprehensive Pharmaceutical Claims Analysis
- 2:30PM-4:00PM
-
Abstract Number: 2026
A Novel Technique for Quantifying Synovial Enhancement of Temporomandibular Joints from Mris of Patients with Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2055
A Phase III, Randomized, Double-Blind Clinical Study Comparing SB4, an Etanercept Biosimilar, with Etanercept Reference Product (Enbrel®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (52-week Results)
- 2:30PM-4:00PM
-
Abstract Number: 2047
A Randomised Double-Blind Placebo-Controlled Trial of Vitamin D Supplementation in Juvenile-Onset Systemic Lupus Erythematosus: Effects on Microarchitecture Measured By HR-pQCT
- 2:30PM-4:00PM
-
Abstract Number: 2056
A Randomized, Double-Blind, Phase III Study Comparing SB2, an Infliximab Biosimilar, to the Infliximab Reference Product (Remicade®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy: 54-Week Results
- 2:30PM-4:00PM
-
Abstract Number: 2075
A Unique Naturally-Occurring Regulatory T Cell Subset Associated with Disease Activity in Patients with Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2038
Adalimumab in Patients with Active, Noninfectious Uveitis Using High-Dose Corticosteroids
- 2:30PM-4:00PM
-
Abstract Number: 2010
Adenosine A2A Receptor, but Not A2B Receptor, Deletion Leads to Development of Osteoarthritis (OA) in Mice and Administration of a Liposomal Suspension of Adenosine Prevents/Treats Osteoarthritis in Rats
- 2:30PM-4:00PM
-
Abstract Number: 2022
Adherence to the Dietary Guidelines for Americans and Risk of Developing Rheumatoid Arthritis in Young and Middle-Aged Women
- 2:30PM-4:00PM
-
Abstract Number: 2053
Adjustment of Skeletal Muscle Mass Estimates for the Extent of Adiposity Strengthens Relationships with Functional Outcomes in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2057
Antibodies to Infliximab in Remicade-Treated Rheumatic Patients Show Identical Reactivity Towards Biosimilars
- 2:30PM-4:00PM
-
Abstract Number: 2044
Axonal Dysfunction in Childhood-Onset Systemic Lupus Erythematosus. Association with Neuropsychiatric Manifestations and Disease Activity
- 2:30PM-4:00PM
-
Abstract Number: 2041
Baseline Clinical and Laboratory Features of IgG4-Related Disease: Retrospective Japanese Multicenter Study of 333 Cases
- 2:30PM-4:00PM
-
Abstract Number: 2023
Breastfeeding, Oral Contraceptive and the Risk of Rheumatoid Arthritis: Results from the Swedish Epidemiological Investigation of RA Study
- 2:30PM-4:00PM
-
Abstract Number: 2009
CC-Chemokine Receptor 7 (CCR7) Deficiency Reduces Early Structural and Functional Features of Disease in a Murine Model of Osteoarthritis
- 2:30PM-4:00PM
-
Abstract Number: 2043
Cell-Bound Complement Activation Products Have High Sensitivity and Specificity in Childhood-Onset Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2032
Chaperonin Protein 14-3-3eta, Cyclic Citrullinated Peptide Antibody, and Rheumatoid Factor in the Differential Diagnosis of Chikungunya Arthritis Versus Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2005
Circulating Mirnas As Potential Disease Biomarkers in Antiphospholipid Syndrome Patients
- 2:30PM-4:00PM
-
Abstract Number: 2035
Clinical Characteristics and Outcomes of Polyarticular Septic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2033
Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection
- 2:30PM-4:00PM
-
Abstract Number: 2028
Contribution of 18f-Fluoro-Dexoxyglucose Positron Emission Tomography for the Diagnosis of Polymyalgia Rheumatica: A Controlled Study
- 2:30PM-4:00PM
-
Abstract Number: 2045
Cross-Validation of the Pediatric Automated Neuropsychological Assessment Metrics-Cognitive Performance Scores in the Screening of Neurocognitive Impairment in Childhood-Onset Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2067
De-Convolution of Whole Blood Transcriptomic Data from a Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2014
Deficiency of IL-27 Exacerbate Sjögren’s Syndrome through Inhibiting Differentiation of Type 1 Regulatory T Cells
- 2:30PM-4:00PM
-
Abstract Number: 2027
Development of a Dual Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout
- 2:30PM-4:00PM
-
Abstract Number: 2076
Development of Lupus Nephritis: Preclinical Evaluation of Patients Who Subsequently Develop Systemic Lupus Erythematosus Demonstrate Elevation of Select Soluble Mediators Prior to and at Disease Classification in Patients with Nephritis
- 2:30PM-4:00PM
-
Abstract Number: 2007
Discovery of an Intra-Articular Injection Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Disease Modifying Treatment for Knee Osteoarthritis
- 2:30PM-4:00PM
-
Abstract Number: 2011
Disruption of the Molecular Clock in Mesenchymal Cells Causes an Osteoarthritis-like Disease in Mice
- 2:30PM-4:00PM
-
Abstract Number: 2017
DNA Methylation Governs the Ability of Apoptotic Cells to Suppress Inflammatory Arthritis Via Reciprocal Regulation of IL-6 and TGF-Beta
- 2:30PM-4:00PM
-
Abstract Number: 2002
Dnase Treatment Protects Against DVT Formation in a Mouse Model of Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 2077
Does Dysbiosis within the Intestinal Microbiome Contribute to SLE Pathogenesis?
- 2:30PM-4:00PM
-
Abstract Number: 2074
Dominant Chilblain Lupus Due to an Activating Mutation of Sting – Suppression of Constitutive Type I Interferon Activation By JAK Inhibition
- 2:30PM-4:00PM
-
Abstract Number: 2039
Effect of Adalimumab on Visual Functioning (VFQ-25) in Visual-1 Trial Patients with Non-Anterior Non-Infectious Uveitis
- 2:30PM-4:00PM
-
Abstract Number: 2006
Effect Size of the Anti-Aggrecanase-2 Monoclonal Antibody CRB0017 in Rodent Models of Osteoarthritis
- 2:30PM-4:00PM
-
Abstract Number: 2079
Effectiveness of Renoprotective Approaches in Lupus Nephritis: More Than Just Immunosuppression
- 2:30PM-4:00PM
-
Abstract Number: 2058
Efficacy and Safety of Rituximab Biosimilar Candidate (CT-P10) and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase I Randomized Controlled Trial over 72 Weeks
- 2:30PM-4:00PM
-
Abstract Number: 2020
Elevated BMI and ACPA Together Increase RA Risk and Independently Accelerate Time to RA
- 2:30PM-4:00PM
-
Abstract Number: 2066
Elevated Innate, Adaptive, and TNF-Superfamily Soluble Inflammatory Mediators Mark Impending Disease Flare, While Regulatory Mediators Distinguish Lack of Impending Disease Flare in African-American SLE Patients with Active Disease
- 2:30PM-4:00PM
-
Abstract Number: 2082
Evaluations of Social Support Are Associated with Well-Being Outcomes in Women with Systemic Lupus Erythematosus (SLE)
- 2:30PM-4:00PM
-
Abstract Number: 2029
Fever of Unknown Origin (FUO) and Inflammation of Unknown Origin (IUO): Is 18f-FDG-PET/CT a Useful First Line Diagnostic Strategy?
- 2:30PM-4:00PM
-
Abstract Number: 2016
Functional Tertiary Lymphoid Structures within the Kidneys of Lupus Prone Mice Resembles Lymph Nodes in Gene Expression Profiling Analysis and Are Detected By in Vivo Imaging
- 2:30PM-4:00PM
-
Abstract Number: 2050
Herpes Zoster during the Tofacitinib Clinical Development Program for RA: Characterization of Herpes Zoster Incidence and Evaluation of Whether Herpes Zoster Predicts Subsequent Serious Infections or Malignancy
- 2:30PM-4:00PM
-
Abstract Number: 2069
High Interferon Gene Signature Is Associated with Increased Disease Activity, Reduced Complement C3 and C4, and Increased Oral Corticosteroid Use in Systemic Lupus Erythematosus (SLE)
- 2:30PM-4:00PM
-
Abstract Number: 2048
Hospitalization Trends of Rheumatoid Arthritis and Gout in the United States: A Crossroad
- 2:30PM-4:00PM
-
Abstract Number: 2062
How Reliable Is Self-Evaluation of Symptoms of Inflammatory Back Pain By Patients?
- 2:30PM-4:00PM
-
Abstract Number: 2000
Immune Response Against  β2GPI Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 2064
Increase in IL-31 Serum Level in Recent Onset Spondyloarthritis – Data from the DESIR Cohort
- 2:30PM-4:00PM
-
Abstract Number: 2036
Infliximab Versus Adalimumab in Severe Uveitis: Multicenter Study from the French Uveitis Network
- 2:30PM-4:00PM
-
Abstract Number: 2049
Long Term Effectiveness of Herpes Zoster Vaccine Among Patients with Autoimmune and Inflammatory Diseases
- 2:30PM-4:00PM
-
Abstract Number: 2046
Long-Term Outcomes in Cardiac Neonatal Lupus and Associated Risk Factors for Morbidity
- 2:30PM-4:00PM
-
Abstract Number: 2068
Low Complement Is Associated with SLE Classification Criteria and Organ Damage
- 2:30PM-4:00PM
-
Abstract Number: 2052
Lymphoma in Patients with Rheumatoid Arthritis Treated with Biologic Drugs: Long-Term Follow-up of Risks and Lymphoma Subtypes
- 2:30PM-4:00PM
-
Abstract Number: 2060
Microscopic Bowel Inflammation in Spondyloarthritis As a Baseline Predictor of Anti-TNF Response
- 2:30PM-4:00PM
-
Abstract Number: 2072
Mitochondrial Reactive Oxygen Species Modulate Autoimmunity in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2073
Mitochondrial ROS Is a Novel Regulator of Sting-Mediated Type I IFN Production By Governing Extrusion of Oxidized Mitochondrial DNA upon Neutrophil Extracellular Trap Formation.
- 2:30PM-4:00PM
-
Abstract Number: 2025
Modification of Structural Lesions on Magnetic Resonance Imaging By Etanercept: A 12-Week Randomized Placebo-Controlled Trial
- 2:30PM-4:00PM
-
Abstract Number: 2030
MRI Changes Associated with Neurological Compromise in Acute Pyogenic Vertebral Osteomyelitis: A Retrospective Study of 121 Patients
- 2:30PM-4:00PM
-
Abstract Number: 2034
Nontuberculous Mycobacterial Diseases Do Not Cause Positive Autoantibody Testing, Results from a Tertiary Pulmonary Care Center
- 2:30PM-4:00PM
-
Abstract Number: 2021
Omega-3 Fatty Acids Are Associated with a Lower Prevalence of Autoantibody Positivity in HLA-DR Shared Epitope Positive Subjects Who Are at Increased Risk for Future RA
- 2:30PM-4:00PM
-
Abstract Number: 2042
Pancreatitis Subtypes Survey in 852 Childhood-Onset Systemic Lupus Erythematosus Patients: A Multicenter Cohort
- 2:30PM-4:00PM
-
Abstract Number: 2083
Predictors of Health Perceptions Among Women with Lupus
- 2:30PM-4:00PM
-
Abstract Number: 2003
Primary Antiphospholipid Syndrome Is Characterized By Endothelial Progenitor Dysfunction and a Type I Interferon Signature
- 2:30PM-4:00PM
-
Abstract Number: 2004
Procoagulant Property of a Novel Patient-Derived Autoimmune IgG Type Monoclonal Anticardiolipin Antibody That Binds to Beta 2 Glycoprotein Domain I but Not to Total Beta 2 Glycoprotein I Molecule
- 2:30PM-4:00PM
-
Abstract Number: 2054
Randomized, Double-Blind, Phase 3 Study of Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2001
Reduction of HLA Class II Expression and Beta-2-Glycoprotein I Presentation By Fluvastatin in Vitro and in Vivo: Possible Mechanism of Statin-Induced-Deprocoagulation in the Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 2024
Replacing Radiographic Sacroiliitis By Structural Lesions on MRI of the Sacroiliac Joints in Two Early Axial Spa Cohorts: What Is the Impact on the Classification of Patients According to the ASAS Axial Spa Criteria?
- 2:30PM-4:00PM
-
Abstract Number: 2078
Reserve Capacity: Explaining the Link Between Socioeconomic Status and Depression/Anxiety Among Patients with Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2037
Rheumatic Manifestations May be the First Clinical Presentation of Arterial Calcification Due to CD73 Deficiency
- 2:30PM-4:00PM
-
Abstract Number: 2051
Risk for Lower Intestinal Perforations in RA Patients Treated with Tocilizumab in Comparison to Treatment with TNF Inhibitors, Rituximab, Abatacept or Conventional Synthetic Dmards
- 2:30PM-4:00PM
-
Abstract Number: 2019
Serum Biomarkers of Inflammatory Arthritis in First Degree Relatives of Patients with Rheumatoid Arthritis and Their Association with Lifestyle Risk Factors
- 2:30PM-4:00PM
-
Abstract Number: 2018
Sodium Chloride Consumption, Together with Smoking, Is Associated with ACPA Positivity
- 2:30PM-4:00PM
-
Abstract Number: 2040
T Follicular Helper like CD4+CXCR5+pd-1+ Cells and T Follicular Helper like Type 2 Cells Subsets Are Increased in IgG4-Related Disease Patients
- 2:30PM-4:00PM
-
Abstract Number: 2015
Targeting Non-Canonical NF-Kappa B Signaling Inhibits Angiogenesis in a Novel 3D Model of Rheumatoid Arthritis Synovial Angiogenesis
- 2:30PM-4:00PM
-
Abstract Number: 2080
Teaching Fellows in Lupus: Rheumatology Fellows Are Successful Educators in Improving Lupus Recognition By Frontline Healthcare Providers
- 2:30PM-4:00PM
-
Abstract Number: 2081
The SLE Workshop: An Evaluation of a Long-Standing Hospital-Based Psychoeducational Program
- 2:30PM-4:00PM
-
Abstract Number: 2063
The Survival Impact of Statins in Psoriasis and Psoriatic Arthritis: A General Population-Based Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 2013
TIARP Attenuates Autoantibody-Mediated Arthritis Via the Suppression of Neutrophil Infiltration into the Joint
- 2:30PM-4:00PM
-
Abstract Number: 2012
TNF Confers Pathogenic Memory in Synovial Fibroblasts Via Chromatin Remodeling, NF-Kb-Dependent Transcription and MAPK-Mediated mRNA Stabilization
- 2:30PM-4:00PM
-
Abstract Number: 2031
Tuberculosis in Patients Treated with Biological Drugs
- 2:30PM-4:00PM
-
Abstract Number: 2059
Tumor Necrosis Factor Inhibitor Tapering Induced Radiographic Progression Is Driven By Weighted Mean Disease Activity over Time, Not Flaring or Lower TNFi Exposition
- 2:30PM-4:00PM
-
Abstract Number: 2061
Uncovering Crohn’s Disease in Patients with Spondyloarthropathies Using Videocapsule Endoscopy
- 2:30PM-4:00PM
-
Abstract Number: 2070
Urinary Biomarker Based “a-RAIL”� Study in Adults with Lupus Nephritis
- 2:30PM-4:00PM
-
Abstract Number: 2071
Urinary Osteoprotegerin As Biomarker of Lupus Nephritis Disease Activity: Cross Sectional and Longitudinal Study
- 2:30PM-4:00PM
-
Abstract Number: 2065
Verification of Novel Soluble Biomarkers That Differentiate Patients with Psoriatic Arthritis from Those with Psoriasis without Psoriatic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2008
WISP1 Aggravates Osteoarthritis By Modulation of TGF-β Signaling and Positive Regulation of Canonical Wnt Signaling
- 4:30PM-6:00PM
-
Abstract Number: 2171
A Comparison of Maternal Outcomes in Women with and without Juvenile Idiopathic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2122
A Novel Severity Score Based on Cardiac Neonatal Lupus Manifestations Serves As a Predictor and Outcome Measure of Morbidity in Anti-Ro Exposed Fetuses
- 4:30PM-6:00PM
-
Abstract Number: 2108
A Pragmatic Cluster-Randomized Controlled Trial of an Automated, Pharmacy-Based Intervention to Optimize Allopurinol Therapy in Gout
- 4:30PM-6:00PM
-
Abstract Number: 2143
A Safety Analysis of Tofacitinib 5mg Twice Daily Administered As Monotherapy or in Combination with Background Conventional Synthetic Dmards in a Phase 3 Rheumatoid Arthritis Population
- 4:30PM-6:00PM
-
Abstract Number: 2111
A Study to Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
- 4:30PM-6:00PM
-
Abstract Number: 2116
Advice to Remain Active While Awaiting Physiotherapy Is Associated with Superior Long-Term Outcome Among Patients with Distal Arm Pain – Results from a Randomised Controlled Trial
- 4:30PM-6:00PM
-
Abstract Number: 2120
Alterations in Complement C3 and iC3b in SLE Pregnancies
- 4:30PM-6:00PM
-
Abstract Number: 2112
Analysis of Gout Subjects Receiving Lesinurad and Allopurinol Combination Therapy By Baseline Renal Function
- 4:30PM-6:00PM
-
Abstract Number: 2167
Application of Combined Reporting of Benefit and Harm (OMERACT 3×3 methodology) to the Rheumatoid Arthritis Comparison of Active Therapies Trial
- 4:30PM-6:00PM
-
Abstract Number: 2093
Are General and Central Adiposity Associated with MRI-Assessed Structural Changes in the Knees of Older Adults?
- 4:30PM-6:00PM
-
Abstract Number: 2162
Associations Between Education and Health Status Among Hispanics with Self-Reported Arthritis and/or Joint Pain
- 4:30PM-6:00PM
-
Abstract Number: 2163
Associations Between Sex Differences, Pain, Insomnia, and Depression in Older Adults with Osteoarthritis: A Cross-Sectional Study
- 4:30PM-6:00PM
-
Abstract Number: 2165
Awareness and Reasons for Lack of Post-Fracture Osteoporosis Therapy: A Survey of Post-Menopausal Women
- 4:30PM-6:00PM
-
Abstract Number: 2164
Burden of Symptomatic Knee Osteoarthritis in the United States: Impact of Race/Ethnicity, Age and Sex
- 4:30PM-6:00PM
-
Abstract Number: 2142
Comparison of Interferon-y Release Assay Versus Tuberculin Skin Test in the Golimumab UC and the Golimumab SC Rheumatology (RA, PsA, and AS) Clinical Study Programs
- 4:30PM-6:00PM
-
Abstract Number: 2137
Critical Role of Fibroblast-like Synoviocytes Glycolytic Metabolism in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2156
Damage Assessment in Giant Cell Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 2085
DC-STAMP Regulates Osteoclastogenesis through the Ca2+ /NFATc1 Axis
- 4:30PM-6:00PM
-
Abstract Number: 2087
Defective Circadian Control in Mesenchymal Cells Reduces Adult Bone Mass
- 4:30PM-6:00PM
-
Abstract Number: 2084
Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Modulates Bone Resorption in Inflammatory Arthritis and Fracture Repair
- 4:30PM-6:00PM
-
Abstract Number: 2095
Dietary Patterns (DASH, Prudent, Western Diets) and the Risk of Gout in US Women – the Nurses Health Study
- 4:30PM-6:00PM
-
Abstract Number: 2172
Distribution of Clinical Osteoarthritis and Associations to Health-Related Quality of Life in a Population-Based Osteoarthritis Cohort
- 4:30PM-6:00PM
-
Abstract Number: 2149
Dose Reduction Compared with Standard Dosing for Maintenance of Remission in Patients with Spondyloarthropathies and Clinical Remission with Anti-TNF: A Randomised Real-Life Trial
- 4:30PM-6:00PM
-
Abstract Number: 2140
Drug Specific Risk and Associated Factors for Vasculitis-like Events in Patients Exposed to Tumour Necrosis Factor-α Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2105
Drug Survival and Cost Effectiveness in Patients on Reduced Dose Anti-TNF: Results of a 4 Year Prospective Observational Study
- 4:30PM-6:00PM
-
Abstract Number: 2144
Efficacy and Safety of Different Dose Regimens of a Selective IL-23p19 Inhibitor (BI 655066) Compared with Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis with and without Psoriatic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2127
Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Subclinical Coronary Atherosclerosis Is Higher Among Rheumatoid Arthritis Patients with the Lowest Circulating Low Density Lipoprotein Concentrations Compared with Controls
- 4:30PM-6:00PM
-
Abstract Number: 2119
Findings and Therapeutic Impact of Magnetic Resonance Imaging (MRI) Studies for Patients with Lower Back Pain with Neurologic Symptoms. Are We Choosing Wisely?
- 4:30PM-6:00PM
-
Abstract Number: 2090
Gender-Specific Pathways Linking Arthritis, Activity Limitation and Incident Heart Disease: A Causal Mediation Analysis of the Canadian Longitudinal National Population Health Survey
- 4:30PM-6:00PM
-
Abstract Number: 2099
Genome-Wide Association Study of Clinically-Defined Gout Identifies Multiple Risk Loci: A Clue for Future Companion Diagnostics of Gout
- 4:30PM-6:00PM
-
Abstract Number: 2102
Higher Persistence and Adherence with Combination Therapy with Tumor Necrosis Factor Inhibitor+Methotrexate Combination Versus Triple Therapy in US Veterans with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2114
Higher Total Knee Arthroplasty Revision Rates in Black Americans: A Systematic Literature Review and Meta-Analysis
- 4:30PM-6:00PM
-
Abstract Number: 2101
HLA Associations in Mothers of Children with Cardiac Manifestations of Neonatal Lupus
- 4:30PM-6:00PM
-
Abstract Number: 2097
HLA-B27 Expression Profoundly Shapes the Host-Microbiota Metabolome
- 4:30PM-6:00PM
-
Abstract Number: 2100
Hypomethylation in Enhancer and Promoter Regions of Interferon Regulated Genes in Multiple Tissues Is Associated with Primary Sjögren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 2094
Identification of Gout Flare Using an Administrative Claims Based Algorithm
- 4:30PM-6:00PM
-
Abstract Number: 2136
Identification of Synovial Fibroblast Subsets That Define Pathology in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2110
Imaging and Safety Assessments Following Treatment with Febuxostat and Placebo for 2 Years in Subjects with Early Gout
- 4:30PM-6:00PM
-
Abstract Number: 2088
Immature Dendritic Are Potent OC Precursors in RA and Are Targeted By RA-Specific Antibodies
- 4:30PM-6:00PM
-
Abstract Number: 2096
Immune Dysregulation in Patients with TRNT1 Deficiency
- 4:30PM-6:00PM
-
Abstract Number: 2173
Impact of Smoking on Patient-Reported Disease Status and Symptoms Among Women with Lupus
- 4:30PM-6:00PM
-
Abstract Number: 2123
Incidence and Prognosis of Neonatal and Late-Onset Dilated Cardiomyopathy Associated with Cardiac Neonatal Lupus
- 4:30PM-6:00PM
-
Abstract Number: 2091
Influence of Increasing Physical Activity on Longitudinal Changes in Disability Status Among Inactive Older Adults
- 4:30PM-6:00PM
-
Abstract Number: 2104
Influence on Treatment Decision Making of Providing Numerical Ranges of Side-Effect Risks
- 4:30PM-6:00PM
-
Abstract Number: 2154
Inhibition of Gli Ameliorates the Pro-Fibrotic Effects of Transforming Growth Factor-β in Systemic Sclerosis
- 4:30PM-6:00PM
-
Abstract Number: 2086
Inhibition of Macrophage Inflammatory Protein 1-Alpha (CCL3) Significantly Reduced Bone Resorption in Vitro and the Development of Erosive Joint Pathology in Collagen-Induced Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2151
Inhibition of Myeloid-Associated Gene Expression in Skin Biopsy Samples of Systemic Sclerosis Patients Treated with Tocilizumab
- 4:30PM-6:00PM
-
Abstract Number: 2155
Inhibition of Sphingosine-1-Phosphate Signaling By AB22 As a Novel Strategy in the Treatment of Pulmonary Fibrosis Associated with Scleroderma
- 4:30PM-6:00PM
-
Abstract Number: 2107
Initiation of Combination Triple Therapy in Real World Clinical Practice Rarely Replicates the Protocols Used in Randomized Controlled Trials.
- 4:30PM-6:00PM
-
Abstract Number: 2106
Intensification to Triple Therapy Non-Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States from 2009 to 2014
- 4:30PM-6:00PM
-
Abstract Number: 2115
Intra-Operative Synovitis Predicts Worse Pain and Function 2 Years after Total Knee Arthroplasty for Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 2145
Ixekizumab Improves Physical Function, Quality of Life, and Work Productivity in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2092
Knee Pain Burden Is Associated with Decreased Moderate to Vigorous Physical Activity: Data from the Osteoarthritis Initiative
- 4:30PM-6:00PM
-
Abstract Number: 2113
Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout
- 4:30PM-6:00PM
-
Abstract Number: 2152
Long Noncoding H19X Is a Key Mediator of Tgf-Beta Induced Pro-Fibrotic Effects in the Pathogenesis of Systemic Sclerosis and Other Fibrotic Diseases
- 4:30PM-6:00PM
-
Abstract Number: 2169
Low Education Is Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project
- 4:30PM-6:00PM
-
Abstract Number: 2134
Metabolic Reprogramming in the Inflamed Joint Inhibits Pro-Inflammatory Mechanisms
- 4:30PM-6:00PM
-
Abstract Number: 2135
miRNA-223 Delivery to Synovial Fibroblasts Via Monocyte-Derived Extracellular Vesicles Promotes Their Proliferation
- 4:30PM-6:00PM
-
Abstract Number: 2132
Monocarboxylate Transporter 4, Associated with the Acidification of Synovial Fluid, Is a Novel Therapeutic Target for Inflammatory Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2158
Mortality Associated with Giant Cell Arteritis from 1980 to 2011: An Analysis of the French National Death Certificate Database
- 4:30PM-6:00PM
-
Abstract Number: 2089
Netrin-1 and Its Receptors Unc5b and DCC May be Useful Targets for Preventing Multiple Myeloma Bone Lesions
- 4:30PM-6:00PM
-
Abstract Number: 2153
Nintedanib Ameliorates Fibrotic and Vascular Manifestations in Preclinical Models of Systemic Sclerosis
- 4:30PM-6:00PM
-
Abstract Number: 2121
Placentas of Lupus Pregnancies Are Characterized By Marked Inflammatory Changes Despite Good Disease Control
- 4:30PM-6:00PM
-
Abstract Number: 2118
Prescription Medication Use in Community-Based US Adults with Chronic Low Back Pain: Nhanes 2009-2010
- 4:30PM-6:00PM
-
Abstract Number: 2130
Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Low-Dose Aspirin: A Case-Crossover Study
- 4:30PM-6:00PM
-
Abstract Number: 2098
Prioritizing Likely Causative Genes in Genome-Wide Association Studies (GWAS) Identified Risk Loci for Immune-Mediated Inflammatory Disorders Using Cell-Type Specific Expression Quantitative Loci (eQTL) Information
- 4:30PM-6:00PM
-
Abstract Number: 2124
Racial Disparities in Lupus Pregnancy
- 4:30PM-6:00PM
-
Abstract Number: 2109
Racial Disparities in the Risk of Hospitalized Severe Allopurinol Hypersensitivity Syndrome – a US Nationwide Study (2009-2011)
- 4:30PM-6:00PM
-
Abstract Number: 2133
Receptor Protein Tyrosine Phosphatase Alpha Enhances Rheumatoid Synovial Fibroblast Signaling and Promotes Arthritis in Mice
- 4:30PM-6:00PM
-
Abstract Number: 2157
Relapse Characteristics and Glucocorticoid Use in Patients with Biopsy-Proven Giant Cell Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 2139
Results of a Phase 1b/2a Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XmAb®5871 in Patients with Rheumatoid Arthritis (RA)
- 4:30PM-6:00PM
-
Abstract Number: 2125
Rheumatic and Non-Rheumatic Autoimmune Diseases in SLE Offspring
- 4:30PM-6:00PM
-
Abstract Number: 2141
Risk of Cancer in Non-TNFi Biologics-Treated RA
- 4:30PM-6:00PM
-
Abstract Number: 2138
Safety and Efficacy Results of a Phase 2, Double-Blind, Placebo-Controlled Clinical Study of Duvelisib with Background Methotrexate (MTX) in Adults with Moderate-to-Severe Rheumatoid Arthritis (RA)
- 4:30PM-6:00PM
-
Abstract Number: 2159
Second Temporal Artery Biopsies in Patients with Temporal Arteritis (TA)
- 4:30PM-6:00PM
-
Abstract Number: 2148
Secukinumab Provides Sustained Improvements in Psoriatic Arthritis: 2-Year Efficacy and Safety Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
- 4:30PM-6:00PM
-
Abstract Number: 2146
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis in Anti-TNF-Naive Patients and Those Previously Exposed to Anti-TNF Therapy: 52-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with Subcutaneous Dosing
- 4:30PM-6:00PM
-
Abstract Number: 2170
Sleep Efficiency and Cardiovascular Risk Burden in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2103
Temporal Trends in Drug Prescription, Utilization and Costs Among Rheumatoid Arthritis (RA) Patients Show Wide Regional Variation Despite Universal Drug Coverage
- 4:30PM-6:00PM
-
Abstract Number: 2147
The Effect of Sulfasalazine and Methotrexate on the Immunogenicity of Infliximab and Adalimumab in Patients with Spondyloarthritis
- 4:30PM-6:00PM
-
Abstract Number: 2128
The Role of Insulin Resistance in the Development of Premature Atherosclerosis in Patients with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2160
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis: A Diagnostic Accuracy and Cost-Effectiveness Study
- 4:30PM-6:00PM
-
Abstract Number: 2168
The Smoking Paradox in the Development of Myocardial Infarction Among Rheumatoid Arthritis Patients
- 4:30PM-6:00PM
-
Abstract Number: 2150
Treatment with Abatacept Prevents Experimental Dermal Fibrosis and Induces Regression of Established Inflammation-Driven Fibrosis
- 4:30PM-6:00PM
-
Abstract Number: 2129
Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Abnormalities of Vascular and Myocardial Function on Cardiac MRI
- 4:30PM-6:00PM
-
Abstract Number: 2126
Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2161
Ustekinumab for the Treatment of Refractory Giant Cell Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 2117
Weight Predicts Back Pain in Young Adult Women, Independent of Physical Activity: Data from the Australian Longitudinal Study on Women’s Health
- 4:30PM-6:00PM
-
Abstract Number: 2166
Work Productivity in Newly Diagnosed, Untreated Rheumatoid Arthritis Patients
- 4:30PM-6:00PM
-
Abstract Number: 2131
Younger Age and Female Gender Are the Main Determinants of Underestimation of Cardiovascular Risk in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2282
“Doing Every-Day Life” with Primary Sjögren’s Syndrome: Factors Predicting Difficulties Performing Daily Activities and Taking on Life Roles
- 9:00AM-11:00AM
-
Abstract Number: 2338
“It Was like No One Is Listening to Me”�: A Qualitative Study of the Lived Experiences of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance in Assessments of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2217
#Rheumjc: Development, Implementation and Analysis of an International Twitter-Based Rheumatology Journal Club
- 9:00AM-11:00AM
-
Abstract Number: 2555
14-3-3η As a Novel RA Drug Target: Anti-14-3-3η Monoclonal Antibody Delays the Onset and Mitigates the Severity of Arthritis in CIA Mice
- 9:00AM-11:00AM
-
Abstract Number: 2605
14-3-3η Positive Status and Higher Titres Are Associated with More Severe RA
- 9:00AM-11:00AM
-
Abstract Number: 2957
25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus: Results from a Controlled Study
- 9:00AM-11:00AM
-
Abstract Number: 2706
3D Location of Erosions in an Early Rheumatoid Arthritis Population: An MRI Study Using Statistical Shape Models with Implications for Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 2344
A 3-Year Follow-up Study of Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant, or Unresponsive to Nonsteroidal Anti-Inflammatory Drugs and/or Colchicine
- 9:00AM-11:00AM
-
Abstract Number: 2682
A Brief Patient-Reported Measure of Physical Function Is Sensitive to Changes in a Composite Disease Activity Measure in a Diverse Rheumatoid Arthritis Clinic Setting
- 9:00AM-11:00AM
-
Abstract Number: 2289
A Cervical Radiculopathy Can Cause Chest Pain
- 9:00AM-11:00AM
-
Abstract Number: 3034
A Comparative Metabolomic Evaluation of Behcet’s Disease with Arthritis and Seronegative Arthritis Using Synovial Fluid
- 9:00AM-11:00AM
-
Abstract Number: 2738
A Comparison of EQ5D Index from the UK, US, and Japan Preference Weights Model, and Mapping Algorithm from Clinical Outcomes in Patients with Rheumatoid Arthritis: Results from Golimumab Intravenous Study
- 9:00AM-11:00AM
-
Abstract Number: 2533
A Comparison of Pregnancy Outcomes before and after Lupus Diagnosis
- 9:00AM-11:00AM
-
Abstract Number: 2815
A Comparison of Th17 Gene Expression in Psoriatic Arthritis Synovial Fluid and Peripheral Blood
- 9:00AM-11:00AM
-
Abstract Number: 2505
A Fellow Led Quality Improvement Project for Improving Contraceptive Compliance in Women Receiving Teratogenic Medications
- 9:00AM-11:00AM
-
Abstract Number: 2997
A Genome-Wide Association Study of a Hispanic Systemic Sclerosis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2977
A Meta-Analysis of Phosphodiesterase 5 Inhibitors for the Treatment of Raynaud’s Phenomenon
- 9:00AM-11:00AM
-
Abstract Number: 2530
A Multicenter Evaluation of Obstetric and Maternal Outcome in Prospectively Followed Pregnant Patients with Confirmed Positivity for Antiphospholipid Antibodies (aPL)
- 9:00AM-11:00AM
-
Abstract Number: 2794
A New Scoring System for Ultrasonographic Evaluation of Salivary Gland in Sjogren: Multireader Reliability
- 9:00AM-11:00AM
-
Abstract Number: 2713
A Novel Paradigm in the Clinical Context of Rheumatoid Arthritis: Role of Tfh and Th17 Cells in Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 2262
A Novel Study Instrument to Identify Household Work Related Musculoskeletal Disorders – Development and Validation
- 9:00AM-11:00AM
-
Abstract Number: 2749
A Phase 1 Study of FPA008, an Anti-Colony Stimulating Factor 1 Receptor (anti-CSF1R) Antibody in Patients (pts) with Rheumatoid Arthritis (RA): Preliminary Results
- 9:00AM-11:00AM
-
Abstract Number: 8L
A Phase III, Randomized, Double-Blind Clinical Study Comparing SB5, an Adalimumab Biosimilar, with Adalimumab Reference Product (Humira®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (24-week Results)
- 9:00AM-11:00AM
-
Abstract Number: 2858
A Phosphodiesterase 4 Inhibitor for Psoriatic Arthritis: Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2538
A Population-Based Assessment of Induced Abortions in Women with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2383
A Qualitative Study of Barriers and Facilitators to Arthritis Patients Use of Physical Activity Monitoring Tools
- 9:00AM-11:00AM
-
Abstract Number: 2507
A Quality Indicator for the Screening of Latent Tuberculosis Infection and the Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
- 9:00AM-11:00AM
-
Abstract Number: 2218
A Randomized Controlled Trial to Evaluate a Multimedia Patient Education Tool in Patients with Knee Osteoarthritis. Six-Month Results
- 9:00AM-11:00AM
-
Abstract Number: 9L
A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2845
A Randomized, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of Etoricoxib in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2932
A Retrospective Observational Study of Patients with Lupus Nephritis Treated with Rituximab in Combination with Cyclophosphamide
- 9:00AM-11:00AM
-
Abstract Number: 2989
A Romanian Version of the University of Californa at Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0) Instrument
- 9:00AM-11:00AM
-
Abstract Number: 2351
A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
- 9:00AM-11:00AM
-
Abstract Number: 2831
A Subset of Natural Killer Cells Are Expanded in Synovial Fluid of Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2909
A Systematic Review and Meta-Analysis of Cutaneous Manifestations in Late Versus Early-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2705
AAA-Atpase p97-HDAC6 Controlled Poly-Ubiquitin Turnover Regulates Apoptotic and Autophagy-Associated Cell Death in Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2361
Abatacept in the Treatment of Adult Dermatomyositis and Polymyositis: a Randomized, Treatment Delayed-Start Trial
- 9:00AM-11:00AM
-
Abstract Number: 2778
Abatacept-Treated Rheumatoid Arthritis Patients Have Better Drug-Survival Rate When Abatacept Is the First or Second Line Biologic Agent with an Excellent Overall Safety Profile: A Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 2577
Ablation of Fc Gamma Receptors Leads to a Decreased Bone Erosion in Experimental Arthritis Not By Altering Osteoclast Numbers within the Inflamed Joint but By Inhibiting Osteoclast Activation
- 9:00AM-11:00AM
-
Abstract Number: 3059
Abnormal Body Composition in Takayasu Arteritis Patients: Role of Inflammatory Cytokines and Adipokines
- 9:00AM-11:00AM
-
Abstract Number: 2781
Absence of Effects of Filgotinib on Erythrocytes, CD8+ and NK Cells in Rheumatoid Arthritis Patients Brings Further Evidence for the JAK1 Selectivity of Filgotinib
- 9:00AM-11:00AM
-
Abstract Number: 2444
Accelerometer-Assessed Daily Physical Activity in Relation to Pain Cognitions and Quality of Life in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2740
ACPA Positivity in the Elderly and Concomitant MTX Use in Younger May be Useful Predictive Factors for Superior Clinical Efficacy with Abatacept in Japanese Biological-Naïve RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 2565
ACPA Specific IVIG Attenuate Collagen Induced Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2772
Activated Memory B Cells in Rheumatoid Arthritis and Relationship to Anti-TNF Treatment
- 9:00AM-11:00AM
-
Abstract Number: 2214
Activation Feature of RANKL/RANK Signaling Pathway in Ankylosing Spondylitis Patients Compared with Healthy People
- 9:00AM-11:00AM
-
Abstract Number: 2483
Adherence to 2011 American Academy of Ophthalmology Guidelines to Perform Objective Screening Tests for Detection of Antimalarial Retinal Toxicity Is Suboptimal
- 9:00AM-11:00AM
-
Abstract Number: 2508
Adherence to ACR Guidelines in the Management of Lupus Nephritis – a Quality Improvement Initiative
- 9:00AM-11:00AM
-
Abstract Number: 3013
Adipose Loss of Co-Repressor Ncor Attenuates Bleomycin-Induced Skin Fibrosis By Enhancing PPAR-Gamma Signaling
- 9:00AM-11:00AM
-
Abstract Number: 2284
Age and Sex Stratified Normative Data for Shoulder Range of Movement
- 9:00AM-11:00AM
-
Abstract Number: 2580
Age-Related Differences in Collagen-Induced Arthritis: Clinical, Imaging and Biological Characteristics in Juvenile Compared to Adult Animals
- 9:00AM-11:00AM
-
Abstract Number: 2331
Agreement Between Patient’s and Physician’s Reported Bath Ankylosing Spondylitis Disease Activity Index in Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 10L
Aiming for Remission in Rheumatoid Arthritis: Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen
- 9:00AM-11:00AM
-
Abstract Number: 2718
Along Those Lines: Synoviocyte Cell-to-Cell Communication Via Nanotubes
- 9:00AM-11:00AM
-
Abstract Number: 2552
Alterations in the Colonic Microbiome Precede the Development of Murine Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2462
Altered Expression of IL-10 Family Cytokines in Chronic Recurrent Multifocal Osteomyelitis Result in Enhanced Inflammasome Activation
- 9:00AM-11:00AM
-
Abstract Number: 2976
Ambrisentan Dose Migration over 3 Years in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension (CTD-PAH)
- 9:00AM-11:00AM
-
Abstract Number: 2741
An Analysis of the Efficacy of Tofacitinib Monotherapy in MTX-Naïve Patients with Early RA Compared with Patients with Established RA
- 9:00AM-11:00AM
-
Abstract Number: 2494
An Electronic Safety Dashboard for Rheumatology Clinics
- 9:00AM-11:00AM
-
Abstract Number: 2316
An Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic Naïve Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2987
An EULAR Study Group Pilot Study on Reliability of Simple� Capillaroscopic Definitions to Describe Capillary Morphology in Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2701
An Expansion of Rare Lineage Intestinal Microbes Characterize Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2707
An in Vitro Bovine Bone Chip Model with Micro-CT: A Model for the Assessment of Autoantibody Mediated Bone Resorption
- 9:00AM-11:00AM
-
Abstract Number: 2423
An Open-Label Extension Study to Assess the Long-Term Safety and Clinical Benefit of Etanercept on Children and Adolescents with Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, or Psoriatic Arthritis: A 4-Year Update
- 9:00AM-11:00AM
-
Abstract Number: 2382
An Outsourced Health-Enhancing Physical Activity Program for People with Rheumatoid Arthritis. Exploration of the Maintenance Phase
- 9:00AM-11:00AM
-
Abstract Number: 2827
Analysis of HLA-B27 Transgenic Rats Reveals Specific Gut Transcriptome and Microbiome Signatures Associated with Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 2656
Analysis of Morning Stiffness Response in Rheumatoid Arthritis Patients with Low Disease Activity Receiving Delayed-Release Prednisone Plus Dmards As Compared to Placebo Plus Dmards
- 9:00AM-11:00AM
-
Abstract Number: 2916
Analysis of Risk Factors of the Progression to Chronic Kidney Disease and Comorbidities in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2377
Anti 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase in Systremic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2433
Anti Interferon-Gamma (IFNg) Monoclonal Antibody Treatment in a Child with NLRC4-Related Disease and Severe Hemophagocytic Lymphohistiocytosis (HLH)
- 9:00AM-11:00AM
-
Abstract Number: 2456
Anti SRP+Ve Myositis in Childhood. Presentation and Physiotherapy Treatment of This Rare Childhood Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2364
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive Myopathy Patients without Statin Exposure May Have a Progressive Disease That Worsens Despite Aggressive Immunosuppressive Therapy
- 9:00AM-11:00AM
-
Abstract Number: 3045
Anti-Alpha-Enolase Antibodies in Behçet’s Disease: A Marker of Articular Disease Activity?
- 9:00AM-11:00AM
-
Abstract Number: 2590
Anti-Citrullinated Protein Antibody and Radiographic Disease Progression in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2607
Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis Hispanics Exposed to Biomass Smoke
- 9:00AM-11:00AM
-
Abstract Number: 2901
Anti-dsDNA Antibodies Measured By Chemiluminescent Immunoassay Show Strong Association with Active Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2571
Anti-IL-6 Receptor Antibody Prevents Loss of Bone Strength in a Mouse Model of Collagen-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2951
Anti-NR2 Antibody and Blood-Brain Barrier Disruption in Systemic Lupus Erythematosus Patients with Cognitive Dysfunction
- 9:00AM-11:00AM
-
Abstract Number: 2187
Anti-Phosholipid Antibodies and Female Infertility: A Systematic Revision of Literature
- 9:00AM-11:00AM
-
Abstract Number: 2875
Anti-TNF Therapy Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry
- 9:00AM-11:00AM
-
Abstract Number: 2851
Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry
- 9:00AM-11:00AM
-
Abstract Number: 2468
Antibodies to Histocompatibility Antigens in Juvenile Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 2551
Antibodies to Malondialdehyde-Acetaldhyde Adducts Are Increased in the Serum of Mice Following Infection with P. Gingivalis and/or Injection of Citrullinated Mouse Type II Collagen: a Model of Human Disease Response
- 9:00AM-11:00AM
-
Abstract Number: 2194
Anticoagulation and Longterm Outcomes in Patients with Renal Artery Stenosis and Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2188
Antiphospholipid Antibodies and the Risk of Damage Accrual in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2181
Antiphospholipid Antibody-Mediated Increase of Tissue Factor in Arterial Wall Is Associated with Increased Thrombus Size in a Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 2198
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Clinical Database and Repository Analysis: Determinants of Thrombosis in Patients Presenting with Obstetric APS
- 9:00AM-11:00AM
-
Abstract Number: 2190
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Core Laboratory Validation Exercise: Comparison of Enzyme-Linked Immunosorbant Assay (ELISA) and Chemiluminescence Immunoassay (CIA)
- 9:00AM-11:00AM
-
Abstract Number: 2189
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository (“Registry”) Prospective Follow-up Analysis: One-Year First and Recurrent Thrombosis Risk
- 9:00AM-11:00AM
-
Abstract Number: 2200
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository Cluster Analysis: Identification of Different Clinical Phenotypes Among Antiphospholipid Antibody-Positive Female Patients
- 9:00AM-11:00AM
-
Abstract Number: 2220
Appropriate Investigations and Costs in Rheumatology: Residents’ Attitudes and Knowledge
- 9:00AM-11:00AM
-
Abstract Number: 2849
Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 2888
Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 2889
Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Improvements in Nail and Scalp Psoriasis and Psoriasis Area and Severity Index in Patients with Moderate to Severe Plaque Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 2385
Arthritis Management in Primary Care and Adherence to National Guidelines – a Swedish Survey Based on the Canadian Physiotherapists Arthritis Care Questionnaire
- 9:00AM-11:00AM
-
Abstract Number: 2661
Assessing Information Needs for Chronic Disease Management in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2412
Assessment and Comparison of Responsiveness of Four Patient Reported Outcome Measures to Assess Physical Function in Patients with Knee Osteoarthritis: WOMAC-PF Subscale Responds Best
- 9:00AM-11:00AM
-
Abstract Number: 2891
Assessment of Disability Levels in a Cohort of 1,489 Patients with Active Psoriatic Arthritis, and the Effect of Apremilast Treatment: Pooled Data from Three Phase III, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 12L
Assessment of Immunogenicity of Live Zoster Vaccination (Zostavax®) in Rheumatoid Arthritis Patients on Background Methotrexate before and after Initiating Tofacitinib or Placebo
- 9:00AM-11:00AM
-
Abstract Number: 2990
Assessment of NT-Pro BNP As a Potential Marker for Pulmonary Hypertension in Systemic Sclerosis: Data from a Large, Prospective and Unselected Patient Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2980
Assessment of Sublingual Frenulum Perfusion in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2751
Assessment of the Effect of CYP3A Inhibition, CYP Induction, OATP1B Inhibition and Administration of High-Fat Meal on the Pharmacokinetics of the Potent and Selective JAK1 Inhibitor ABT-494
- 9:00AM-11:00AM
-
Abstract Number: 2196
Association Between Antiphospholipid Antibodies and All-Cause Mortality Among End Stage Renal Disease Patients with and without SLE
- 9:00AM-11:00AM
-
Abstract Number: 2684
Association Between Anxiety and Depression and Rheumatoid Arthritis Outcome: Results from an Inception Early Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2673
Association Between Anxiety and Depression and Rheumatoid Disease Severity: Results from an Established Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2299
Association Between Catechol-O-Methyl Transferase Gene Polymorphisms and Fibromyalgia in a Korean Population: A Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2475
Association Between Fibromyalgia and Suicidal Risk: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2261
Association Between Musculoskeletal Pain, Fat Mass and Fat Free Mass: Results from a Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2516
Association Between Primary Sjögren’s Syndrome and Pregnancy Outcome: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 3047
Association Between Red Blood Cell Distribution Width and Disease Activity in Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2400
Association Between Serum Urate and Osteoarthritis Progression in a Non-Obese Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2785
Association of Anti-Glutamate Receptor Subunit NR2 Antibody and Psychiatric Disorder in Patients with Primary Sjögren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2947
Association of Anti-NR2 and U1RNP Antibodies with Neurotoxic Inflammatory Mediators in Cerebrospinal Fluid from Patients with Neuropsychiatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2633
Association of Medication Beliefs, Self-Efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2589
Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2634
Associations Between Health Literacy, Ethnicity, Communication Quality and Beliefs about Medicines in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2818
Associations of IL23R, BMP6 and PTGS1 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2359
Atorvastatin-Induced Autoimmune Myopathy: An Emerging Dominant Entity in Patients with Autoimmune Myopathy Presenting with a Pure Polymyositis Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 2824
Autoantibodies Against CD74 – a New Diagnostic Marker for Spondyloarthritis (SpA)
- 9:00AM-11:00AM
-
Abstract Number: 2595
Autoantibodies to Citrullinated Fibrinogen, Anti-CCP2 and Anti-MCV Antibodies in Early Rheumatoid Arthritis Patients with Rapid Radiographic Progression at 1-Year
- 9:00AM-11:00AM
-
Abstract Number: 2420
Azathioprine for Glucocorticoid Resistant Non-Renal Henoch-Schönlein Purpura
- 9:00AM-11:00AM
-
Abstract Number: 2394
B-Flow Imaging of Synovial Tissue in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2460
B10 Cells May be Involved in Controlling Disease Activity in Polyarticular Juvenile Idiopathic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2806
Bacterial Skin Microbiome in Psoriatic Arthritis – Pilot Data from Psoriatic Plaques on Dry Skin Sites from Patients with Psoriasis (PsC) and Psoriatic Arthritis (PsA)
- 9:00AM-11:00AM
-
Abstract Number: 2498
Barriers to Appointment Compliance and the Effect of Reminder Phone Calls on Lupus Clinic Show Rate in an Underserved Community
- 9:00AM-11:00AM
-
Abstract Number: 2723
Basal STAT5 Signaling Is Elevated in Multiple Peripheral Blood Cell Subsets in Rheumatoid Arthritis and Is Markedly Downregulated By IFN-γ in T Lymphocytes
- 9:00AM-11:00AM
-
Abstract Number: 2728
Baseline Characteristics and Changes in Disease Activity at 12 Months in Patients Treated with Abatacept Versus Other Biologic Disease-Modifying Antirheumatic Drugs in Clinical Practice Setting
- 9:00AM-11:00AM
-
Abstract Number: 2876
Baseline Demographic and Disease Characteristics Associated with Response to Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2882
Baseline Extent of Damage at the Spine Predicts Radiographic Progression in Korean Patients Using Golimumab for Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2399
Baseline Fibulin3 Concentrations Are Associated with Incidence of Clinical Knee OA after 30 Months in Overweight and Obese Women
- 9:00AM-11:00AM
-
Abstract Number: 2938
Baseline Predictors of Remission and Low Disease Activity Using Recently Defined International Criteria in a Multi-Center Lupus Registry Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2309
Bedtime, Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia: Results of a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
- 9:00AM-11:00AM
-
Abstract Number: 2779
Better Drug Survival of Non-TNFi Compared to TNFi Biologics after Non-TNFi Failure in RA Patients: A Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 2727
BI 695501, a Proposed Biosimilar for Adalimumab, Shows Bioequivalence to Adalimumab Reference Products in a Randomized, Double-Blind Phase I Trial in Healthy Subjects
- 9:00AM-11:00AM
-
Abstract Number: 2789
Blood and Salivary Gland BAFF-Driven B-Cell Hyperactivity in Rituximab Non-Responder Patients with Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2982
Blood Perfusion in Different Skin Areas of Hands in Primary Raynaud’s Phenomenon and Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2238
Body Mass Index Modulates the Relationship Between Sugar-Sweetened Beverage Intake and Serum Urate Concentration
- 9:00AM-11:00AM
-
Abstract Number: 2800
Bone Microarchitecture and Bone Strength in Patients with Primary Sjögren’s Syndrome: A Case-Control Study Using HR-pQCT
- 9:00AM-11:00AM
-
Abstract Number: 2228
Brief Educational Intervention Improves Gout Patients’ Understanding of Their Disease
- 9:00AM-11:00AM
-
Abstract Number: 3016
Bromodomain Inhibitor JQ1 Modulates Smooth Muscle Cell Switching and Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension in Mice
- 9:00AM-11:00AM
-
Abstract Number: 3051
Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behçet’s Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment
- 9:00AM-11:00AM
-
Abstract Number: 3052
Budd-Chiari Syndrome in Behçet’s Disease:a Retrospective Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 2906
Can Immunosuppressive Drug Treatment Reduce Mortality in Patients with Systemic Lupus Erythematosus (SLE): A Propensity Score Analysis of a Longitudinal Cohort of 803 Patients?
- 9:00AM-11:00AM
-
Abstract Number: 2234
Can the Fracture Risk Assessment Tool (FRAX) Also Predict Falls in Older Women?
- 9:00AM-11:00AM
-
Abstract Number: 3057
Can We Differentiate Takayasu’s Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?
- 9:00AM-11:00AM
-
Abstract Number: 2347
Can We Predict the Dose of Allopurinol to Achieve Target Urate?
- 9:00AM-11:00AM
-
Abstract Number: 2345
Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Long-Term Safety and Efficacy Results from a 36-Week Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 2255
Capillaroscopic Patterns in a Healthy Population
- 9:00AM-11:00AM
-
Abstract Number: 2586
Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 3064
Cardiac Manifestation of Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2972
Cardiopulmonary Exercise Testing in Patients with Systemic Sclerosis: Unexplored Mechanisms of Dyspnea
- 9:00AM-11:00AM
-
Abstract Number: 2270
Cardiovascular Disease: The Hidden Risk in Persons with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2578
Cardiovascular Effects of Etanercept in an Animal Model of Rheumatoid Arthritis: Mechanisms Involved
- 9:00AM-11:00AM
-
Abstract Number: 2602
CCP Antibody Negativity Is Associated with Higher Fatigue in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 3028
CD1d Regulates iNKT Cell Autoreactivity
- 9:00AM-11:00AM
-
Abstract Number: 3006
Cell-Free Circulating DNA in Systemic Sclerosis: Increased Levels and Global Cytosine Hypomethylation
- 9:00AM-11:00AM
-
Abstract Number: 2615
Changes in a Patient-Reported Measure of Physical Function, PF-10a, Are Most Strongly Associated with Changes in the Patient Global Assessment Portion of a Composite Measure of RA Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2645
Changes in Clinical Disease Activity Index and Changes in Sleep Among RA Patients Initiating Disease Modifying Antirheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 2841
Changes in Treatment Patterns in Psoriatic Arthritis Patients Newly Initiated on Biologic and Non-Biologic Therapy Enrolled in a North American Clinical Registry
- 9:00AM-11:00AM
-
Abstract Number: 2523
Characteristics and Outcomes of Prospectively-Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database
- 9:00AM-11:00AM
-
Abstract Number: 2621
Characteristics of Histopathology and Clinical Course of 19 Cases That Developed a Lymphoproliferative Disease (LPD) during Methotrexate (MTX) Treatment.
- 9:00AM-11:00AM
-
Abstract Number: 2832
Characterization of Leukocyte Subsets in Ankylosing Spondylitis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2825
Characterization of Mesenchymal Stem Cells Generated from Axial Spondyloarthritis Patient-Derived Induced Pluripotent Stem Cells
- 9:00AM-11:00AM
-
Abstract Number: 3015
Characterization of the Profibrotic/Antifibrotic Profile of microRNA Contained in Exosomes Isolated from Cultured Normal Human Dermal and Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition in Vitro
- 9:00AM-11:00AM
-
Abstract Number: 2464
Characterization of the Serum Anti-Citrullinated Protein Antibody Profile in Juvenile Idiopathic Arthritis: Association with Oral Health
- 9:00AM-11:00AM
-
Abstract Number: 3022
Characterizing a Novel Gene, Mosaic, and Its Role in Mediating a Multisystem Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 2549
Characterizing the RPTPσ Mediated Proteoglycan Switch As a Target for Rheumatoid Arthritis Therapy
- 9:00AM-11:00AM
-
Abstract Number: 3072
Childhood Takayasu Arteritis. a Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 2482
Choosing Subserologies More Wisely: Implementing Anti-Nuclear Antibody (ANA) Reflex Testing and Education to Reduce Unnecessary Costs in an Integrated Healthcare System
- 9:00AM-11:00AM
-
Abstract Number: 2611
Circulating Monocyte Count Is Significantly Associated with Interstitial Pneumonia in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Cohort Study (Keio First-Bio Cohort Study)
- 9:00AM-11:00AM
-
Abstract Number: 2183
Clinical and Epidemiological Correlates of the Adjusted Global Anti-Phospholipid Syndrome Score in a Large Cohort of Chinese APS Patients
- 9:00AM-11:00AM
-
Abstract Number: 2452
Clinical and Functional Outcomes in Patients with Polyarticular Juvenile Idiopathic Arthritis Following Treatment with Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 2729
Clinical and Radiographic Outcome of Iguratimod for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2667
Clinical Characteristics and Health Outcomes of RA Patients Not Adequately Controlled By Current Treatment
- 9:00AM-11:00AM
-
Abstract Number: 2370
Clinical Characteristics of Anti-MDA5 (+) Dermatomyositis Patients in North America
- 9:00AM-11:00AM
-
Abstract Number: 2256
Clinical Characteristics, Laboratory Findings and Nailfold Capillaroscopy Microscopy Patterns in a Monocentric Series of 123 Patients with Idiopathic Pernio
- 9:00AM-11:00AM
-
Abstract Number: 2438
Clinical Examination of the Temporomandibular Joint; A Eurotmjoint Initiative
- 9:00AM-11:00AM
-
Abstract Number: 3066
Clinical Features and Treatments of Takayasu Arteritis Complicated with Ulcerative Colitis
- 9:00AM-11:00AM
-
Abstract Number: 2376
Clinical Features in Dermatomyositis Patients with Novel Autoantibody to Small Ubiquitin-like Modifier Activating Enzymes (Anti-SAE Antibody) and Relationship to Interstitial Lung Disease: A Systematic Review of 29 Cases
- 9:00AM-11:00AM
-
Abstract Number: 2379
Clinical Follow-up Predictors of Disease Pattern Change in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International and Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 2487
Clinical Practices Participating in a Quality Improvement Project Make Progress in Implementing Population Management
- 9:00AM-11:00AM
-
Abstract Number: 2860
Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 2687
Clinical Significance of Patient-Reported Pain and Stiffness at Each Joint Level in the Evaluation of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2619
Clinical Usefulness of Periodic Detection of Serum 14-3-3η for Predicting Efficacy of Tocilizumab in RA
- 9:00AM-11:00AM
-
Abstract Number: 2758
Clinical Utility and Factors Associated with Certolizumab Pegol Drug Levels and Anti-Drug Antibodies in the Long-Term Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2304
Clinical, Ultrasonographic and Neurophysiological Correlation of Patients with Carpal Tunnel Syndrome in Santo Domingo, Dominican Republic
- 9:00AM-11:00AM
-
Abstract Number: 2655
Clinically Important Worsening (CIW) of RA Disease Activity Requiring an Increase in Therapy Can be Identified Using a Combined Patient and Physician Report of Flare
- 9:00AM-11:00AM
-
Abstract Number: 2802
Co-Occurence of Anti-Ro52/TRIM21 and Anti-TRIM38 Autoantibodies Is Associated with Higher Severity of Dry Eye in Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 3049
Cognitive Dysfunction in Chronic Progressive Neuro-Behçet’s Disease: Comparative Study of the Brainstem and Hippocampus Region Using Brain Magnetic Resonance Imaging
- 9:00AM-11:00AM
-
Abstract Number: 2955
Cognitive Impairment in Lupus Patients: Identification of the Best Screening Test and Assessment for Associated Factors
- 9:00AM-11:00AM
-
Abstract Number: 3007
Cold Receptor Expression and Function in Human Dermal Fibroblast: Possible Role in the Pathogenesis of Scleroderma Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 2917
Combined Proliferative and Membranous Lupus Nephritis: Is the Prognosis Really Poor?
- 9:00AM-11:00AM
-
Abstract Number: 2557
Comparable Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Collagen Induced Arthritis with Anti-Tumor Necrosis Factor or Anti-CD20
- 9:00AM-11:00AM
-
Abstract Number: 2570
Comparative Analysis of Collagen-Antibody Induced Arthritis and the Arthritis Inhibitory Potential of Specific ACPA in Two Mouse Subspecies Genetically Separated about One Million Years Ago
- 9:00AM-11:00AM
-
Abstract Number: 2767
Comparative Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated By Serum Amyloid a
- 9:00AM-11:00AM
-
Abstract Number: 2175
Comparative Study Between Coagucheck XS Versus Standard Laboratory Practice Protrombine Time for Monitoring Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2693
Comparing Eight Year Clinical and Radiographic Outcome in Two Cohorts of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2636
Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-Based Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2407
Comparison of Knee Osteoarthritis Treatment in the Non-Obese Versus Obese Populations Across Different Medical Specialties
- 9:00AM-11:00AM
-
Abstract Number: 2670
Comparison of M-DAS and DAS28, Two Composite Scores for Prediction of Structural Damages in Rheumatoid Arthritis: Data from the Espoir Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2402
Comparison of Synovitis on MRI and Pain in Knee Osteoarthritis Patients with and without Chondrocalcinosis: Data from the Osteoarthritis Initiative (OAI)
- 9:00AM-11:00AM
-
Abstract Number: 2746
Comparison Study of Tests Available to Monitor Tocilizumab Therapy in Rheumatic Patients
- 9:00AM-11:00AM
-
Abstract Number: 2242
Compliance with Allopurinol Among Hypertensive Patients with Gout Diagnosis and the Relationship to Onset of End-Stage Renal Disease
- 9:00AM-11:00AM
-
Abstract Number: 2912
Concomitant Kidney Disease in Patients with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2573
Confirmatory Analysis of Methylome Signatures in Rheumatoid Arthritis Using an Independent Dataset
- 9:00AM-11:00AM
-
Abstract Number: 2737
Consistency of Treatment Effects Across Different High-Risk Clinical Phenotypes in the Tofacitinib Clinical Program
- 9:00AM-11:00AM
-
Abstract Number: 2263
Construct and Convergent Validity of Four Global Measures of at-Work Productivity Loss in Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2540
Construct Validity of the Promis-29 in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2543
Content Validity of the Improved Health Assessment Questionnaire in Knee Osteoarthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2513
Contraception Use Amongst Women Ages 18-45 Taking Known Teratogenic Medications in an Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2683
Contribution of Subjective Patient Reported Components of Disease Activity Scores Differs in Disease Activity Measures and Their Changes over Time Are Closely Associated with Objective Measures
- 9:00AM-11:00AM
-
Abstract Number: 2413
Contributors to Walking Disability in People with Osteoarthritis: Results from a Population-Based Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2286
Correlation of Magnesium Levels and IGF-! Levels in Fibromyalgia Patients
- 9:00AM-11:00AM
-
Abstract Number: 2708
Correlation of Peripheral Blood Th-17 and Th-1 with Synovitis and Osteitis By MRI in Recent Onset Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2641
Correlation of Rheumatologists’ Perceptions of RA Severity with Observed Disease Activity, Patient Impact and Treatment Patterns
- 9:00AM-11:00AM
-
Abstract Number: 2963
Correlations Between Microvasculature Changes and Angiogenic Factors in Systemic Sclerosis – Data from a Single Center Registry
- 9:00AM-11:00AM
-
Abstract Number: 2647
Correlations Between Personality Types, Disease Activity and Quality of Life in As and RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 2587
CRP and 14-3-3η Are Each Associated with Joint Damage Progression, Their Titres Do Not Correlate and Are Better Predictors of Progression Together Than Alone
- 9:00AM-11:00AM
-
Abstract Number: 2720
Crucial Role of Nuclear Factor of Activated T Cell 5 (NFAT5), an Osmo-Protective Factor, in Migration and Invasion of Rheumatoid Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 2283
Current and Lifetime Smoking Among US Adults with Arthritis: A Serious Clinical and Public Health Issue
- 9:00AM-11:00AM
-
Abstract Number: 2251
Current Tobacco Use and the Rates of Postoperative Complications after Total Knee Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 2834
CXCL10 Expression Is Elevated in Synovial Fluid of Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2722
Cyclic Phosphatidic Acid (CPA) Suppresses Expression of Cartilage Degrading Enzymes Such As MMP-3, MMP-13 and Adamts-4 in Inflammatory Synovial Fibroblasts and Articular Chondrocytes Induced By IL-1 Beta and/or TNF ALFA
- 9:00AM-11:00AM
-
Abstract Number: 2926
Cytochrome P450 Polymorphisms on Blood Hydroxychloroquine Levels in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2465
Cytokine Profile Comparison of Monogenic and Complex Conditions with Interferon-Regulated Gene Signatures in Chronic Atypical Neutrophilic Dermatosis with Lipodsytrophy and Elevated Temperature (CANDLE), SAVI, Aicardi-Goutieres Syndrome, JDM, and SLE
- 9:00AM-11:00AM
-
Abstract Number: 2812
Cytokine Secretion By Peripheral Blood Mononuclear Cells in Patients with Axial Spondyloarthritis and the Effect of Thymoquinone on Cytokine Profile
- 9:00AM-11:00AM
-
Abstract Number: 3031
Dalazatide (ShK-186), a Kv1.3 Channel Inhibitor That Targets Effector Memory T Cells: Ex Vivo Studies in Pediatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 3068
Damage Assessment in Takayasu’s Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2623
DAS28-ESR and DAS28-CRP Are Not Exchangeable in Daily Clinical Practice: Data from a Large Outpatient Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2257
Decline of Lung Function Is Associated with the Presence of Rheumatoid Factor in Korean Health Screening Subjects without Clinically Apparent Lung Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2252
Declining Post-Arthroplasty Mortality after Total Knee Arthroplasty in the U.S.: A Time-Trends Study
- 9:00AM-11:00AM
-
Abstract Number: 3023
Decreased Intracellular Calcium Flux in Follicular Helper T Cells after T Cell Receptor Stimulation
- 9:00AM-11:00AM
-
Abstract Number: 2643
Decreased Pain Level with Aging Leads to Underestimation of Disease Activity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2529
Decreased Programmed Death Ligand-1 (PD-L1) in Systemic Lupus Erythematosus (SLE) Placenta
- 9:00AM-11:00AM
-
Abstract Number: 2512
Depot Medroxyprogesterone Acetate Birth Control May Suppress Toll-like Receptor 7-Induced Interferon-Alpha Production By Plasmacytoid Dendritic Cells in Women
- 9:00AM-11:00AM
-
Abstract Number: 2337
Depression, Bad Sleep Quality, and Functional Deficit Are Independently Associated with Persistent Fatigue in Arthritic Patients with Low Disease Activity Under Biological Dmards
- 9:00AM-11:00AM
-
Abstract Number: 2332
Deriving ‘population References’ of Health Utilities for Patients with Spondyloarthritis Based on the ASAS Health Index
- 9:00AM-11:00AM
-
Abstract Number: 2369
Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: A Longitudinal Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2329
Describe Treatments As ‘new’ or ‘old’ at Your Peril: Influences on Patient Decision Making
- 9:00AM-11:00AM
-
Abstract Number: 2397
Detection of Changes in the Serum and Synovial Fluid Levels of Resistin during Flare Ups and Remissions in Primary Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2924
Determinants of Damage in an SLE Cohort: Real World Data
- 9:00AM-11:00AM
-
Abstract Number: 2672
Determinants of Patient- Physician Discordance in Assessment of Global Disease Activity in Latinos with Rheumatoid Arthritis in the United States
- 9:00AM-11:00AM
-
Abstract Number: 2501
Determining the Rate of Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis at Federally Qualified Outpatient Continuity Clinic – a Performance Improvement Project
- 9:00AM-11:00AM
-
Abstract Number: 2445
Development and Usability Testing of an Ipad-Based Psycho-Educational Game for Children with Juvenile Idiopathic Arthritis and Their Parents
- 9:00AM-11:00AM
-
Abstract Number: 2679
Development and Validation of a HAQ-Derived Tool to Detect Muscle Mass Deficits in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2632
Development and Validation of a Questionnaire Assessing the Fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2952
Diagnosis of Primary Neuropsychiatric Systemic Lupus Erythematosus: Attribution Models Versus Physician Judgment
- 9:00AM-11:00AM
-
Abstract Number: 2908
Diagnostic and Screening Accuracy of Spot Urinary Protein-Creatinine Ratio Compared to Protein Content in a 24 Hour-Urine Collection in Systemic Lupus Erythematosus: Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2653
Diagnostic Value of the Prednisolone Test in Patients with Possible Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2929
Diet and Glucocorticoid Treatment in Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 2202
Different Patterns of Positivity for IgG Anti-Cardiolipin, Anti-Beta-2-Glycoprotein I and Anti-Domain I Antibodies within the First Year of Disease in 501 Patients with SLE – Associations with Different Clinical Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 2317
Different Rheumatoid Arthritis Disease Activity Measures Often Provide Discordant Results in Clinical Practice Populations
- 9:00AM-11:00AM
-
Abstract Number: 2646
Different Wording of the Patient Global Assessment Scale Leads to Different Rating of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2949
Differential Serum Cytokine Profile in Patients with Systemic Lupus Erythematosus and Posterior Reversible Encephalopathy Syndrome: A Single-Center Study
- 9:00AM-11:00AM
-
Abstract Number: 2945
Diffuse Alveolar Hemorrhage in SLE: Risk Factors, Response to Therapy, and Survival
- 9:00AM-11:00AM
-
Abstract Number: 2297
Dinamyx Neuromodulation in Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2863
Discontinuation of Anti-TNF Therapy in Patients with Axial Spondyloarthritis. a Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 2689
Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity Are Multifactorial in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2839
Disease Activity and Safety during Long-Term (104-Week) Treatment with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension
- 9:00AM-11:00AM
-
Abstract Number: 2532
Disease Activity in Women with Systemic Lupus Erythematosus during Pregnancy and the First Year Post Partum
- 9:00AM-11:00AM
-
Abstract Number: 2927
Disease Activity Patterns over Time in Patients with SLE – a Retrospective Descriptive Analysis of the Hopkins Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2626
Disease Activity Predicts ABCB1 and ABCG2 Drug-Efflux Transporters Function in Rheumatoid Arthritis (RA) Patients
- 9:00AM-11:00AM
-
Abstract Number: 2935
Disease Evolution in Late Onset and Early Onset Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 2788
DNA Microarray Analysis of Labial Salivary Glands in Patients with Sjögren’s Syndrome: Comparison with IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 2918
Do Patients with Lupus Nephritis Who Achieve Complete Proteinuria Recovery at 2 Years Have Better Long Term Outcomes Compared to Patients with Partial Proteinuria Recovery?
- 9:00AM-11:00AM
-
Abstract Number: 2327
Documentation of Clinical Improvement in Patient with Polymyalgia Rheumatica According to MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data): Longitudinal Analysis from Routine Care
- 9:00AM-11:00AM
-
Abstract Number: 2491
Documentation of Disease Activity Score As Part of a Treat to Target Strategy in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2627
Does 14-3-3 ETA Protein Offer Any Additional Diagnostic Value in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 2478
Does Affect Predict Willingness to Take Medication?
- 9:00AM-11:00AM
-
Abstract Number: 2449
Does Antinuclear Antibodies Predict Remission in JIA ?
- 9:00AM-11:00AM
-
Abstract Number: 2271
Does Arthritis in the Young Adult Life Phase Impact Involvement in Transitional Social Roles?
- 9:00AM-11:00AM
-
Abstract Number: 2518
Does the Cytokine Pattern, Including the IL23 – IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 2206
Dopamine Pathway and Bone Metabolism in Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2777
Drug Retention Rates of Biologic Monotherapies for Patients with Rheumatoid Arthritis Receiving TNF Inhibiting Fusion Protein Agent and Antibody Agent; From Multicenter Registry in Japan
- 9:00AM-11:00AM
-
Abstract Number: 2716
Dysregulated Osteoclastogenesis Is Related to Natural Killer T Cell Dysfunction in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2836
Early Clinical Response Is a Better Predictor of Long-Term Remission Than Baseline Disease Characteristics Following Adalimumab Treatment in Peripheral Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2243
Economic Burden of Controlled Gout, Uncontrolled Gout, and Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
- 9:00AM-11:00AM
-
Abstract Number: 2733
Effect of Abatacept on Telomerase Activity of Lymphocytes of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2668
Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 2579
Effect of Tacrolimus on Endoplasmic Reticulum Stress-Mediated Osteoclastogenesis in a Collagen-Induced Arthritis Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 2919
Effect of Thrombotic Microangiopathy on Clinical Outcomes in LUPUS Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2859
Effect of Weight on Efficacy of Certolizumab Pegol in Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2871
Effectiveness and Safety of Golimumab in the Treatment of Ankylosing Spondylitis over a 12 Month Period
- 9:00AM-11:00AM
-
Abstract Number: 2866
Effectiveness and Safety of Golimumab in the Treatment of Psoriatic Arthritis over a 12 Month Period
- 9:00AM-11:00AM
-
Abstract Number: 2753
Effectiveness and Safety of Tocilizumab in Biologics-Naive RA Patients – Postmarketing Surveillance for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-Naive RA Patients (FIRST Bio) Study
- 9:00AM-11:00AM
-
Abstract Number: 2240
Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate: A Study Using Large Intergrated National Health Network
- 9:00AM-11:00AM
-
Abstract Number: 2288
Effectiveness of Dry Needling and Exercise in Dizziness Caused By Cervical Myofascial Pain Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2237
Effects of Coffee Consumption on Serum Uric Acid. a Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2355
Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet on Serum Uric Acid Levels: A Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2489
Effects of Two Interventions on Rheumatologists Adherence to Optimal Care Recommendations in Rheumatoid Arthritis: A Combined before/after and Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2352
Efficacy and Safety in Patients with Tophaceous Gout Receiving Lesinurad and Febuxostat Combination Therapy: Interim Analysis of an Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 2428
Efficacy and Safety of Adalimumab in Adult Patients with Polyarticular Juvenille Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2363
Efficacy and Safety of Adrenocorticotropic Hormone Gel (Acthar Gel ®) in Refractory Dermatomyositis or Polymyositis
- 9:00AM-11:00AM
-
Abstract Number: 2422
Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis: Results from the Phase 3 Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 2350
Efficacy and Safety of Febuxostat in 55 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Results from a Retrospective Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 2760
Efficacy and Safety of Sarilumab Plus MTX in Subgroups of Patients with Rheumatoid Arthritis in a Phase 3 Study
- 9:00AM-11:00AM
-
Abstract Number: 2742
Efficacy and Safety of Tofacitinib Monotherapy Versus Combination Therapy in a Latin American Subpopulation of Patients with Rheumatoid Arthritis: A Pooled Phase 3 Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2856
Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylarthritis As Well As Peripheral Arthritis: Results from 2 Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
- 9:00AM-11:00AM
-
Abstract Number: 2962
Efficacy of Mycophenolate As a Maintenance Therapy Following the Administration of Cyclophosphamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2770
Efficacy of Sarilumab Plus Methotrexate in Achieving Clinical Remission, Using 4 Different Definitions, in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis in a Phase 3 Study
- 9:00AM-11:00AM
-
Abstract Number: 2660
Elevated 14-3-3η Serum Protein Levels Increase RA Confirmation Rates in Recent-Onset Polyarthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2796
Elevated Serum Immunoglobulin G Is a Prognostic Factor for Progression of Interstitial Lung Disease in Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2721
Elevated Subgingival Levels of Periodontal Pathogens in Rheumatoid Arthritis Patients, Particularly Leptotrichia species in New-Onset Disease
- 9:00AM-11:00AM
-
Abstract Number: 2934
Endothelial Dysfunction in SLE-the Role of Platelets and Type I Interferon
- 9:00AM-11:00AM
-
Abstract Number: 3014
Endotrophin: A Novel Adipokine Linking Adipose Tissue and Skin Fibrosis in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2221
Engaging Learners in Lupus Education with Pivot (Practice Improvement using Virtual Online Training), a Novel, Digital Case-Based Curriculum
- 9:00AM-11:00AM
-
Abstract Number: 2829
Enhanced Expression of the Transcription Factor T-Bet Alters Pro-Inflammatory Cytokine Profile in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2226
Enhancing Medicine Trainees’ Exposure to Common Musculoskeletal Disorders through a Primary Care Musculoskeletal Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2805
Enteric Flora in Newly Diagnosed Spondyloarthritis: A Collaborative Study
- 9:00AM-11:00AM
-
Abstract Number: 2884
Epidemiological Parameters Affecting Therapeutic Response in Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2466
Epigenetic Traits Correlate with Clinical Activity in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2898
Erythrocytes, Acanthocytes, and Proteins in Urine Reflect Lupus Nephritis Histology
- 9:00AM-11:00AM
-
Abstract Number: 3010
Estrogens Inhibit the Profibrotic Effects of Transforming Growth Factor-Beta and Protect from the Development of Experimental Dermal Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 2850
Etanercept Treatment in Psoriatic Arthritis: Need for Co-Medication?
- 9:00AM-11:00AM
-
Abstract Number: 2755
Evaluating Pharmacokinetic Predictors of Tofacitinib Clinical Response in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 3065
Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Takayasu’s Arteritis in Large Healthcare Administrative Databases
- 9:00AM-11:00AM
-
Abstract Number: 2663
Evaluation of Anti-Cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice and Its Association with Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2310
Evaluation of Fibromyalgia Syndrome in Patients Undergoing Peritoneal Dialysis
- 9:00AM-11:00AM
-
Abstract Number: 3050
Evaluation of Olfactory Function in Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2748
Evaluation of Patient-Reported Outcomes By Baseline Disease Duration: 6-Month Data from Two Clinical Trials of Patients with Early Rheumatoid Arthritis Treated with Abatacept
- 9:00AM-11:00AM
-
Abstract Number: 3055
Evaluation of Plasma Pentraxin-3 Level in Patients with Takayasu’s Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2991
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2604
Evaluation of Serum Undercarboxylated Osteocalcin in Premenopausal Rheumatoid Arthritis Patients; Its Correlation with Disease Activity and Bone Mineral Density
- 9:00AM-11:00AM
-
Abstract Number: 2996
Evaluation of Systemic Sclerosis Risk Genes in the Turkish Population
- 9:00AM-11:00AM
-
Abstract Number: 2287
Evaluation of the Fibromyalgia Rapid Screening Tool (FiRST) Questionnaire to Screen Fibromyalgia Associated with Inflammatory Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 2651
Evaluation of the Impact of Disease-Modifying Antirheumatic Drugs on Anti-Cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 2838
Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target?
- 9:00AM-11:00AM
-
Abstract Number: 2453
Evidence-Based Decision Support for Pediatric Rheumatology Reduces Diagnostic Errors, with the Potential to Reduce Capacity Shortage
- 9:00AM-11:00AM
-
Abstract Number: 2936
Evolution of Disease Burden over 7 Years in a Multicentre Inception SLE Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2450
Examination of the Clinical Significance of 14-3-3 Eta in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2973
Exercise Intolerance Evaluated By Invasive Cardiopulmonary Exercise Testing in Connective Tissue Disease: Beyond Pulmonary Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 3001
Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2421
Experience with Adalimumab for Treatment of 568 Juvenile Idiopathic Arthritis Patients in the German JIA Biologics Register
- 9:00AM-11:00AM
-
Abstract Number: 2437
Experience with Tocilizumab for Treatment of 56 Children with Systemic Juvenile Idiopathic Arthritis in the German JIA Biologics Register
- 9:00AM-11:00AM
-
Abstract Number: 2787
Expression of Interferons Lambda in Salivary Glands of Patients with Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2211
Extracellular Vesicles from Cow Milk Accelerate Osteoblast Differentiation into Osteocytes, However, Type I Collagen Synthesis Is Reduced and Bone Matrix Organization Is Impaired
- 9:00AM-11:00AM
-
Abstract Number: 2301
Facing Fibromyalgia; How Patients Describe Their Symptoms Based on a Retrospective Evaluation of a Patient Survey and Vitality Assessment in Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 2925
Factors Associated with Early Damage Accrual in Patients with Systemic Lupus Erythematosus: 12-Month Preliminary Results from the Inception Cohort of the Multicenter Early Lupus Project
- 9:00AM-11:00AM
-
Abstract Number: 2409
Factors Associated with Physical Therapy Use in Osteoarthritis of the Knee: Results from a Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2769
Factors Associated with TNF Switching: a Retrospective Real-World Study of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2640
Factors Influencing Treatment Adjustments in RA Patients – Biologic DMARD Treatment Start and Options
- 9:00AM-11:00AM
-
Abstract Number: 2784
Faecal Levels of Calprotectin Are Increased in Patients with Primary Sjögren’s Syndrome and Correlates with Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2795
Fatigue in Primary Sjögren’s Syndrome: Clinical, Laboratory, Psychometric and Biological Associations
- 9:00AM-11:00AM
-
Abstract Number: 3025
FcγRIIIa-Psyk Signaling up-Regulates TLR3 and TLR5 in Human Naïve CD4+ T-Cells
- 9:00AM-11:00AM
-
Abstract Number: 3024
Fcγriiia Mediated Signal Cause Epigenetic Changes in Human Naive CD4+ T-Cells
- 9:00AM-11:00AM
-
Abstract Number: 2763
Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, Shows Similar Pharmacokinetics and Pharmacodynamics Profiles in Japanese and Caucasian Healthy Volunteers
- 9:00AM-11:00AM
-
Abstract Number: 2597
Fine Specificity of Anti-Citrullinated Peptide Antibodies Is Associated with Left Ventricular Mass Index in Rheumatoid Arthritis Patients without Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 2448
Flare Definitions for Juvenile Idiopathic Arthritis (JIA) Based on ACR Core Set Variables and Patient Reported Outcomes: Results from the Research in Arthritis in Canadian Children-Emphasizing Outcomes Prospective Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2664
Flares Occur Frequently in RA Patients Undergoing Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 3009
Fli1 Deficiency Contributes to the Downregulation of Endothelial Protein C Receptor in Systemic Sclerosis: A Possible Role in Pro-Thrombotic Condition
- 9:00AM-11:00AM
-
Abstract Number: 2698
Follicular Helper T Cells in Peripheral Blood of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2390
Foot Kinematics and Foot Center of Pressure and Their Association with Medial Knee Load Reduction with Use of Flexible Shoes in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2373
Frequency of Antinuclear (ANA), Myositis-Specific (MSA) and Myositis-Associated Antibodies (MAA) in Patients with Idiopathic Inflammatory Myopathies (IIM) from Mexico, Central and South America Centers: Data from the Panlar Myositis Study Group.
- 9:00AM-11:00AM
-
Abstract Number: 3062
Frequency, Presentation and Outcome of Takayasu Arteritis in Western Australia
- 9:00AM-11:00AM
-
Abstract Number: 2556
Functional Genetics of PTPN2 in Rheumatoid Arthritis: Haploinsufficiency of PTPN2 Promotes Severity of CD4+ T-Cell Mediated Autoimmune Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2808
Genetic Variants at Chromosome 5q15 Associated with Immune-Mediated Diseases Influence Gene Expression and Isoform Profile of the Endoplasmic Reticulum Aminopeptidase
- 9:00AM-11:00AM
-
Abstract Number: 2995
Genome Wide Analysis in Scleroderma Renal Crisis: Defining Genetic Risk in Patients with RNA Polymerase III Auto-Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 2696
Geography and Association Between Patient Reported Outcomes and Disease Activity (DAS28) Components in Patients with Rheumatoid Arthritis, Among 17 Countries
- 9:00AM-11:00AM
-
Abstract Number: 2236
Global Prevalence of Hyperuricemia: A Systematic Review of Population-Based Epidemiological Studies
- 9:00AM-11:00AM
-
Abstract Number: 2509
Glucocorticoid Induced Osteoporosis Screening and Treatment: A Gender Comparison in a Cohort of Patients with Underlying Rheumatologic Diagnosis in a Tertiary Care Setting
- 9:00AM-11:00AM
-
Abstract Number: 2766
Glucocorticoid-Sparing Effects of Abatacept in Real Life Practice: Data from a Paneuropean Analysis of RA Registries
- 9:00AM-11:00AM
-
Abstract Number: 7L
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015
- 9:00AM-11:00AM
-
Abstract Number: 2823
Gut Inflammation in HLA-B27 Transgenic Rats Alters the Monocyte Compartment and Its Osteoclastogenic Potential
- 9:00AM-11:00AM
-
Abstract Number: 2675
Has the Relationship Between Disease Activity and Disability in Rheumatoid Arthritis Changed?
- 9:00AM-11:00AM
-
Abstract Number: 2764
Head-to-Head Comparison of the Retention Rate of First Biologics in Elderly Patients with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
- 9:00AM-11:00AM
-
Abstract Number: 2247
Health Care Practices and Care Consumption in a Population Based Cohort of Symptomatic Knee and/or Hip OA Patients
- 9:00AM-11:00AM
-
Abstract Number: 2531
Hematologic Disorder during Pregnancy Associated with Adverse Pregnancy Outcomes Among Women with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2685
High Levels of 25(OH)D Are Associated with Lower Disease Activity in Patients with Newly Diagnosed Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2260
High Prevalence of Hypomagnesemia and Its Relation to BMI, Type 2 Diabetes, and Clinical Disease Measures in a VA Outpatient Rheumatology Clinic Population
- 9:00AM-11:00AM
-
Abstract Number: 2522
High Risk of Flares during Pregnancy in Women with Rheumatoid Arthritis Who Discontinue Treatment with TNF Inhibitors at Conception
- 9:00AM-11:00AM
-
Abstract Number: 2414
High-Intensity Versus Low-Intensity Physical Activity or Exercises in Patients with Hip or Knee Osteoarthritis: A Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2811
Higher Serum Level of Leptin Protects from Radiographic Spinal Progression in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2472
Highly Elevated S100A8/A9 and S100A12 Levels May Distinguish Systemic Juvenile Idiopathic Arthritis Patients with New Onset Disease and Subclinical Macrophage Activation Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2391
Hip Osteoarthritis As the Cause for Knee Osteoarthritis in the Multicenter Osteoarthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 3035
HLA B51 and Possible Associated Autoimmune Disorders Other Than Behcets Disease: A Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2922
HLA-Specific Antibody Profile in Renal Transplant Patients with Systemic LUPUS Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2910
How Accurate Is Spot Urine Protein/Creatinine Ratio in Measuring the Change over Time in Proteinuria Level Compared to the 24 Hour Proteinuria Test?
- 9:00AM-11:00AM
-
Abstract Number: 2948
How Do Patients with Newly Diagnosed SLE Present? a Multicenter Cohort Analysis to Inform the Development of New Classification Criteria for SLE
- 9:00AM-11:00AM
-
Abstract Number: 2335
How Much Does Fatigue Contribute to the Physician and Patient Global Estimates in Different Rheumatic Diseases? Analysis from Routine Care on a Multidimensional Health Assessment Questionnaire (MDHAQ)
- 9:00AM-11:00AM
-
Abstract Number: 3027
Hyperactivated State of Mucosal Associated Invariant T Cells Due to Activation Potency of Monocytes in Systemic Lupus Erythematous
- 9:00AM-11:00AM
-
Abstract Number: 2401
Identification and Characterization of Two Osteoarthritis Phenotypes Applying Two Clinically Tested Biomarkers
- 9:00AM-11:00AM
-
Abstract Number: 2992
Identification of a New Set of Activity Criteria for Systemic Sclerosis. Preliminary Report
- 9:00AM-11:00AM
-
Abstract Number: 2212
Identification of a Novel Chemokine-Dependent Molecular Mechanism Underlying Rheumatoid Arthritis-Associated Autoantibody-Mediated Bone Destruction
- 9:00AM-11:00AM
-
Abstract Number: 15L
Identification of Four-and-a-Half-LIM Domain 1 (FHL1) As a New Autoantibody Target in Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 2278
Identification of Long-Term Physical Activity Trajectories in Individuals with Chronic Widespread Pain Who Received Exercise Treatment As Part of a Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2797
Identification of Serum Biomarker for the Glandular Dysfunction of Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2461
Identification of Target Antigens for Anti-Endothelial Cell Antibodies in Patients with Pediatric Rheumatic Diseases Using Proteomics
- 9:00AM-11:00AM
-
Abstract Number: 2628
Identifying Anxiety and Depression Among Rheumatoid Arthritis Patients Using the Multidimensional Health Assessment Questionnaire
- 9:00AM-11:00AM
-
Abstract Number: 2814
IL-10 May Mitigate Cardiovascular Risk in Psoriatic Arthritis Via an Anti-Atherosclerotic Effect on Cellular Cholesterol Transport
- 9:00AM-11:00AM
-
Abstract Number: 3043
IL-17 Expression By Lymphocytes Is Higher in Behcet’s Disease Compared to Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2813
IL-17 Induces Skin Inflammation Independently of IL-23R+ T Cells and Is Protected By Conditional Deletion of Wdfy3 in Neutrophils
- 9:00AM-11:00AM
-
Abstract Number: 3020
IL-21 Abrogates CD4+CD25+FOXP3+ Treg Differentiation in Part By Suppressing Treg GATA-3 Expression in SLE
- 9:00AM-11:00AM
-
Abstract Number: 2761
IL-6R Blockade with Sarilumab Plus Methotrexate Results in Changes in Clinical and Laboratory Parameters Associated with Chronic Inflammation in Patients with Moderate-to-Severe RA in a Phase 3 Study
- 9:00AM-11:00AM
-
Abstract Number: 2793
IL35 Serum Level Is Decreased in Patients with Primary Sjogren Syndrome, Essentially in Patients with the More Active Disease Data from the French Prospective Assess Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2709
Immediate Release of Peripheral Neutrophil Myeloperoxidase and Elastase and Formation of Extracellular Traps to Cigarette Smoking in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2563
Immune Regulation By Migrating Mesenchymal Stem Cells Ameliorate Inflammatory Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2210
Immunological Dysregulation and Inadequate Hypoxia Adaptation – HIF-Stabilization As Possible Prevention of Fracture Healing Disorders in RA or Immune-Suppressed Patients
- 9:00AM-11:00AM
-
Abstract Number: 2430
Immunological Risk Factors after Rituximab Therapy in Patients with Pediatric Rheumatic Diseases – a Prospective Single-Center Study
- 9:00AM-11:00AM
-
Abstract Number: 2702
Immunophenotyping of Rheumatoid Arthritis Reveals the Linkage Between HLA-DRB1 Genotype, CXCR4 Expressions on Memory CD4+ T Cells, and Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2612
Impact of a Multibiomarker Disease Activity Score in Patients with Rheumatoid Arthritis Treated in a Real World Setting
- 9:00AM-11:00AM
-
Abstract Number: 2339
Impact of Abbvie’s Patient Support Program on Resource Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2343
Impact of Colchicine Use on the Development of Incident Coronary Artery Disease
- 9:00AM-11:00AM
-
Abstract Number: 2500
Impact of Health Portal Enrollment and Electronic Appointment Reminders to Improve Appointment Attendance at an Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2869
Impact of Methotrexate on the Real-World Effectiveness of Golimumab in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2650
Impact of Patient Education on the Satisfaction of Rheumatoid Arthritis Patient : A Randomized Trial of Nurse-Led Vs. Physician-Led Education
- 9:00AM-11:00AM
-
Abstract Number: 2488
Impact of Protocolized Tight Control and Biological Dose Optimization in Daily Clinical Practice: Results of a Pilot Implementation Study
- 9:00AM-11:00AM
-
Abstract Number: 2867
Impact of Timely Versus Delayed Use of Anti-Tumor Necrosis Factor (TNF) Biologics in the Treatment of Psoriatic Arthritis: Results from a Modeling Study
- 9:00AM-11:00AM
-
Abstract Number: 2771
Impact of Tocilizumab Monotherapy in Patients with Moderate to High Disease Activity: Real-World Analyses from the US Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 2756
Impact of Tocilizumab Monotherapy on Patient-Reported Quality of Life Outcomes in the US Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 2279
Impacts on Work: Arthritis Vs Chronic Joint Symptoms without Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2490
Implementation of Disease Activity Measurement for Rheumatoid Arthritis Patients in an Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2502
Implementation of New Pneumococcal Vaccination Recommendations in an Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2492
Implementation of the Clinical Disease Activity Index to Treat to Target Rheumatoid Arthritis in the Ambulatory Setting: A Plan Do Study Act Quality Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2404
Implications of a Positive Patellar Bulge Sign of Knee Joint Effusion in Patients with Osteoarthritis: Association with MRI Signs of Inflammation and with Increased Rate of 5-Year Total Knee Arthroplasty. Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 2583
Important Role of CD11c+ Dendritic Cells in Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2665
Improved Flare/ Remission Pattern in Rheumatoid Arthritis over the Recent Decades
- 9:00AM-11:00AM
-
Abstract Number: 2503
Improved Pneumococcal Vaccination in Rheumatoid Arthritis Patients in an Urban Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2292
Improvement in Function and Pain Due to Subacromial Bursitis As Related to Dose of Triamcinolone Acetonide or Methylprednisolone Acetate
- 9:00AM-11:00AM
-
Abstract Number: 2340
Improvement in Treat to Target Serum Urate Levels: Preliminary Results from a Comparison Between Two Audits of Management
- 9:00AM-11:00AM
-
Abstract Number: 2493
Improvement of Disease Activity and Quality of Care in a Cohort of Rheumatoid Arthritis Patients Treated with Conventional Dmard Therapy Under Treat to Target Recommendations and a Model of Patient-Centered Care
- 9:00AM-11:00AM
-
Abstract Number: 2541
Improving Adherence with Treat to Target in Rheumatoid Arthritis through a Learning Collaborative: Rationale and Design of the Traction Trial
- 9:00AM-11:00AM
-
Abstract Number: 2223
Improving Clinical Decisions for Rheumatoid Arthritis Management Using Online Medical Simulations
- 9:00AM-11:00AM
-
Abstract Number: 2219
Improving Outcomes with a Multimedia Patient Education Tool in Patients with Osteoporosis after 6 Months. a Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2199
in Vivo Ubiquinol Supplementation Reduces the Pro-Atherothrombotic Status in Antiphospholipid Syndrome Patients. Preliminary Results of a Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2259
Incidence of Obesity, Diabetes and High Blood Pressure Associated with Arthritis: Analysis of the Canadian Longitudinal National Population Health Survey
- 9:00AM-11:00AM
-
Abstract Number: 2821
Increased CD4 T Cell GM-CSF Production in Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 3056
Increased Circulating Th17 Cells, Serum IL-17 and Serum IL-23 in Takayasu’s Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2535
Increased Direct Healthcare Costs in SLE Pregnancies
- 9:00AM-11:00AM
-
Abstract Number: 2809
Increased Frequencies of IL-23R Positive T Cells and IL-22 and IL-17 Producing MAIT Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis: Preliminary Results.
- 9:00AM-11:00AM
-
Abstract Number: 2715
Increased Frequency of Dysfunctional Hematopoietic Stem and Progenitor Cell Subpopulations in Treatment Naïve Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2798
Increased Frequency of the PTPN22W* Variant in Primary Sjögren’s Syndrome-Association with Low Type I IFN Scores in Peripheral Blood
- 9:00AM-11:00AM
-
Abstract Number: 3003
Increased Heparanase Expression in Keratinocytes Promotes Dermal Fibrosis in Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 3030
Increased Localization of Spleen Tyrosine Kinase (Syk) in Lipid Rafts of in Vitro TCR/CD3-CD28 Activated Lupus T Cells
- 9:00AM-11:00AM
-
Abstract Number: 2582
Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice
- 9:00AM-11:00AM
-
Abstract Number: 2471
Increased Muscle Interferon-Gamma Expression Levels in Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2822
Increased Peripheral Blood CCR6+/IL-23R+ Gamma Delta T Cells Are Associated with High Disease Activity in Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 3029
Increased Plasticity of Non-Classic Th1 Cells Towards the Th17 Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 2191
Increased Risk of Acute and Chronic Renal Lesions Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2534
Increased Risk of Allergic Conditions in Children Born to Women with SLE
- 9:00AM-11:00AM
-
Abstract Number: 2193
Increased Risk of Hemolytic Anemia Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2182
Increased Risk of Livedo Reticularis Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2192
Increased Risk of Thrombocytopenia Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2274
Increasing Moderate-to-Vigorous Activity and Decreasing Sedentary Time Are Associated with 2-Year Weight Loss in Obese Persons with or at Risk for Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2975
Induced Sputum Analysis in Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2417
Induction and Maintenance of Remission By Etanercept in Enthesitis Related Arthritis JIA-Patients
- 9:00AM-11:00AM
-
Abstract Number: 2318
Inflammatory Arthritis Patient Perspectives on Strategies to Support Medication Adherence: A Qualitative Study Using a Novel Group Exercise
- 9:00AM-11:00AM
-
Abstract Number: 2881
Infliximab in Spondyloarthritis Patients: Utility of Drug Level Monitoring
- 9:00AM-11:00AM
-
Abstract Number: 2657
Influence of Anxiety and Depression on the Swollen to Tender Joint Count Ratio: In Pursuit of a Phenotype of RA Patients with Somatic Complaints in a U.S. Veteran Population
- 9:00AM-11:00AM
-
Abstract Number: 2964
Influences of Various Factors on Survival of Patients Treated with Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Patients with Connective Tissue Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2205
Inhibition of Dickkopf1 Dampens Anti Osteogenic Effect of Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 2554
Inhibition of IL6 Receptor Improves Arthritis and Atherosclerosis in a Mouse Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2974
Insulin Resistance Is Associated with the Digital Ulcer in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2386
Integrating Wearable Physical Activity Monitoring Tools into Rehabilitation Practice for Patients with Arthritis: The Healthcare Professional Perspective
- 9:00AM-11:00AM
-
Abstract Number: 2913
Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation
- 9:00AM-11:00AM
-
Abstract Number: 2467
Interaction Between Senescent T Cells and Fibrocyte-like Cells through CD31, TNFα, and IL-17 Create a Tissue Destructive Environment in the Synovium in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2207
Interleukin-32γ Exhibited Protective Effects on Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 2968
Interrater Reliability of Nailfold Capillaroscopy in Systemic Sclerosis Using Widefield Microscopy
- 9:00AM-11:00AM
-
Abstract Number: 2375
Interstitial Lung Disease in Patients with Anti-PM-Scl Antibody
- 9:00AM-11:00AM
-
Abstract Number: 2895
Intraarticular Sacroiliac Corticosteroid Injections in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2712
Intracellular O-Glc-Nac Alterations in Mononuclear Blood Cell of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 3000
Intrinsic Gene Expression Subset Predicts Improvement in Systemic Sclerosis Patients during Dasatinib (SprycelTM) Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2296
Investigation of Environmental Associations of Fibromyalgia Pain Using Twitter Content Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2553
Involvement of M2 Macrophages in the Pathogenesis of Arthritis in a Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 2862
Is Anti-TNF Tapering Possible in Patients with Axial Spondyloarthritis? a Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 2735
Is Disease Duration an Independent Predictor of Treatment Response Among Patients with Rheumatoid Arthritis Initiating Abatacept?
- 9:00AM-11:00AM
-
Abstract Number: 2676
Is It Useful to Determine All Rheumatoid Factors Isotypes to Enhance Rheumatoid Arthritis Detection? a Clinical Laboratory Perspective
- 9:00AM-11:00AM
-
Abstract Number: 2931
Is Pregnancy a Risk Factor for the Onset of Systemic Lupus Erythematosus (SLE) in Women of the Reproductive Age: A Population Based Case-Control Study?
- 9:00AM-11:00AM
-
Abstract Number: 2266
Is Rheumatic Disease Really More Severe in Indigenous Populations? a Systematic Review of Clinical Outcomes in Indigenous Populations of Canada, the United States, Australia and New Zealand
- 9:00AM-11:00AM
-
Abstract Number: 2816
Is the Gender Difference in As Linked to IL-23?
- 9:00AM-11:00AM
-
Abstract Number: 2295
Is There Peripheral Large Nerve Involvement in Fibromyalgia? a Systematic EMG / Nerve Conduction Study Evaluation of 55 Consecutive FM Patients
- 9:00AM-11:00AM
-
Abstract Number: 2380
Jo-1 Positive Myositis Patients Tend to Have More Severe Muscle and Lung Involvement Than PM-Scl Positive Patients
- 9:00AM-11:00AM
-
Abstract Number: 2248
Knee Pain Burden Is Associated with Decreased Motor Performance: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 2405
Knee Sounds May Predict Osteoarthritis Severity, Symptoms and Function: Pilot Investigation Toward a Novel Dynamic Imaging System
- 9:00AM-11:00AM
-
Abstract Number: 2979
Laser Speckled Imaging and Videomicroscopy Assessment of Sublingual Perfusion in Systemic Sclerosis and Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 2903
Late-Onset Neutropenia Following Rituximab Treatment in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2790
Leflunomide/Hydroxychoroquine Combination Treatment Additively Inhibits T Cell Receptor/Toll-like Receptor 9-Triggered Th1 and Th17 Cytokine Secretion
- 9:00AM-11:00AM
-
Abstract Number: 2353
Lesinurad and Febuxostat Combination Therapy: Analysis of Treatment Based on Patient Baseline Renal Function
- 9:00AM-11:00AM
-
Abstract Number: 2596
Less Musculoskeletal Ultrasound Power Doppler Activity Seen in Obese Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2336
Literature Review of Patient Reported Outcome and Health Related Quality of Life Measures for Biologic Therapies in the Management of Psoriatic Arthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 3041
Long Term Biological Therapy in Uveitis Refractory Due to Behçet’s Disease. Multicenter Study of 165 Patients.
- 9:00AM-11:00AM
-
Abstract Number: 3069
Long Term Follow-up Results of Endovascular Repair in the Management of Arterial Stenosis Caused By Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2195
Long Term Outcome of Primary Antiphospholipid Syndrome Patients: A Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 2840
Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 2843
Long-Term (156-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)
- 9:00AM-11:00AM
-
Abstract Number: 2885
Long-Term Effects of Etanercept on Patient-Reported Outcomes in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Results of a Phase III Study
- 9:00AM-11:00AM
-
Abstract Number: 2427
Long-Term Efficacy and Safety of Mycophenolate Mofetil in Childhood Primary Central Nervous System Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 2835
Long-Term Improvements with Certolizumab Pegol in Joints and Extra-Articular Manifestations of Psoriatic Arthritis in Patients with and without Prior Anti-TNF Exposure
- 9:00AM-11:00AM
-
Abstract Number: 2765
Long-Term Retention Rate of First Biologics in Patients of Age over 75 Years with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
- 9:00AM-11:00AM
-
Abstract Number: 2431
Long-Term Safety of Adalimumab Treatment in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis and Enthesitis-Related Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2759
Long-Term Survival of Biological Therapy in Rheumatoid Arthritis Elderly Patients in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 2854
Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study
- 9:00AM-11:00AM
-
Abstract Number: 2864
Long-Term Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Analysis of 3 Phase 3 Studies
- 9:00AM-11:00AM
-
Abstract Number: 2942
Longitudinal Analyses of Progression of Brain Athrophy in Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2978
Longitudinal Assessment of Gastrointestinal Symptoms in the Prospective Registry of Early Systemic Sclerosis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2524
Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2774
Longterm Outcome of Patients Switched from Iv to Sc Formulation of Abatacept: A Monocentric Study
- 9:00AM-11:00AM
-
Abstract Number: 2203
Loss of Wdfy3 Leads to Enhanced Osteoclastogenesis Via NF-κB Activation
- 9:00AM-11:00AM
-
Abstract Number: 2658
Low Disease Activity Is Associated with Higher HDL and a Trend to Lower Insulin Resistance in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2933
Low Prevalence of PCP in Hospitalized Patients with SLE: Review of a Clinical Database Warehouse
- 9:00AM-11:00AM
-
Abstract Number: 2921
Lupus Nephritis: An Exploration of Management Style
- 9:00AM-11:00AM
-
Abstract Number: 2548
M-CSF-R Is a Critical Determinant for the Differentiation of Classical to Non-Classical Monocytes
- 9:00AM-11:00AM
-
Abstract Number: 2424
Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis Patients Treated with Canakinumab: Results from Phase 3 Trial Program
- 9:00AM-11:00AM
-
Abstract Number: 2208
Macrophage Migration Inhibitory Factor: A Novel Biomarker in Ankylosing Spondylitis That Can Drive Spinal Fusion
- 9:00AM-11:00AM
-
Abstract Number: 2356
Major Cardiovascular Events in Gout Patients with Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating on Allopurinol or Febuxostat (Uloric)
- 9:00AM-11:00AM
-
Abstract Number: 2671
Male Gender and Higher Hemoglobin Predict Response to Methotrexate in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2999
Maternal Microchimerism Is Increased in Multiple Cellular Subsets of Patients with Systemic Sclerosis Compared to Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 2981
Measurement of Tissue Damage in Scleroderma Using Digital Mammographic Xrays: A Proof of Concept Study
- 9:00AM-11:00AM
-
Abstract Number: 2426
Medication Taper and Risk of Relapse in Pediatric Uveitis
- 9:00AM-11:00AM
-
Abstract Number: 2515
MEK5/ERK5, a Lynchpin of Human Cardiac Fibroblast Transdifferentiation to a Scarring Phenotype in Autoimmune Congenital Heart Block
- 9:00AM-11:00AM
-
Abstract Number: 2550
Metabolomic Profiling of Joints in Murine Models of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2865
Methotrexate and Leflunomide Survival in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2618
Methotrexate Dose May Associated with the Frequency of Lymphoproliferative Disorders in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2439
Methotrexate Failure in Pediatric Uveitis
- 9:00AM-11:00AM
-
Abstract Number: 2724
Methotrexate Treatment Could Modulate the Abnormal CD4+T Lymphocyte Subset Distribution in NaÏve Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2998
Microchimerism Is Present in Systemic Sclerosis Lung and Includes CD31-Positive Cells
- 9:00AM-11:00AM
-
Abstract Number: 3044
Microparticles (MPs) Derived from Cell Plasma Membranes Are Increased in Behcet’s Syndrome (BS) and a Low Ratio of Tissue Factor Pathway Inhibitor Positive Mps to Tissue Factor Positive Mps (TFPI/TF) Is Associated with Thrombosis
- 9:00AM-11:00AM
-
Abstract Number: 2398
Microrna Biomarker Signature in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 3067
Microscopic Colitis in Patients with Takayasu Arteritis; A Potential Association Between the Two Disease Entities
- 9:00AM-11:00AM
-
Abstract Number: 2965
Might Troponin be a Marker for Subclinical Scleroderma Heart Involvement (SHI)?
- 9:00AM-11:00AM
-
Abstract Number: 2314
Minimal Important Difference in HAQ: A Validation from Health Economic Perspectives in Patient with Rheumatoid Arthritis Using Real-World Data
- 9:00AM-11:00AM
-
Abstract Number: 2786
miR200b-5p: A Possible Predictor of Lymphoma Development in Sjögren’s Syndrome (SS)?
- 9:00AM-11:00AM
-
Abstract Number: 2298
Misdiagnosis of Fibromyalgia (FM) As Axial Spondylarthritis (SpA): Lessons from Analysis of 26 Cases
- 9:00AM-11:00AM
-
Abstract Number: 2319
Mobile Medical Documentation of Patient-Reported-Outcome
- 9:00AM-11:00AM
-
Abstract Number: 2914
Modifiable and Non-Modifiable Correlates of Satisfaction with Care in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2846
Modifications to Biologic Therapy and Economic Implications in Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2946
Mortality Among SLE Patients in the National Data Bank for Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2899
Mortality Related to Pediatric Systemic Lupus Erythematosus: A Multiple Cause-of-Death Analysis in France
- 9:00AM-11:00AM
-
Abstract Number: 2594
Multi-Biomarker Disease Activity Score As a Predictor of Flare in Patients with Rheumatoid Arthritis Who Stop TNF-Alpha-Inhibitor Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2820
Multi-Omics Studies of Gut Microbiota in Enthesitis-Related Arthritis Identify Diminished Microbial Diversity and Altered Typtophan Metabolism As Potential Factors in Disease Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 2638
Multiple Psychosocial Factors Influence Subjective Assessments of Disease Activity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2699
Muscle Inflammation Relates to Disease Activity and Disability but Not Insulin Resistance in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2967
Musculoskeletal Involvement in SSc Correlates with Poor Short Form 36 and SSc Health Assessment Questionnaire Scores As Well As Lower TNF-Alpha Gene Expression in PBMCs
- 9:00AM-11:00AM
-
Abstract Number: 2691
Musculoskeletal Ultrasound in Multi-Center Rheumatoid Arthritis Clinical Trials: Methodology for Optimizing Reliability of Acquisition and Real-Time Scoring
- 9:00AM-11:00AM
-
Abstract Number: 2985
Mycophenolate Mofetil (MMF) Use in Systemic Sclerosis (SSc) Patients with a Designation of Elevated Systolic Pulmonary Artery Pressure (sPAP): Forced Vital Capacity (FVC), Outcomes and Survival from the European Scleroderma Trials and Research (EUSTAR) Database
- 9:00AM-11:00AM
-
Abstract Number: 2378
Mycophenolate Mofetil As a Steroid Sparing Agent in Polymyositis and Dermatomyositis: a Systematic Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 2368
Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 2710
Necrox-7 Inhibits Cell Aggressiveness By Suppressing of NF-Kappa B Activation and Reactive Oxygen Species Generation in Human Rheumatoid Arthritis Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 2833
Negative Regulator, MiR-23a, Down-Regulated in Psoriatic Arthritis. Implications for Disease Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 2527
Neonatal Outcome to Paternal Exposures with Anti-Rheumatic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2848
Network Meta-Analysis of Tumor Necrosis Factor, Interleukins, and Phosphodiesterase-4 Inhibitor in the Treatment of Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2598
Neutrophil Extracellular Trap Levels Measured By Cell Free Nucleosome ELISA in Serum Are Highly Specific and Sensitive for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2704
Neutrophil-Derived Lactoferrin Regulates the Activity of NFAT5 in Rheumatoid Arthritis Synovial Fibroblasts Via Toll-like Receptor 4
- 9:00AM-11:00AM
-
Abstract Number: 2174
Neutrophils in Primary Antiphospholipid Syndrome Are Characterized By a Prominent Activated Phenotype and Uniquely Remodeled Chromatin Architecture
- 9:00AM-11:00AM
-
Abstract Number: 2229
New Frontiers: Teaching Quality Improvement to First Year Medical Students in a Rheumatology Safety Net Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2547
NIP-565, a Novel JAK1-Selective Inhibitor, for the Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 3058
NMR-Based Metabolomics Provides New Insights into the Inflammatory Processes in Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2686
No Clear Association Between the Presence of Ultrasound Synovitis and Patient Reported Outcomes in Rheumatoid Arthritis Patients in Remission
- 9:00AM-11:00AM
-
Abstract Number: 2499
No More No Shows: Improving the Appointment Reminder System at an Urban County Hospital Outpatient Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2184
Non-Criteria Clinical Manifestations in Antiphospholipid Syndrome: Clinical Behavior and Association with Damage Accrual
- 9:00AM-11:00AM
-
Abstract Number: 2855
Non-Response to Antitnf Treatment in Psoriatic Arthritis Can be Predicted By an Objective Automated Measurement of Fluorescence-Signal Intensities in Fluorescence-Optical Imaging Technique – the First Interims Analysis of the Xplore-Study
- 9:00AM-11:00AM
-
Abstract Number: 2782
Not Only 5 but Also 6 Weeks Intervals of Tocilizumab Infusion Induce Clinical Remission in Patients with Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2792
Not Only Sjögren’s Syndrome. EBV Infection Reactivation As a Risk Factor of the Dryness Symptome Development
- 9:00AM-11:00AM
-
Abstract Number: 2773
Novel Mechanisms of Action for Methotrexate and Doxycycline: Prevention of Protein Adduct Formation and Free Radical Scavenging
- 9:00AM-11:00AM
-
Abstract Number: 2566
Novel Therapeutic Compound Tuftsin-Phosphorylcholine Attenuate Collagen Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2988
Novel Use of Musculoskeletal Ultrasound (MSUS) to Measure Ulcers in the Skin of Systemic Sclerosis (SSc) Patients.
- 9:00AM-11:00AM
-
Abstract Number: 2564
Nuclear Receptor 4A2 Is Selectively Upregulated in the Human TNF-Alpha Transgenic Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2246
Occupations Involving Manual Labor Increase the Risk for Incident Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 3063
Ocular Findings and Ocular Blood Flow Changes in Takayasu Arteritis: A Subclinical Reduction in Blood Flow with a Milder Clinical Course of Retinopathy
- 9:00AM-11:00AM
-
Abstract Number: 2930
Outcome of Patients with Systemic Lupus Erythematous (SLE) after Thrombotic Events
- 9:00AM-11:00AM
-
Abstract Number: 3070
Outcome of Pregnancies in Patients with Takayasu Arteritis with Special Focus on Risk Factors and Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2941
Outcomes in Lupus Nephritis Patients Previously Randomized to Receive Either Low Dose Cyclophosphamide Versus Oral Mycophenolate Mofetil on Azathioprine Maintenance
- 9:00AM-11:00AM
-
Abstract Number: 2510
Outpatient Consultation Requests: A Failure to Communicate
- 9:00AM-11:00AM
-
Abstract Number: 3012
Over-Expression of Ubiquitin-Specific Peptidases in Systemic Sclerosis Fibroblasts Increases Responses to TGF-Beta
- 9:00AM-11:00AM
-
Abstract Number: 2178
Oxidation of beta2-Glycoprotein I (beta2-GPI) Associates with the Presence of Antibodies to Domain I of beta2-GPI in Patients with the Antiphospholipid Syndrome but Is Not Affected By the Antibodies in Vivo in a Rat Model
- 9:00AM-11:00AM
-
Abstract Number: 3018
Paracrine Effect of Proteins Secreted By Normal Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition on the Expression of Genes Associated with Tissue Fibrosis in Normal Human Lung Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 2674
Patient Global Assessment in Evaluating Boolean-Based Remission in Rheumatoid Arthritis-Is It Really Required Instead of Physician Global Assessment? a Comparative Study with Ultrasound
- 9:00AM-11:00AM
-
Abstract Number: 2411
Patient Preference for Using Technology to Track and Self-Manage Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2312
Patient Preferences for Total Knee Replacement Surgery: Two Year Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 2326
Patient Preferences Regarding Route of Biologic Administration in an Inflammatory Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2323
Patient Priorities in Rheumatoid Arthritis (RA) Research: An Exploration of Patient Perspectives from Those Enrolled in an Ontario RA Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2642
Patient Reported Outcome Assessment of Rheumatoid Arthritis Patients Experience with IV Administered Biologic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2613
Patient Reported Physical Capacity Correlates with Phenylalanine Serum Levels in Patients with Early Untreated Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2476
Patient-Reported Cognitive Impairment, Pain, and Depressive Symptoms in Patients with Systemic Lupus Erythematosus and Comorbid Depression
- 9:00AM-11:00AM
-
Abstract Number: 2730
Patient-Reported Outcomes from a Phase 3 Study of Baricitinib in Patients with Rheumatoid Arthritis with Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 3053
Patients Treated for Behcet Syndrome in the US Have Higher Disease Activity Scores at Presentation If They Fulfill ISG Criteria and If They Are Females, However Have Less Severe Disease Overall
- 9:00AM-11:00AM
-
Abstract Number: 2333
Patients’ Prioritization of Patient-Centered Education and Research Topics in Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 2956
Patients’ Reported Perceived Deficits Questionnaire – 5-Item Is Not Valid to Screen for Cognitive Impairment in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 2525
Patterns and Secular Trends in Use of Immunosuppressive Agents during Pregnancy in Women with Rheumatologic Conditions
- 9:00AM-11:00AM
-
Abstract Number: 2959
Patterns of Vascular Brain Injury in Systemic Lupus Erythematosus Patients with Ischemic Stroke: Impact on Neuropsychological, Neurobehavioral and Physical Function Outcome
- 9:00AM-11:00AM
-
Abstract Number: 3073
Patterns of Vascular Involvement in Childhood Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2418
Pediatric Enthesitis-Related Arthritis: Variation in Disease Characteristics and Treatments Among 5 Large Centers
- 9:00AM-11:00AM
-
Abstract Number: 2443
Pediatric Tele-Rheumatology: A Pilot Project to Assess Accuracy of Physical Examination Findings and Diagnostic Concordance at a Distance
- 9:00AM-11:00AM
-
Abstract Number: 2177
Pegylated Recombinant Domain I of Beta-2-Glycoprotein I, a Potential Therapeutic Agent for Antiphospholipid Syndrome, Fully Retains Its Ability to Inhibit Binding of IgG or IgA Antibodies from Patients with APS to Beta-2-Glycoprotein I in Vitro
- 9:00AM-11:00AM
-
Abstract Number: 2321
Performance of Patient Reported Outcomes in the Assessment of Rheumatoid Arthritis Disease Activity: The Experience of the Espoir Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2245
Periarticular Bone Mineral Density Predicts Structural Progression of Knee Osteoarthritis Independently of Static Alignment
- 9:00AM-11:00AM
-
Abstract Number: 2526
Perinatal Patterns of Medication Use in Women with Rheumatoid Arthritis: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2268
Peripheral Joint MRI for Inflammatory Arthritis and the Choosing Wisely Campaign – Evidence for Wide Variations in Use
- 9:00AM-11:00AM
-
Abstract Number: 2669
Persistency of Patient Reported Morning (AM) Stiffness in a Large US Registry Cohort of Rheumatoid Arthritis (RA) Patients Initiating New DMARD Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2731
Persistency of Tocilizumab As Monotherapy or Combination Therapy in Patients with Rheumatoid Arthritis–Real-World Analyses from the US Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 2928
Persistent Disease Activity over Time in a Large Canadian Cohort of Prevalent Lupus Patients
- 9:00AM-11:00AM
-
Abstract Number: 2459
Personal and Environmental Factors Associated with Leisure Participation Among Children and Adolescents with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2416
Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Pediatric Patients from Six to Less Than Eighteen Years of Age with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2873
Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the EULAR Recommendations for the Management of PSA
- 9:00AM-11:00AM
-
Abstract Number: 2697
Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2900
Phospholipase A2 Receptor 1 Antibody in Membranous Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2457
Physical Function and Psychological Well-Being in Teens with Juvenile Idiopathic Arthritis (JIA): Characterization and Exploration of Technology-Assisted Self-Management
- 9:00AM-11:00AM
-
Abstract Number: 2681
Physical Function, Sleep, Depression but Not CRP Level Is Associated with Fatigue in Patients with Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2272
Physical Performance Contributes Only Marginally in Explaining Fatigue Variation in Persons with RA Moderately Affected By Their Disease
- 9:00AM-11:00AM
-
Abstract Number: 3033
Polyarteritis Nodosa and Cutaneous Arteritis: Are They Distinct Diseases?
- 9:00AM-11:00AM
-
Abstract Number: 2300
Polymorphisms of Transient Receptor Potential Vanilloid (TRPV) 2 and TRPV3 Gene Polymorphisms Were Associated with Fibromyalgia in a Korean Population
- 9:00AM-11:00AM
-
Abstract Number: 2659
Poor Correlation Between Vectra DA and DAS28 Scores in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2285
Poor Quality of Sleep Is Associated with Increased Disease Activity and Fatigue in Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 3039
Possible Contribution of HLA-A0207, B5201 and IL-23 Receptor Polymorphism in Ocular Behçet Disease
- 9:00AM-11:00AM
-
Abstract Number: 2381
Postural Stability in Adolescents with Ehlers-Danlos Syndrome (Hypermobility Type) Following an Exercise Intervention
- 9:00AM-11:00AM
-
Abstract Number: 2652
Power Doppler Ultrasound Features in Rheumatoid Arthritis Patients in Clinical Remission: Reclassifying Disease Activity?
- 9:00AM-11:00AM
-
Abstract Number: 2584
Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment
- 9:00AM-11:00AM
-
Abstract Number: 3040
Predictive Factors of Long-Term Clinical Outcome in Patients with Ocular Involvement Secondary to Behcet’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2620
Predictive Value of Anti-Carbamylated Protein Antibodies in Patients with Early Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2395
Predictors of and Longitudinal Factors Associated with Change in Pain, Stiffness and Physical Function over 8 Years in a Midlife Cohort with a Low Prevalence of Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2870
Predictors of Early Minimal Disease Activity in Psa Patients Treated with Anti-TNF in a Real-World Registry
- 9:00AM-11:00AM
-
Abstract Number: 2233
Predictors of Imminent Fracture Risk in Women Aged >=65 Years with Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 2897
Predictors of Organ Damage Progression and Impact on Health-Related Quality of Life in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2847
Predictors of Therapeutic Response in Ankylosing Spondylitis Patients Initiating Therapy with Adalimumab in a German Non-Interventional Study
- 9:00AM-11:00AM
-
Abstract Number: 2521
Pregnancies in Patients with Long-Standing Rheumatoid Arthritis and Biologic DMARD Treatment: Course of Disease during Pregnancy and Pregnancy Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 2519
Pregnancy in Psoriatic Arthritis: A Case Series
- 9:00AM-11:00AM
-
Abstract Number: 2435
Pregnancy Outcomes in Adult Juvenile Idiopathic Arthritis Patients Treated with Biologic Agents
- 9:00AM-11:00AM
-
Abstract Number: 2624
Preliminary Content Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) Short Forms in People Living with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2943
Preliminary Population-Based Incidence and Prevalence Estimates of Systemic Lupus Erythematous from the Manhattan Lupus Surveillance Program
- 9:00AM-11:00AM
-
Abstract Number: 11L
Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2537
Prescription Medication Use in Sweden Among Pregnant Women with Systemic Lupus Erythematosus and General Population Comparators
- 9:00AM-11:00AM
-
Abstract Number: 2944
Presepsin (sCD14 subtype) Concentration Is Elevated and Reflects Disease Activity in Systemic Lupus Erythematous Patients
- 9:00AM-11:00AM
-
Abstract Number: 2265
Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from a National Health Survey
- 9:00AM-11:00AM
-
Abstract Number: 2264
Prevalence and Social Burden of Active Chronic Low Back Pain in the Adult Portuguese Population – Results from a National Survey
- 9:00AM-11:00AM
-
Abstract Number: 2306
Prevalence of Fibromyalgia in Inflammatory Rheumatic Disease. Single-Center Cross-Sectional Study in 691 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2239
Prevalence of Gout and Hyperuricemia and Association with Fat Mass and Fat Free Mass: Results from a Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2637
Prevalence of Unacceptable Pain and the Risk of Fatigue and Sleeping Problems in Early Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2180
Primary Antiphospholipid Syndrome Patients Display Increased Levels of Cell-Bound C4d in Comparison to SLE and Healthy Donors
- 9:00AM-11:00AM
-
Abstract Number: 2970
Primary Care Assessment of Capillaroscopy Abnormalities in Patients with Raynaud’s Phenomenon
- 9:00AM-11:00AM
-
Abstract Number: 2511
Primary Care Management of Patients with Rheumatic Diseases Prior to Rheumatologist Consultation
- 9:00AM-11:00AM
-
Abstract Number: 2517
Primary Sjögren’s Syndrome and Pregnancy: Evolution of Thyroid Function, Xerostomia, Xerophthalmia and Salivary Test for Dental Caries Risk
- 9:00AM-11:00AM
-
Abstract Number: 2559
PRO-Resolving Mediators Issued from Apoptotic CELL Efferocytosis (SUPERMAPO) Modulate Antigen Presenting CELL Properties Toward a Tolerogenic Profile: Efficacy in the Treatment of Collagen- Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2752
Profile of Joint Involvement over Time in Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Anti-TNF in a Real-World Setting
- 9:00AM-11:00AM
-
Abstract Number: 2776
Profiling Compounds in Human Primary Cell-Based Disease Models Guide Indication Selection
- 9:00AM-11:00AM
-
Abstract Number: 2828
Profiling Immunogenic Bacteria within the Microbiota of ZAP-70 Mutant SKG Mice Associated with Spondyloarthritis and Ileitis Using IgA-SEQ
- 9:00AM-11:00AM
-
Abstract Number: 2434
Promis Tools for Measurement of Patient-Reported Outcomes in Children with Juvenile Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2334
Proof of Concept Study of the Arthritis Health Journal: An Online Tool to Promote Self-Monitoring in People with Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 2572
Protective and Therapeutic Effects of Growth Hormone on Collagen-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2520
Psoriatic Arthritis Activity during Pregnancy and the Postpartum� Period
- 9:00AM-11:00AM
-
Abstract Number: 2473
Psycho-Socio-Economic Burdens of Childhood Onset Rheumatic Diseases on Families
- 9:00AM-11:00AM
-
Abstract Number: 2474
Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-Centered Intervention Network Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2545
Psychometric Testing of the Valued Life Activities Questionnaire in People with Rheumatoid Arthritis in the UK: Rasch Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2303
Psychometrics of Online Administration of Fibromyalgia Impact Questionnaire – Revised
- 9:00AM-11:00AM
-
Abstract Number: 2458
Psychostimulant-Induced Vasculopathy: A Retrospective Study in a Pediatric Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2374
Pulmonary Arterial Hypertension in Patients with Anti-PM-Scl Antibody
- 9:00AM-11:00AM
-
Abstract Number: 3005
Pulmonary Arterial Hypertension-Associated Single Nucleotide Polymorphisms of Hypoxia-Inducible Factor-3a Gene Cause Constitutive Activation of the Endothelin-1 Gene Promoter
- 9:00AM-11:00AM
-
Abstract Number: 2966
Pulmonary Involvement in Systemic Sclerosis at Initial Presentation: A Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 2403
Quadriceps Muscle Weakness and the Risk of Knee Cartilage Loss on MRI in a Population-Based Cohort with Knee Pain
- 9:00AM-11:00AM
-
Abstract Number: 2216
Quality Assessment of Websites Providing Educational Content about Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2485
Quality of Evidence of the American College of Rheumatology (ACR) Clinical Practice Guidlines
- 9:00AM-11:00AM
-
Abstract Number: 2893
Quality of Life in Patients with Active Nonradiographic Axial Spondyloarthritis after 16 Weeks of Golimumab Treatment
- 9:00AM-11:00AM
-
Abstract Number: 2325
Quantitative Clues to Recognize and Document Comorbid Fibromyalgia in Routine Care of Patients with Other Rheumatic Diagnoses on a 10 Cm Distress Visual Analog Scale Found on 1-Page Physician Rheumetric Checklist
- 9:00AM-11:00AM
-
Abstract Number: 2213
RA-Associated Autoantibodies Promote Synovial Fibroblasts Migration and Adhesion through a Peptidylarginine Deiminases (PAD) Dependent Pathway
- 9:00AM-11:00AM
-
Abstract Number: 2253
Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes Are Persisting
- 9:00AM-11:00AM
-
Abstract Number: 2971
Raynaud Phenomenon Subjects with Abnormal Capillary Dilations Show a Risk Threshold Diameter Value for the Transition to the Capillaroscopic Early� Scleroderma Pattern: A Case Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2294
Re-Scoring the 2011 Fibromyalgia Survey Criteria to be a Better Surrogate for Pain Centralization
- 9:00AM-11:00AM
-
Abstract Number: 2745
Real World Evaluation of Patients with Rheumatoid Arthritis Initiating Tofacitinib Vs. Adalimumab and Etanercept
- 9:00AM-11:00AM
-
Abstract Number: 2880
Real-World Impact of Anti-TNF Medication Use on Patient Reported Outcomes in a Prospective Cohort of Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2610
Real-World Use of Tocilizumab in Rheumatoid Arthritis Patients: Cardiovascular Risk, Concomitant Treatment, and Outcomes over 6 Months of Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 2346
Rebamipide Suppresses Monosodium Urate Crystal-Induced Interleukin-1b Production through Regulation of Oxidative Stress and Caspase-1 in THP-1 Cells
- 9:00AM-11:00AM
-
Abstract Number: 2703
Reduction in Matrix Metalloproteinase-1 and -2 Secretion from Fibroblast-like Synoviocytes after Induction of Adipogenesis By a Natural Peroxisome Proliferator-Activated Receptor Gamma Ligand, Arterpilin-C
- 9:00AM-11:00AM
-
Abstract Number: 2736
Reduction of Disease Burden on Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in DMARD-Naïve Patients with Active, Severe, Progressive Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2569
Regulation of SIRT1 Maybe a Perfect Strategy in Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2389
Relation of Pronated Foot Posture to Risk of Worsening Knee Pain during Gait and Compartment-Specific Knee Cartilage Damage
- 9:00AM-11:00AM
-
Abstract Number: 2305
Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 2780
Relationship Between Immunogenicity, Hypersensitivity Reactions and Skin Tests Against Infliximab, Etanercept and Adalimumab in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2883
Relationship Between Improvements in Fatigue and Signs & Symptoms of Active Psoriatic: Arthritis a Sub-Analysis of a Phase 3 Study with Secukinumab
- 9:00AM-11:00AM
-
Abstract Number: 2593
Relationship Between Index of Activity Speed (Time Up and Go test) and Patient-Reported Outcome in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
- 9:00AM-11:00AM
-
Abstract Number: 2307
Relationship of Sleep Quality and Fibromyalgia Outcomes in a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of Bedtime, Rapidly Absorbed, Sublingual Cyclobenzaprine (TNX-102 SL)
- 9:00AM-11:00AM
-
Abstract Number: 2868
Relative Efficacy of Adalimumab Versus Secukinumab in Active Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
- 9:00AM-11:00AM
-
Abstract Number: 2961
Reliability and Validity of the Total Joint Count and Swollen Joint Count in Early Diffuse Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2410
Report from the International Consortium of Health Outcome Measurement Hip and Knee Osteoarthritis Working Group: Consensus on an International Standard Set of Outcomes Measures for Patients with Hip or Knee Osteoarthritis.
- 9:00AM-11:00AM
-
Abstract Number: 2544
Representing the Variability in Patients’ Preferences
- 9:00AM-11:00AM
-
Abstract Number: 2227
Resident’s Guide to Pediatric Rheumatology Mobile App: Assessing Enablers and Barriers of Use through Qualitative Focus Groups
- 9:00AM-11:00AM
-
Abstract Number: 2308
Responder Compared to Mean Change Analyses in a Fibromyalgia Phase 2b Clinical Study of Bedtime Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL)
- 9:00AM-11:00AM
-
Abstract Number: 2313
Responder Rates and Numbers Needed to Treat Based on Clinically Meaningful Improvements in Patient Reported Outcomes (PROs) Including Health-Related Quality of Life (HRQoL) after Sarilumab Treatment during a Phase III Randomized Controlled Trial (RCT)
- 9:00AM-11:00AM
-
Abstract Number: 2574
Rheumatoid Arthritis Leads to Altered Gene Expression in the Brain and Behavioral Changes in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2630
Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 2592
Rheumatoid Arthritis Patients with Many Autoantibodies Have Different Characteristics at Presentation Compared to Patients with Few Autoantibodies
- 9:00AM-11:00AM
-
Abstract Number: 2486
Rheumatoid Arthritis Quality Measures – Automated Display of Care Gaps and Capture of Physician Decision Making at the Clinic Visit
- 9:00AM-11:00AM
-
Abstract Number: 2714
Rheumatoid Arthritis Synovial Fibroblast Potentiates Mast Cell Degranulation and Migration Independent of Cell-to-Cell Contact
- 9:00AM-11:00AM
-
Abstract Number: 2269
Rheumatologists Consider Patient Preferences and Costs When Choosing Treatments for Rheumatoid Arthritis (RA) Patients. a Cross-European Discrete Choice Experiment
- 9:00AM-11:00AM
-
Abstract Number: 2631
Rheumatologists More Likely to Perform Tobacco Cessation Counselling in Uncontrolled Rheumatoid Arthritis Visits
- 9:00AM-11:00AM
-
Abstract Number: 2267
Rheumatology Work Force Planning in Western Countries – a Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 2249
Risk and Risk Perception of Knee Osteoarthritis in the US: Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2197
Risk Factors for Adverse Pregnancy Outcome in First-Line Treated Pregnancies in Antiphospholip Antibodies-Positive Women According to Different Treatment Protocols: A Single Center Experience over 30 Years
- 9:00AM-11:00AM
-
Abstract Number: 2940
Risk Factors for Late-Onset Thrombosis in Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 2244
Risk of Incident Atrial Fibrillation in Gout
- 9:00AM-11:00AM
-
Abstract Number: 2367
Risk of Malignancy in Dermatomyositis with Anti-CADM-140/ Melanoma Differentiation- Associated Gene 5 Autoantibody
- 9:00AM-11:00AM
-
Abstract Number: 2232
Risk of Osteoporotic Fractures with Use of Cyclooxygenase-2 Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 2362
Rituximab in the Treatment of Jo-1 Antibody-Associated Antisynthetase Syndrome: Anti-Ro52 Positivity As a Marker for Severity and Treatment Response
- 9:00AM-11:00AM
-
Abstract Number: 3032
Role of Adenosine and Neutrophils in Inflammation Associated with Mutations in CECR1 Gene
- 9:00AM-11:00AM
-
Abstract Number: 3008
Role of PTP4A1 Tyrosine Phosphatase in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2819
Rorc Antagonism Inhibits IL-23-Dependent Aberrant Bone Formation in Vivo
- 9:00AM-11:00AM
-
Abstract Number: 14L
Safety and Efficacy of ABT-494, a Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Anti-TNF Biologic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 13L
Safety and Efficacy of E6011, an Anti-Fractalkine Monoclonal Antibody, in a First-in-Patient Phase 1/2 Study in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2419
Safety and Efficacy of Etanercept in 2000 Patients with Juvenile Idiopathic Arthritis (JIA) in the JIA Biologics Register
- 9:00AM-11:00AM
-
Abstract Number: 2887
Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 2311
Safety of Pregabalin for Treatment of Fibromyalgia Is Comparable Between Subjects with Moderate or Severe Baseline Widespread Pain
- 9:00AM-11:00AM
-
Abstract Number: 2425
Safety of Tocilizumab in Young Adults with Juvenile Idiopathic Arthritis (JIA)
- 9:00AM-11:00AM
-
Abstract Number: 2754
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of BI 655064, an Antagonistic Anti-CD40 Antibody Following Single-Dose Administration in Chinese and Japanese Healthy Volunteers
- 9:00AM-11:00AM
-
Abstract Number: 2762
Sarilumab Dose Reduction to Manage Laboratory Abnormalities in an Open-Label Extension Study in RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 2497
Satisfaction with the Initial Evaluation for a Rheumatologic Complaint Using Telemedicine
- 9:00AM-11:00AM
-
Abstract Number: 2984
Scleroderma Bronchoalveolar Lavage Fluid Thrombin Activity: Correlation with Pulmonary Function
- 9:00AM-11:00AM
-
Abstract Number: 3004
Scleroderma Keratinocytes Promote Fibroblast Activation Independent of TGF-ß
- 9:00AM-11:00AM
-
Abstract Number: 2451
Scoring Medication Requirements and Side-Effects in Juvenile Idiopathic Arthritis: Perspectives of Patients, Parents and Clinicians
- 9:00AM-11:00AM
-
Abstract Number: 2625
SDAI 50 Is More Stringent Than the EULAR Response Measure and a Better Predictor of Low Disease State/Remission in Early Rheumatoid Arthritis: Results from an Early Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2757
Secondary Efficacy Endpoints: Results from a Phase 3 Study Comparing ABP 501 with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2853
Secukinumab Improves Skin Symptoms and Physical Functioning Compared with Ustekinumab in Patients with Moderate to Severe Psoriasis with Concomitant Psoriatic Arthritis: Subanalysis of a Randomized, Double Blind, Parallel-Group, Active Comparator-Controlled Phase 3b Trial
- 9:00AM-11:00AM
-
Abstract Number: 2890
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis in Anti-TNF-Naïve Patients and Those Previously Exposed to Anti-TNF Therapy: 52-Week Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
- 9:00AM-11:00AM
-
Abstract Number: 2896
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 2-Year Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2844
Secukinumab Reduces the Burden of Nail and Skin Disease in Patients with Psoriasis and Patients with Psoriatic Arthritis: Results from Two Phase 3 Studies
- 9:00AM-11:00AM
-
Abstract Number: 2886
Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis and Psoriasis: Results from a Pooled Safety Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2725
Secular Trends in Use of Disease Modifying Anti-Rheumatic Drugs for the Treatment of Rheumatoid Arthritis in the United States
- 9:00AM-11:00AM
-
Abstract Number: 2585
Serum 14-3-3η Is an RA Specific Mechanistic Marker
- 9:00AM-11:00AM
-
Abstract Number: 2441
Serum 14-3-3η Is Present in JIA and Is Not Associated with RF+ Polyarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2617
Serum 14-3-3eta Protein Elevation in Osteoarthritis Suggests Misclassification or Concurrent Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2954
Serum and CSF Biomarkers of Neuropsychiatric Involvement in Primary Sjogren Syndrome and Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 3037
Serum Anti-Lysozyme Is Associated with Disease Activity of Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2993
Serum CXCL4 Increase in Patients with Undifferentiated Connective Tissue Disease at Risk for Systemic Sclerosis Is Associated with Anti-Scl70 Antibodies and ICAM-1, a Marker of Endothelial Activation
- 9:00AM-11:00AM
-
Abstract Number: 3038
Serum CXCL8, 10 and 12 Are Increased in Patients with Behcet’s Disease and CXCL10 Levels Are Correlated with Number of Erythema Nodosum
- 9:00AM-11:00AM
-
Abstract Number: 2606
Serum Myeloid Related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate in DMARD Naïve Patients
- 9:00AM-11:00AM
-
Abstract Number: 2622
Serum RANKL Levels, Associate with Anti Citrullinated Proteins Antibodies (ACPA) in Early-Untreated Rheumatoid Arthritis and Is Modulated Following Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 2680
Severity of Morning Stiffness Is Associated More Strongly with Disease Activity in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2235
Shocking? a Systematic Review of Adrenal Insufficiency in Adults on Oral Steroids
- 9:00AM-11:00AM
-
Abstract Number: 2179
Signaling By Mammalian Target of Rapamycin (mTORC) Highlight Pathological IgG and IgA in SLE Patients with Secondary APS
- 9:00AM-11:00AM
-
Abstract Number: 2600
Signs of Immune Activation and Local Inflammation Are Present in the Bronchial Tissue of Patients with Untreated Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2614
Single Academic Center Experience with 14-3-3 Eta in the Evaluation of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2470
Single Center Experience in Next Generation Sequencing for Genetic Diagnosis of Autoinflammatory Disorders
- 9:00AM-11:00AM
-
Abstract Number: 2315
Six-Month Effects of a Multimedia Patient Education Tool in Patients with Rheumatoid Arthritis. a Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2185
Small but Clinically Insignificant Decreases in Antiphospholipid Antibody Titers Occur in aPL-Positive Patients during Pregnancy
- 9:00AM-11:00AM
-
Abstract Number: 2254
Socio-Economically Deprived Patients Have a Higher Likelihood for Having Any Type of Rheumatic and Musculoskeletal Diseases and Have Higher Healthcare Costs – Results from a Population-Based Administrative Database Including 1.9 Million Persons (Basque country, Spain)
- 9:00AM-11:00AM
-
Abstract Number: 2688
Socioeconomic Status, Ethnicity/Race, and Autoantibody Status in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2960
Sodium Thiosulfate in Calcinosis
- 9:00AM-11:00AM
-
Abstract Number: 2463
Soluble Low-Density Lipoprotein Receptor-Related Protein 1 in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2567
SPACIA1/SAAL1-Deficient Mice Show Reduced Disease Progression in Collagen-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2892
Statin Treatment in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2717
Stf-083010, the Inhibitor of ER Stress Transducer IRE1, Suppresses Rheumatoid Synovitis
- 9:00AM-11:00AM
-
Abstract Number: 2826
Stimulation of Autophagy Reduces Misfolded HLA-B27 in a Rat Model of Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2209
Stimulation of the Adenosine A2A Receptor (A2AR) Regulates the Expression of Netrin-1 (Ntn1) and Its Receptors (Unc5b, DCC) and Inhibits Wear Particle-Induced Inflammatory Osteolysis in a Model of Joint Prosthesis Loosening
- 9:00AM-11:00AM
-
Abstract Number: 2747
Study Completion and Etanercept Retention in Patients with Rheumatoid Arthritis Treated with Etanercept Monotherapy Versus Etanercept and Methotrexate Combination Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2616
Study of Anti-Carbamylated Protein Antibody in the Rheumatoid Patients Who Were Clinically Active and Under Treatment with Biological Dmards
- 9:00AM-11:00AM
-
Abstract Number: 2514
Subclinical Reduced Ovarian Reserve in Adult Polymiositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2837
Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2739
Survival of Etanercept (ETN) Responders after Methotrexate (MTX) Failure When ETN Is Initiated As Mono or Combination Therapy or after MTX Withdrawal from ETN/MTX Combination in Long Standing Rheumatoid Arthritis (RA). a Single Center Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 2588
Survivin Links Smoking and High Prevalence of Rheumatoid Arthritis in Women
- 9:00AM-11:00AM
-
Abstract Number: 2506
Sustained Improvement in Teratogenic Risk Education in a Pediatric Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2446
Synovial Fluid Proteins Differentiate Patients with Oligoarticular Juvenile Idiopathic Arthritis Who Are Destined to Extend from Those Who Will Remain Persistent in Course
- 9:00AM-11:00AM
-
Abstract Number: 2830
Synovial Fluid T Cells of Patients with Reactive Arthritis and Undifferentiated Spondyloarthropathy Respond to Salmonella Typhimurium Outer Membrane Protein a and Induces IL17 and IL23 Production By Synovial Fluid Mononuclear Cells
- 9:00AM-11:00AM
-
Abstract Number: 2803
Systemic Interferon Type I and Type II Signatures Present in Distinct Subsets of Primary Sjögren’s Syndrome: En Route Towards More Selective Targeting
- 9:00AM-11:00AM
-
Abstract Number: 2986
Systemic Sclerosis Patients on Intensive Care Unit – Reasons for Admission and Determinants of Outcome
- 9:00AM-11:00AM
-
Abstract Number: 2224
Tailored, Online Education on Comparative Effectiveness Studies in Rheumatoid Arthritis: Success in Improving Knowledge and Clinical Decisions
- 9:00AM-11:00AM
-
Abstract Number: 3071
Takayasu’s Arteritis and Pregnancy
- 9:00AM-11:00AM
-
Abstract Number: 3054
Takayasu’s Arteritis Associated with Behçet’s Syndrome: A Case Series of 8 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2204
Tankyrase Regulates Osteoclastogenesis Via SH3BP2 Expression
- 9:00AM-11:00AM
-
Abstract Number: 2454
Target and Targetoid Reactions at Bacillus Calmettee-Guérin Inoculation Site Revealed By Dermatoscopy Correlate with Systemic Involvements in Patients with Kawasaki Disease
- 9:00AM-11:00AM
-
Abstract Number: 2677
Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2546
Targeting Synovial Fibroblasts By the Intra-Articular Delivery of microRNA-140-3p and -5p Ameliorates Experimental Autoimmune Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2561
TAS5315, a Novel Bruton’s Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2222
Teaching Rheumatology in Undergraduate Medical Education: What Are the Students Saying?
- 9:00AM-11:00AM
-
Abstract Number: 2230
Teaching the Teachers: Report of an Effective Mixed-Method Course Training Clinical Educators to Provide Instruction in Musculoskeletal Care to Other Providers and Learners in Primary Care
- 9:00AM-11:00AM
-
Abstract Number: 2495
Tele-Monitoring of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2496
Telerheumatology: A Technology Not Appropriate for All
- 9:00AM-11:00AM
-
Abstract Number: 2649
Test-Retest Reliability of the 5-Item Compliance Questionnaire Rheumatology and Factors Influencing Its Assessment of Adherence in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2695
Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2608
The “Rheumatoid Arthritis Impact of Disease”� Score Correlates with Other Patient Reported Outcomes and with Disease Activity Scores in Patients with RA and Its Patient Acceptable Symptom State Is More Stringent Than DAS28-Remission
- 9:00AM-11:00AM
-
Abstract Number: 2406
The 2011 Fibromyalgia (FM) Criteria Are Helpful in Identifying Central Sensitization in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2290
The 2011 Fibromyalgia (FM) Survey Criteria Are a Surrogate Measure of Pain Centralization
- 9:00AM-11:00AM
-
Abstract Number: 2857
The 8-Year Retention Rate of the First TNF-Inhibitor in the Treatment of Spondyloarthropathies: Real-Life Data from Three Local Registries
- 9:00AM-11:00AM
-
Abstract Number: 2176
The Ability of Recombinant Domain I of Beta-2-Glycoprotein I to Inhibit Lupus Anticoagulant Effect of IgG from Patients with APS Is Enhanced By Pegylation
- 9:00AM-11:00AM
-
Abstract Number: 2396
The Absence of Symptom in Subjects with Advanced Knee OA
- 9:00AM-11:00AM
-
Abstract Number: 3021
The Adaptor Protein Crkii Regulates Rap1 Activation in the Immunological Synapse
- 9:00AM-11:00AM
-
Abstract Number: 2366
The Anti-MDA5 Autoantibody Phenotype: Defining Clinical, Biochemical and Radiological Features Suggestive of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 3060
The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center
- 9:00AM-11:00AM
-
Abstract Number: 3036
The Association Between Behcet’s Disease, Myelodysplastic Syndrome and Trisomy 8
- 9:00AM-11:00AM
-
Abstract Number: 2479
The Association Between Social Networks, Disease Activity, and Pain in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2276
The Association of Knee Pain and Knee Osteoarthritis with Incident Widespread Pain: The Multicenter Osteoarthritis (MOST) Study
- 9:00AM-11:00AM
-
Abstract Number: 2275
The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups
- 9:00AM-11:00AM
-
Abstract Number: 3019
The CD4+CD52low T Cell Contributes to Disease Activity and Autoantybody Production in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2371
The Clinical Features of Recurrent Interstitial Lung Disease in Dermatomyositis Patients with Anti- Melanoma Differentiation-Associated Gene 5 Antibody
- 9:00AM-11:00AM
-
Abstract Number: 2384
The Comparative Efficacy of Dry Needling, Kinesio Taping and Physical Therapy in Patients with Myofascial Pain Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2328
The Correlation of Childhood Health Assessment Questionnaire with Disease Activity in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2732
The Effect of Adrenocorticotropin Gel (HP Acthar Gel) in Combination with MTX in Newly Diagnosed RA Patients from a Clinical and Structural Perspective
- 9:00AM-11:00AM
-
Abstract Number: 2387
The Effect of Arthroscopic Partial Meniscectomy in Patients with Osteoarthritis on Meniscal Body Extrusion
- 9:00AM-11:00AM
-
Abstract Number: 2599
The Effect of Daily Low Dose Prednisone (divided daily versus single daily dose) in the Treatment of African Americans (AA) with Early Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 2575
The Effect of mPGES-1 Deletion on Platelet Function in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2726
The Effect of Prior Disease Duration and Prior DMARD Use on Treatment Outcomes in Patients with Early or Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2273
The Effect of Widespread Pain on Incident Knee Pain and Knee Osteoarthritis: The Multicenter Osteoarthritis (MOST) Study
- 9:00AM-11:00AM
-
Abstract Number: 2360
The Effectiveness of Tacrolimus in Patients with Interstitial Lung Disease Secondary to Autoimmune Disease
- 9:00AM-11:00AM
-
Abstract Number: 2923
The Effects of Disease Activity and Mood Disorders on Cognitive Function in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2690
The Effects of Disease of the Joints on Modified Health Assessment Questionnaire Scores in Rheumatoid Arthritis Patients: A Retrospective Study Using the National Database of Rheumatic Diseases By Ir-Net in Japan
- 9:00AM-11:00AM
-
Abstract Number: 3026
The Effects of Lrg on the Differentiation of Naïve T Cells
- 9:00AM-11:00AM
-
Abstract Number: 2349
The Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients with Severe Renal Impairment
- 9:00AM-11:00AM
-
Abstract Number: 2953
The Emergency Room and SLE: What Characteristics Are Associated with Increased Emergency Room Utilization in Lupus Patients?
- 9:00AM-11:00AM
-
Abstract Number: 2291
The Factors That Might be Responsible for the Improvement of Fibromyalgia Patients: A Sub-Group That Improved Significantly over Three to Six Months
- 9:00AM-11:00AM
-
Abstract Number: 2442
The Family Journey to Diagnosis with Systemic Juvenile Idiopathic Arthritis As Evidenced through Changing Social Media Presence
- 9:00AM-11:00AM
-
Abstract Number: 2994
The Global Microrna Profile of Systemic Sclerosis Whole Skin/Dermal Fibroblasts and the Role of the Xq26.3 miRNA Cluster As a TGF-b Pathway Positive Feedback Mechanism
- 9:00AM-11:00AM
-
Abstract Number: 2804
The Global miRNA Whole Blood Profile of Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 3011
The Homeoprotein Engrailed-1 Regulates Canonical TGF Beta Signaling in Experimental Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2480
The Impact of Emotional Trade-Off Difficulty on Choice
- 9:00AM-11:00AM
-
Abstract Number: 2302
The Impact of Prior Fibromyalgia Treatment on the Response to Pregabalin in Fibromyalgia Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 2939
The Impact of Tabalumab on the Kidney in Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 2654
The Influence of Patient Reported Morning Stiffness on Patient Global Assessment in Rheumatoid Arthritis Patients Not Achieving ACR/EULAR Boolean Remission in a Large US Registry
- 9:00AM-11:00AM
-
Abstract Number: 2562
The Inhibition of Wnt/Beta-Catenin Signaling Pathway Via Paricalcitol and Pyrvinium Ameliorates Experimental Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2902
The Initial Presentation of Cerebrovascular Disease Attributed to Lupus Is Most Frequent Early in the Disease Course: Results from an International, Inception Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2447
The Juvenile Arthritis Disease Activity Score Remains the Disease Activity Marker of Choice for Adults with Polyarticular Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2711
The Lung Microbiome in Rheumatoid Arthritis and Associated Local/Systemic Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 2469
The Lymphocyte Repertoire in Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2894
The Majority of Patients with Moderate to Severe Psoriatic Arthritis Had Existing Structural Damage, Predisposing Them to Further Progression, Which Was Markedly Inhibited By Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 2609
The Measurement of the Skin Autofluorescence As an Indicator of Disease Progression in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2560
The Mer Tyrosine Kinase Receptor Plays a Protective Role in Joint Inflammation By Mediating Efferocytosis
- 9:00AM-11:00AM
-
Abstract Number: 2817
The Microbiome of Reactive Arthritis in a Guatemalan Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2629
The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire
- 9:00AM-11:00AM
-
Abstract Number: 2601
The Multi-Biomarker Disease Activity Score in a TNF Inhibitor Tapering Study in Rheumatoid Arthritis Patients: Predictive Value for Successful Tapering, Flaring and Radiographic Progression
- 9:00AM-11:00AM
-
Abstract Number: 2542
The Multidimensional Assessment of Fatigue Scale: A 25-Year Review and Evaluation
- 9:00AM-11:00AM
-
Abstract Number: 2907
The Natural History of Thrombotic Events in Systemic Lupus Erythematosus and Associated Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 2568
The Osteoimmunological Mechanistic Basis of Low-Dose Radiotherapy in TNF Driven Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2692
The Patients Evaluation of Pain and Disease Activity As Well As Improvement during One-Year Follow-up on Etanercept Treatment Is Highly Associated to Subjective Factors and Not to Objective Assessments Including Ultrasound
- 9:00AM-11:00AM
-
Abstract Number: 2281
The Prediction of Fatigue in Early Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2810
The Presence of HLA-B27 Increases Severity of Arthritis but Does Not Appear to Influence New Bone Formation in Different in Vitro and in Vivo Models
- 9:00AM-11:00AM
-
Abstract Number: 2432
The Preventive Effect of Methotrexate on Uveitis Onset in JIA Depends on Uveitis Risk Factors
- 9:00AM-11:00AM
-
Abstract Number: 2408
The Quality of Community-Based Osteoarthritis Care Can be Improved. Results from a Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 3002
The Regulatory Role of Gammadelta T Cells in Bleomycin-Induced Pulmonary Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 2644
The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2250
The Relationship Between Sex and Incident Knee Osteoarthritis Is Mediated By Shape
- 9:00AM-11:00AM
-
Abstract Number: 2186
The Role of Hydroxychloroquine Treatment on Pregnancy Outcome in Women with Antiphospholipid Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 2558
The Role of Leukocyte Associated Immunoglobulin-like Receptor-1 (LAIR-1) in Collagen-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2536
The Role of Race/Ethnicity and SES in Adverse Pregnancy Outcome in SLE and Apl
- 9:00AM-11:00AM
-
Abstract Number: 2354
The Safety and Efficacy of Lower Serum Urate Levels: A Pooled Analysis of Gout Subjects Receiving Lesinurad and Xanthine Oxidase Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 2330
The Turkish Validity and Reliability of the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL)
- 9:00AM-11:00AM
-
Abstract Number: 2320
The Use of Doppler Ultrasound in Patients with Rheumatoid Arthritis Improves Patient Understanding of Disease and Adherence to Treatment and Alters Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 2915
The Utility of Lupus Serology in Predicting Outcomes of Renal Transplantation in Lupus Patients: Systematic Review and Analysis of a Large Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2539
The Validity and Reliability of Turkish Version of the Jenkins Sleep Scale in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2215
Ticagrelor Regulates Osteoblast and Osteoclast Function and Promotes Bone Formation in Vivo By Increasing Adenosine Levels
- 9:00AM-11:00AM
-
Abstract Number: 2920
Time to Recovery of Individual Lupus Manifestations on Standard of Care Treatment
- 9:00AM-11:00AM
-
Abstract Number: 2372
Timing of Onset and Cluster with Other Manifestations Influence the Spectrum of Arthritis in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International, Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 2581
TNF-Alpha Receptor II Signaling Plays an Important Role in Maintaining the Expression of Forkhead Box P3 in Murine Regulatory T Cells
- 9:00AM-11:00AM
-
Abstract Number: 3061
Tocilizumab in Refractory Takayasu Arteritis. a Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 3042
Tocilizumab in Refractory Uveitis Associated with Behçet’s Disease. Multicenter Study of 7 Patients.
- 9:00AM-11:00AM
-
Abstract Number: 2750
Tocilizumab Is Effective As 1st, 2nd and 3rd-Line Biologic DMARD in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2801
Tofacitinib Suppresses Lymphocytic Infiltration in the Salivary Gland of Non-Obese Diabetic Mice; The Animal Model of Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2639
Towards Patient-Centeredness of the Treat-to-Target Paradigm: Development of a Framework for Evaluation of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance
- 9:00AM-11:00AM
-
Abstract Number: 2700
Trabecular Thinning in Metacarpophalangeal Joints of Anticitrullinated Peptide Antibody Positive Patients with Arthralgia
- 9:00AM-11:00AM
-
Abstract Number: 2719
Track Along: Monocytes Follow Fibroblast-like Synoviocyte Network for Movement and Rest within the Synovial Tissue
- 9:00AM-11:00AM
-
Abstract Number: 2666
Trajectories of EQ-5D in RA Patients Treated with Biologics Using the IORRA Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2807
Transcriptome Profiling of Synovium from Patients with Psoriatic Arthritis or Osteoarthritis Using RNA Sequencing Provides Insights into Disease Mechanisms Involved in Heterotopic Ossification with Potential Therapeutic Implications
- 9:00AM-11:00AM
-
Abstract Number: 2878
Treating Axial Spondyloarthritis to Target: Influence of the Population Characteristics and Comorbidities in Reaching Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Tnfalpha Inhibitors Agents
- 9:00AM-11:00AM
-
Abstract Number: 2241
Treating to Target in Gout: The Epidemiology of Serum Urate Measurement Among Patients with Incident Gout in Usual Care Settings in the United States
- 9:00AM-11:00AM
-
Abstract Number: 2341
Treatment of Gout with Pharmacological Vs. Non-Pharmacological Complementary Therapy in the U.S.: An Internet Survey
- 9:00AM-11:00AM
-
Abstract Number: 2576
Treatment of Inflammatory Arthritis with a Hybrid Compound, LLP2A-Ale, Can Prevent Joint Destruction
- 9:00AM-11:00AM
-
Abstract Number: 2937
Treatment Patterns Differ Based on Age of Systemic Lupus Erythematosus Onset: A Comparison of Azathioprine and Mycophenolate on the Prevention of Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2861
Treatment Patterns of Subcutaneous Biologic Agent Use Among Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2743
Treatment Target Status at 6 Months and Long-Term Outcomes at 5 Years: Analysis of Methotrexate-Naïve Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2768
Trend and Factors Associated with Switching Treatment after Initial Anti-TNF Therapy Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2791
TREX-1 Variants in Sjögren’s Syndrome Related Lymphomagenesis
- 9:00AM-11:00AM
-
Abstract Number: 2201
Triple Positivity of Antiphospholipid Antibody As the Main Thrombotic Factor in a Long-Term Follow-up Study of 98 Asymptomatic Apl-Positive Carriers
- 9:00AM-11:00AM
-
Abstract Number: 2911
Tubulointerstitial Involvement in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2842
Tumor Necrosis Factor Alpha Inhibition in Ankylosing Spondylitis and Non Radiographic Axial Spondyloarthritis: Treatment Response, Drug Survival and Patient Outcome
- 9:00AM-11:00AM
-
Abstract Number: 2225
Twitter and Rheumatology: Significant and Incremental Growth in Usage
- 9:00AM-11:00AM
-
Abstract Number: 2872
Two-Year Clinical Response to Brodalumab, an Anti-Interleukin-17 Receptor Antibody, in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2874
Two-Years Survival of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis and Predictors Thereof in Real-Life Settings
- 9:00AM-11:00AM
-
Abstract Number: 3017
TYK2 and Systemic Sclerosis Susceptibility: a New Associated Locus in the IL-12 Pathway
- 9:00AM-11:00AM
-
Abstract Number: 2591
Ultrasound Residual Synovitis Has an Impact on the Time to Relapse in RA Patients Considered in Clinical Remission: A Real Life Study of 211 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2324
Understanding the Importance of a Patient’s Role in the Management of RA: Results from a Patient-Based Survey
- 9:00AM-11:00AM
-
Abstract Number: 2342
Uric Acid-Lowering Therapy Management Among Rural Veterans Affairs Primary Care Providers
- 9:00AM-11:00AM
-
Abstract Number: 2905
Urinary Protein:Urinary Creatinine Ratio in an Untimed Urine Specimen and Estimated Glomerular Filtration Rate Are Reliable Measures of Proteinuria and Renal Function in Patients with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2484
Use of Lean Six Sigma Methodology to Improve Time to Scheduling for New Patient Referrals to Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 2365
Use of Long Term Subscutaneous Immunoglobulins in Inflammatory Myopathies: A Retrospective Analysis of 19 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2415
Use of Plasma Exchange for Children Hospitalized with ANCA-Associated Vasculitis in the United States
- 9:00AM-11:00AM
-
Abstract Number: 2950
Using Electronic Health Record Algorithms to Accurately Identify Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2440
Using Patient-Relevant Variables to Describe the Disease Course in Children with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2904
Utility of Untimed Single Urine Protein/Creatinine Ratio As a Substitute for the 24 Hour Proteinuria for the Assessment of Proteinuria in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2455
Utilization and Education of Nurse Practitioners in Pediatric Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 2528
Utilization of Immune-Suppressive Medications during Pregnancy Among Women with Inflammatory Arthritis and Other Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2635
Validating Arthroscopic Findings Using Histology, Status for Erosive Disease, and CRP in RA
- 9:00AM-11:00AM
-
Abstract Number: 2734
Validation and Comparison Study of Immunoassays for the Measurement of Golimumab and Antibodies to Golimumab in Rheumatic Patients
- 9:00AM-11:00AM
-
Abstract Number: 2393
Validation of a Web-Based Overlay for Sectoral Scoring of Active Lesions on MRI in Hip Osteoarthritis: Femoral Bone Marrow Lesions Predict Response to Intra-Articular Hyaluronate
- 9:00AM-11:00AM
-
Abstract Number: 2662
Validation of the Quickdash in the Assessment of Rheumatoid Arthritis Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2388
Variations in Hip Morphology Are Associated with Hip Symptoms: Preliminary Results from a Large Community-Based Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2694
Variations in the Metabolome in Response to Disease Activity of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2429
Varicella Vaccination in Patients with Pediatric Rheumatic Diseases Receiving Immunosuppression: Proposal of a Pre-Vaccination Checklist to Ensure Safety
- 9:00AM-11:00AM
-
Abstract Number: 2799
Varicella Zoster Reactivation in Patients with Primary Sjögren’s Syndrome and SLE
- 9:00AM-11:00AM
-
Abstract Number: 3046
Venous Disease-Specific Quality-of-Life Is Impaired in Patients with Vascular Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2392
Vibration Perception Threshold and Hip Osteoarthritis in Multicenter Ostoearthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 2436
Views and Prescribing Habits of Pneumocystis Prophylaxis in the Pediatric Rheumatology Community
- 9:00AM-11:00AM
-
Abstract Number: 2648
Vitality, Presenteeism, and Their Determinants in Patients with Early Rheumatoid Arthritis Treated with a 6-Month Induction Infliximab Therapy Added on a Triple Combination Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2231
Vitamin D Deficiency States Can be Actively Prevented. Results from a Cross-Sectional Study of over 3000 Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2678
Vitamin D Serum Level in Early Arthritis Patients: Association with Disease Activity, Disability and Severity in the Espoir Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2958
Vitamin D, Cognition and Cerebral Structural Abnormalities in Childhood- Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2775
What Factors Are Associated with Starting an Intravenous Vs. Sub-Cutaneous Biologic in Patients with RA?
- 9:00AM-11:00AM
-
Abstract Number: 2879
What Is the Location of Dactylitis in Ankylosing Spondylitis and Psoriatic Arthritis Patients and How Do They Respond to Anti-TNF Treatment?
- 9:00AM-11:00AM
-
Abstract Number: 2877
What Is the Location of Enthesitis in Ankylosing Spondylitis and Psoriatic Arthritis Patients and How Do They Respond to Anti-TNF Treatment?
- 9:00AM-11:00AM
-
Abstract Number: 2783
What Is the Rate of Primary and Secondary Failure of Anti-TNF in RA Patients? Data from a Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2744
What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? an Analysis from a Real-World Registry
- 9:00AM-11:00AM
-
Abstract Number: 2603
What Is the Variability of HAQ over Time in Patients with Rheumatoid Arthritis Treated with Anti-TNF?
- 9:00AM-11:00AM
-
Abstract Number: 2477
What Older Adults with Restricting Back Pain Worry about: Deteriorating Function, Reliance on Others, Distrust of Medications
- 9:00AM-11:00AM
-
Abstract Number: 2293
What Types of Exercises Can Fibromyalgia Patients Perform?
- 9:00AM-11:00AM
-
Abstract Number: 2481
Work Disability in a Cohort of Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 3048
Work Disability over Time in Behcet’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2277
Working Harder to Stay in Control: Patient Reports of Flare in Early RA Are Associated with Higher Disease Activity and More Intensive Self Management
- 9:00AM-11:00AM
-
Abstract Number: 2969
X-Ray Diffraction of Spontaneously Draining Calcinosis in Patients with Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 2357
Xanthine Oxidase Inhibitors for the Prevention of Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 2504
Zoster Vaccination in Rheumatoid Arthritis Patients: An Unmet Care Gap
- 11:00AM-12:30PM
-
Abstract Number: 3078
ABCG2 rs2231142 predicts Poor Response to Allopurinol in Patients with Gout
- 11:00AM-12:30PM
-
Abstract Number: 3077
Anakinra in Patients with Cortico-Dependent Idiopathic Recurrent Pericarditis: A Randomised Double-Blind Placebo-Controlled Withdrawal Trial
- 11:00AM-12:30PM
-
Abstract Number: 3079
Efficacy and Safety of Riociguat in Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disease (CTD)
- 11:00AM-12:30PM
-
Abstract Number: 3076
Interferon Gamma (IFNg) Is the Driving Mediator of Secondary Hemophagocytic Lymphohistiocytosis (sHLH) in TLR9-Mediated Pathogenesis in Mice and Is Correlated to Disease Parameters in Children
- 11:00AM-12:30PM
-
Abstract Number: 3075
Salivary Gland FcRL4+ B-Cells Are a Potential Source of Progenitor Cells for MALT Lymphoma in Primary Sjögren’s Syndrome
- 11:00AM-12:30PM
-
Abstract Number: 3074
The Shared Rheumatoid Arthritis HLA-DRB1 Susceptibility Epitope Shapes the Molecular Orientation of Citrulline and the Autoreactive T Cell Receptor Repertoire
- 2:30PM-4:00PM
-
Abstract Number: 3122
A Longitudinal Analysis of Change in Lupus Nephritis in an International Inception Cohort Using a Multistate Markov Model Approach
- 2:30PM-4:00PM
-
Abstract Number: 3140
A Meta-Immunochip Analysis Suggests IL12B As a Common Susceptibility Factor for Large-Vessel Vasculitides
- 2:30PM-4:00PM
-
Abstract Number: 3091
A Randomized, Controlled Trial of Pregabalin in Adolescent Patients (12-17 years) with Fibromyalgia
- 2:30PM-4:00PM
-
Abstract Number: 3104
Abnormal DNA Methylation in a Novel PTPN11 Enhancer Increases Destructive Potential of Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS) and Joint Inflammation
- 2:30PM-4:00PM
-
Abstract Number: 3100
Anti-RA33 Citrullinated/Native Double-Reactive Antibodies Identify Patients with the Highest Risk of Radiographic Progression in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3083
Antibody Array Based Proteomic Screening of 274 Serum Markers in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 3124
Associations of Circulating Cell-Free Micro-RNA with Vasculopathy and Vascular Events in SLE Patients
- 2:30PM-4:00PM
-
Abstract Number: 3115
Autoantibodies of the IgA Type a Link Between the Gut and the Anti-TNF Therapy Response in Rheumatoid Arthritis Patients Analysed in Two Clinical Trials
- 2:30PM-4:00PM
-
Abstract Number: 3126
Biomarkers Associated with Hyperintense White Matter Lesions in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 3103
Carbamylated Human Albumin Is One of the Target Antigens of Anti-Carbamylated Protein Antibodies
- 2:30PM-4:00PM
-
Abstract Number: 3087
Cell Bound Complement Activation Products in Multianalyte Assay with Algorithm Have Utility in Distinguishing Primary Fibromyalgia from Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 3118
Clinical Characteristics and Disease Outcomes in Psoriatic Arthritis Patients By Extent of Body Surface Area Affected By Psoriasis: Results from Corrona Registry
- 2:30PM-4:00PM
-
Abstract Number: 3092
Deficiency of Adenosine Deaminase Type II – Expanding the Clinical Spectrum
- 2:30PM-4:00PM
-
Abstract Number: 3093
Development and Validation of Diagnostic Criteria for Cryopyrin Associated Periodic Syndromes
- 2:30PM-4:00PM
-
Abstract Number: 3099
Differential Effects of IL-6 Blockade Tocilizumab and TNF Inhibitors on the Reduced Angiogenesis and Lining Layer Degeneration in Synovial Tissues from Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3094
Dose Adjustment of Anakinra (Kineret®) Based on Clinical Response in Patients with Severe Cryopyrin-Associated Periodic Syndromes
- 2:30PM-4:00PM
-
Abstract Number: 3145
Efficacy and Safety of Modified-Release Prednisone in Patients with Polymyalgia Rheumatica: Results of a Multicenter, Randomized, Active-Controlled Phase 3 Study
- 2:30PM-4:00PM
-
Abstract Number: 3144
Efficacy and Safety of Tocilizumab for Polymyalgia Rheumatica
- 2:30PM-4:00PM
-
Abstract Number: 3141
Endothelial Cells Regulate Proinflammatory T Cell Responses in Large Vessel Vasculitis Via NOTCH-NOTCH Ligand Interactions
- 2:30PM-4:00PM
-
Abstract Number: 3130
Epstein-Barr Virus Induces Activation of Infammatory Markers Via the TLR8 Transduction Pathway in Infected Scleroderma Monocytes
- 2:30PM-4:00PM
-
Abstract Number: 3089
Evaluation of Learned Helplessness, Perceived Self-Efficacy and Functional Capacity in Patients with Fibromyalgia and Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3123
Evidence of Altered Blood Brain Barrier Permeability in Systemic Lupus Erythematosus Using Magnetic Resonance Imaging
- 2:30PM-4:00PM
-
Abstract Number: 3090
Fibromyalgia Predicts Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients
- 2:30PM-4:00PM
-
Abstract Number: 3121
Gender Differences in Patient Reported Outcomes (PROs) in Psoriatic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3088
Genome Wide Expression Analyses Reveal Potentially Novel Drug Targets in Fibromyalgia
- 2:30PM-4:00PM
-
Abstract Number: 3128
Genome-Wide DNA Methylation Analysis in Blood and Dermal Fibroblasts from Twin Pairs Discordant for Systemic Sclerosis
- 2:30PM-4:00PM
-
Abstract Number: 3146
Health Related Quality of Life in Adults with JIA – a 30 Year Longitudinal Study
- 2:30PM-4:00PM
-
Abstract Number: 3116
High Level of Inflammation Predicts the Development of Diabetes Mellitus in Patients with Psoriatic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3132
Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis Via Repressing Pro-Angiogenic Factors
- 2:30PM-4:00PM
-
Abstract Number: 3080
Histone H2AX Phosphorylation As a Measure of DNA Double Strand Breaks and a Marker of Environmental Stress and Disease Activity in Lupus
- 2:30PM-4:00PM
-
Abstract Number: 3114
Immunogenicity of Subcutaneous and Intravenous Tocilizumab As Monotherapy or in Combination with Dmards
- 2:30PM-4:00PM
-
Abstract Number: 3136
Impact of Prokinetic Agents on Systemic Sclerosis-Associated Gastrointestinal Disease: A Systematic Review
- 2:30PM-4:00PM
-
Abstract Number: 3110
In the Multicenter Randomized Controlled Rotation or Change Trial, a Non-TNF Targeted Therapy Has a Higher Efficacy Than a Second Anti-TNF at 3, 6 and 12 Months
- 2:30PM-4:00PM
-
Abstract Number: 3112
Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
- 2:30PM-4:00PM
-
Abstract Number: 3135
Incidences and Predictors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal Study
- 2:30PM-4:00PM
-
Abstract Number: 3102
Increasing Circulating Adiponectin after DMARD Initiation Is Associated with Radiographic Progression in Early Aggressive RA, Regardless of Treatment Strategy
- 2:30PM-4:00PM
-
Abstract Number: 3095
Initial Results of a Pilot Juvenile Localized Scleroderma (jLS) Comparative Effectiveness Study
- 2:30PM-4:00PM
-
Abstract Number: 3097
Innovative Approach for the Identification of an Appropriate Dose Regimen of a Targeted Treatment, NI-0501, an Anti-Interferon Gamma (IFNg) Antibody, in Patients with Hemophagocytic Lymphohistiocytosis (HLH)
- 2:30PM-4:00PM
-
Abstract Number: 3129
Integrative Analysis of the Colonic Microbiota in Systemic Sclerosis
- 2:30PM-4:00PM
-
Abstract Number: 3147
Inter-Provider Reliability in Scoring the Physician Global Assessment of Disease Activity Among Patients with Juvenile Idiopathic Arthritis Patients Who Met the ACR Provisional Criteria for Clinical Inactive Disease
- 2:30PM-4:00PM
-
Abstract Number: 3113
Interest of Assessing Anti-Drug Antibodies for the Choice Between a Second Anti-TNF and a Non-TNF-Targeted Biologic in Patients with Inadequate Response to a First Anti-TNF : Results from the Randomized Controlled Trial « Rotation or Change »
- 2:30PM-4:00PM
-
Abstract Number: 3131
Interferon Regulatory Factor 7 (IRF7): The Possible Link Between Inflammation and Fibrosis in SSc Pathogenesis
- 2:30PM-4:00PM
-
Abstract Number: 3096
Interferon-Gamma (IFNg) in Macrophage Activation Syndrome (MAS): CXCL9 Levels As a Biomarker for IFNg Production in MAS
- 2:30PM-4:00PM
-
Abstract Number: 3107
Investigating the Ameliorating Effect of Pregnancy on Rheumatoid Arthritis Using Whole Transcriptome Analysis
- 2:30PM-4:00PM
-
Abstract Number: 3081
IRF5 Deletion Prevents the SLE-like Disease Initiated By Dendritic Cell-Specific Loss of Caspase 8
- 2:30PM-4:00PM
-
Abstract Number: 3111
Long-term Safety and Efficacy of Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-α (GM–CSFR-α) Monoclonal Antibody, in Patients with Rheumatoid Arthritis (RA)
- 2:30PM-4:00PM
-
Abstract Number: 3143
Mapping the Back-Door Routes into the Vascular Wall: 3D Microscopic Reconstruction of Microvasculature in the Normal Temporal Artery and in Giant Cell Arteritis
- 2:30PM-4:00PM
-
Abstract Number: 3082
Nanogel Based Delivery of an Inhibitor of Calcium/ Calmodulin- Dependent Protein Kinase 4 Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice
- 2:30PM-4:00PM
-
Abstract Number: 3148
Physical Activity in Children and Adolescents with Juvenile Idiopathic Arthritis and Associated Factors
- 2:30PM-4:00PM
-
Abstract Number: 3085
Platelet Activation and Endothelial Reactivity in the Pathogenesis of Tissue Inflammation/Injury in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 3149
Predictors of Longitudinal Quality of Life Impact in Pediatric Localized Scleroderma
- 2:30PM-4:00PM
-
Abstract Number: 3138
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis
- 2:30PM-4:00PM
-
Abstract Number: 3084
Progression of Lupus Pathology Is Correlative with Cardiac Magnetic Resonance Imaging Abnormalities, Diminished Function, and Inflammatory Histopathology in an Animal Model
- 2:30PM-4:00PM
-
Abstract Number: 3101
Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Sclerostin Are Related to Joint Destruction in Early Rheumatoid Arthritis Unrelated to Polymorphisms of the Genes
- 2:30PM-4:00PM
-
Abstract Number: 3106
Regulation of ASK1 Expression By microRNA-17 and Their Correlation with Rheumatoid Arthritis Pathogenesis
- 2:30PM-4:00PM
-
Abstract Number: 3134
Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease
- 2:30PM-4:00PM
-
Abstract Number: 3137
Scleroderma Hand Contracture Study
- 2:30PM-4:00PM
-
Abstract Number: 3139
Screening Algorithm for Pulmonary Hypertension in Systemic Sclerosis – Comparison of Predictive Accuracy of Three Algorithms
- 2:30PM-4:00PM
-
Abstract Number: 3127
Serologic Diagnosis of Human Neuropsychiatric Lupus Using the Immunarray ICHIP®
- 2:30PM-4:00PM
-
Abstract Number: 3108
Serum 14-3-3eta Are Elevated in Indigenous North Americans with Rheumatoid Arthritis and May Predict Imminent Synovitis in Their at-Risk First Degree Relatives
- 2:30PM-4:00PM
-
Abstract Number: 3109
Single Cell Gene Expression in Classical Monocytes Correlates with Treatment Response Groups to TNF-Alpha Inhibition in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3098
Synovial Lymphocytic Aggregates Associate with Highly Active RA and Predict Erosive Disease at 12 Months: Results from the Pathobiology of Early Arthritis Cohort
- 2:30PM-4:00PM
-
Abstract Number: 3133
The Anti-Fibrotic Effect of Endostatin-Derived Peptide Is Mediated By the Urokinase Pathway Via Binding to Enolase-1 and Urokinase Plasminogen Activator Receptor
- 2:30PM-4:00PM
-
Abstract Number: 3120
The Prevalence, Incidence and Management of Hypertension, Diabetes and Hyperlipidemia in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3105
The RA Immune System Recreated in Immunodeficient Mice By Thymic Differentiation from RA Patients’ Hematopoietic Stem Cells Exhibits Marked CD4 T Cell Activation and Differentiation
- 2:30PM-4:00PM
-
Abstract Number: 3119
The Risk of Venous Thromboembolism in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3086
The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia
- 2:30PM-4:00PM
-
Abstract Number: 3142
Tocilizumab Enhances Regulatory T-Cell Activation and Proliferation in Giant Cell Arteritis
- 2:30PM-4:00PM
-
Abstract Number: 3117
Under-Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease – an International Multicentre Study
- 2:30PM-4:00PM
-
Abstract Number: 3151
Validation of Patient-Reported Outcomes Measurement Information System (PROMIS®) Modules for Use in Childhood-Onset Lupus
- 2:30PM-4:00PM
-
Abstract Number: 3150
Virtual Peer-to-Peer Mentoring Support for Adolescents with Juvenile Idiopathic Arthritis: The Virtual Peer-to-Peer Program
- 2:30PM-4:00PM
-
Abstract Number: 3125
White Matter Magnetization Transfer Ratio Histogram Peak Height Helps Identifying Inflammatory Neuropsychiatric Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3185
A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach in the Clinical Care of Rheumatoid Arthritis Patients in the United States
- 4:30PM-6:00PM
-
Abstract Number: 3233
A Comparison of Interobserver Agreement Between Advanced Practice Physiotherapists and Rheumatologists in the Detection of Axial Spondyloarthritis
- 4:30PM-6:00PM
-
Abstract Number: 3L
A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis
- 4:30PM-6:00PM
-
Abstract Number: 3218
A Randomized, Double-Blind, Placebo-Controlled, 52-Week Study of the Efficacy and Safety of Belimumab Administered Subcutaneously Plus Standard Care to Patients with Systemic Lupus Erythematosus (SLE)
- 4:30PM-6:00PM
-
Abstract Number: 3231
A Systematic Review of the Persuasive Design Principles Used in Health Apps for Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3220
Anifrolumab Differentially Suppresses Peripheral Biomarkers of Systemic Lupus Erythematosus Compared with Placebo in a Phase IIb Trial
- 4:30PM-6:00PM
-
Abstract Number: 3223
Anifrolumab, an Anti-Interferon Alpha Receptor Monoclonal Antibody, in Moderate to Severe Systemic Lupus Erythematosus (SLE)
- 4:30PM-6:00PM
-
Abstract Number: 3167
Association of the Apolipoprotein A1-C3-A4 Gene Cluster with the Risk of Gout: Evidence for a Causal Role in Gout
- 4:30PM-6:00PM
-
Abstract Number: 3207
Axial Disease in Psoriatic Arthritis: A Clinical and Radiographic Comparison with Ankylosing Spondylitis
- 4:30PM-6:00PM
-
Abstract Number: 3157
B Cell Profile As a Biomarker of Disease Segmentation and Flare Prognosis in SLE
- 4:30PM-6:00PM
-
Abstract Number: 2L
Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study
- 4:30PM-6:00PM
-
Abstract Number: 3215
Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses
- 4:30PM-6:00PM
-
Abstract Number: 3155
Bob1 Expression Is Elevated in Rheumatoid Synovium and Its Expression in B Cells Is Required for Development of Collagen-Induced Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3164
Calcium Pyrophosphate Deposition Disease and Associated Medical Co-Morbidities in the Veteran Population
- 4:30PM-6:00PM
-
Abstract Number: 3200
Characterization of Early and Progressive Autoimmunity in Sjogrens Syndrome: The Incomplete Sjogrens Syndrome Model
- 4:30PM-6:00PM
-
Abstract Number: 3212
Characterizing the Effects of the G-CSF-R Coding rs13377964 SNP Located within Murine Lupus Susceptibility Locus Sle2c2
- 4:30PM-6:00PM
-
Abstract Number: 3195
Circulating Micro-RNA Profiles in Responders to Adalimumab Plus Methotrexate Versus Methotrexate Alone: A Placebo-Controlled Clinical Trial
- 4:30PM-6:00PM
-
Abstract Number: 3197
Clinical Practice Experience in Rheumatoid Arthritis Patients Treated with Triple Therapy and Methotrexate-Tumor Necrosis Factor Inhibition Differs from That of Randomized Controlled Trials
- 4:30PM-6:00PM
-
Abstract Number: 3171
Combination Therapy with Denosumab and Biologic DMARD Associated with Higher Risk of Serious Infections Compared to Denosumab Alone and Biologic DMARD Alone
- 4:30PM-6:00PM
-
Abstract Number: 3160
Comparative Rates of Serious Infections and All-Cause Mortality Among Systemic Lupus Erythematosus Patients Receiving Mycophenolate Mofetil Versus Azathioprine
- 4:30PM-6:00PM
-
Abstract Number: 3211
Current Smoking, Its Intensity and Duration, Is Associated with Fat Metaplasia on MRI in Patients with Spondyloarthritis
- 4:30PM-6:00PM
-
Abstract Number: 3179
Diagnosing Childhood Small Vessel CNS Vasculitis
- 4:30PM-6:00PM
-
Abstract Number: 3169
Diagnostic Value of Ultrasound for the Diagnosis of Gout in a Prospective Cross-Sectional Study
- 4:30PM-6:00PM
-
Abstract Number: 3165
Do Omega-3 Fatty Acids Reduce Risk of Recurrent Gout Attacks?
- 4:30PM-6:00PM
-
Abstract Number: 3172
Effect of Anti Citrullinated Protein Antibodies on Periarticular and Systemic Bone Mass in Early Arthritis Patients
- 4:30PM-6:00PM
-
Abstract Number: 6L
Effect of Interleukin-17A Inhibition on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of a Phase 3 Study with Secukinumab
- 4:30PM-6:00PM
-
Abstract Number: 3219
Efficacy and Safety of 4 Weeks Administration of Arsenic Trioxide in Moderate Active Systemic Lupus Erythematosus. a Phase I/II Proof-of-Concept Sequential Dose Escalation Multicenter Study
- 4:30PM-6:00PM
-
Abstract Number: 4L
Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials
- 4:30PM-6:00PM
-
Abstract Number: 3189
Enhancement of Mitochondrial Biogenesis Inhibits Cell Proliferation and MMP-3/RANKL Secretion in Rheumatoid Arthritis Fibroblast-like Synovial Cells and Joint Destruction in Arthritis Model Mice
- 4:30PM-6:00PM
-
Abstract Number: 3166
Epistatic Interaction of Functional Inflammasome Genetic Variants in Determining the Risk of Gout
- 4:30PM-6:00PM
-
Abstract Number: 3210
Evaluation of Sacroiliac Joint Radiographs in Patients with Chronic Low Back Pain: Is Erosion the Main Driver of Interreader Disagreement?
- 4:30PM-6:00PM
-
Abstract Number: 3235
Factors Associated with Nonadherence to Recently Initiated Disease-Modifying Antirheumatic Drugs
- 4:30PM-6:00PM
-
Abstract Number: 3186
Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes
- 4:30PM-6:00PM
-
Abstract Number: 3202
Functional Anti-Muscarinic Receptor-3 Monoclonal Antibodies Derived from Salivary Gland in Patients of Sjögren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 3182
High Body Mass Index Negatively Impacts Time to Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from a Multicenter Early Arthritis Cohort Study
- 4:30PM-6:00PM
-
Abstract Number: 3181
How Common Is Inactive Disease in a Prospective Cohort of Patients with Juvenile Idiopathic Arthritis? the Importance of Definition
- 4:30PM-6:00PM
-
Abstract Number: 3168
How Strong Cardiovascular Risk Factor Are Gouty Tophi?
- 4:30PM-6:00PM
-
Abstract Number: 3204
Hypoechoic Lesions on Parotid Gland Ultrasound Are a Surrogate Marker of Focal Lymphocytic Sialadenitis on Minor Salivary Gland Biopsy in Sjögren’s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 3227
Identification of Novel Protein-Coding Genetic Variants Associated with Takayasu Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 3201
IL-7 Drives Cytokine Secretion of IL-7Rabright CCR9-Expressing T-Follicular Helper-like Cells: Potential New Axis in Lymphoid Neogenesis in Salivary Glands of Primary Sjogren s Syndrome Patients
- 4:30PM-6:00PM
-
Abstract Number: 3156
IL17 Promotes Development of Autoreactive Early Stage B Cells in Distinct Regions of the Spleen Follicle
- 4:30PM-6:00PM
-
Abstract Number: 3193
Immunomodulatory and Antiviral Therapies in a Mouse Model of Chikungunya Viral Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3158
Impact of Family History of Systemic Lupus Erythematosus on Risk of Autoimmune Diseases: National Cohort Study in Denmark 1977-2012
- 4:30PM-6:00PM
-
Abstract Number: 3214
Impaired Phagocytosis of Apoptotic Cells in Pristane-Induced Lupus Simulates the Clearance Defect in Human SLE
- 4:30PM-6:00PM
-
Abstract Number: 3199
In Rheumatoid Arthritis (RA) Patients, Retreatment with Rituximab (RTX) at Half Dose Does Not Alter Maintenance on Drug and Allows One Third Reduction of Cumulative Dose of Drug/Year: Data from the Autoimmunity and Rituximab (AIR) Registry
- 4:30PM-6:00PM
-
Abstract Number: 3226
Increased Serum Levels of IgG Antibodies Against to Alpha-Enolase Are Associated with Severity of Oral Ulcers in Patients with Behcet’s Disease
- 4:30PM-6:00PM
-
Abstract Number: 3206
Inflammation on MRI in Sacroiliac-Joints and Spine Is Longitudinally Related to Disease Activity in Male but Not in Female Patients with Axial Spondyloarthritis: 2-Year Data from the DESIR Cohort
- 4:30PM-6:00PM
-
Abstract Number: 3188
Inhibition of Lymphatic Muscle Contraction By Lymphatic Endothelial iNOS Impairs Lymph Drainage from Arthritic Joints in TNF-Tg Mice and Is Prevented By Herbal Drugs
- 4:30PM-6:00PM
-
Abstract Number: 3184
Is Treat-to-Target Really Working? a Longitudinal Analysis in Biodam
- 4:30PM-6:00PM
-
Abstract Number: 3192
KCa3.1 Ion Channel in the Pathogenesis of Rheumatoid Arthritis: KCa3.1-/- Mice Do Not Develop CIA
- 4:30PM-6:00PM
-
Abstract Number: 3217
Macrophage Depletion Using a Specific CSF-1R Kinase Inhibitor Ameliorates Kidney and Skin Disease in a Mouse Model of Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3180
Mesenchymal Stromal Cell Treatment in Juvenile Idiopathic Arthritis: A Pilot Study
- 4:30PM-6:00PM
-
Abstract Number: 3153
Microrna-155/PU.1 Axis As an Epigenetic Regulator of B-Cells in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3190
Netrin-1 and Its Receptor Unc5b Are Novel Targets for the Treatment of Inflammatory Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3176
New Prospects for Interpreting Bony Depressions in Juvenile Idiopathic Arthritis: A Novel MRI Computer-Assisted Technique for Detection of Erosive Progression
- 4:30PM-6:00PM
-
Abstract Number: 3194
Oral to Subcutaneous Methotrexate Dose-Conversion Strategies in the Treatment of Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3230
Perceived Barriers in Care for Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3170
Peripheral Osteoblastogenesis in Rheumatoid Arthritis Is Enhanced after TNF Blocker Treatment, Irrespective of Systemic Inflammation
- 4:30PM-6:00PM
-
Abstract Number: 3196
Predictive Biomarkers for Response or Non-Response to MTX Monotherapy in Early RA
- 4:30PM-6:00PM
-
Abstract Number: 3187
Predictors of Disease Relapse and Recapture of Remission Following Relapse in an Ontario Rheumatoid Arthritis Population
- 4:30PM-6:00PM
-
Abstract Number: 3173
Premature Mortality Due to Fractures in a Population-Based Prospective Cohort Study of 238,673 Older Women and Men
- 4:30PM-6:00PM
-
Abstract Number: 3162
Prevalence of Chronic Comorbidities in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Systemic Lupus Erythematosus: An Analysis of UK Biobank Data
- 4:30PM-6:00PM
-
Abstract Number: 3161
Rates of Hospitalization for Infection and Related Mortality By Race/Ethnicity and Sex Among Patients with End-Stage Renal Disease Due to Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3222
Repeated Administration of Dapirolizumab Pegol (DZP) Appears Safe and Well Tolerated in Patients with Systemic Lupus Erythematosus (SLE) and Is Accompanied By an Improvement in Disease Activity: Results from a Phase 1 Study
- 4:30PM-6:00PM
-
Abstract Number: 3234
Roadblocks Perceived By Canadian Dermatologists for Referring Patients with Suspected Psoriatic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3221
Safety and Efficiency of Low-Dose Interleukin-2 Treatment in Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3224
Salivary IL-1 Alpha and IL-1 Beta Levels Are Associated with Oral Mucosal Activity in Behcet’s Disease
- 4:30PM-6:00PM
-
Abstract Number: 3191
Siglec9 Suppresses Arthritis in Collagen-Induced Mice Model and Inhibits M1 Activation of RAW264.7 Macrophages
- 4:30PM-6:00PM
-
Abstract Number: 3228
Sofosbuvir Plus Ribavirin for Hepatitis C Virus Associated Cryoglobulinemia Vasculitis: Vascuvaldic Study
- 4:30PM-6:00PM
-
Abstract Number: 3208
Spinal Radiographic Progression in Early Axial Spondyloarthritis: Data from the DESIR Cohort
- 4:30PM-6:00PM
-
Abstract Number: 3175
Strength at the Lumbar Spine and Hip Improves with Romosozumab Compared with Teriparatide in Postmenopausal Women with Low Bone Mass
- 4:30PM-6:00PM
-
Abstract Number: 3159
Systemic Lupus Erythematosus Is a Risk Factor for Young Stroke: A Population-Based Cohort Study
- 4:30PM-6:00PM
-
Abstract Number: 3216
T Cell Restricted Deletion of Serine/Arginine-Rich Splicing Factor 1 (SRSF1) in Mice Causes Immune Cell Dysfunction and Contributes to Lupus-like Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 3183
The Clinical and Economic Costs of Not Achieving Remission in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3203
The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, in Primary Sjögren’s Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial
- 4:30PM-6:00PM
-
Abstract Number: 3232
The Comparative Efficacy of Kinesio Taping and Local Steroid Injection in Patients with Subacromial Impingement Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 3152
The IL-21 Signaling Pathway Is Enhanced in RA B Cells and Has the Potential to Alter Development and Cytokine Production in RA B Cells
- 4:30PM-6:00PM
-
Abstract Number: 3154
The Importance of Somatic Hypermutation for the Immunoreactivity Towards Neutrophil Extracellular Traps (NETs)-Citrullinated Autoantigens of RA Synovial Monoclonal Antibodies
- 4:30PM-6:00PM
-
Abstract Number: 3163
The Smoking Paradox in the Development of Psoriatic Arthritis Among Psoriasis Patients
- 4:30PM-6:00PM
-
Abstract Number: 1L
Tocilizumab for the Treatment of Giant Cell Arteritis – a Randomized Placebo-Controlled Trial
- 4:30PM-6:00PM
-
Abstract Number: 3178
Tocilizumab in Refractory Uveitis Associated to Juvenile Idiopathic Arthritis. Multicenter Study of 13 Cases
- 4:30PM-6:00PM
-
Abstract Number: 5L
Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study
- 4:30PM-6:00PM
-
Abstract Number: 3198
Treatment of Rheumatoid Arthritis with an Anti-Tumor Necrosis Factor Agent or Tocilizumab As First Biologic Therapy in a Global Comparative Observational Study
- 4:30PM-6:00PM
-
Abstract Number: 3205
Treatment with Abatacept or Rituximab Targets T Follicular Helper Cells in Patients with Primary Sjogren s Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 3229
Using Exome Sequencing to Identify Novel Genetic Associations with Granulomatosis with Polyangiitis Susceptibility
- 4:30PM-6:00PM
-
Abstract Number: 3209
Utility of Power Doppler Ultrasound-Detected Synovitis for the Prediction of Short Term Flare in Psoriatic Arthritis Patients in Clinical Remission
- 4:30PM-6:00PM
-
Abstract Number: 3174
Vitamin D Binding Protein and Tenofovir-Associated Bone Loss Among Individuals with HIV
- 4:30PM-6:00PM
-
Abstract Number: 3225
Whole Exome Sequencing Identifies Rare Protein-Coding Variants in Behcet’s Disease
- 4:30PM-6:00PM
-
Abstract Number: 3177
Whole-Body MRI: A Valuable Diagnostic Tool for the Assessment of Disease Damage in Juvenile Dermatomyositis
- 9:00AM-10:30AM
-
Abstract Number: 3242
A Comprehensive Method for Using Sensewear MiniTM Monitors to Explore Differences in Ambulatory Activities in People Living with and without Early Rheumatoid Arthritis: Moving Beyond Measuring Total Steps
- 9:00AM-10:30AM
-
Abstract Number: 3243
A Randomized Controlled Trial for a Physical Activity Intervention for RA Fatigue
- 9:00AM-10:30AM
-
Abstract Number: 3236
Circulating Cytokine/Chemokine Concentrations Predict Cancer Mortality in Men with Rheumatoid Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3237
Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?
- 9:00AM-10:30AM
-
Abstract Number: 3241
Do Boosters Support Long-Term Physical Activity Maintenance after an Intervention? a Systematic Review
- 9:00AM-10:30AM
-
Abstract Number: 3246
Does Loss of a Community Walking Speed Lead to More Symptoms of Depression in Knee OA? a Trajectory Analysis from the Osteoarthritis Initiative
- 9:00AM-10:30AM
-
Abstract Number: 3244
Evaluation of a Self-Directed Walking Program in Hispanics with Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3245
Factors Associated with Physical Activity in Older Children with Juvenile Idiopathic Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3240
Improved Survival in Rheumatoid Arthritis: A General Population-Based Study
- 9:00AM-10:30AM
-
Abstract Number: 3239
Response to Methotrexate Predicts Mortality in Rheumatoid Arthritis up to 30 Years
- 9:00AM-10:30AM
-
Abstract Number: 3238
The Impact of Biologic DMARD Treatment on Sepsis and Mortality after Serious Infection
- 11:00AM-12:30PM
-
Abstract Number: 3254
A Clinical Risk Score to Predict Functional Disability at 1 Year in an Early Rheumatoid Arthritis Inception Cohort
- 11:00AM-12:30PM
-
Abstract Number: 3255
Brain White Matter Integrity: A Future Biomarker for Rheumatoid Arthritis Related Fatigue?
- 11:00AM-12:30PM
-
Abstract Number: 3270
Correction of Limb Length Inequality in Adults with Knee or Hip Symptoms: A Pilot Study
- 11:00AM-12:30PM
-
Abstract Number: 3247
Dietary Intake of Omega-3 Fatty Acids and Vitamin C and D Associate with Decreased Pain, Independent of Inflammation, in MTX Treated Early RA Patients
- 11:00AM-12:30PM
-
Abstract Number: 3258
Different Perception of Disease Activity in Multimorbid Rheumatoid Arthritis Patients
- 11:00AM-12:30PM
-
Abstract Number: 3256
Epigenetic Chromosome Conformations Predict MTX Responsiveness in Early Rheumatoid Arthritis Patients
- 11:00AM-12:30PM
-
Abstract Number: 3261
Examining the Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients with Breast Cancer
- 11:00AM-12:30PM
-
Abstract Number: 3268
Foot and Ankle Characteristics Associated with Falls in People with Rheumatoid Arthritis: A Prospective Longitudinal Study
- 11:00AM-12:30PM
-
Abstract Number: 3267
Functional Disability in Adolescents Is Predicted By Self-Report of Sleep Problems, Depressive Symptoms, Low Physical Activity and Worst Pain Intensity Levels
- 11:00AM-12:30PM
-
Abstract Number: 3259
Immunoablation Followed By Autologous Stem Cell Transplantation in Systemic Sclerosis Patients Decreases Significantly the Interferon Signatrue
- 11:00AM-12:30PM
-
Abstract Number: 3252
Impact of Knee Pain Frequency on Physical Function in the Osteoarthritis Initiative
- 11:00AM-12:30PM
-
Abstract Number: 3260
Increased Frequency of Malignancies Synchronous to the Onset of Systemic Sclerosis in Anti-RNA Polymerase III Antibodies Positive Patients: A Eustar Multicentre Study
- 11:00AM-12:30PM
-
Abstract Number: 3266
Keeping Baby Boomers in the Labour Force Longer: What Does It Mean for Workers with Arthritis?
- 11:00AM-12:30PM
-
Abstract Number: 3264
Multiplex Serum Protein Analysis in Systemic Sclerosis Defines Potential Anti-Fibrotic Mechanisms and Markers of Response to Hyperimmune Caprine Serum
- 11:00AM-12:30PM
-
Abstract Number: 3249
Pooled Efficacy and Safety from Phase 3 Controlled Studies of Tanezumab in Patients with Osteoarthritis
- 11:00AM-12:30PM
-
Abstract Number: 3265
Sustaining Employment with Arthritis: Can Existing Workplace Policies and Accommodations Make a Difference?
- 11:00AM-12:30PM
-
Abstract Number: 3250
Systemic Inflammation and Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
- 11:00AM-12:30PM
-
Abstract Number: 3262
The Influence of Immunosuppressive Therapy on Microangiopathy in Systemic Sclerosis As Measured with Nailfoldcapillaroscopy
- 11:00AM-12:30PM
-
Abstract Number: 3257
The Link Between DAS28 and the Short-Term Risk of Acute Coronary Syndrome in RA, and Its Driving Factors
- 11:00AM-12:30PM
-
Abstract Number: 3253
The Predictive Value of Antibodies to Cyclic Citrullinated Peptide in Two Prospective Early Rheumatoid Arthritis Cohorts 10 Years Apart
- 11:00AM-12:30PM
-
Abstract Number: 3263
The Promis-29 in Systemic Sclerosis: Associations with Clinical Characteristics in the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort
- 11:00AM-12:30PM
-
Abstract Number: 3251
The Relation of Massive Weight Loss to Changes in Knee Pain and Sensitization
- 11:00AM-12:30PM
-
Abstract Number: 3269
Trends in Prevalence of Knee Pain Among US Adults, National Health Interview Survey, 2002-2010
- 11:00AM-12:30PM
-
Abstract Number: 3248
Which Factors Explain Multi-Site Pain Caused By Obesity: A 5-Year Follow-up Study in Older Adults?